P-value | ln(P) | Term | GO Tree | GO ID | # of Genes in Term | # of Target Genes in Term | # of Total Genes | # of Target Genes | Common Genes |
1.477e-14 | -31.85 | Burkitt_lymphoma | COSMIC cancer mutations | Burkitt_lymphoma | 2119 | 29 | 16828 | 49 |
SLC8A1,DOCK4,ZFAND3,SLC9A9,SSH2,ZSWIM6,TBC1D22A,FRMD4A,ITPR2,ARHGAP26,ELMO1,DIP2B,KCNQ3,MED13L,MAML2,SYNDIG1,MAP4K4,ST6GAL1,ST6GALNAC3,ABCC4,PLXDC2,ANKRD44,PTPRJ,ATP8B4,ZFHX3,DSCAM,GNAQ,SORL1,CHST11 |
1.477e-14 | -31.85 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-Burkitt_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-Burkitt_lymphoma | 2119 | 29 | 16828 | 49 |
CHST11,SORL1,GNAQ,ATP8B4,DSCAM,ZFHX3,ST6GALNAC3,ABCC4,PLXDC2,PTPRJ,ANKRD44,SYNDIG1,ST6GAL1,MAP4K4,MED13L,MAML2,KCNQ3,DIP2B,FRMD4A,ITPR2,ELMO1,ARHGAP26,SSH2,ZSWIM6,TBC1D22A,ZFAND3,SLC9A9,SLC8A1,DOCK4 |
1.218e-11 | -25.13 | central_nervous_system-brainstem-glioma-astrocytoma_Grade_IV | COSMIC cancer mutations | central_nervous_system-brainstem-glioma-astrocytoma_Grade_IV | 2531 | 28 | 16828 | 49 |
ELMO1,ARHGAP26,ITPR2,FRMD4A,TBC1D22A,ZBTB20,SLC9A9,ZFAND3,EPB41L2,SFMBT2,SLC8A1,MAML2,TCF12,KCNQ3,QKI,DIP2B,ZFHX3,DSCAM,ATP8B4,PTPRJ,ANKRD44,PLXDC2,ABCC4,ST6GALNAC3,MAP4K4,SYNDIG1,SORL1,GNAQ |
2.876e-11 | -24.27 | blood_vessel | COSMIC cancer mutations | blood_vessel | 2211 | 26 | 16828 | 49 |
PTPRJ,PLXDC2,ZFHX3,DSCAM,ATP8B4,SYNDIG1,ARHGAP24,PICALM,CHST11,GNAQ,SORL1,ADAM28,UBE2E2,TBC1D22A,ZSWIM6,ARHGAP26,ELMO1,ITPR2,FRMD4A,SFMBT2,SLC9A9,MAML2,MED13L,TCF12,DIP2B,KCNQ3 |
3.132e-11 | -24.19 | mantle_cell_lymphoma | COSMIC cancer mutations | mantle_cell_lymphoma | 2849 | 29 | 16828 | 49 |
NAV3,GNAQ,UBE2E2,APBB1IP,SORL1,PLXDC2,ANKRD44,ST6GALNAC3,ATP8B4,DSCAM,ZFHX3,MAP4K4,ARHGAP24,MAML2,MAML3,DIP2B,KCNQ3,ZSWIM6,TBC1D22A,SSH2,ARHGAP26,ELMO1,MEF2A,FRMD4A,ITPR2,SLC8A1,SFMBT2,ZFAND3,SLC9A9 |
3.886e-11 | -23.97 | brainstem | COSMIC cancer mutations | brainstem | 3102 | 30 | 16828 | 49 |
SYNDIG1,MAP4K4,ST6GALNAC3,ABCC4,PLXDC2,PTPRJ,ANKRD44,ATP8B4,DSCAM,ZFHX3,GNAQ,UBE2E2,SORL1,SLC8A1,SFMBT2,EPB41L2,ZFAND3,SLC9A9,ZBTB20,TBC1D22A,FRMD4A,ITPR2,ARHGAP26,ELMO1,DIP2B,MAML3,QKI,KCNQ3,TCF12,MAML2 |
8.233e-11 | -23.22 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-mantle_cell_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-mantle_cell_lymphoma | 2737 | 28 | 16828 | 49 |
KCNQ3,DIP2B,MAML3,MAML2,SLC9A9,SFMBT2,SLC8A1,ITPR2,FRMD4A,MEF2A,ELMO1,ARHGAP26,SSH2,TBC1D22A,ZSWIM6,SORL1,APBB1IP,UBE2E2,GNAQ,NAV3,ARHGAP24,MAP4K4,ZFHX3,DSCAM,ATP8B4,ST6GALNAC3,ANKRD44,PLXDC2 |
1.746e-10 | -22.47 | angiosarcoma | COSMIC cancer mutations | angiosarcoma | 2192 | 25 | 16828 | 49 |
UBE2E2,SORL1,ADAM28,CHST11,SYNDIG1,PICALM,ARHGAP24,PLXDC2,PTPRJ,ATP8B4,ZFHX3,DSCAM,DIP2B,KCNQ3,MED13L,MAML2,TCF12,SFMBT2,SLC9A9,ZSWIM6,TBC1D22A,ARHGAP26,ELMO1,FRMD4A,ITPR2 |
1.746e-10 | -22.47 | soft_tissue-blood_vessel-angiosarcoma | COSMIC cancer mutations | soft_tissue-blood_vessel-angiosarcoma | 2192 | 25 | 16828 | 49 |
ITPR2,FRMD4A,ARHGAP26,ELMO1,TBC1D22A,ZSWIM6,SLC9A9,SFMBT2,TCF12,MAML2,MED13L,KCNQ3,DIP2B,ZFHX3,DSCAM,ATP8B4,PTPRJ,PLXDC2,ARHGAP24,PICALM,SYNDIG1,CHST11,SORL1,ADAM28,UBE2E2 |
6.230e-10 | -21.20 | central_nervous_system-brain-primitive_neuroectodermal_tumour-medulloblastoma | COSMIC cancer mutations | central_nervous_system-brain-primitive_neuroectodermal_tumour-medulloblastoma | 7205 | 42 | 16828 | 49 |
MED13L,MAML2,TCF12,MAML3,HDAC9,DIP2B,DOCK8,QKI,KCNQ3,ZSWIM6,TBC1D22A,SSH2,ARHGAP26,ELMO1,FRMD4A,ITPR2,DOCK4,EPB41L2,SLC8A1,SFMBT2,ZFAND3,ZBTB20,SLC9A9,NAV3,CHST11,GNAQ,UBE2E2,APBB1IP,SORL1,ADAM28,PLXDC2,PTPRJ,ANKRD44,ST6GALNAC3,ABCC4,ATP8B4,DSCAM,ZFHX3,SYNDIG1,MAP4K4,PICALM,ARHGAP22 |
1.050e-08 | -18.37 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-diffuse_large_B_cell_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-diffuse_large_B_cell_lymphoma | 3608 | 29 | 16828 | 49 |
SORL1,APBB1IP,UBE2E2,GNAQ,NAV3,CHST11,SYNDIG1,ZFHX3,DSCAM,ATP8B4,ANKRD44,PLXDC2,ABCC4,ST6GALNAC3,KCNQ3,QKI,DIP2B,MEF2C,MAML2,MED13L,SLC9A9,ZFAND3,SLC8A1,ELMO1,ITPR2,FRMD4A,TBC1D22A,ZSWIM6,SSH2 |
1.793e-08 | -17.84 | acute_myeloid_leukaemia_therapy_related | COSMIC cancer mutations | acute_myeloid_leukaemia_therapy_related | 1523 | 19 | 16828 | 49 |
QKI,UBE2E2,KCNQ3,DIP2B,GNAQ,CHST11,MAML2,SLC9A9,SLC8A1,FRMD4A,ATP8B4,ZFHX3,ITPR2,DSCAM,ELMO1,ARHGAP26,ST6GALNAC3,PLXDC2,TBC1D22A |
1.793e-08 | -17.84 | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-acute_myeloid_leukaemia_therapy_related | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-acute_myeloid_leukaemia_therapy_related | 1523 | 19 | 16828 | 49 |
TBC1D22A,PLXDC2,ST6GALNAC3,ELMO1,ARHGAP26,DSCAM,ITPR2,ZFHX3,ATP8B4,FRMD4A,SLC8A1,SLC9A9,MAML2,CHST11,GNAQ,DIP2B,KCNQ3,UBE2E2,QKI |
3.218e-08 | -17.25 | soft_tissue | COSMIC cancer mutations | soft_tissue | 5828 | 36 | 16828 | 49 |
SFMBT2,SLC8A1,EPB41L2,DOCK4,SLC9A9,ZFAND3,TBC1D22A,ZSWIM6,ITPR2,FRMD4A,MEF2A,ARHGAP26,ELMO1,DIP2B,HDAC9,MAML3,KCNQ3,DOCK8,TCF12,MAML2,MED13L,ARHGAP24,PICALM,MAP4K4,SYNDIG1,ABCC4,PTPRJ,PLXDC2,DSCAM,ZFHX3,ATP8B4,GNAQ,ADAM28,SORL1,UBE2E2,CHST11 |
3.828e-08 | -17.08 | central_nervous_system-brain-glioma-astrocytoma_Grade_III | COSMIC cancer mutations | central_nervous_system-brain-glioma-astrocytoma_Grade_III | 1419 | 18 | 16828 | 49 |
ELMO1,ARHGAP26,DSCAM,ZFHX3,FRMD4A,PTPRJ,ZSWIM6,PLXDC2,ABCC4,ST6GALNAC3,SFMBT2,PICALM,MAML2,MED13L,KCNQ3,ADAM28,UBE2E2,GNAQ |
4.276e-08 | -16.97 | acute_lymphoblastic_B_cell_leukaemia | COSMIC cancer mutations | acute_lymphoblastic_B_cell_leukaemia | 3828 | 29 | 16828 | 49 |
SLC9A9,ZBTB20,ZFAND3,SLC8A1,EPB41L2,ITPR2,FRMD4A,ARHGAP26,ELMO1,TBC1D22A,ZSWIM6,HDAC9,MEF2C,TCF12,MAML2,MED13L,PICALM,MAP4K4,SYNDIG1,DSCAM,ATP8B4,ABCC4,ST6GALNAC3,PTPRJ,ANKRD44,PLXDC2,SORL1,GNAQ,NAV3 |
4.276e-08 | -16.97 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-acute_lymphoblastic_B_cell_leukaemia | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-acute_lymphoblastic_B_cell_leukaemia | 3828 | 29 | 16828 | 49 |
HDAC9,MED13L,MAML2,TCF12,MEF2C,EPB41L2,SLC8A1,ZFAND3,ZBTB20,SLC9A9,ZSWIM6,TBC1D22A,ARHGAP26,ELMO1,FRMD4A,ITPR2,GNAQ,SORL1,NAV3,SYNDIG1,MAP4K4,PICALM,PLXDC2,ANKRD44,PTPRJ,ST6GALNAC3,ABCC4,ATP8B4,DSCAM |
5.023e-08 | -16.81 | prostate-carcinoma | COSMIC cancer mutations | prostate-carcinoma | 9000 | 44 | 16828 | 49 |
SSH2,TBC1D22A,ZSWIM6,ITPR2,FRMD4A,MEF2A,ARHGAP26,ELMO1,SFMBT2,SLC8A1,EPB41L2,SLC9A9,ZBTB20,ZFAND3,TCF12,MAML2,MED13L,MEF2C,DIP2B,HDAC9,MAML3,KCNQ3,QKI,DOCK8,ABCC4,ST6GALNAC3,PTPRJ,ANKRD44,PLXDC2,DSCAM,ZFHX3,ATP8B4,ARHGAP22,PICALM,ARHGAP24,MAP4K4,SYNDIG1,CHST11,NAV3,GNAQ,SORL1,APBB1IP,UBE2E2,FCHSD2 |
5.785e-08 | -16.67 | bone | COSMIC cancer mutations | bone | 8157 | 42 | 16828 | 49 |
GNAQ,FCHSD2,ADAM28,SORL1,APBB1IP,UBE2E2,HS3ST4,NAV3,CHST11,MAP4K4,SYNDIG1,PTPRJ,ANKRD44,ABCC4,ST6GALNAC3,DSCAM,ZFHX3,ATP8B4,HDAC9,MAML3,DIP2B,DOCK8,KCNQ3,QKI,MAML2,MED13L,TCF12,MEF2C,DOCK4,EPB41L2,SFMBT2,SLC8A1,ZBTB20,SLC9A9,ZFAND3,TBC1D22A,SSH2,MEF2A,ELMO1,ARHGAP26,ITPR2,FRMD4A |
1.394e-07 | -15.79 | astrocytoma_Grade_III | COSMIC cancer mutations | astrocytoma_Grade_III | 1544 | 18 | 16828 | 49 |
GNAQ,UBE2E2,ADAM28,KCNQ3,MED13L,MAML2,PICALM,SFMBT2,ZSWIM6,PLXDC2,PTPRJ,ST6GALNAC3,ABCC4,ARHGAP26,ELMO1,FRMD4A,DSCAM,ZFHX3 |
1.683e-07 | -15.60 | upper_aerodigestive_tract-larynx-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | upper_aerodigestive_tract-larynx-carcinoma-squamous_cell_carcinoma | 1946 | 20 | 16828 | 49 |
HDAC9,GNAQ,DOCK8,KCNQ3,ADAM28,SORL1,UBE2E2,APBB1IP,MAML2,NAV3,MEF2C,MAP4K4,DOCK4,SFMBT2,ARHGAP22,ZBTB20,ANKRD44,PTPRJ,DSCAM,ITPR2 |
1.712e-07 | -15.58 | larynx | COSMIC cancer mutations | larynx | 1948 | 20 | 16828 | 49 |
MEF2C,NAV3,MAML2,APBB1IP,UBE2E2,KCNQ3,SORL1,ADAM28,DOCK8,GNAQ,HDAC9,ITPR2,DSCAM,ANKRD44,PTPRJ,ZBTB20,ARHGAP22,SFMBT2,DOCK4,MAP4K4 |
2.123e-07 | -15.37 | stomach-adenocarcinoma | COSMIC cancer mutations | stomach-adenocarcinoma | 4101 | 29 | 16828 | 49 |
GNAQ,APBB1IP,UBE2E2,ADAM28,SORL1,NAV3,CHST11,PICALM,ARHGAP22,PLXDC2,ANKRD44,PTPRJ,ATP8B4,DSCAM,ZFHX3,DOCK8,QKI,KCNQ3,MED13L,TCF12,SLC8A1,SFMBT2,ZFAND3,SLC9A9,TBC1D22A,SSH2,ELMO1,FRMD4A,ITPR2 |
2.803e-07 | -15.09 | diffuse_large_B_cell_lymphoma | COSMIC cancer mutations | diffuse_large_B_cell_lymphoma | 4151 | 29 | 16828 | 49 |
ZFHX3,DSCAM,ATP8B4,ANKRD44,PLXDC2,ABCC4,ST6GALNAC3,SYNDIG1,NAV3,CHST11,SORL1,UBE2E2,APBB1IP,GNAQ,ELMO1,ITPR2,FRMD4A,TBC1D22A,ZSWIM6,SSH2,SLC9A9,ZFAND3,SLC8A1,MEF2C,MAML2,MED13L,KCNQ3,QKI,DIP2B |
3.602e-07 | -14.84 | central_nervous_system-brain-primitive_neuroectodermal_tumour-medulloblastoma-large_cell | COSMIC cancer mutations | central_nervous_system-brain-primitive_neuroectodermal_tumour-medulloblastoma-large_cell | 1117 | 15 | 16828 | 49 |
KCNQ3,QKI,GNAQ,MED13L,SLC9A9,DOCK4,ARHGAP22,SFMBT2,SLC8A1,ARHGAP26,DSCAM,FRMD4A,ATP8B4,ABCC4,ST6GALNAC3 |
4.557e-07 | -14.60 | cell junction | cellular component | GO:0030054 | 2224 | 19 | 19108 | 47 |
DSCAM,PTPRJ,GNAQ,ARHGAP26,FRMD4A,FCHSD2,SSH2,APBB1IP,QKI,MAP4K4,DISC1,ARHGAP24,ARHGAP22,SYNDIG1,KCNQ3,SLC8A1,EPB41L2,MEF2C,PICALM |
7.980e-07 | -14.04 | HNRNPL (heterogeneous nuclear ribonucleoprotein L) | protein interactions | 3191 | 1958 | 18 | 19454 | 50 |
SFMBT2,ABCC4,ZFHX3,PTPRJ,MEF2A,TBC1D22A,PLXDC2,DIP2B,MAML3,ZSWIM6,UBE2E2,QKI,ARHGAP24,ZFAND3,CHST11,DOCK4,ZBTB20,ANKRD44 |
1.475e-06 | -13.43 | cerebellum | COSMIC cancer mutations | cerebellum | 769 | 12 | 16828 | 49 |
ELMO1,ITPR2,DSCAM,TBC1D22A,PLXDC2,SSH2,MAP4K4,SFMBT2,SLC8A1,MAML2,QKI,GNAQ |
2.598e-06 | -12.86 | MEF2B (myocyte enhancer factor 2B) | protein interactions | 100271849 | 11 | 3 | 19454 | 50 |
HDAC9,MEF2C,MEF2A |
3.027e-06 | -12.71 | oesophagus-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | oesophagus-carcinoma-squamous_cell_carcinoma | 6486 | 35 | 16828 | 49 |
MED13L,MAML2,DOCK8,KCNQ3,MAML3,HDAC9,DIP2B,MEF2A,FRMD4A,ITPR2,ZSWIM6,SSH2,ZBTB20,DOCK4,EPB41L2,SLC8A1,SFMBT2,NAV3,HS3ST4,FCHSD2,APBB1IP,DISC1,ADAM28,SORL1,GNAQ,ATP8B4,DSCAM,ZFHX3,ANKRD44,ST6GALNAC3,ABCC4,SYNDIG1,MAP4K4,ARHGAP24,ARHGAP22 |
3.596e-06 | -12.54 | stomach-carcinoma-intestinal_adenocarcinoma | COSMIC cancer mutations | stomach-carcinoma-intestinal_adenocarcinoma | 7225 | 37 | 16828 | 49 |
ABCC4,PTPRJ,ANKRD44,ZFHX3,DSCAM,ATP8B4,ARHGAP22,ARHGAP24,MAP4K4,ST6GAL1,SYNDIG1,HS3ST4,NAV3,SORL1,ADAM28,APBB1IP,FCHSD2,SSH2,TBC1D22A,ZSWIM6,ITPR2,FRMD4A,ELMO1,ARHGAP26,SFMBT2,SLC8A1,EPB41L2,DOCK4,ZBTB20,ZFAND3,MAML2,MED13L,HDAC9,MAML3,KCNQ3,QKI,DOCK8 |
3.596e-06 | -12.54 | intestinal_adenocarcinoma | COSMIC cancer mutations | intestinal_adenocarcinoma | 7225 | 37 | 16828 | 49 |
APBB1IP,ADAM28,SORL1,FCHSD2,HS3ST4,NAV3,ARHGAP24,ARHGAP22,SYNDIG1,ST6GAL1,MAP4K4,ABCC4,PTPRJ,ANKRD44,ATP8B4,ZFHX3,DSCAM,MAML3,HDAC9,QKI,KCNQ3,DOCK8,MED13L,MAML2,SLC8A1,SFMBT2,DOCK4,EPB41L2,ZFAND3,ZBTB20,SSH2,ZSWIM6,TBC1D22A,FRMD4A,ITPR2,ARHGAP26,ELMO1 |
3.969e-06 | -12.44 | pancreas-carcinoid-endocrine_tumour | COSMIC cancer mutations | pancreas-carcinoid-endocrine_tumour | 7250 | 37 | 16828 | 49 |
EPB41L2,SLC8A1,SFMBT2,ZFAND3,SLC9A9,ZSWIM6,TBC1D22A,SSH2,ARHGAP26,ELMO1,MEF2A,FRMD4A,ITPR2,MAML3,DIP2B,QKI,KCNQ3,MED13L,MAML2,SYNDIG1,MAP4K4,ST6GAL1,PICALM,PLXDC2,ANKRD44,PTPRJ,ST6GALNAC3,ABCC4,ATP8B4,ZFHX3,DSCAM,GNAQ,UBE2E2,APBB1IP,ADAM28,SORL1,CHST11 |
4.959e-06 | -12.21 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm | 7307 | 37 | 16828 | 49 |
SLC8A1,SFMBT2,EPB41L2,ZFAND3,SLC9A9,SSH2,ZSWIM6,TBC1D22A,FRMD4A,ITPR2,ELMO1,ARHGAP26,DIP2B,QKI,KCNQ3,DOCK8,MED13L,MAML2,PICALM,SYNDIG1,ST6GAL1,MAP4K4,ST6GALNAC3,ABCC4,PLXDC2,ANKRD44,PTPRJ,ATP8B4,DSCAM,ZFHX3,GNAQ,APBB1IP,UBE2E2,SORL1,ADAM28,CHST11,NAV3 |
5.326e-06 | -12.14 | prostate-carcinoma-adenocarcinoma | COSMIC cancer mutations | prostate-carcinoma-adenocarcinoma | 12379 | 48 | 16828 | 49 |
CHST11,GNAQ,UBE2E2,SORL1,DISC1,ABCC4,PLXDC2,ANKRD44,PTPRJ,ATP8B4,DSCAM,ARHGAP24,ARHGAP22,ST6GAL1,MAP4K4,TCF12,MED13L,HDAC9,QKI,KCNQ3,SSH2,ZSWIM6,ARHGAP26,ELMO1,MEF2A,SLC8A1,SFMBT2,DOCK4,EPB41L2,ZFAND3,ZBTB20,HS3ST4,NAV3,APBB1IP,ADAM28,ST6GALNAC3,ZFHX3,PICALM,SYNDIG1,MAML2,MEF2C,DIP2B,MAML3,DOCK8,TBC1D22A,FRMD4A,ITPR2,SLC9A9 |
6.242e-06 | -11.98 | ovary-carcinoma-serous_carcinoma | COSMIC cancer mutations | ovary-carcinoma-serous_carcinoma | 10710 | 45 | 16828 | 49 |
CHST11,SORL1,FCHSD2,GNAQ,ATP8B4,DSCAM,ABCC4,PLXDC2,ANKRD44,PTPRJ,ARHGAP24,ARHGAP22,MAP4K4,ST6GAL1,TCF12,MED13L,QKI,KCNQ3,HDAC9,ARHGAP26,ELMO1,MEF2A,SSH2,ZFAND3,ZBTB20,SLC8A1,SFMBT2,DOCK4,EPB41L2,NAV3,HS3ST4,APBB1IP,ADAM28,ZFHX3,ST6GALNAC3,PICALM,MEF2C,MAML2,DOCK8,DIP2B,MAML3,FRMD4A,ITPR2,TBC1D22A,SLC9A9 |
6.705e-06 | -11.91 | carcinoid-endocrine_tumour | COSMIC cancer mutations | carcinoid-endocrine_tumour | 7752 | 38 | 16828 | 49 |
CHST11,ADAM28,SORL1,APBB1IP,UBE2E2,GNAQ,ZFHX3,DSCAM,ATP8B4,PTPRJ,ANKRD44,PLXDC2,ABCC4,ST6GALNAC3,MAP4K4,ST6GAL1,SYNDIG1,PICALM,MAML2,MED13L,DOCK8,KCNQ3,QKI,MAML3,DIP2B,MEF2A,ELMO1,ARHGAP26,ITPR2,FRMD4A,TBC1D22A,ZSWIM6,SSH2,SLC9A9,ZFAND3,EPB41L2,SFMBT2,SLC8A1 |
6.847e-06 | -11.89 | bone-Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour | COSMIC cancer mutations | bone-Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour | 6023 | 33 | 16828 | 49 |
ADAM28,SORL1,APBB1IP,UBE2E2,GNAQ,NAV3,MAP4K4,DSCAM,ZFHX3,ATP8B4,PTPRJ,ANKRD44,ABCC4,DOCK8,KCNQ3,HDAC9,MAML3,DIP2B,MEF2C,MAML2,MED13L,TCF12,SLC9A9,ZBTB20,ZFAND3,DOCK4,EPB41L2,MEF2A,ELMO1,ITPR2,FRMD4A,TBC1D22A,SSH2 |
8.738e-06 | -11.65 | TWIST2 (twist family bHLH transcription factor 2) | protein interactions | 117581 | 16 | 3 | 19454 | 50 |
TCF12,ZBTB20,MEF2C |
8.906e-06 | -11.63 | anchoring junction | cellular component | GO:0070161 | 902 | 11 | 19108 | 47 |
ARHGAP22,FRMD4A,ARHGAP24,APBB1IP,SSH2,EPB41L2,SLC8A1,FCHSD2,PTPRJ,MAP4K4,ARHGAP26 |
1.041e-05 | -11.47 | lung-carcinoma-small_cell_carcinoma | COSMIC cancer mutations | lung-carcinoma-small_cell_carcinoma | 9908 | 43 | 16828 | 49 |
ZFAND3,DOCK4,EPB41L2,SLC8A1,SFMBT2,ELMO1,ARHGAP26,MEF2A,SSH2,QKI,KCNQ3,HDAC9,MED13L,TCF12,MAP4K4,ST6GAL1,ARHGAP24,ARHGAP22,ATP8B4,DSCAM,ANKRD44,PTPRJ,ABCC4,FCHSD2,UBE2E2,DISC1,SORL1,GNAQ,SLC9A9,FRMD4A,ITPR2,DOCK8,MAML3,DIP2B,MEF2C,MAML2,SYNDIG1,PICALM,ZFHX3,ST6GALNAC3,APBB1IP,ADAM28,NAV3 |
1.060e-05 | -11.45 | small_cell_carcinoma | COSMIC cancer mutations | small_cell_carcinoma | 9913 | 43 | 16828 | 49 |
PTPRJ,ANKRD44,ST6GALNAC3,ABCC4,ATP8B4,ZFHX3,DSCAM,SYNDIG1,MAP4K4,ST6GAL1,PICALM,ARHGAP24,ARHGAP22,NAV3,GNAQ,FCHSD2,UBE2E2,APBB1IP,SORL1,ADAM28,DISC1,SSH2,ELMO1,ARHGAP26,MEF2A,FRMD4A,ITPR2,EPB41L2,DOCK4,SLC8A1,SFMBT2,ZFAND3,SLC9A9,MED13L,MAML2,TCF12,MEF2C,MAML3,HDAC9,DIP2B,DOCK8,QKI,KCNQ3 |
1.660e-05 | -11.01 | serous_carcinoma | COSMIC cancer mutations | serous_carcinoma | 10987 | 45 | 16828 | 49 |
GNAQ,SORL1,FCHSD2,CHST11,ARHGAP24,ARHGAP22,ST6GAL1,MAP4K4,ABCC4,PLXDC2,PTPRJ,ANKRD44,ATP8B4,DSCAM,HDAC9,QKI,KCNQ3,TCF12,MED13L,SLC8A1,SFMBT2,EPB41L2,DOCK4,ZFAND3,ZBTB20,SSH2,ARHGAP26,ELMO1,MEF2A,APBB1IP,ADAM28,HS3ST4,NAV3,PICALM,ST6GALNAC3,ZFHX3,DIP2B,MAML3,DOCK8,MAML2,MEF2C,SLC9A9,TBC1D22A,FRMD4A,ITPR2 |
2.065e-05 | -10.79 | oesophagus-lower_third-carcinoma-adenocarcinoma | COSMIC cancer mutations | oesophagus-lower_third-carcinoma-adenocarcinoma | 6302 | 33 | 16828 | 49 |
ARHGAP26,ELMO1,FRMD4A,ITPR2,EPB41L2,DOCK4,SLC8A1,SFMBT2,SLC9A9,ZBTB20,MED13L,MAML3,HDAC9,DIP2B,QKI,KCNQ3,PLXDC2,ANKRD44,PTPRJ,ST6GALNAC3,ABCC4,ATP8B4,ZFHX3,DSCAM,PICALM,HS3ST4,NAV3,CHST11,GNAQ,APBB1IP,ADAM28,DISC1,SORL1 |
2.139e-05 | -10.75 | MAML1-3 | interpro domains | IPR046369 | 3 | 2 | 18521 | 50 |
MAML2,MAML3 |
2.139e-05 | -10.75 | Mastermind-like_N | interpro domains | IPR019082 | 3 | 2 | 18521 | 50 |
MAML2,MAML3 |
2.139e-05 | -10.75 | MAML_N_sf | interpro domains | IPR046370 | 3 | 2 | 18521 | 50 |
MAML3,MAML2 |
2.224e-05 | -10.71 | MamL-1 | pfam domains | PF09596 | 3 | 2 | 17795 | 49 |
MAML3,MAML2 |
2.706e-05 | -10.52 | - | gene3d domains | 6.10.250.970 | 3 | 2 | 14470 | 44 |
MAML2,MAML3 |
3.019e-05 | -10.41 | Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour | COSMIC cancer mutations | Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour | 7434 | 36 | 16828 | 49 |
MEF2C,MED13L,MAML2,TCF12,DOCK8,QKI,KCNQ3,MAML3,HDAC9,DIP2B,ELMO1,MEF2A,FRMD4A,ITPR2,TBC1D22A,SSH2,ZFAND3,SLC9A9,ZBTB20,EPB41L2,DOCK4,SLC8A1,NAV3,FCHSD2,APBB1IP,UBE2E2,ADAM28,SORL1,GNAQ,ATP8B4,ZFHX3,DSCAM,PTPRJ,ANKRD44,ABCC4,MAP4K4 |
3.647e-05 | -10.22 | regulation of anatomical structure size | biological process | GO:0090066 | 498 | 8 | 18204 | 47 |
FCHSD2,DISC1,SLC8A1,PICALM,DSCAM,DOCK4,SSH2,DIP2B |
3.969e-05 | -10.13 | upper_arm | COSMIC cancer mutations | upper_arm | 582 | 9 | 16828 | 49 |
PTPRJ,PLXDC2,ST6GALNAC3,SSH2,ITPR2,ATP8B4,GNAQ,SLC9A9,ADAM28 |
3.994e-05 | -10.13 | MamL-1 | smart domains | SM01275 | 3 | 2 | 9717 | 36 |
MAML3,MAML2 |
4.271e-05 | -10.06 | HJURP_C | interpro domains | IPR022102 | 4 | 2 | 18521 | 50 |
MEF2A,MEF2C |
4.271e-05 | -10.06 | MADS_MEF2-like | interpro domains | IPR033896 | 4 | 2 | 18521 | 50 |
MEF2C,MEF2A |
4.441e-05 | -10.02 | HJURP_C | pfam domains | PF12347 | 4 | 2 | 17795 | 49 |
MEF2C,MEF2A |
4.999e-05 | -9.90 | Apelin signaling pathway | KEGG pathways | hsa04371 | 138 | 5 | 7161 | 22 |
MEF2C,ITPR2,SLC8A1,MEF2A,GNAQ |
5.003e-05 | -9.90 | diffuse_adenocarcinoma | COSMIC cancer mutations | diffuse_adenocarcinoma | 4383 | 26 | 16828 | 49 |
DSCAM,ZFHX3,ATP8B4,PTPRJ,PLXDC2,ST6GALNAC3,MAP4K4,SYNDIG1,ARHGAP22,CHST11,HS3ST4,SORL1,ADAM28,UBE2E2,GNAQ,ELMO1,ARHGAP26,ZFAND3,DOCK4,SFMBT2,SLC8A1,MED13L,DOCK8,KCNQ3,QKI,MAML3 |
5.003e-05 | -9.90 | stomach-carcinoma-diffuse_adenocarcinoma | COSMIC cancer mutations | stomach-carcinoma-diffuse_adenocarcinoma | 4383 | 26 | 16828 | 49 |
MED13L,MAML3,KCNQ3,QKI,DOCK8,ARHGAP26,ELMO1,SFMBT2,SLC8A1,DOCK4,ZFAND3,HS3ST4,CHST11,GNAQ,ADAM28,SORL1,UBE2E2,ST6GALNAC3,PTPRJ,PLXDC2,DSCAM,ZFHX3,ATP8B4,ARHGAP22,MAP4K4,SYNDIG1 |
5.094e-05 | -9.88 | astrocytoma_Grade_I | COSMIC cancer mutations | astrocytoma_Grade_I | 139 | 5 | 16828 | 49 |
QKI,SLC8A1,GNAQ,PLXDC2,TBC1D22A |
5.335e-05 | -9.84 | lower_third | COSMIC cancer mutations | lower_third | 7961 | 37 | 16828 | 49 |
ITPR2,FRMD4A,ELMO1,ARHGAP26,SSH2,ZBTB20,SLC9A9,SFMBT2,SLC8A1,EPB41L2,DOCK4,MEF2C,MED13L,KCNQ3,QKI,DIP2B,HDAC9,MAML3,ZFHX3,DSCAM,ATP8B4,ABCC4,ST6GALNAC3,PTPRJ,ANKRD44,PLXDC2,PICALM,ARHGAP24,SYNDIG1,CHST11,NAV3,HS3ST4,DISC1,ADAM28,SORL1,APBB1IP,GNAQ |
5.474e-05 | -9.81 | GTPase regulator activity | molecular function | GO:0030695 | 491 | 8 | 18094 | 50 |
ELMO1,ARHGAP22,GNAQ,DOCK4,TBC1D22A,ARHGAP26,ARHGAP24,DOCK8 |
5.474e-05 | -9.81 | nucleoside-triphosphatase regulator activity | molecular function | GO:0060589 | 491 | 8 | 18094 | 50 |
ARHGAP22,ELMO1,DOCK8,ARHGAP24,ARHGAP26,TBC1D22A,GNAQ,DOCK4 |
5.695e-05 | -9.77 | VIRMA (vir like m6A methyltransferase associated) | protein interactions | 25962 | 2914 | 19 | 19454 | 50 |
MAML3,SSH2,DISC1,CHST11,ANKRD44,ITPR2,ZBTB20,DOCK4,ZFHX3,ABCC4,ARHGAP26,SFMBT2,LDLRAD4,MED13L,MAML2,PTPRJ,PLXDC2,MAP4K4,DIP2B |
7.106e-05 | -9.55 | TF_MADSbox_sf | interpro domains | IPR036879 | 5 | 2 | 18521 | 50 |
MEF2A,MEF2C |
7.106e-05 | -9.55 | TF_MADSbox | interpro domains | IPR002100 | 5 | 2 | 18521 | 50 |
MEF2A,MEF2C |
7.389e-05 | -9.51 | SRF-TF | pfam domains | PF00319 | 5 | 2 | 17795 | 49 |
MEF2C,MEF2A |
7.699e-05 | -9.47 | focal adhesion | cellular component | GO:0005925 | 427 | 7 | 19108 | 47 |
EPB41L2,SSH2,APBB1IP,MAP4K4,ARHGAP26,ARHGAP22,ARHGAP24 |
7.798e-05 | -9.46 | lung-right_lower_lobe-carcinoma-adenocarcinoma | COSMIC cancer mutations | lung-right_lower_lobe-carcinoma-adenocarcinoma | 5692 | 30 | 16828 | 49 |
TCF12,MED13L,MAML2,DIP2B,MAML3,HDAC9,ITPR2,ELMO1,SSH2,TBC1D22A,SLC9A9,SLC8A1,EPB41L2,DOCK4,NAV3,HS3ST4,APBB1IP,SORL1,ADAM28,DISC1,FCHSD2,ATP8B4,ZFHX3,DSCAM,ABCC4,PLXDC2,ANKRD44,PTPRJ,MAP4K4,ST6GAL1 |
7.798e-05 | -9.46 | right_lower_lobe | COSMIC cancer mutations | right_lower_lobe | 5692 | 30 | 16828 | 49 |
TBC1D22A,SSH2,ELMO1,ITPR2,DOCK4,EPB41L2,SLC8A1,SLC9A9,MED13L,MAML2,TCF12,MAML3,HDAC9,DIP2B,PLXDC2,ANKRD44,PTPRJ,ABCC4,ATP8B4,ZFHX3,DSCAM,MAP4K4,ST6GAL1,HS3ST4,NAV3,FCHSD2,APBB1IP,ADAM28,DISC1,SORL1 |
7.937e-05 | -9.44 | prostate | COSMIC cancer mutations | prostate | 13883 | 49 | 16828 | 49 |
EPB41L2,DOCK4,SLC8A1,SFMBT2,ZFAND3,ZBTB20,ZSWIM6,SSH2,ARHGAP26,ELMO1,MEF2A,HDAC9,QKI,KCNQ3,MED13L,TCF12,MAP4K4,ST6GAL1,ARHGAP24,ARHGAP22,PLXDC2,ANKRD44,PTPRJ,ABCC4,ATP8B4,DSCAM,GNAQ,FCHSD2,UBE2E2,SORL1,DISC1,CHST11,SLC9A9,TBC1D22A,FRMD4A,ITPR2,MAML3,DIP2B,DOCK8,MAML2,MEF2C,SYNDIG1,PICALM,ST6GALNAC3,ZFHX3,APBB1IP,ADAM28,HS3ST4,NAV3 |
7.971e-05 | -9.44 | MADS_BOX_1 | prosite domains | PS00350 | 5 | 2 | 12186 | 35 |
MEF2C,MEF2A |
7.971e-05 | -9.44 | MADS_BOX_2 | prosite domains | PS50066 | 5 | 2 | 12186 | 35 |
MEF2C,MEF2A |
8.898e-05 | -9.33 | cell-substrate junction | cellular component | GO:0030055 | 437 | 7 | 19108 | 47 |
ARHGAP26,MAP4K4,EPB41L2,APBB1IP,SSH2,ARHGAP24,ARHGAP22 |
8.984e-05 | -9.32 | Transcription factor, MADS-box | gene3d domains | 3.40.1810.10 | 5 | 2 | 14470 | 44 |
MEF2C,MEF2A |
9.646e-05 | -9.25 | central_nervous_system-cerebellum-primitive_neuroectodermal_tumour-medulloblastoma-SHH_subtype | COSMIC cancer mutations | central_nervous_system-cerebellum-primitive_neuroectodermal_tumour-medulloblastoma-SHH_subtype | 653 | 9 | 16828 | 49 |
GNAQ,SFMBT2,MAP4K4,ITPR2,DSCAM,ELMO1,SSH2,MAML2,PLXDC2 |
9.759e-05 | -9.23 | SHH_subtype | COSMIC cancer mutations | SHH_subtype | 654 | 9 | 16828 | 49 |
GNAQ,SFMBT2,MAP4K4,SSH2,MAML2,PLXDC2,ITPR2,DSCAM,ELMO1 |
9.900e-05 | -9.22 | MADSDOMAIN | prints domains | PR00404 | 5 | 2 | 5227 | 17 |
MEF2A,MEF2C |
1.017e-04 | -9.19 | GTPase activator activity | molecular function | GO:0005096 | 273 | 6 | 18094 | 50 |
DOCK4,GNAQ,TBC1D22A,ARHGAP26,ARHGAP24,ARHGAP22 |
1.027e-04 | -9.18 | kidney-carcinoma | COSMIC cancer mutations | kidney-carcinoma | 3720 | 23 | 16828 | 49 |
QKI,HDAC9,MEF2C,TCF12,MED13L,MAML2,SLC9A9,FRMD4A,ITPR2,ARHGAP26,APBB1IP,UBE2E2,ADAM28,FCHSD2,GNAQ,NAV3,PICALM,ARHGAP24,ARHGAP22,MAP4K4,ST6GAL1,PTPRJ,ANKRD44 |
1.039e-04 | -9.17 | CDO in myogenesis | REACTOME pathways | R-HSA-375170 | 29 | 3 | 10285 | 33 |
MEF2C,TCF12,MEF2A |
1.039e-04 | -9.17 | Myogenesis | REACTOME pathways | R-HSA-525793 | 29 | 3 | 10285 | 33 |
MEF2C,MEF2A,TCF12 |
1.073e-04 | -9.14 | neurogenesis | biological process | GO:0022008 | 1334 | 12 | 18204 | 47 |
KCNQ3,QKI,MEF2C,DSCAM,MAP4K4,PTPRJ,MEF2A,HDAC9,NAV3,PICALM,DISC1,ZSWIM6 |
1.106e-04 | -9.11 | cGMP-PKG signaling pathway | KEGG pathways | hsa04022 | 163 | 5 | 7161 | 22 |
ITPR2,MEF2C,SLC8A1,MEF2A,GNAQ |
1.106e-04 | -9.11 | cGMP-PKG signaling pathway | KEGG pathways | ko04022 | 163 | 5 | 7161 | 22 |
SLC8A1,MEF2A,MEF2C,ITPR2,GNAQ |
1.292e-04 | -8.95 | regulation of small GTPase mediated signal transduction | biological process | GO:0051056 | 306 | 6 | 18204 | 47 |
ARHGAP22,PICALM,ARHGAP24,ARHGAP26,DOCK8,MAP4K4 |
1.325e-04 | -8.93 | MADS | smart domains | SM00432 | 5 | 2 | 9717 | 36 |
MEF2C,MEF2A |
1.328e-04 | -8.93 | regulation of multicellular organismal process | biological process | GO:0051239 | 3113 | 19 | 18204 | 47 |
DSCAM,DOCK4,MAP4K4,ZFHX3,QKI,MEF2C,GNAQ,DOCK8,SLC8A1,DISC1,LDLRAD4,SORL1,ZBTB20,DIP2B,MEF2A,PTPRJ,SYNDIG1,HDAC9,NAV3 |
1.359e-04 | -8.90 | positive regulation of transcription of Notch receptor target | biological process | GO:0007221 | 7 | 2 | 18204 | 47 |
MAML2,MAML3 |
1.435e-04 | -8.85 | regulation of locomotion | biological process | GO:0040012 | 1164 | 11 | 18204 | 47 |
HDAC9,ST6GAL1,PTPRJ,DOCK8,NAV3,MEF2C,DSCAM,DOCK4,LDLRAD4,SORL1,MAP4K4 |
1.476e-04 | -8.82 | ASCL1 (achaete-scute family bHLH transcription factor 1) | protein interactions | 429 | 40 | 3 | 19454 | 50 |
MEF2C,MEF2A,TCF12 |
1.482e-04 | -8.82 | PH-like_dom_sf | interpro domains | IPR011993 | 431 | 7 | 18521 | 50 |
ARHGAP24,FRMD4A,ARHGAP26,EPB41L2,APBB1IP,ELMO1,ARHGAP22 |
1.610e-04 | -8.73 | bounding membrane of organelle | cellular component | GO:0098588 | 2198 | 15 | 19108 | 47 |
HS3ST4,SLC9A9,SYNDIG1,SORL1,CHST11,ST6GALNAC3,NAV3,ABCC4,ATP8B4,ST6GAL1,ITPR2,ARHGAP26,GNAQ,PTPRJ,LDLRAD4 |
1.777e-04 | -8.64 | skin-upper_arm-malignant_melanoma | COSMIC cancer mutations | skin-upper_arm-malignant_melanoma | 553 | 8 | 16828 | 49 |
ADAM28,SLC9A9,SSH2,ST6GALNAC3,PTPRJ,PLXDC2,ITPR2,ATP8B4 |
1.786e-04 | -8.63 | positive regulation of hydrolase activity | biological process | GO:0051345 | 466 | 7 | 18204 | 47 |
ARHGAP24,DOCK8,TBC1D22A,GNAQ,MEF2C,ARHGAP22,MAP4K4 |
1.795e-04 | -8.63 | ZCWPW1 (zinc finger CW-type and PWWP domain containing 1) | protein interactions | 55063 | 8 | 2 | 19454 | 50 |
PLXDC2,MEF2A |
1.856e-04 | -8.59 | upper_leg | COSMIC cancer mutations | upper_leg | 880 | 10 | 16828 | 49 |
DSCAM,ELMO1,SSH2,PTPRJ,PLXDC2,KCNQ3,ADAM28,DOCK8,GNAQ,SLC8A1 |
1.951e-04 | -8.54 | rhabdomyosarcoma | COSMIC cancer mutations | rhabdomyosarcoma | 4150 | 24 | 16828 | 49 |
MAML2,MAML3,HDAC9,GNAQ,DIP2B,DOCK8,KCNQ3,SORL1,PTPRJ,ABCC4,ARHGAP26,ELMO1,MEF2A,ATP8B4,FRMD4A,ZFHX3,DSCAM,SYNDIG1,DOCK4,EPB41L2,MAP4K4,SLC8A1,SFMBT2,ZFAND3 |
1.998e-04 | -8.52 | biological regulation | biological process | GO:0065007 | 12501 | 43 | 18204 | 47 |
ELMO1,CHST11,GNAQ,MEF2C,MED13L,ITPR2,MAP4K4,ZFHX3,ATP8B4,HDAC9,DIP2B,SYNDIG1,ARHGAP26,SLC9A9,NAV3,FRMD4A,PICALM,ARHGAP22,SLC8A1,TCF12,MAML3,EPB41L2,MAML2,ST6GAL1,ARHGAP24,QKI,KCNQ3,DOCK8,DOCK4,DSCAM,SFMBT2,FCHSD2,MEF2A,PTPRJ,TBC1D22A,SSH2,UBE2E2,APBB1IP,ABCC4,LDLRAD4,ZBTB20,SORL1,DISC1 |
2.008e-04 | -8.51 | scalp | COSMIC cancer mutations | scalp | 2110 | 16 | 16828 | 49 |
SORL1,KCNQ3,ADAM28,GNAQ,NAV3,CHST11,MED13L,SYNDIG1,SLC8A1,SFMBT2,ARHGAP22,ARHGAP26,ELMO1,ZFHX3,DSCAM,PTPRJ |
2.060e-04 | -8.49 | positive regulation of GTPase activity | biological process | GO:0043547 | 211 | 5 | 18204 | 47 |
ARHGAP24,ARHGAP22,MAP4K4,TBC1D22A,DOCK8 |
2.071e-04 | -8.48 | lung-right_upper_lobe-carcinoma-adenocarcinoma | COSMIC cancer mutations | lung-right_upper_lobe-carcinoma-adenocarcinoma | 10376 | 42 | 16828 | 49 |
PLXDC2,PTPRJ,ANKRD44,ST6GALNAC3,ABCC4,ATP8B4,ZFHX3,DSCAM,SYNDIG1,MAP4K4,ST6GAL1,ARHGAP24,PICALM,ARHGAP22,HS3ST4,NAV3,CHST11,FCHSD2,APBB1IP,UBE2E2,ADAM28,SORL1,DISC1,TBC1D22A,SSH2,ELMO1,ARHGAP26,FRMD4A,ITPR2,EPB41L2,DOCK4,SLC8A1,SFMBT2,SLC9A9,ZBTB20,MED13L,MEF2C,MAML3,HDAC9,DIP2B,DOCK8,KCNQ3 |
2.071e-04 | -8.48 | right_upper_lobe | COSMIC cancer mutations | right_upper_lobe | 10376 | 42 | 16828 | 49 |
FCHSD2,SORL1,ADAM28,DISC1,UBE2E2,APBB1IP,HS3ST4,NAV3,CHST11,MAP4K4,ST6GAL1,SYNDIG1,ARHGAP22,ARHGAP24,PICALM,ANKRD44,PTPRJ,PLXDC2,ABCC4,ST6GALNAC3,DSCAM,ZFHX3,ATP8B4,HDAC9,MAML3,DIP2B,DOCK8,KCNQ3,MED13L,MEF2C,EPB41L2,DOCK4,SFMBT2,SLC8A1,SLC9A9,ZBTB20,TBC1D22A,SSH2,ARHGAP26,ELMO1,ITPR2,FRMD4A |
2.101e-04 | -8.47 | MEF2C (myocyte enhancer factor 2C) | protein interactions | 4208 | 45 | 3 | 19454 | 50 |
HDAC9,MEF2A,MEF2C |
2.193e-04 | -8.42 | regulation of cellular component biogenesis | biological process | GO:0044087 | 1016 | 10 | 18204 | 47 |
SYNDIG1,PTPRJ,ARHGAP24,MEF2C,NAV3,SSH2,TBC1D22A,MAP4K4,FCHSD2,SORL1 |
2.443e-04 | -8.32 | central_nervous_system-cerebellum-glioma-astrocytoma_Grade_I | COSMIC cancer mutations | central_nervous_system-cerebellum-glioma-astrocytoma_Grade_I | 105 | 4 | 16828 | 49 |
TBC1D22A,PLXDC2,SLC8A1,QKI |
2.496e-04 | -8.30 | lymph_node | COSMIC cancer mutations | lymph_node | 1703 | 14 | 16828 | 49 |
MAML2,TCF12,NAV3,MEF2C,GNAQ,ZSWIM6,ELMO1,ITPR2,ZFHX3,DSCAM,ATP8B4,MAP4K4,ARHGAP24,ZFAND3 |
2.531e-04 | -8.28 | large_intestine-colon | COSMIC cancer mutations | large_intestine-colon | 1291 | 12 | 16828 | 49 |
ATP8B4,ANKRD44,ZBTB20,MAP4K4,ARHGAP24,SFMBT2,NAV3,MEF2C,HS3ST4,MED13L,SORL1,KCNQ3 |
2.585e-04 | -8.26 | nervous system development | biological process | GO:0007399 | 2185 | 15 | 18204 | 47 |
QKI,KCNQ3,MEF2C,DSCAM,MAP4K4,HDAC9,DIP2B,MEF2A,ARHGAP26,PTPRJ,NAV3,PICALM,TCF12,ZSWIM6,DISC1 |
2.646e-04 | -8.24 | striated_muscle | COSMIC cancer mutations | striated_muscle | 4228 | 24 | 16828 | 49 |
MAML2,DIP2B,HDAC9,MAML3,KCNQ3,DOCK8,FRMD4A,MEF2A,ELMO1,ARHGAP26,SFMBT2,SLC8A1,EPB41L2,DOCK4,ZFAND3,GNAQ,SORL1,ABCC4,PTPRJ,ZFHX3,DSCAM,ATP8B4,MAP4K4,SYNDIG1 |
2.722e-04 | -8.21 | large_intestine-caecum-carcinoma-adenocarcinoma | COSMIC cancer mutations | large_intestine-caecum-carcinoma-adenocarcinoma | 14236 | 49 | 16828 | 49 |
SYNDIG1,PICALM,ZFHX3,ST6GALNAC3,APBB1IP,ADAM28,NAV3,HS3ST4,SLC9A9,FRMD4A,ITPR2,TBC1D22A,DOCK8,MAML3,DIP2B,MEF2C,MAML2,ST6GAL1,MAP4K4,ARHGAP24,ARHGAP22,ATP8B4,DSCAM,PLXDC2,PTPRJ,ANKRD44,ABCC4,FCHSD2,UBE2E2,DISC1,SORL1,GNAQ,CHST11,ZFAND3,ZBTB20,EPB41L2,DOCK4,SLC8A1,SFMBT2,ELMO1,ARHGAP26,MEF2A,ZSWIM6,SSH2,QKI,KCNQ3,HDAC9,MED13L,TCF12 |
2.755e-04 | -8.20 | regulation of cellular component size | biological process | GO:0032535 | 352 | 6 | 18204 | 47 |
SSH2,DIP2B,FCHSD2,DISC1,PICALM,DSCAM |
2.837e-04 | -8.17 | caecum | COSMIC cancer mutations | caecum | 14248 | 49 | 16828 | 49 |
PICALM,SYNDIG1,ZFHX3,ST6GALNAC3,APBB1IP,ADAM28,NAV3,HS3ST4,SLC9A9,FRMD4A,ITPR2,TBC1D22A,DOCK8,DIP2B,MAML3,MEF2C,MAML2,ARHGAP24,ARHGAP22,ST6GAL1,MAP4K4,ATP8B4,DSCAM,ABCC4,PLXDC2,ANKRD44,PTPRJ,UBE2E2,DISC1,SORL1,FCHSD2,GNAQ,CHST11,ZFAND3,ZBTB20,SLC8A1,SFMBT2,EPB41L2,DOCK4,ELMO1,ARHGAP26,MEF2A,SSH2,ZSWIM6,QKI,KCNQ3,HDAC9,TCF12,MED13L |
2.925e-04 | -8.14 | Pleckstrin-homology domain (PH domain)/Phosphotyrosine-binding domain (PTB) | gene3d domains | 2.30.29.30 | 431 | 7 | 14470 | 44 |
ARHGAP22,APBB1IP,EPB41L2,ARHGAP26,ELMO1,FRMD4A,ARHGAP24 |
2.935e-04 | -8.13 | lung-carcinoma | COSMIC cancer mutations | lung-carcinoma | 4255 | 24 | 16828 | 49 |
ARHGAP22,ARHGAP24,PICALM,ST6GAL1,MAP4K4,ZFHX3,ANKRD44,PTPRJ,ADAM28,APBB1IP,UBE2E2,FCHSD2,GNAQ,NAV3,SLC9A9,ITPR2,FRMD4A,ARHGAP26,QKI,HDAC9,MEF2C,TCF12,MAML2,MED13L |
2.971e-04 | -8.12 | upper_aerodigestive_tract-head_neck-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | upper_aerodigestive_tract-head_neck-carcinoma-squamous_cell_carcinoma | 9263 | 39 | 16828 | 49 |
SORL1,ADAM28,UBE2E2,APBB1IP,FCHSD2,GNAQ,CHST11,NAV3,ARHGAP22,PICALM,ARHGAP24,MAP4K4,ST6GAL1,DSCAM,ZFHX3,ATP8B4,ST6GALNAC3,ANKRD44,PTPRJ,KCNQ3,QKI,DOCK8,DIP2B,HDAC9,MAML3,MEF2C,TCF12,MAML2,MED13L,SLC9A9,SFMBT2,SLC8A1,DOCK4,EPB41L2,ITPR2,FRMD4A,ARHGAP26,TBC1D22A,ZSWIM6 |
3.095e-04 | -8.08 | oesophagus-carcinoma | COSMIC cancer mutations | oesophagus-carcinoma | 4269 | 24 | 16828 | 49 |
ST6GALNAC3,ABCC4,DSCAM,ZFHX3,SYNDIG1,MAP4K4,ST6GAL1,HS3ST4,CHST11,NAV3,SORL1,ADAM28,FRMD4A,ITPR2,ELMO1,MEF2A,SFMBT2,DOCK4,ZBTB20,MED13L,DIP2B,MAML3,HDAC9,DOCK8 |
3.099e-04 | -8.08 | CALD1 (caldesmon 1) | protein interactions | 800 | 231 | 5 | 19454 | 50 |
DISC1,QKI,ITPR2,DOCK8,EPB41L2 |
3.134e-04 | -8.07 | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm | 764 | 9 | 16828 | 49 |
UBE2E2,SORL1,ZFAND3,SLC9A9,ST6GALNAC3,MAML2,FRMD4A,DSCAM,ARHGAP26 |
3.356e-04 | -8.00 | Lima1 (LIM domain and actin binding 1) | protein interactions | 65970 | 129 | 4 | 19454 | 50 |
ZBTB20,ITPR2,PICALM,SSH2 |
3.536e-04 | -7.95 | regulation of macrophage apoptotic process | biological process | GO:2000109 | 11 | 2 | 18204 | 47 |
MEF2C,ST6GAL1 |
3.647e-04 | -7.92 | lung-carcinoma-non_small_cell_carcinoma | COSMIC cancer mutations | lung-carcinoma-non_small_cell_carcinoma | 5198 | 27 | 16828 | 49 |
FRMD4A,ITPR2,ARHGAP26,SSH2,SLC9A9,SLC8A1,MEF2C,TCF12,MED13L,MAML2,QKI,HDAC9,DSCAM,ZFHX3,PTPRJ,ANKRD44,ARHGAP24,PICALM,ARHGAP22,MAP4K4,ST6GAL1,NAV3,UBE2E2,APBB1IP,ADAM28,FCHSD2,GNAQ |
3.647e-04 | -7.92 | non_small_cell_carcinoma | COSMIC cancer mutations | non_small_cell_carcinoma | 5198 | 27 | 16828 | 49 |
GNAQ,FCHSD2,UBE2E2,APBB1IP,ADAM28,NAV3,MAP4K4,ST6GAL1,PICALM,ARHGAP24,ARHGAP22,ANKRD44,PTPRJ,DSCAM,ZFHX3,HDAC9,QKI,MED13L,MAML2,TCF12,MEF2C,SLC8A1,SLC9A9,SSH2,ARHGAP26,FRMD4A,ITPR2 |
3.815e-04 | -7.87 | DOCK3 (dedicator of cytokinesis 3) | protein interactions | 1795 | 55 | 3 | 19454 | 50 |
ELMO1,HS3ST4,DOCK4 |
3.868e-04 | -7.86 | DOCKER_dom | interpro domains | IPR027357 | 11 | 2 | 18521 | 50 |
DOCK8,DOCK4 |
3.868e-04 | -7.86 | DOCK_C_lobe_A | interpro domains | IPR043161 | 11 | 2 | 18521 | 50 |
DOCK4,DOCK8 |
3.868e-04 | -7.86 | DOCK | interpro domains | IPR026791 | 11 | 2 | 18521 | 50 |
DOCK8,DOCK4 |
3.868e-04 | -7.86 | DOCKER_Lobe_B | interpro domains | IPR046770 | 11 | 2 | 18521 | 50 |
DOCK8,DOCK4 |
3.868e-04 | -7.86 | DOCKER_Lobe_C | interpro domains | IPR046773 | 11 | 2 | 18521 | 50 |
DOCK8,DOCK4 |
3.868e-04 | -7.86 | C2_DOCK-type_domain | interpro domains | IPR027007 | 11 | 2 | 18521 | 50 |
DOCK8,DOCK4 |
3.868e-04 | -7.86 | DOCKER_Lobe_A | interpro domains | IPR046769 | 11 | 2 | 18521 | 50 |
DOCK4,DOCK8 |
3.868e-04 | -7.86 | DOCK_C_lobe_C | interpro domains | IPR043162 | 11 | 2 | 18521 | 50 |
DOCK4,DOCK8 |
3.895e-04 | -7.85 | cell body | cellular component | GO:0044297 | 556 | 7 | 19108 | 47 |
DISC1,SLC8A1,PICALM,SORL1,DSCAM,SYNDIG1,DIP2B |
4.021e-04 | -7.82 | DOCK-C2 | pfam domains | PF14429 | 11 | 2 | 17795 | 49 |
DOCK8,DOCK4 |
4.021e-04 | -7.82 | DHR-2_Lobe_B | pfam domains | PF20422 | 11 | 2 | 17795 | 49 |
DOCK8,DOCK4 |
4.021e-04 | -7.82 | DHR-2_Lobe_A | pfam domains | PF06920 | 11 | 2 | 17795 | 49 |
DOCK4,DOCK8 |
4.021e-04 | -7.82 | DHR-2_Lobe_C | pfam domains | PF20421 | 11 | 2 | 17795 | 49 |
DOCK4,DOCK8 |
4.052e-04 | -7.81 | oesophagus-lower_third-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | oesophagus-lower_third-carcinoma-squamous_cell_carcinoma | 3507 | 21 | 16828 | 49 |
SFMBT2,ARHGAP24,EPB41L2,DOCK4,SYNDIG1,ZBTB20,SSH2,ZFHX3,DSCAM,FRMD4A,ATP8B4,ARHGAP26,DIP2B,HDAC9,MAML3,SORL1,ADAM28,KCNQ3,HS3ST4,MEF2C,NAV3 |
4.062e-04 | -7.81 | positive regulation of cell-matrix adhesion | biological process | GO:0001954 | 56 | 3 | 18204 | 47 |
DISC1,MAP4K4,PTPRJ |
4.337e-04 | -7.74 | DOCKER | prosite domains | PS51651 | 11 | 2 | 12186 | 35 |
DOCK4,DOCK8 |
4.337e-04 | -7.74 | C2_DOCK | prosite domains | PS51650 | 11 | 2 | 12186 | 35 |
DOCK4,DOCK8 |
4.593e-04 | -7.69 | haematopoietic_neoplasm | COSMIC cancer mutations | haematopoietic_neoplasm | 11082 | 43 | 16828 | 49 |
NAV3,CHST11,FCHSD2,UBE2E2,ADAM28,SORL1,GNAQ,ATP8B4,DSCAM,ZFHX3,PLXDC2,ANKRD44,PTPRJ,ST6GALNAC3,ABCC4,MAP4K4,ST6GAL1,ARHGAP24,PICALM,MEF2C,MED13L,MAML2,TCF12,DOCK8,QKI,KCNQ3,MAML3,HDAC9,DIP2B,ARHGAP26,ELMO1,MEF2A,FRMD4A,ITPR2,ZSWIM6,TBC1D22A,SSH2,ZFAND3,SLC9A9,EPB41L2,DOCK4,SLC8A1,SFMBT2 |
4.718e-04 | -7.66 | NOTCH1 Intracellular Domain Regulates Transcription | REACTOME pathways | R-HSA-2122947 | 48 | 3 | 10285 | 33 |
MAML2,HDAC9,MAML3 |
4.884e-04 | -7.62 | - | gene3d domains | 1.20.58.740 | 11 | 2 | 14470 | 44 |
DOCK4,DOCK8 |
4.884e-04 | -7.62 | - | gene3d domains | 1.25.40.410 | 11 | 2 | 14470 | 44 |
DOCK8,DOCK4 |
4.895e-04 | -7.62 | trunk | COSMIC cancer mutations | trunk | 3554 | 21 | 16828 | 49 |
TCF12,MAML2,DIP2B,GNAQ,ADAM28,SORL1,DISC1,APBB1IP,DOCK8,FCHSD2,ABCC4,SSH2,PTPRJ,ANKRD44,DSCAM,ZFHX3,ATP8B4,ARHGAP26,SFMBT2,SLC8A1,SYNDIG1 |
4.949e-04 | -7.61 | SOX2 (SRY-box transcription factor 2) | protein interactions | 6657 | 1342 | 11 | 19454 | 50 |
MEF2A,ITPR2,NAV3,FRMD4A,MED13L,ARHGAP26,ZFHX3,MEF2C,QKI,TCF12,PICALM |
5.137e-04 | -7.57 | PLCG1 (phospholipase C gamma 1) | protein interactions | 5335 | 258 | 5 | 19454 | 50 |
DISC1,PICALM,EPB41L2,PTPRJ,LDLRAD4 |
5.247e-04 | -7.55 | thyroid-carcinoma | COSMIC cancer mutations | thyroid-carcinoma | 4126 | 23 | 16828 | 49 |
MEF2C,MED13L,DOCK8,HDAC9,FRMD4A,ITPR2,ARHGAP26,ELMO1,ZFAND3,SLC9A9,SLC8A1,SFMBT2,DOCK4,CHST11,NAV3,HS3ST4,SORL1,ZFHX3,DSCAM,PLXDC2,ANKRD44,PTPRJ,MAP4K4 |
5.287e-04 | -7.55 | oesophagus-carcinoma-adenocarcinoma | COSMIC cancer mutations | oesophagus-carcinoma-adenocarcinoma | 13112 | 47 | 16828 | 49 |
DOCK4,EPB41L2,SFMBT2,SLC8A1,ZBTB20,ZFAND3,ZSWIM6,SSH2,ELMO1,ARHGAP26,HDAC9,KCNQ3,QKI,MED13L,TCF12,ST6GAL1,MAP4K4,ARHGAP22,ARHGAP24,PTPRJ,ANKRD44,PLXDC2,ABCC4,DSCAM,ATP8B4,GNAQ,SORL1,DISC1,UBE2E2,CHST11,SLC9A9,TBC1D22A,ITPR2,FRMD4A,MAML3,DIP2B,DOCK8,MAML2,MEF2C,SYNDIG1,PICALM,ST6GALNAC3,ZFHX3,ADAM28,APBB1IP,HS3ST4,NAV3 |
5.776e-04 | -7.46 | BORCS8-MEF2B (BORCS8-MEF2B readthrough) | protein interactions | 4207 | 14 | 2 | 19454 | 50 |
MEF2A,MEF2C |
5.821e-04 | -7.45 | ventricular cardiac muscle cell differentiation | biological process | GO:0055012 | 14 | 2 | 18204 | 47 |
MEF2C,MEF2A |
6.018e-04 | -7.42 | dendrite morphogenesis | biological process | GO:0048813 | 64 | 3 | 18204 | 47 |
DSCAM,PICALM,MEF2A |
6.523e-04 | -7.34 | MAML1 (mastermind like transcriptional coactivator 1) | protein interactions | 9794 | 66 | 3 | 19454 | 50 |
MAML2,MAML3,HDAC9 |
6.604e-04 | -7.32 | pleura-mesothelioma | COSMIC cancer mutations | pleura-mesothelioma | 4189 | 23 | 16828 | 49 |
GNAQ,ADAM28,UBE2E2,APBB1IP,FCHSD2,NAV3,ARHGAP22,PICALM,ARHGAP24,ST6GAL1,MAP4K4,ANKRD44,PTPRJ,HDAC9,QKI,TCF12,MAML2,MED13L,MEF2C,SLC9A9,ITPR2,FRMD4A,ARHGAP26 |
6.740e-04 | -7.30 | regulation of biological quality | biological process | GO:0065008 | 2936 | 17 | 18204 | 47 |
DISC1,PICALM,ARHGAP22,SLC8A1,SLC9A9,SSH2,DIP2B,SYNDIG1,PTPRJ,FCHSD2,ATP8B4,DOCK4,DSCAM,GNAQ,MEF2C,QKI,KCNQ3 |
6.811e-04 | -7.29 | skin-upper_leg-malignant_melanoma | COSMIC cancer mutations | skin-upper_leg-malignant_melanoma | 850 | 9 | 16828 | 49 |
DSCAM,ELMO1,SSH2,PTPRJ,PLXDC2,KCNQ3,ADAM28,DOCK8,SLC8A1 |
7.118e-04 | -7.25 | MYOG (myogenin) | protein interactions | 4656 | 68 | 3 | 19454 | 50 |
TCF12,MEF2C,MEF2A |
7.156e-04 | -7.24 | system development | biological process | GO:0048731 | 3533 | 19 | 18204 | 47 |
HDAC9,ARHGAP26,PTPRJ,MEF2A,DIP2B,NAV3,PICALM,ARHGAP22,SLC8A1,ZSWIM6,TCF12,DISC1,ARHGAP24,QKI,CHST11,KCNQ3,MEF2C,DSCAM,MAP4K4 |
7.186e-04 | -7.24 | synapse | cellular component | GO:0045202 | 1473 | 11 | 19108 | 47 |
DISC1,SLC8A1,PICALM,MEF2C,SYNDIG1,ARHGAP22,KCNQ3,GNAQ,DSCAM,FCHSD2,QKI |
7.188e-04 | -7.24 | RhoGAP_dom | interpro domains | IPR000198 | 65 | 3 | 18521 | 50 |
ARHGAP22,ARHGAP24,ARHGAP26 |
7.275e-04 | -7.23 | regulation of GTPase activity | biological process | GO:0043087 | 278 | 5 | 18204 | 47 |
ARHGAP24,ARHGAP22,TBC1D22A,DOCK8,MAP4K4 |
7.356e-04 | -7.21 | PH_domain | interpro domains | IPR001849 | 266 | 5 | 18521 | 50 |
ARHGAP26,ARHGAP24,ARHGAP22,APBB1IP,ELMO1 |
7.371e-04 | -7.21 | SRF and miRs in Smooth Muscle Differentiation and Proliferation | WikiPathways | WP1991 | 13 | 2 | 5310 | 17 |
MEF2A,MEF2C |
7.601e-04 | -7.18 | RhoGAP | pfam domains | PF00620 | 65 | 3 | 17795 | 49 |
ARHGAP24,ARHGAP26,ARHGAP22 |
7.617e-04 | -7.18 | NOTCH2 intracellular domain regulates transcription | REACTOME pathways | R-HSA-2197563 | 13 | 2 | 10285 | 33 |
MAML2,MAML3 |
7.617e-04 | -7.18 | Notch-HLH transcription pathway | REACTOME pathways | R-HSA-350054 | 13 | 2 | 10285 | 33 |
MAML2,MAML3 |
7.634e-04 | -7.18 | regulation of cellular process | biological process | GO:0050794 | 11468 | 40 | 18204 | 47 |
DSCAM,DOCK4,SFMBT2,FCHSD2,ARHGAP24,QKI,ST6GAL1,KCNQ3,DOCK8,UBE2E2,APBB1IP,ZBTB20,SORL1,LDLRAD4,DISC1,PTPRJ,MEF2A,SSH2,TBC1D22A,MED13L,ITPR2,ZFHX3,MAP4K4,CHST11,ELMO1,GNAQ,MEF2C,PICALM,ARHGAP22,SLC8A1,TCF12,MAML2,EPB41L2,MAML3,HDAC9,SYNDIG1,ARHGAP26,DIP2B,FRMD4A,NAV3 |
7.916e-04 | -7.14 | face | COSMIC cancer mutations | face | 2139 | 15 | 16828 | 49 |
ITPR2,DSCAM,ZFHX3,PTPRJ,ABCC4,SFMBT2,SLC8A1,ARHGAP24,PICALM,NAV3,MED13L,SORL1,ADAM28,KCNQ3,GNAQ |
8.065e-04 | -7.12 | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-acute_myeloid_leukaemia | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-acute_myeloid_leukaemia | 10418 | 41 | 16828 | 49 |
FCHSD2,ADAM28,SORL1,UBE2E2,GNAQ,NAV3,ST6GAL1,MAP4K4,ARHGAP24,PICALM,DSCAM,ZFHX3,ATP8B4,PTPRJ,ANKRD44,PLXDC2,ABCC4,ST6GALNAC3,DOCK8,KCNQ3,QKI,HDAC9,MAML3,DIP2B,MEF2C,MAML2,MED13L,TCF12,SLC9A9,DOCK4,EPB41L2,SFMBT2,SLC8A1,MEF2A,ELMO1,ARHGAP26,ITPR2,FRMD4A,TBC1D22A,ZSWIM6,SSH2 |
8.065e-04 | -7.12 | acute_myeloid_leukaemia | COSMIC cancer mutations | acute_myeloid_leukaemia | 10418 | 41 | 16828 | 49 |
DSCAM,ZFHX3,ATP8B4,ABCC4,ST6GALNAC3,PTPRJ,ANKRD44,PLXDC2,ARHGAP24,PICALM,MAP4K4,ST6GAL1,NAV3,SORL1,ADAM28,UBE2E2,FCHSD2,GNAQ,ITPR2,FRMD4A,MEF2A,ELMO1,ARHGAP26,SSH2,TBC1D22A,ZSWIM6,SLC9A9,SFMBT2,SLC8A1,EPB41L2,DOCK4,MEF2C,TCF12,MAML2,MED13L,KCNQ3,QKI,DOCK8,DIP2B,HDAC9,MAML3 |
8.235e-04 | -7.10 | Constitutive Signaling by NOTCH1 PEST Domain Mutants | REACTOME pathways | R-HSA-2644606 | 58 | 3 | 10285 | 33 |
MAML3,HDAC9,MAML2 |
8.235e-04 | -7.10 | Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | REACTOME pathways | R-HSA-2894862 | 58 | 3 | 10285 | 33 |
HDAC9,MAML2,MAML3 |
8.235e-04 | -7.10 | Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | REACTOME pathways | R-HSA-2894858 | 58 | 3 | 10285 | 33 |
HDAC9,MAML2,MAML3 |
8.235e-04 | -7.10 | Signaling by NOTCH1 PEST Domain Mutants in Cancer | REACTOME pathways | R-HSA-2644602 | 58 | 3 | 10285 | 33 |
MAML2,HDAC9,MAML3 |
8.235e-04 | -7.10 | Signaling by NOTCH1 in Cancer | REACTOME pathways | R-HSA-2644603 | 58 | 3 | 10285 | 33 |
MAML3,MAML2,HDAC9 |
8.392e-04 | -7.08 | RHOGAP | prosite domains | PS50238 | 65 | 3 | 12186 | 35 |
ARHGAP22,ARHGAP24,ARHGAP26 |
8.491e-04 | -7.07 | cellular response to calcium ion | biological process | GO:0071277 | 72 | 3 | 18204 | 47 |
MEF2C,KCNQ3,MEF2A |
8.590e-04 | -7.06 | NOTCH4 (notch receptor 4) | protein interactions | 4855 | 17 | 2 | 19454 | 50 |
MAML3,MAML2 |
8.681e-04 | -7.05 | lymphoid_neoplasm | COSMIC cancer mutations | lymphoid_neoplasm | 12233 | 45 | 16828 | 49 |
ARHGAP24,MAP4K4,ST6GAL1,ATP8B4,DSCAM,ABCC4,PLXDC2,PTPRJ,ANKRD44,UBE2E2,SORL1,GNAQ,CHST11,ZFAND3,ZBTB20,SLC8A1,SFMBT2,DOCK4,EPB41L2,ELMO1,ARHGAP26,MEF2A,SSH2,ZSWIM6,QKI,KCNQ3,HDAC9,TCF12,MED13L,PICALM,SYNDIG1,ZFHX3,ST6GALNAC3,APBB1IP,ADAM28,NAV3,SLC9A9,FRMD4A,ITPR2,TBC1D22A,DOCK8,DIP2B,MAML3,MEF2C,MAML2 |
9.104e-04 | -7.00 | regulation of cellular component organization | biological process | GO:0051128 | 2455 | 15 | 18204 | 47 |
MEF2C,ARHGAP24,MAP4K4,FCHSD2,DSCAM,NAV3,SSH2,TBC1D22A,SYNDIG1,PTPRJ,DIP2B,DISC1,SORL1,ARHGAP22,PICALM |
9.140e-04 | -7.00 | embryonal | COSMIC cancer mutations | embryonal | 2659 | 17 | 16828 | 49 |
MEF2A,ELMO1,ZFHX3,DSCAM,ATP8B4,PTPRJ,ABCC4,ZFAND3,DOCK4,SYNDIG1,SFMBT2,MAML2,DOCK8,KCNQ3,SORL1,DIP2B,GNAQ |
9.140e-04 | -7.00 | soft_tissue-striated_muscle-rhabdomyosarcoma-embryonal | COSMIC cancer mutations | soft_tissue-striated_muscle-rhabdomyosarcoma-embryonal | 2659 | 17 | 16828 | 49 |
DIP2B,GNAQ,DOCK8,SORL1,KCNQ3,MAML2,DOCK4,SYNDIG1,SFMBT2,ZFAND3,PTPRJ,ABCC4,MEF2A,ELMO1,ZFHX3,DSCAM,ATP8B4 |
9.470e-04 | -6.96 | HDAC9 (histone deacetylase 9) | protein interactions | 9734 | 75 | 3 | 19454 | 50 |
MEF2C,HDAC9,MEF2A |
9.470e-04 | -6.96 | MEF2A (myocyte enhancer factor 2A) | protein interactions | 4205 | 75 | 3 | 19454 | 50 |
HDAC9,MEF2A,MEF2C |
9.479e-04 | -6.96 | cervix-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | cervix-carcinoma-squamous_cell_carcinoma | 11789 | 44 | 16828 | 49 |
TCF12,MED13L,HDAC9,QKI,KCNQ3,SSH2,ZSWIM6,ELMO1,MEF2A,SLC8A1,SFMBT2,DOCK4,ZBTB20,CHST11,GNAQ,DISC1,SORL1,FCHSD2,ABCC4,PLXDC2,PTPRJ,ANKRD44,ATP8B4,DSCAM,ARHGAP24,ARHGAP22,ST6GAL1,MAP4K4,MAML2,MEF2C,DIP2B,MAML3,DOCK8,TBC1D22A,FRMD4A,ITPR2,SLC9A9,NAV3,APBB1IP,ADAM28,ST6GALNAC3,ZFHX3,PICALM,SYNDIG1 |
9.587e-04 | -6.95 | cervix | COSMIC cancer mutations | cervix | 11793 | 44 | 16828 | 49 |
CHST11,NAV3,GNAQ,APBB1IP,ADAM28,DISC1,SORL1,FCHSD2,ST6GALNAC3,ABCC4,PLXDC2,ANKRD44,PTPRJ,ATP8B4,DSCAM,ZFHX3,ARHGAP24,PICALM,ARHGAP22,SYNDIG1,MAP4K4,ST6GAL1,TCF12,MED13L,MAML2,MEF2C,DIP2B,MAML3,HDAC9,QKI,KCNQ3,DOCK8,SSH2,ZSWIM6,TBC1D22A,FRMD4A,ITPR2,ELMO1,MEF2A,SLC8A1,SFMBT2,DOCK4,SLC9A9,ZBTB20 |
9.648e-04 | -6.94 | ZNF365 (zinc finger protein 365) | protein interactions | 22891 | 18 | 2 | 19454 | 50 |
DSCAM,DISC1 |
9.750e-04 | -6.93 | regulation of cell adhesion | biological process | GO:0030155 | 807 | 8 | 18204 | 47 |
DOCK8,ST6GAL1,PTPRJ,DISC1,MAP4K4,ZFHX3,DSCAM,APBB1IP |
9.903e-04 | -6.92 | skin-leg-malignant_melanoma | COSMIC cancer mutations | skin-leg-malignant_melanoma | 549 | 7 | 16828 | 49 |
ZBTB20,SORL1,APBB1IP,SFMBT2,GNAQ,PTPRJ,PLXDC2 |
9.936e-04 | -6.91 | regulation of axon extension | biological process | GO:0030516 | 76 | 3 | 18204 | 47 |
DISC1,DIP2B,DSCAM |
1.030e-03 | -6.88 | FLOT1 (flotillin 1) | protein interactions | 10211 | 453 | 6 | 19454 | 50 |
DISC1,MAP4K4,PICALM,DIP2B,EPB41L2,SLC9A9 |
1.032e-03 | -6.88 | clear_cell_renal_cell_carcinoma | COSMIC cancer mutations | clear_cell_renal_cell_carcinoma | 13924 | 48 | 16828 | 49 |
APBB1IP,ADAM28,NAV3,SYNDIG1,PICALM,ST6GALNAC3,ZFHX3,MAML3,DIP2B,DOCK8,MAML2,MEF2C,SLC9A9,TBC1D22A,FRMD4A,ITPR2,GNAQ,FCHSD2,UBE2E2,SORL1,DISC1,CHST11,MAP4K4,ST6GAL1,ARHGAP24,ARHGAP22,PLXDC2,PTPRJ,ANKRD44,ABCC4,ATP8B4,DSCAM,HDAC9,QKI,KCNQ3,MED13L,TCF12,EPB41L2,DOCK4,SLC8A1,SFMBT2,ZFAND3,ZBTB20,ZSWIM6,SSH2,ARHGAP26,ELMO1,MEF2A |
1.032e-03 | -6.88 | kidney-carcinoma-clear_cell_renal_cell_carcinoma | COSMIC cancer mutations | kidney-carcinoma-clear_cell_renal_cell_carcinoma | 13924 | 48 | 16828 | 49 |
ABCC4,PTPRJ,ANKRD44,PLXDC2,DSCAM,ATP8B4,ARHGAP22,ARHGAP24,ST6GAL1,MAP4K4,CHST11,GNAQ,DISC1,SORL1,UBE2E2,FCHSD2,SSH2,ZSWIM6,MEF2A,ELMO1,ARHGAP26,SFMBT2,SLC8A1,DOCK4,EPB41L2,ZBTB20,ZFAND3,TCF12,MED13L,HDAC9,KCNQ3,QKI,ST6GALNAC3,ZFHX3,PICALM,SYNDIG1,NAV3,ADAM28,APBB1IP,TBC1D22A,ITPR2,FRMD4A,SLC9A9,MAML2,MEF2C,DIP2B,MAML3,DOCK8 |
1.040e-03 | -6.87 | regulation of biological process | biological process | GO:0050789 | 12079 | 41 | 18204 | 47 |
DISC1,LDLRAD4,ZBTB20,SORL1,APBB1IP,ABCC4,UBE2E2,TBC1D22A,SSH2,MEF2A,PTPRJ,FCHSD2,SFMBT2,DSCAM,DOCK4,DOCK8,KCNQ3,ST6GAL1,QKI,ARHGAP24,EPB41L2,MAML3,MAML2,TCF12,SLC8A1,ARHGAP22,PICALM,NAV3,FRMD4A,DIP2B,ARHGAP26,SYNDIG1,HDAC9,MAP4K4,ZFHX3,ITPR2,MED13L,MEF2C,GNAQ,ELMO1,CHST11 |
1.050e-03 | -6.86 | Rho GTPase activation protein | gene3d domains | 1.10.555.10 | 66 | 3 | 14470 | 44 |
ARHGAP24,ARHGAP26,ARHGAP22 |
1.075e-03 | -6.84 | regulation of nervous system development | biological process | GO:0051960 | 456 | 6 | 18204 | 47 |
QKI,SYNDIG1,DIP2B,DSCAM,SORL1,DISC1 |
1.113e-03 | -6.80 | skin-arm-malignant_melanoma | COSMIC cancer mutations | skin-arm-malignant_melanoma | 1308 | 11 | 16828 | 49 |
PTPRJ,MED13L,PLXDC2,ZFHX3,ATP8B4,GNAQ,SLC8A1,ADAM28,SORL1,ZBTB20,DOCK8 |
1.165e-03 | -6.76 | lung-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | lung-carcinoma-squamous_cell_carcinoma | 14664 | 49 | 16828 | 49 |
TCF12,MED13L,HDAC9,KCNQ3,QKI,SSH2,ZSWIM6,MEF2A,ELMO1,ARHGAP26,SFMBT2,SLC8A1,DOCK4,EPB41L2,ZBTB20,ZFAND3,CHST11,GNAQ,SORL1,DISC1,UBE2E2,FCHSD2,ABCC4,ANKRD44,PTPRJ,PLXDC2,DSCAM,ATP8B4,ARHGAP22,ARHGAP24,ST6GAL1,MAP4K4,MAML2,MEF2C,DIP2B,MAML3,DOCK8,TBC1D22A,ITPR2,FRMD4A,SLC9A9,HS3ST4,NAV3,ADAM28,APBB1IP,ST6GALNAC3,ZFHX3,PICALM,SYNDIG1 |
1.194e-03 | -6.73 | MYF6 (myogenic factor 6) | protein interactions | 4618 | 20 | 2 | 19454 | 50 |
TCF12,DISC1 |
1.194e-03 | -6.73 | HAND1 (heart and neural crest derivatives expressed 1) | protein interactions | 9421 | 20 | 2 | 19454 | 50 |
MEF2A,TCF12 |
1.196e-03 | -6.73 | positive regulation of biological process | biological process | GO:0048518 | 6326 | 27 | 18204 | 47 |
TCF12,MAML2,MAML3,EPB41L2,PICALM,SLC8A1,NAV3,FRMD4A,HDAC9,DIP2B,SYNDIG1,MAP4K4,ZFHX3,MEF2C,SORL1,ZBTB20,DISC1,UBE2E2,APBB1IP,MEF2A,PTPRJ,FCHSD2,DSCAM,DOCK4,DOCK8,ST6GAL1,QKI |
1.233e-03 | -6.70 | intracellular signaling cassette | biological process | GO:0141124 | 837 | 8 | 18204 | 47 |
DOCK8,MAP4K4,MEF2C,DOCK4,ITPR2,ELMO1,MEF2A,SLC8A1 |
1.264e-03 | -6.67 | signaling | biological process | GO:0023052 | 4968 | 23 | 18204 | 47 |
KCNQ3,CHST11,ELMO1,ARHGAP24,MEF2C,GNAQ,DOCK8,ITPR2,DOCK4,DSCAM,MAP4K4,FCHSD2,ARHGAP26,PTPRJ,MEF2A,SLC8A1,ABCC4,APBB1IP,ARHGAP22,MAML3,MAML2,DISC1,SORL1 |
1.271e-03 | -6.67 | oesophagus-middle_third-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | oesophagus-middle_third-carcinoma-squamous_cell_carcinoma | 3531 | 20 | 16828 | 49 |
DOCK8,SORL1,DIP2B,NAV3,MEF2C,MAML2,SLC9A9,ZBTB20,MAP4K4,EPB41L2,SYNDIG1,SFMBT2,SLC8A1,PICALM,MEF2A,ZFHX3,DSCAM,FRMD4A,ATP8B4,PTPRJ |
1.281e-03 | -6.66 | middle_third | COSMIC cancer mutations | middle_third | 3533 | 20 | 16828 | 49 |
SLC9A9,ZBTB20,SYNDIG1,MAP4K4,EPB41L2,SLC8A1,PICALM,SFMBT2,MEF2A,FRMD4A,ATP8B4,ZFHX3,DSCAM,PTPRJ,DOCK8,SORL1,DIP2B,NAV3,MEF2C,MAML2 |
1.284e-03 | -6.66 | arm | COSMIC cancer mutations | arm | 1331 | 11 | 16828 | 49 |
GNAQ,DOCK8,ADAM28,SORL1,MED13L,SLC8A1,ZBTB20,PTPRJ,PLXDC2,ZFHX3,ATP8B4 |
1.306e-03 | -6.64 | SMAD binding | molecular function | GO:0046332 | 78 | 3 | 18094 | 50 |
LDLRAD4,MEF2A,TCF12 |
1.316e-03 | -6.63 | Glyco_trans_29 | interpro domains | IPR001675 | 20 | 2 | 18521 | 50 |
ST6GAL1,ST6GALNAC3 |
1.328e-03 | -6.62 | negative regulation of cellular process | biological process | GO:0048523 | 5320 | 24 | 18204 | 47 |
NAV3,FRMD4A,SSH2,DIP2B,MEF2A,PTPRJ,HDAC9,LDLRAD4,SORL1,ZBTB20,SLC8A1,PICALM,MEF2C,DOCK8,GNAQ,CHST11,ST6GAL1,QKI,ARHGAP24,MAP4K4,ZFHX3,SFMBT2,ITPR2,DSCAM |
1.331e-03 | -6.62 | early endosome membrane | cellular component | GO:0031901 | 195 | 4 | 19108 | 47 |
SORL1,SLC9A9,SYNDIG1,LDLRAD4 |
1.367e-03 | -6.59 | Glyco_transf_29 | pfam domains | PF00777 | 20 | 2 | 17795 | 49 |
ST6GALNAC3,ST6GAL1 |
1.374e-03 | -6.59 | regulation of cell migration | biological process | GO:0030334 | 1061 | 9 | 18204 | 47 |
PTPRJ,HDAC9,NAV3,MEF2C,DOCK8,DOCK4,MAP4K4,LDLRAD4,SORL1 |
1.430e-03 | -6.55 | cell communication | biological process | GO:0007154 | 5010 | 23 | 18204 | 47 |
ITPR2,MAP4K4,CHST11,ELMO1,MEF2C,GNAQ,SLC8A1,ARHGAP22,MAML3,MAML2,ARHGAP26,DSCAM,DOCK4,FCHSD2,KCNQ3,ARHGAP24,DOCK8,ABCC4,APBB1IP,DISC1,SORL1,PTPRJ,MEF2A |
1.452e-03 | -6.54 | GT29-like_sf | interpro domains | IPR038578 | 21 | 2 | 18521 | 50 |
ST6GAL1,ST6GALNAC3 |
1.490e-03 | -6.51 | positive regulation of cell adhesion | biological process | GO:0045785 | 486 | 6 | 18204 | 47 |
APBB1IP,ZFHX3,MAP4K4,DISC1,PTPRJ,DOCK8 |
1.506e-03 | -6.50 | stomach-carcinoma-mixed_intestinal_and_diffuse_adenocarcinoma-unclassifiable | COSMIC cancer mutations | stomach-carcinoma-mixed_intestinal_and_diffuse_adenocarcinoma-unclassifiable | 951 | 9 | 16828 | 49 |
SLC8A1,SFMBT2,GNAQ,ANKRD44,ATP8B4,ITPR2,ZFHX3,DSCAM,ELMO1 |
1.506e-03 | -6.50 | mixed_intestinal_and_diffuse_adenocarcinoma-unclassifiable | COSMIC cancer mutations | mixed_intestinal_and_diffuse_adenocarcinoma-unclassifiable | 951 | 9 | 16828 | 49 |
ANKRD44,ELMO1,ATP8B4,ITPR2,DSCAM,ZFHX3,SLC8A1,SFMBT2,GNAQ |
1.517e-03 | -6.49 | skin-face-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | skin-face-carcinoma-squamous_cell_carcinoma | 2036 | 14 | 16828 | 49 |
ITPR2,ZFHX3,DSCAM,ABCC4,PTPRJ,SFMBT2,SLC8A1,PICALM,ARHGAP24,NAV3,MED13L,ADAM28,SORL1,KCNQ3 |
1.520e-03 | -6.49 | sialyltransferase activity | molecular function | GO:0008373 | 21 | 2 | 18094 | 50 |
ST6GALNAC3,ST6GAL1 |
1.553e-03 | -6.47 | SLC25A41 (solute carrier family 25 member 41) | protein interactions | 284427 | 89 | 3 | 19454 | 50 |
MAP4K4,PICALM,GNAQ |
1.558e-03 | -6.46 | positive regulation of cellular process | biological process | GO:0048522 | 5719 | 25 | 18204 | 47 |
ZFHX3,MAP4K4,MEF2C,PICALM,TCF12,EPB41L2,MAML3,MAML2,HDAC9,SYNDIG1,FRMD4A,NAV3,DOCK4,DSCAM,FCHSD2,QKI,ST6GAL1,DOCK8,UBE2E2,APBB1IP,SORL1,ZBTB20,DISC1,PTPRJ,MEF2A |
1.565e-03 | -6.46 | neuron differentiation | biological process | GO:0030182 | 1081 | 9 | 18204 | 47 |
MEF2C,HDAC9,KCNQ3,MEF2A,ZSWIM6,DISC1,MAP4K4,DSCAM,PICALM |
1.568e-03 | -6.46 | regulation of leukocyte apoptotic process | biological process | GO:2000106 | 89 | 3 | 18204 | 47 |
MEF2C,DOCK8,ST6GAL1 |
1.572e-03 | -6.46 | Myh9 (myosin, heavy polypeptide 9, non-muscle) | protein interactions | 17886 | 195 | 4 | 19454 | 50 |
EPB41L2,SSH2,PICALM,ZBTB20 |
1.606e-03 | -6.43 | Signaling by NOTCH1 | REACTOME pathways | R-HSA-1980143 | 73 | 3 | 10285 | 33 |
MAML2,HDAC9,MAML3 |
1.626e-03 | -6.42 | FERM_1 | prosite domains | PS00660 | 21 | 2 | 12186 | 35 |
EPB41L2,FRMD4A |
1.637e-03 | -6.42 | negative regulation of biological process | biological process | GO:0048519 | 5737 | 25 | 18204 | 47 |
DOCK4,DSCAM,ITPR2,SFMBT2,ZFHX3,MAP4K4,ARHGAP24,QKI,ST6GAL1,CHST11,DOCK8,GNAQ,MEF2C,PICALM,SLC8A1,SORL1,ZBTB20,LDLRAD4,HDAC9,PTPRJ,DIP2B,MEF2A,SSH2,FRMD4A,NAV3 |
1.666e-03 | -6.40 | RhoGAP | smart domains | SM00324 | 64 | 3 | 9717 | 36 |
ARHGAP24,ARHGAP22,ARHGAP26 |
1.671e-03 | -6.39 | regulation of smooth muscle cell migration | biological process | GO:0014910 | 91 | 3 | 18204 | 47 |
MEF2C,SORL1,DOCK4 |
1.714e-03 | -6.37 | leg | COSMIC cancer mutations | leg | 969 | 9 | 16828 | 49 |
PTPRJ,PLXDC2,SLC9A9,ZBTB20,SORL1,APBB1IP,SFMBT2,GNAQ,SLC8A1 |
1.716e-03 | -6.37 | NOTCH1 (notch receptor 1) | protein interactions | 4851 | 338 | 5 | 19454 | 50 |
MAML2,ANKRD44,TCF12,MEF2C,MAML3 |
1.723e-03 | -6.36 | VGLL4 (vestigial like family member 4) | protein interactions | 9686 | 24 | 2 | 19454 | 50 |
MEF2C,MEF2A |
1.730e-03 | -6.36 | PH | pfam domains | PF00169 | 187 | 4 | 17795 | 49 |
ARHGAP24,ARHGAP26,ARHGAP22,APBB1IP |
1.737e-03 | -6.36 | sodium ion import across plasma membrane | biological process | GO:0098719 | 24 | 2 | 18204 | 47 |
SLC8A1,SLC9A9 |
1.761e-03 | -6.34 | mesothelioma | COSMIC cancer mutations | mesothelioma | 4477 | 23 | 16828 | 49 |
ARHGAP26,FRMD4A,ITPR2,SLC9A9,MED13L,MAML2,TCF12,MEF2C,HDAC9,QKI,PTPRJ,ANKRD44,MAP4K4,ST6GAL1,PICALM,ARHGAP24,ARHGAP22,NAV3,GNAQ,FCHSD2,APBB1IP,UBE2E2,ADAM28 |
1.778e-03 | -6.33 | Golgi apparatus | cellular component | GO:0005794 | 1645 | 11 | 19108 | 47 |
LDLRAD4,GNAQ,ST6GAL1,ATP8B4,ABCC4,SORL1,DOCK4,CHST11,ST6GALNAC3,PICALM,HS3ST4 |
1.779e-03 | -6.33 | regulation of extent of cell growth | biological process | GO:0061387 | 93 | 3 | 18204 | 47 |
DIP2B,DSCAM,DISC1 |
1.786e-03 | -6.33 | FERM_2 | prosite domains | PS00661 | 22 | 2 | 12186 | 35 |
EPB41L2,FRMD4A |
1.786e-03 | -6.33 | import into cell | biological process | GO:0098657 | 687 | 7 | 18204 | 47 |
PICALM,ELMO1,SLC8A1,KCNQ3,SLC9A9,SORL1,FCHSD2 |
1.829e-03 | -6.30 | Glycosyl transferase family 29 | gene3d domains | 3.90.1480.20 | 21 | 2 | 14470 | 44 |
ST6GAL1,ST6GALNAC3 |
1.844e-03 | -6.30 | Rho_GTPase_activation_prot | interpro domains | IPR008936 | 90 | 3 | 18521 | 50 |
ARHGAP22,ARHGAP24,ARHGAP26 |
1.873e-03 | -6.28 | skin-foot-malignant_melanoma | COSMIC cancer mutations | skin-foot-malignant_melanoma | 84 | 3 | 16828 | 49 |
ADAM28,GNAQ,PTPRJ |
1.890e-03 | -6.27 | cardiac muscle cell differentiation | biological process | GO:0055007 | 95 | 3 | 18204 | 47 |
MEF2A,SLC8A1,MEF2C |
1.898e-03 | -6.27 | FERM_CS | interpro domains | IPR019747 | 24 | 2 | 18521 | 50 |
FRMD4A,EPB41L2 |
1.913e-03 | -6.26 | human chr6q23.1-q23.2 | chromosome location | human chr6q23.1-q23.2 | 1 | 1 | 26134 | 50 |
EPB41L2 |
1.913e-03 | -6.26 | human chr16q22.2-q22.3 | chromosome location | human chr16q22.2-q22.3 | 1 | 1 | 26134 | 50 |
ZFHX3 |
1.913e-03 | -6.26 | human chr10q11.22-q11.23 | chromosome location | human chr10q11.22-q11.23 | 1 | 1 | 26134 | 50 |
ARHGAP22 |
1.913e-03 | -6.26 | human chr7p14.2-p14.1 | chromosome location | human chr7p14.2-p14.1 | 1 | 1 | 26134 | 50 |
ELMO1 |
1.913e-03 | -6.26 | human chr4q21.23-q21.3 | chromosome location | human chr4q21.23-q21.3 | 1 | 1 | 26134 | 50 |
ARHGAP24 |
2.023e-03 | -6.20 | regulation of cell motility | biological process | GO:2000145 | 1122 | 9 | 18204 | 47 |
NAV3,MEF2C,DOCK8,PTPRJ,HDAC9,MAP4K4,LDLRAD4,SORL1,DOCK4 |
2.038e-03 | -6.20 | positive regulation of focal adhesion assembly | biological process | GO:0051894 | 26 | 2 | 18204 | 47 |
MAP4K4,PTPRJ |
2.118e-03 | -6.16 | renal_cell_carcinoma | COSMIC cancer mutations | renal_cell_carcinoma | 4535 | 23 | 16828 | 49 |
ANKRD44,PTPRJ,ARHGAP22,PICALM,ARHGAP24,MAP4K4,ST6GAL1,NAV3,GNAQ,ADAM28,APBB1IP,UBE2E2,FCHSD2,ITPR2,FRMD4A,ARHGAP26,SLC9A9,TCF12,MAML2,MED13L,MEF2C,HDAC9,QKI |
2.118e-03 | -6.16 | kidney-carcinoma-renal_cell_carcinoma | COSMIC cancer mutations | kidney-carcinoma-renal_cell_carcinoma | 4535 | 23 | 16828 | 49 |
ARHGAP26,FRMD4A,ITPR2,SLC9A9,MED13L,MAML2,TCF12,MEF2C,HDAC9,QKI,ANKRD44,PTPRJ,MAP4K4,ST6GAL1,PICALM,ARHGAP24,ARHGAP22,NAV3,GNAQ,FCHSD2,APBB1IP,UBE2E2,ADAM28 |
2.118e-03 | -6.16 | muscle structure development | biological process | GO:0061061 | 521 | 6 | 18204 | 47 |
QKI,SLC8A1,MEF2A,TCF12,ZFHX3,MEF2C |
2.127e-03 | -6.15 | activation of GTPase activity | biological process | GO:0090630 | 99 | 3 | 18204 | 47 |
TBC1D22A,ARHGAP22,ARHGAP24 |
2.146e-03 | -6.14 | Globo Sphingolipid Metabolism | WikiPathways | WP1424 | 22 | 2 | 5310 | 17 |
ST6GAL1,ST6GALNAC3 |
2.168e-03 | -6.13 | ANXA6 (annexin A6) | protein interactions | 309 | 100 | 3 | 19454 | 50 |
ARHGAP24,DOCK8,CHST11 |
2.168e-03 | -6.13 | HRAS (HRas proto-oncogene, GTPase) | protein interactions | 3265 | 712 | 7 | 19454 | 50 |
EPB41L2,FRMD4A,APBB1IP,GNAQ,PTPRJ,DOCK8,MAP4K4 |
2.215e-03 | -6.11 | ERK/MAPK targets | REACTOME pathways | R-HSA-198753 | 22 | 2 | 10285 | 33 |
MEF2C,MEF2A |
2.220e-03 | -6.11 | autonomic_ganglia-neuroblastoma | COSMIC cancer mutations | autonomic_ganglia-neuroblastoma | 3970 | 21 | 16828 | 49 |
ATP8B4,ZFHX3,ELMO1,ARHGAP26,ABCC4,TBC1D22A,PICALM,SLC8A1,DOCK4,EPB41L2,MEF2C,CHST11,NAV3,MAML2,ADAM28,KCNQ3,SORL1,DOCK8,FCHSD2,GNAQ,DIP2B |
2.227e-03 | -6.11 | neuroblastoma | COSMIC cancer mutations | neuroblastoma | 3971 | 21 | 16828 | 49 |
DIP2B,GNAQ,DOCK8,FCHSD2,KCNQ3,ADAM28,SORL1,MAML2,NAV3,MEF2C,CHST11,EPB41L2,DOCK4,PICALM,SLC8A1,TBC1D22A,ABCC4,ARHGAP26,ELMO1,ATP8B4,ZFHX3 |
2.261e-03 | -6.09 | skin-scalp-malignant_melanoma | COSMIC cancer mutations | skin-scalp-malignant_melanoma | 634 | 7 | 16828 | 49 |
PTPRJ,MED13L,ARHGAP26,ARHGAP22,GNAQ,ADAM28,SORL1 |
2.345e-03 | -6.06 | regulation of cell junction assembly | biological process | GO:1901888 | 217 | 4 | 18204 | 47 |
PTPRJ,SYNDIG1,MEF2C,MAP4K4 |
2.362e-03 | -6.05 | skin-head_neck-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | skin-head_neck-carcinoma-squamous_cell_carcinoma | 14191 | 48 | 16828 | 49 |
MEF2C,MAML2,DOCK8,DIP2B,MAML3,FRMD4A,ITPR2,TBC1D22A,SLC9A9,NAV3,HS3ST4,APBB1IP,ADAM28,ZFHX3,ST6GALNAC3,PICALM,SYNDIG1,TCF12,MED13L,QKI,KCNQ3,HDAC9,ARHGAP26,ELMO1,MEF2A,SSH2,ZSWIM6,ZFAND3,ZBTB20,SLC8A1,SFMBT2,EPB41L2,DOCK4,CHST11,SORL1,DISC1,FCHSD2,GNAQ,ATP8B4,DSCAM,ABCC4,PLXDC2,PTPRJ,ANKRD44,ARHGAP24,ARHGAP22,ST6GAL1,MAP4K4 |
2.401e-03 | -6.03 | FERM_PH-like_C | interpro domains | IPR018980 | 27 | 2 | 18521 | 50 |
EPB41L2,FRMD4A |
2.424e-03 | -6.02 | GRK2 (G protein-coupled receptor kinase 2) | protein interactions | 156 | 104 | 3 | 19454 | 50 |
GNAQ,ARHGAP24,PTPRJ |
2.441e-03 | -6.02 | regulation of hydrolase activity | biological process | GO:0051336 | 726 | 7 | 18204 | 47 |
ARHGAP24,TBC1D22A,DOCK8,GNAQ,MEF2C,ARHGAP22,MAP4K4 |
2.448e-03 | -6.01 | circulatory system development | biological process | GO:0072359 | 933 | 8 | 18204 | 47 |
PTPRJ,MEF2A,QKI,ARHGAP24,HDAC9,MEF2C,SLC8A1,ARHGAP22 |
2.455e-03 | -6.01 | SMAD2 (SMAD family member 2) | protein interactions | 4087 | 367 | 5 | 19454 | 50 |
DOCK8,LDLRAD4,MEF2C,MEF2A,TCF12 |
2.490e-03 | -6.00 | autonomic_ganglia | COSMIC cancer mutations | autonomic_ganglia | 4005 | 21 | 16828 | 49 |
DIP2B,GNAQ,DOCK8,FCHSD2,ADAM28,KCNQ3,SORL1,MAML2,NAV3,MEF2C,CHST11,DOCK4,EPB41L2,SLC8A1,PICALM,TBC1D22A,ABCC4,ELMO1,ARHGAP26,ATP8B4,ZFHX3 |
2.495e-03 | -5.99 | FERM_C | pfam domains | PF09380 | 27 | 2 | 17795 | 49 |
EPB41L2,FRMD4A |
2.506e-03 | -5.99 | regulation of cell-substrate adhesion | biological process | GO:0010810 | 221 | 4 | 18204 | 47 |
PTPRJ,ST6GAL1,DISC1,MAP4K4 |
2.509e-03 | -5.99 | generation of neurons | biological process | GO:0048699 | 1158 | 9 | 18204 | 47 |
DSCAM,PICALM,MAP4K4,DISC1,ZSWIM6,KCNQ3,MEF2A,HDAC9,MEF2C |
2.570e-03 | -5.96 | NTA1 (amidase) | protein interactions | 853525 | 1 | 1 | 19454 | 50 |
DOCK8 |
2.570e-03 | -5.96 | ZNF781 (zinc finger protein 781) | protein interactions | 163115 | 1 | 1 | 19454 | 50 |
ARHGAP24 |
2.570e-03 | -5.96 | ZNF729 (zinc finger protein 729) | protein interactions | 100287226 | 1 | 1 | 19454 | 50 |
ARHGAP24 |
2.570e-03 | -5.96 | ZNF75D (zinc finger protein 75D) | protein interactions | 7626 | 1 | 1 | 19454 | 50 |
ARHGAP24 |
2.570e-03 | -5.96 | ZNF780B (zinc finger protein 780B) | protein interactions | 163131 | 1 | 1 | 19454 | 50 |
ARHGAP24 |
2.570e-03 | -5.96 | PLCB2 (phospholipase C beta 2) | protein interactions | 664713 | 1 | 1 | 19454 | 50 |
GNAQ |
2.570e-03 | -5.96 | ZNF880 (zinc finger protein 880) | protein interactions | 400713 | 1 | 1 | 19454 | 50 |
ARHGAP24 |
2.570e-03 | -5.96 | EUC1 (Euc1p) | protein interactions | 855138 | 1 | 1 | 19454 | 50 |
DOCK8 |
2.577e-03 | -5.96 | upper_back | COSMIC cancer mutations | upper_back | 328 | 5 | 16828 | 49 |
ELMO1,ATP8B4,KCNQ3,PTPRJ,GNAQ |
2.581e-03 | -5.96 | FERM_N | interpro domains | IPR018979 | 28 | 2 | 18521 | 50 |
EPB41L2,FRMD4A |
2.582e-03 | -5.96 | memory T cell proliferation | biological process | GO:0061485 | 1 | 1 | 18204 | 47 |
DOCK8 |
2.582e-03 | -5.96 | positive regulation of early endosome to recycling endosome transport | biological process | GO:1902955 | 1 | 1 | 18204 | 47 |
SORL1 |
2.582e-03 | -5.96 | apoptosome assembly | biological process | GO:0097314 | 1 | 1 | 18204 | 47 |
KCNQ3 |
2.582e-03 | -5.96 | negative regulation of neurofibrillary tangle assembly | biological process | GO:1902997 | 1 | 1 | 18204 | 47 |
SORL1 |
2.582e-03 | -5.96 | membrane bending | biological process | GO:0097753 | 1 | 1 | 18204 | 47 |
PICALM |
2.582e-03 | -5.96 | sinoatrial valve morphogenesis | biological process | GO:0003185 | 1 | 1 | 18204 | 47 |
MEF2C |
2.638e-03 | -5.94 | cytoplasm | cellular component | GO:0005737 | 12081 | 39 | 19108 | 47 |
ST6GAL1,SSH2,ATP8B4,ZFHX3,DOCK8,TCF12,PTPRJ,MEF2A,EPB41L2,PICALM,HS3ST4,SLC9A9,CHST11,DISC1,SFMBT2,DOCK4,ZBTB20,APBB1IP,FCHSD2,QKI,ELMO1,FRMD4A,ADAM28,ITPR2,GNAQ,ARHGAP26,LDLRAD4,DIP2B,SLC8A1,MEF2C,SYNDIG1,ARHGAP22,HDAC9,ARHGAP24,KCNQ3,ST6GALNAC3,MAP4K4,SORL1,ABCC4 |
2.682e-03 | -5.92 | FERM_N | pfam domains | PF09379 | 28 | 2 | 17795 | 49 |
EPB41L2,FRMD4A |
2.700e-03 | -5.91 | FCHSD2_SH3_2 | interpro domains | IPR035556 | 1 | 1 | 18521 | 50 |
FCHSD2 |
2.700e-03 | -5.91 | DHR2_DOCK4 | interpro domains | IPR037014 | 1 | 1 | 18521 | 50 |
DOCK4 |
2.700e-03 | -5.91 | GRAF_SH3 | interpro domains | IPR035481 | 1 | 1 | 18521 | 50 |
ARHGAP26 |
2.700e-03 | -5.91 | MBT_SFMBT2_rpt1 | interpro domains | IPR047353 | 1 | 1 | 18521 | 50 |
SFMBT2 |
2.700e-03 | -5.91 | DISC1 | interpro domains | IPR026081 | 1 | 1 | 18521 | 50 |
DISC1 |
2.700e-03 | -5.91 | ABCC4_TMD1 | interpro domains | IPR030240 | 1 | 1 | 18521 | 50 |
ABCC4 |
2.700e-03 | -5.91 | STAR_dimer | interpro domains | IPR032377 | 1 | 1 | 18521 | 50 |
QKI |
2.700e-03 | -5.91 | K_chnl_volt-dep_KCNQ3 | interpro domains | IPR003948 | 1 | 1 | 18521 | 50 |
KCNQ3 |
2.700e-03 | -5.91 | ABCC4_TMD2 | interpro domains | IPR047083 | 1 | 1 | 18521 | 50 |
ABCC4 |
2.700e-03 | -5.91 | GRAF_BAR | interpro domains | IPR035483 | 1 | 1 | 18521 | 50 |
ARHGAP26 |
2.700e-03 | -5.91 | Quaking_NLS | interpro domains | IPR032367 | 1 | 1 | 18521 | 50 |
QKI |
2.700e-03 | -5.91 | MBT_SFMBT2_rpt3 | interpro domains | IPR047354 | 1 | 1 | 18521 | 50 |
SFMBT2 |
2.700e-03 | -5.91 | NaCa_exhngr1 | interpro domains | IPR002987 | 1 | 1 | 18521 | 50 |
SLC8A1 |
2.700e-03 | -5.91 | DOCK4_SH3 | interpro domains | IPR035769 | 1 | 1 | 18521 | 50 |
DOCK4 |
2.700e-03 | -5.91 | MAML2_TAD | interpro domains | IPR048452 | 1 | 1 | 18521 | 50 |
MAML2 |
2.700e-03 | -5.91 | Mediator_Med13_N | interpro domains | IPR021643 | 1 | 1 | 18521 | 50 |
MED13L |
2.700e-03 | -5.91 | MBT_SFMBT2_rpt4 | interpro domains | IPR047355 | 1 | 1 | 18521 | 50 |
SFMBT2 |
2.700e-03 | -5.91 | FCHSD2_F-BAR_dom | interpro domains | IPR034934 | 1 | 1 | 18521 | 50 |
FCHSD2 |
2.721e-03 | -5.91 | cytoplasmic vesicle membrane | cellular component | GO:0030659 | 1230 | 9 | 19108 | 47 |
SORL1,ARHGAP26,PTPRJ,ABCC4,LDLRAD4,ATP8B4,SLC9A9,ITPR2,SYNDIG1 |
2.754e-03 | -5.89 | MAML2_TAD | pfam domains | PF20804 | 1 | 1 | 17795 | 49 |
MAML2 |
2.754e-03 | -5.89 | STAR_dimer | pfam domains | PF16544 | 1 | 1 | 17795 | 49 |
QKI |
2.754e-03 | -5.89 | Quaking_NLS | pfam domains | PF16551 | 1 | 1 | 17795 | 49 |
QKI |
2.754e-03 | -5.89 | Med13_N | pfam domains | PF11597 | 1 | 1 | 17795 | 49 |
MED13L |
2.763e-03 | -5.89 | internal N(7)-methylguanine-containing RNA reader activity | molecular function | GO:0160089 | 1 | 1 | 18094 | 50 |
QKI |
2.786e-03 | -5.88 | regulation of neurogenesis | biological process | GO:0050767 | 377 | 5 | 18204 | 47 |
DSCAM,QKI,DIP2B,SORL1,DISC1 |
2.842e-03 | -5.86 | NOTCH3 (notch receptor 3) | protein interactions | 4854 | 110 | 3 | 19454 | 50 |
MAML2,ANKRD44,MAML3 |
2.859e-03 | -5.86 | BAND41 | prints domains | PR00935 | 25 | 2 | 5227 | 17 |
FRMD4A,EPB41L2 |
2.860e-03 | -5.86 | Nuclear Events (kinase and transcription factor activation) | REACTOME pathways | R-HSA-198725 | 25 | 2 | 10285 | 33 |
MEF2A,MEF2C |
2.860e-03 | -5.86 | Termination of O-glycan biosynthesis | REACTOME pathways | R-HSA-977068 | 25 | 2 | 10285 | 33 |
ST6GAL1,ST6GALNAC3 |
2.869e-03 | -5.85 | positive regulation of cell junction assembly | biological process | GO:1901890 | 110 | 3 | 18204 | 47 |
PTPRJ,SYNDIG1,MAP4K4 |
2.892e-03 | -5.85 | positive regulation of cell-substrate junction organization | biological process | GO:0150117 | 31 | 2 | 18204 | 47 |
PTPRJ,MAP4K4 |
2.892e-03 | -5.85 | viral protein processing | biological process | GO:0019082 | 31 | 2 | 18204 | 47 |
ST6GALNAC3,ST6GAL1 |
2.922e-03 | -5.84 | cell differentiation | biological process | GO:0030154 | 3645 | 18 | 18204 | 47 |
DSCAM,MAP4K4,ARHGAP24,QKI,KCNQ3,CHST11,MEF2C,ARHGAP22,PICALM,SLC8A1,ZSWIM6,TCF12,DISC1,HDAC9,PTPRJ,MEF2A,SSH2,NAV3 |
2.928e-03 | -5.83 | multicellular organism development | biological process | GO:0007275 | 3957 | 19 | 18204 | 47 |
MAP4K4,DSCAM,MEF2C,QKI,ARHGAP24,CHST11,KCNQ3,TCF12,ZSWIM6,DISC1,PICALM,ARHGAP22,SLC8A1,NAV3,HDAC9,DIP2B,MEF2A,PTPRJ,ARHGAP26 |
2.948e-03 | -5.83 | skin-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | skin-carcinoma-squamous_cell_carcinoma | 493 | 6 | 16828 | 49 |
GNAQ,ABCC4,SLC8A1,MAML2,MAML3,ARHGAP26 |
2.950e-03 | -5.83 | cellular developmental process | biological process | GO:0048869 | 3648 | 18 | 18204 | 47 |
HDAC9,PTPRJ,MEF2A,SSH2,NAV3,PICALM,ARHGAP22,SLC8A1,ZSWIM6,TCF12,DISC1,QKI,ARHGAP24,CHST11,KCNQ3,MEF2C,DSCAM,MAP4K4 |
3.041e-03 | -5.80 | - | gene3d domains | 1.20.5.4010 | 1 | 1 | 14470 | 44 |
QKI |
3.050e-03 | -5.79 | vesicle membrane | cellular component | GO:0012506 | 1251 | 9 | 19108 | 47 |
ARHGAP26,SORL1,ABCC4,LDLRAD4,PTPRJ,ATP8B4,SLC9A9,SYNDIG1,ITPR2 |
3.057e-03 | -5.79 | KCNQ5 (potassium voltage-gated channel subfamily Q member 5) | protein interactions | 56479 | 32 | 2 | 19454 | 50 |
DISC1,KCNQ3 |
3.057e-03 | -5.79 | KRT222 (keratin 222) | protein interactions | 125113 | 32 | 2 | 19454 | 50 |
EPB41L2,DSCAM |
3.080e-03 | -5.78 | regulation of myeloid cell apoptotic process | biological process | GO:0033032 | 32 | 2 | 18204 | 47 |
ST6GAL1,MEF2C |
3.096e-03 | -5.78 | dendrite development | biological process | GO:0016358 | 113 | 3 | 18204 | 47 |
MEF2A,PICALM,DSCAM |
3.210e-03 | -5.74 | oesophagus | COSMIC cancer mutations | oesophagus | 14970 | 49 | 16828 | 49 |
APBB1IP,ADAM28,NAV3,HS3ST4,PICALM,SYNDIG1,ZFHX3,ST6GALNAC3,DOCK8,DIP2B,MAML3,MEF2C,MAML2,SLC9A9,FRMD4A,ITPR2,TBC1D22A,UBE2E2,DISC1,SORL1,FCHSD2,GNAQ,CHST11,ARHGAP24,ARHGAP22,ST6GAL1,MAP4K4,ATP8B4,DSCAM,ABCC4,PLXDC2,ANKRD44,PTPRJ,QKI,KCNQ3,HDAC9,TCF12,MED13L,ZFAND3,ZBTB20,SLC8A1,SFMBT2,EPB41L2,DOCK4,ARHGAP26,ELMO1,MEF2A,SSH2,ZSWIM6 |
3.222e-03 | -5.74 | ARF6 (ADP ribosylation factor 6) | protein interactions | 382 | 568 | 6 | 19454 | 50 |
EPB41L2,ZFHX3,SLC9A9,GNAQ,PICALM,MAP4K4 |
3.231e-03 | -5.74 | Canonical and Non-canonical Notch signaling | WikiPathways | WP3845 | 27 | 2 | 5310 | 17 |
MAML2,MAML3 |
3.241e-03 | -5.73 | positive regulation of multicellular organismal process | biological process | GO:0051240 | 1691 | 11 | 18204 | 47 |
SLC8A1,DSCAM,DISC1,SORL1,ZBTB20,MEF2A,SYNDIG1,PTPRJ,QKI,MEF2C,DOCK8 |
3.249e-03 | -5.73 | ZNF74 (zinc finger protein 74) | protein interactions | 7625 | 33 | 2 | 19454 | 50 |
SORL1,ARHGAP24 |
3.249e-03 | -5.73 | KATNAL1 (katanin catalytic subunit A1 like 1) | protein interactions | 84056 | 33 | 2 | 19454 | 50 |
DISC1,ARHGAP24 |
3.249e-03 | -5.73 | ELMO3 (engulfment and cell motility 3) | protein interactions | 79767 | 33 | 2 | 19454 | 50 |
ELMO1,DOCK4 |
3.252e-03 | -5.73 | NACAEXCHNGR1 | prints domains | PR01260 | 1 | 1 | 5227 | 17 |
SLC8A1 |
3.252e-03 | -5.73 | KCNQ3CHANNEL | prints domains | PR01462 | 1 | 1 | 5227 | 17 |
KCNQ3 |
3.258e-03 | -5.73 | signal transduction | biological process | GO:0007165 | 4637 | 21 | 18204 | 47 |
DISC1,MAML2,MAML3,SORL1,APBB1IP,SLC8A1,ARHGAP22,MEF2A,PTPRJ,ARHGAP26,MAP4K4,ITPR2,DOCK4,DSCAM,MEF2C,GNAQ,DOCK8,ELMO1,CHST11,KCNQ3,ARHGAP24 |
3.274e-03 | -5.72 | clathrin-dependent endocytosis | biological process | GO:0072583 | 33 | 2 | 18204 | 47 |
PICALM,FCHSD2 |
3.289e-03 | -5.72 | breast-carcinoma-basal_(triple-negative)_carcinoma | COSMIC cancer mutations | breast-carcinoma-basal_(triple-negative)_carcinoma | 2981 | 17 | 16828 | 49 |
MEF2C,TCF12,MAML2,SORL1,GNAQ,MAML3,ZFHX3,ARHGAP26,ELMO1,MEF2A,ST6GALNAC3,SSH2,ABCC4,PTPRJ,SLC9A9,PICALM,ARHGAP24 |
3.289e-03 | -5.72 | basal_(triple-negative)_carcinoma | COSMIC cancer mutations | basal_(triple-negative)_carcinoma | 2981 | 17 | 16828 | 49 |
MAML2,TCF12,MEF2C,MAML3,GNAQ,SORL1,PTPRJ,ST6GALNAC3,SSH2,ABCC4,ARHGAP26,ELMO1,MEF2A,ZFHX3,PICALM,ARHGAP24,SLC9A9 |
3.332e-03 | -5.70 | ovary-other-neoplasm | COSMIC cancer mutations | ovary-other-neoplasm | 12717 | 45 | 16828 | 49 |
APBB1IP,ADAM28,NAV3,HS3ST4,PICALM,SYNDIG1,ZFHX3,ST6GALNAC3,DOCK8,DIP2B,MAML3,MEF2C,MAML2,SLC9A9,FRMD4A,ITPR2,TBC1D22A,UBE2E2,SORL1,GNAQ,CHST11,ARHGAP22,MAP4K4,ST6GAL1,ATP8B4,DSCAM,ABCC4,PLXDC2,ANKRD44,PTPRJ,QKI,KCNQ3,TCF12,MED13L,ZFAND3,ZBTB20,SLC8A1,SFMBT2,EPB41L2,DOCK4,ELMO1,ARHGAP26,MEF2A,SSH2,ZSWIM6 |
3.359e-03 | -5.70 | Hemostasis | REACTOME pathways | R-HSA-109582 | 632 | 7 | 10285 | 33 |
DOCK8,ABCC4,SLC8A1,ITPR2,APBB1IP,GNAQ,DOCK4 |
3.384e-03 | -5.69 | nuclear speck | cellular component | GO:0016607 | 414 | 5 | 19108 | 47 |
MAML2,MAML3,TCF12,SFMBT2,MEF2C |
3.446e-03 | -5.67 | KALRN (kalirin RhoGEF kinase) | protein interactions | 8997 | 34 | 2 | 19454 | 50 |
DISC1,DSCAM |
3.590e-03 | -5.63 | ITSN1 (intersectin 1) | protein interactions | 6453 | 245 | 4 | 19454 | 50 |
DISC1,DOCK4,FCHSD2,PICALM |
3.681e-03 | -5.60 | regulation of synapse organization | biological process | GO:0050807 | 246 | 4 | 18204 | 47 |
MEF2C,DISC1,SYNDIG1,ARHGAP22 |
3.803e-03 | -5.57 | CSNK1D (casein kinase 1 delta) | protein interactions | 1453 | 249 | 4 | 19454 | 50 |
ARHGAP22,EPB41L2,ARHGAP26,LDLRAD4 |
3.805e-03 | -5.57 | MED31 (mediator complex subunit 31) | protein interactions | 51003 | 122 | 3 | 19454 | 50 |
QKI,ELMO1,MED13L |
3.857e-03 | -5.56 | MNS1 (meiosis specific nuclear structural 1) | protein interactions | 55329 | 36 | 2 | 19454 | 50 |
FCHSD2,DISC1 |
3.905e-03 | -5.55 | LIMA1 (LIM domain and actin binding 1) | protein interactions | 51474 | 409 | 5 | 19454 | 50 |
SSH2,PICALM,DISC1,ZBTB20,ARHGAP24 |
3.906e-03 | -5.55 | breast-carcinoma | COSMIC cancer mutations | breast-carcinoma | 15030 | 49 | 16828 | 49 |
ZSWIM6,SSH2,ARHGAP26,ELMO1,MEF2A,EPB41L2,DOCK4,SLC8A1,SFMBT2,ZFAND3,ZBTB20,MED13L,TCF12,HDAC9,QKI,KCNQ3,PLXDC2,ANKRD44,PTPRJ,ABCC4,ATP8B4,DSCAM,MAP4K4,ST6GAL1,ARHGAP24,ARHGAP22,CHST11,GNAQ,FCHSD2,UBE2E2,SORL1,DISC1,TBC1D22A,FRMD4A,ITPR2,SLC9A9,MAML2,MEF2C,MAML3,DIP2B,DOCK8,ST6GALNAC3,ZFHX3,SYNDIG1,PICALM,HS3ST4,NAV3,APBB1IP,ADAM28 |
4.010e-03 | -5.52 | regulation of synapse structure or activity | biological process | GO:0050803 | 252 | 4 | 18204 | 47 |
ARHGAP22,SYNDIG1,MEF2C,DISC1 |
4.020e-03 | -5.52 | action potential | biological process | GO:0001508 | 124 | 3 | 18204 | 47 |
KCNQ3,SLC8A1,GNAQ |
4.020e-03 | -5.52 | cardiocyte differentiation | biological process | GO:0035051 | 124 | 3 | 18204 | 47 |
SLC8A1,MEF2A,MEF2C |
4.020e-03 | -5.52 | positive regulation of cell-substrate adhesion | biological process | GO:0010811 | 124 | 3 | 18204 | 47 |
PTPRJ,MAP4K4,DISC1 |
4.053e-03 | -5.51 | adrenal_gland-adrenal_gland-adrenal_cortical_carcinoma-non_functioning | COSMIC cancer mutations | adrenal_gland-adrenal_gland-adrenal_cortical_carcinoma-non_functioning | 224 | 4 | 16828 | 49 |
HDAC9,PTPRJ,ABCC4,ATP8B4 |
4.071e-03 | -5.50 | TRNAU1AP (tRNA selenocysteine 1 associated protein 1) | protein interactions | 54952 | 37 | 2 | 19454 | 50 |
QKI,ZBTB20 |
4.102e-03 | -5.50 | positive regulation of axon extension | biological process | GO:0045773 | 37 | 2 | 18204 | 47 |
DSCAM,DISC1 |
4.102e-03 | -5.50 | smooth muscle cell differentiation | biological process | GO:0051145 | 37 | 2 | 18204 | 47 |
MEF2C,QKI |
4.106e-03 | -5.50 | Pre-NOTCH Transcription and Translation | REACTOME pathways | R-HSA-1912408 | 30 | 2 | 10285 | 33 |
MAML2,MAML3 |
4.112e-03 | -5.49 | regulation of cell-matrix adhesion | biological process | GO:0001952 | 125 | 3 | 18204 | 47 |
MAP4K4,DISC1,PTPRJ |
4.113e-03 | -5.49 | negative regulation of locomotion | biological process | GO:0040013 | 413 | 5 | 18204 | 47 |
MEF2C,NAV3,LDLRAD4,PTPRJ,ST6GAL1 |
4.165e-03 | -5.48 | GET3 (guided entry of tail-anchored proteins factor 3, ATPase) | protein interactions | 439 | 126 | 3 | 19454 | 50 |
DISC1,LDLRAD4,ZFHX3 |
4.186e-03 | -5.48 | cell projection | cellular component | GO:0042995 | 2398 | 13 | 19108 | 47 |
APBB1IP,FCHSD2,PTPRJ,DSCAM,DIP2B,GNAQ,DOCK8,SYNDIG1,ARHGAP24,KCNQ3,SLC8A1,DISC1,DOCK4 |
4.217e-03 | -5.47 | early endosome | cellular component | GO:0005769 | 436 | 5 | 19108 | 47 |
PICALM,SORL1,SLC9A9,LDLRAD4,SYNDIG1 |
4.258e-03 | -5.46 | PAX9 (paired box 9) | protein interactions | 5083 | 127 | 3 | 19454 | 50 |
ARHGAP24,QKI,ZFHX3 |
4.289e-03 | -5.45 | superficial_spreading | COSMIC cancer mutations | superficial_spreading | 1110 | 9 | 16828 | 49 |
KCNQ3,APBB1IP,SLC9A9,GNAQ,DIP2B,SLC8A1,ABCC4,TCF12,PLXDC2 |
4.290e-03 | -5.45 | PIMREG (PICALM interacting mitotic regulator) | protein interactions | 54478 | 38 | 2 | 19454 | 50 |
PICALM,DOCK8 |
4.335e-03 | -5.44 | kidney-other-neoplasm | COSMIC cancer mutations | kidney-other-neoplasm | 10653 | 40 | 16828 | 49 |
ANKRD44,PTPRJ,PLXDC2,ST6GALNAC3,ZFHX3,DSCAM,ATP8B4,MAP4K4,ST6GAL1,SYNDIG1,ARHGAP22,PICALM,ARHGAP24,NAV3,CHST11,GNAQ,SORL1,ADAM28,APBB1IP,UBE2E2,TBC1D22A,ZSWIM6,SSH2,ELMO1,ARHGAP26,ITPR2,FRMD4A,EPB41L2,SFMBT2,SLC8A1,ZBTB20,SLC9A9,ZFAND3,MAML2,MED13L,TCF12,DIP2B,DOCK8,KCNQ3,QKI |
4.361e-03 | -5.43 | secretory vesicle | cellular component | GO:0099503 | 1076 | 8 | 19108 | 47 |
ABCC4,PTPRJ,DISC1,SYNDIG1,ITPR2,PICALM,SSH2,ATP8B4 |
4.380e-03 | -5.43 | MAPK targets/ Nuclear events mediated by MAP kinases | REACTOME pathways | R-HSA-450282 | 31 | 2 | 10285 | 33 |
MEF2A,MEF2C |
4.380e-03 | -5.43 | Platelet calcium homeostasis | REACTOME pathways | R-HSA-418360 | 31 | 2 | 10285 | 33 |
ITPR2,SLC8A1 |
4.391e-03 | -5.43 | central_nervous_system-parietal_lobe-glioma-astrocytoma_Grade_I | COSMIC cancer mutations | central_nervous_system-parietal_lobe-glioma-astrocytoma_Grade_I | 34 | 2 | 16828 | 49 |
QKI,GNAQ |
4.419e-03 | -5.42 | FERM_C | smart domains | SM01196 | 27 | 2 | 9717 | 36 |
FRMD4A,EPB41L2 |
4.545e-03 | -5.39 | KIF3A (kinesin family member 3A) | protein interactions | 11127 | 130 | 3 | 19454 | 50 |
DSCAM,DISC1,SSH2 |
4.601e-03 | -5.38 | SH3 Domains | gene3d domains | 2.30.30.40 | 223 | 4 | 14470 | 44 |
FCHSD2,ELMO1,DOCK4,ARHGAP26 |
4.603e-03 | -5.38 | neuron projection | cellular component | GO:0043005 | 1331 | 9 | 19108 | 47 |
SLC8A1,FCHSD2,SYNDIG1,KCNQ3,DISC1,GNAQ,DOCK4,DSCAM,DIP2B |
4.619e-03 | -5.38 | Cholinergic synapse | KEGG pathways | hsa04725 | 112 | 3 | 7161 | 22 |
GNAQ,KCNQ3,ITPR2 |
4.646e-03 | -5.37 | nuclear body | cellular component | GO:0016604 | 856 | 7 | 19108 | 47 |
MAML3,TCF12,SFMBT2,ZBTB20,MAML2,MEF2C,ZFHX3 |
4.654e-03 | -5.37 | SH3 domain binding | molecular function | GO:0017124 | 122 | 3 | 18094 | 50 |
ELMO1,QKI,DOCK4 |
4.687e-03 | -5.36 | response to calcium ion | biological process | GO:0051592 | 131 | 3 | 18204 | 47 |
MEF2A,KCNQ3,MEF2C |
4.744e-03 | -5.35 | ACO1 (aconitase 1) | protein interactions | 48 | 40 | 2 | 19454 | 50 |
DSCAM,ARHGAP24 |
4.781e-03 | -5.34 | forebrain neuron differentiation | biological process | GO:0021879 | 40 | 2 | 18204 | 47 |
DISC1,ZSWIM6 |
4.837e-03 | -5.33 | actin filament-based process | biological process | GO:0030029 | 616 | 6 | 18204 | 47 |
SSH2,QKI,MEF2A,ELMO1,ARHGAP26,EPB41L2 |
4.912e-03 | -5.32 | central_nervous_system-thalamus-glioma-astrocytoma_Grade_I | COSMIC cancer mutations | central_nervous_system-thalamus-glioma-astrocytoma_Grade_I | 36 | 2 | 16828 | 49 |
QKI,GNAQ |
4.913e-03 | -5.32 | stereocilium shaft | cellular component | GO:0120043 | 2 | 1 | 19108 | 47 |
FCHSD2 |
4.913e-03 | -5.32 | endosome to plasma membrane transport vesicle | cellular component | GO:0070381 | 2 | 1 | 19108 | 47 |
PICALM |
4.954e-03 | -5.31 | Signaling by NOTCH2 | REACTOME pathways | R-HSA-1980145 | 33 | 2 | 10285 | 33 |
MAML3,MAML2 |
4.954e-03 | -5.31 | Sialic acid metabolism | REACTOME pathways | R-HSA-4085001 | 33 | 2 | 10285 | 33 |
ST6GAL1,ST6GALNAC3 |
4.966e-03 | -5.31 | LDLR_class-A_CS | interpro domains | IPR023415 | 39 | 2 | 18521 | 50 |
LDLRAD4,SORL1 |
4.980e-03 | -5.30 | SRGAP3 (SLIT-ROBO Rho GTPase activating protein 3) | protein interactions | 9901 | 41 | 2 | 19454 | 50 |
ARHGAP24,DISC1 |
5.047e-03 | -5.29 | multicellular organismal process | biological process | GO:0032501 | 6177 | 25 | 18204 | 47 |
NAV3,HDAC9,ARHGAP26,DIP2B,TCF12,PICALM,ARHGAP22,SLC8A1,GNAQ,MEF2C,CHST11,MAP4K4,PTPRJ,MEF2A,SORL1,ZSWIM6,DISC1,ABCC4,APBB1IP,DOCK8,ARHGAP24,QKI,KCNQ3,DOCK4,DSCAM |
5.049e-03 | -5.29 | Myo1c (myosin IC) | protein interactions | 17913 | 135 | 3 | 19454 | 50 |
ITPR2,PICALM,SSH2 |
5.096e-03 | -5.28 | non_functioning | COSMIC cancer mutations | non_functioning | 239 | 4 | 16828 | 49 |
ATP8B4,PTPRJ,HDAC9,ABCC4 |
5.134e-03 | -5.27 | ZNF736 (zinc finger protein 736) | protein interactions | 728927 | 2 | 1 | 19454 | 50 |
EPB41L2 |
5.134e-03 | -5.27 | Ric8b (RIC8 guanine nucleotide exchange factor B) | protein interactions | 237422 | 2 | 1 | 19454 | 50 |
GNAQ |
5.134e-03 | -5.27 | ZNF680 (zinc finger protein 680) | protein interactions | 340252 | 2 | 1 | 19454 | 50 |
ARHGAP24 |
5.134e-03 | -5.27 | Zfp521 (zinc finger protein 521) | protein interactions | 225207 | 2 | 1 | 19454 | 50 |
HDAC9 |
5.134e-03 | -5.27 | Agtr1a (angiotensin II receptor, type 1a) | protein interactions | 24180 | 2 | 1 | 19454 | 50 |
GNAQ |
5.134e-03 | -5.27 | ZNF658B (zinc finger protein 658B (pseudogene)) | protein interactions | 401509 | 2 | 1 | 19454 | 50 |
ARHGAP24 |
5.157e-03 | -5.27 | negative regulation of 3'-UTR-mediated mRNA stabilization | biological process | GO:1905869 | 2 | 1 | 18204 | 47 |
QKI |
5.157e-03 | -5.27 | NMDA selective glutamate receptor signaling pathway | biological process | GO:0098989 | 2 | 1 | 18204 | 47 |
MEF2C |
5.157e-03 | -5.27 | regulation of action potential firing threshold | biological process | GO:0099611 | 2 | 1 | 18204 | 47 |
KCNQ3 |
5.157e-03 | -5.27 | myofibroblast contraction | biological process | GO:1990764 | 2 | 1 | 18204 | 47 |
QKI |
5.157e-03 | -5.27 | nephron tubule epithelial cell differentiation | biological process | GO:0072160 | 2 | 1 | 18204 | 47 |
MEF2C |
5.157e-03 | -5.27 | cAMP transport | biological process | GO:0070730 | 2 | 1 | 18204 | 47 |
ABCC4 |
5.157e-03 | -5.27 | polysaccharide localization | biological process | GO:0033037 | 2 | 1 | 18204 | 47 |
CHST11 |
5.157e-03 | -5.27 | regulation of alkaline phosphatase activity | biological process | GO:0010692 | 2 | 1 | 18204 | 47 |
MEF2C |
5.157e-03 | -5.27 | muscle cell fate determination | biological process | GO:0007521 | 2 | 1 | 18204 | 47 |
MEF2C |
5.157e-03 | -5.27 | AMPA selective glutamate receptor signaling pathway | biological process | GO:0098990 | 2 | 1 | 18204 | 47 |
MEF2C |
5.157e-03 | -5.27 | sinoatrial valve development | biological process | GO:0003172 | 2 | 1 | 18204 | 47 |
MEF2C |
5.157e-03 | -5.27 | regulation of neurofibrillary tangle assembly | biological process | GO:1902996 | 2 | 1 | 18204 | 47 |
SORL1 |
5.157e-03 | -5.27 | positive regulation of ARF protein signal transduction | biological process | GO:0032014 | 2 | 1 | 18204 | 47 |
MAP4K4 |
5.157e-03 | -5.27 | post-embryonic retina morphogenesis in camera-type eye | biological process | GO:0060060 | 2 | 1 | 18204 | 47 |
DSCAM |
5.157e-03 | -5.27 | ERK5 cascade | biological process | GO:0070375 | 2 | 1 | 18204 | 47 |
MEF2A |
5.157e-03 | -5.27 | substantia propria of cornea development | biological process | GO:1903701 | 2 | 1 | 18204 | 47 |
KCNQ3 |
5.157e-03 | -5.27 | cellular response to trichostatin A | biological process | GO:0035984 | 2 | 1 | 18204 | 47 |
MEF2C |
5.157e-03 | -5.27 | response to trichostatin A | biological process | GO:0035983 | 2 | 1 | 18204 | 47 |
MEF2C |
5.157e-03 | -5.27 | positive regulation of glial cell-derived neurotrophic factor production | biological process | GO:1900168 | 2 | 1 | 18204 | 47 |
SORL1 |
5.157e-03 | -5.27 | regulation of glial cell-derived neurotrophic factor production | biological process | GO:1900166 | 2 | 1 | 18204 | 47 |
SORL1 |
5.157e-03 | -5.27 | positive regulation of alkaline phosphatase activity | biological process | GO:0010694 | 2 | 1 | 18204 | 47 |
MEF2C |
5.184e-03 | -5.26 | central_nervous_system-third_ventricle-glioma-astrocytoma_Grade_I | COSMIC cancer mutations | central_nervous_system-third_ventricle-glioma-astrocytoma_Grade_I | 37 | 2 | 16828 | 49 |
QKI,GNAQ |
5.184e-03 | -5.26 | fourth_ventricle | COSMIC cancer mutations | fourth_ventricle | 37 | 2 | 16828 | 49 |
QKI,GNAQ |
5.191e-03 | -5.26 | PH_DOMAIN | prosite domains | PS50003 | 246 | 4 | 12186 | 35 |
APBB1IP,ARHGAP26,ARHGAP22,ARHGAP24 |
5.220e-03 | -5.26 | GNPTAB (N-acetylglucosamine-1-phosphate transferase subunits alpha and beta) | protein interactions | 79158 | 42 | 2 | 19454 | 50 |
DISC1,DSCAM |
5.220e-03 | -5.26 | NSMAF (neutral sphingomyelinase activation associated factor) | protein interactions | 8439 | 42 | 2 | 19454 | 50 |
EPB41L2,DOCK8 |
5.319e-03 | -5.24 | histone deacetylase binding | molecular function | GO:0042826 | 128 | 3 | 18094 | 50 |
MEF2A,HDAC9,MEF2C |
5.320e-03 | -5.24 | vascular process in circulatory system | biological process | GO:0003018 | 273 | 4 | 18204 | 47 |
DOCK4,ABCC4,PTPRJ,SLC8A1 |
5.378e-03 | -5.23 | cytoskeletal protein binding | molecular function | GO:0008092 | 989 | 8 | 18094 | 50 |
DISC1,DIP2B,MAP4K4,EPB41L2,SLC8A1,PICALM,NAV3,SSH2 |
5.392e-03 | -5.22 | Ankyrin-G_BS | interpro domains | IPR020969 | 2 | 1 | 18521 | 50 |
KCNQ3 |
5.392e-03 | -5.22 | ANTH_dom_sf | interpro domains | IPR014712 | 2 | 1 | 18521 | 50 |
PICALM |
5.392e-03 | -5.22 | Med13_C | interpro domains | IPR009401 | 2 | 1 | 18521 | 50 |
MED13L |
5.392e-03 | -5.22 | AP180-like | interpro domains | IPR045192 | 2 | 1 | 18521 | 50 |
PICALM |
5.392e-03 | -5.22 | PLXDC | interpro domains | IPR031152 | 2 | 1 | 18521 | 50 |
PLXDC2 |
5.392e-03 | -5.22 | PTPRJ_TM | interpro domains | IPR041201 | 2 | 1 | 18521 | 50 |
PTPRJ |
5.392e-03 | -5.22 | FCHSD_SH3_1 | interpro domains | IPR035460 | 2 | 1 | 18521 | 50 |
FCHSD2 |
5.392e-03 | -5.22 | TMEPAI/LRAD4 | interpro domains | IPR043445 | 2 | 1 | 18521 | 50 |
LDLRAD4 |
5.392e-03 | -5.22 | FRMD4A/B_FERM_C | interpro domains | IPR041785 | 2 | 1 | 18521 | 50 |
FRMD4A |
5.392e-03 | -5.22 | MAML1_3_TAD1 | interpro domains | IPR048456 | 2 | 1 | 18521 | 50 |
MAML3 |
5.392e-03 | -5.22 | Scm-like-4MBT1/2_SAM | interpro domains | IPR037604 | 2 | 1 | 18521 | 50 |
SFMBT2 |
5.392e-03 | -5.22 | MAML1_3_TAD2 | interpro domains | IPR048455 | 2 | 1 | 18521 | 50 |
MAML3 |
5.392e-03 | -5.22 | MID_MedPIWI | interpro domains | IPR041285 | 2 | 1 | 18521 | 50 |
MED13L |
5.392e-03 | -5.22 | C2_Dock-B | interpro domains | IPR037811 | 2 | 1 | 18521 | 50 |
DOCK4 |
5.392e-03 | -5.22 | FRMD4A/B | interpro domains | IPR047176 | 2 | 1 | 18521 | 50 |
FRMD4A |
5.408e-03 | -5.22 | Signaling by NOTCH | REACTOME pathways | R-HSA-157118 | 112 | 3 | 10285 | 33 |
MAML3,MAML2,HDAC9 |
5.416e-03 | -5.22 | regulation of cell development | biological process | GO:0060284 | 839 | 7 | 18204 | 47 |
DIP2B,HDAC9,QKI,MEF2C,DSCAM,DISC1,SORL1 |
5.418e-03 | -5.22 | regulation of axonogenesis | biological process | GO:0050770 | 138 | 3 | 18204 | 47 |
DIP2B,DSCAM,DISC1 |
5.461e-03 | -5.21 | central_nervous_system-brainstem-glioma-astrocytoma_Grade_I | COSMIC cancer mutations | central_nervous_system-brainstem-glioma-astrocytoma_Grade_I | 38 | 2 | 16828 | 49 |
QKI,GNAQ |
5.500e-03 | -5.20 | MID_MedPIWI | pfam domains | PF18296 | 2 | 1 | 17795 | 49 |
MED13L |
5.500e-03 | -5.20 | KCNQC3-Ank-G_bd | pfam domains | PF11956 | 2 | 1 | 17795 | 49 |
KCNQ3 |
5.500e-03 | -5.20 | PTP_tm | pfam domains | PF18861 | 2 | 1 | 17795 | 49 |
PTPRJ |
5.500e-03 | -5.20 | MAML1_3_TAD2 | pfam domains | PF20801 | 2 | 1 | 17795 | 49 |
MAML3 |
5.500e-03 | -5.20 | Med13_C | pfam domains | PF06333 | 2 | 1 | 17795 | 49 |
MED13L |
5.500e-03 | -5.20 | MAML1_3_TAD1 | pfam domains | PF20802 | 2 | 1 | 17795 | 49 |
MAML3 |
5.514e-03 | -5.20 | positive regulation of locomotion | biological process | GO:0040017 | 633 | 6 | 18204 | 47 |
DSCAM,DOCK4,MAP4K4,PTPRJ,HDAC9,DOCK8 |
5.519e-03 | -5.20 | beta-galactoside alpha-2,6-sialyltransferase activity | molecular function | GO:0003835 | 2 | 1 | 18094 | 50 |
ST6GAL1 |
5.519e-03 | -5.20 | netrin receptor binding | molecular function | GO:1990890 | 2 | 1 | 18094 | 50 |
DSCAM |
5.519e-03 | -5.20 | histone H3K14 deacetylase activity | molecular function | GO:0031078 | 2 | 1 | 18094 | 50 |
HDAC9 |
5.519e-03 | -5.20 | 15-hydroxyprostaglandin dehydrogenase (NAD+) activity | molecular function | GO:0016404 | 2 | 1 | 18094 | 50 |
ABCC4 |
5.519e-03 | -5.20 | alpha-N-acetylneuraminyl-2,3-beta-galactosyl-1,3-N-acetyl-galactosaminide 6-alpha-sialyltransferase activity | molecular function | GO:0047290 | 2 | 1 | 18094 | 50 |
ST6GALNAC3 |
5.519e-03 | -5.20 | N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity | molecular function | GO:0050659 | 2 | 1 | 18094 | 50 |
CHST11 |
5.702e-03 | -5.17 | miRs in Muscle Cell Differentiation | WikiPathways | WP2012 | 36 | 2 | 5310 | 17 |
MEF2A,MEF2C |
5.747e-03 | -5.16 | knee | COSMIC cancer mutations | knee | 125 | 3 | 16828 | 49 |
GNAQ,PTPRJ,ADAM28 |
5.760e-03 | -5.16 | synaptic vesicle localization | biological process | GO:0097479 | 44 | 2 | 18204 | 47 |
PICALM,SYNDIG1 |
5.760e-03 | -5.16 | positive regulation of bone mineralization | biological process | GO:0030501 | 44 | 2 | 18204 | 47 |
SLC8A1,MEF2C |
5.775e-03 | -5.15 | hand | COSMIC cancer mutations | hand | 566 | 6 | 16828 | 49 |
ADAM28,SFMBT2,GNAQ,DIP2B,ATP8B4,DSCAM |
5.808e-03 | -5.15 | STRN3 (striatin 3) | protein interactions | 29966 | 142 | 3 | 19454 | 50 |
ARHGAP24,MAP4K4,TCF12 |
5.814e-03 | -5.15 | glycoprotein biosynthetic process | biological process | GO:0009101 | 280 | 4 | 18204 | 47 |
ST6GAL1,ST6GALNAC3,CHST11,HS3ST4 |
5.922e-03 | -5.13 | enzyme activator activity | molecular function | GO:0008047 | 599 | 6 | 18094 | 50 |
ARHGAP22,ARHGAP26,ARHGAP24,GNAQ,DOCK4,TBC1D22A |
5.962e-03 | -5.12 | Ldl_recept_a | pfam domains | PF00057 | 42 | 2 | 17795 | 49 |
SORL1,LDLRAD4 |
5.998e-03 | -5.12 | Diseases of signal transduction | REACTOME pathways | R-HSA-5663202 | 369 | 5 | 10285 | 33 |
MAML3,QKI,MAML2,APBB1IP,HDAC9 |
6.000e-03 | -5.12 | Platelet activation | KEGG pathways | hsa04611 | 123 | 3 | 7161 | 22 |
ITPR2,APBB1IP,GNAQ |
6.005e-03 | -5.12 | metal cation:monoatomic cation antiporter activity | molecular function | GO:0140828 | 42 | 2 | 18094 | 50 |
SLC9A9,SLC8A1 |
6.018e-03 | -5.11 | glutamate receptor signaling pathway | biological process | GO:0007215 | 45 | 2 | 18204 | 47 |
GNAQ,MEF2C |
6.037e-03 | -5.11 | Calml3 (calmodulin-like 3) | protein interactions | 70405 | 144 | 3 | 19454 | 50 |
ZBTB20,SSH2,PICALM |
6.073e-03 | -5.10 | ANTH domain | gene3d domains | 1.20.58.150 | 2 | 1 | 14470 | 44 |
PICALM |
6.083e-03 | -5.10 | endomembrane system | cellular component | GO:0012505 | 4764 | 20 | 19108 | 47 |
ATP8B4,FCHSD2,ST6GAL1,SSH2,ITPR2,ARHGAP26,GNAQ,LDLRAD4,PTPRJ,HS3ST4,PICALM,SLC9A9,SYNDIG1,DOCK4,SORL1,DISC1,ST6GALNAC3,CHST11,NAV3,ABCC4 |
6.147e-03 | -5.09 | neuron development | biological process | GO:0048666 | 859 | 7 | 18204 | 47 |
KCNQ3,MEF2A,DSCAM,PICALM,MEF2C,MAP4K4,DISC1 |
6.224e-03 | -5.08 | fn3 | pfam domains | PF00041 | 136 | 3 | 17795 | 49 |
PTPRJ,SORL1,DSCAM |
6.233e-03 | -5.08 | skin-abdomen-malignant_melanoma | COSMIC cancer mutations | skin-abdomen-malignant_melanoma | 404 | 5 | 16828 | 49 |
ABCC4,GNAQ,PTPRJ,ZFHX3,NAV3 |
6.234e-03 | -5.08 | PACS1 (phosphofurin acidic cluster sorting protein 1) | protein interactions | 55690 | 46 | 2 | 19454 | 50 |
SORL1,ARHGAP24 |
6.295e-03 | -5.07 | Golgi membrane | cellular component | GO:0000139 | 683 | 6 | 19108 | 47 |
HS3ST4,SORL1,CHST11,ST6GALNAC3,ST6GAL1,LDLRAD4 |
6.338e-03 | -5.06 | Cell Differentiation - Index | WikiPathways | WP2029 | 38 | 2 | 5310 | 17 |
MEF2C,MEF2A |
6.398e-03 | -5.05 | pleura | COSMIC cancer mutations | pleura | 4914 | 23 | 16828 | 49 |
SLC9A9,FRMD4A,ITPR2,ARHGAP26,HDAC9,QKI,TCF12,MED13L,MAML2,MEF2C,PICALM,ARHGAP24,ARHGAP22,MAP4K4,ST6GAL1,ANKRD44,PTPRJ,GNAQ,APBB1IP,UBE2E2,ADAM28,FCHSD2,NAV3 |
6.402e-03 | -5.05 | skin-extremity-malignant_melanoma | COSMIC cancer mutations | skin-extremity-malignant_melanoma | 1875 | 12 | 16828 | 49 |
SSH2,ATP8B4,DOCK4,MAP4K4,EPB41L2,SYNDIG1,MED13L,NAV3,HDAC9,FCHSD2,SORL1,APBB1IP |
6.421e-03 | -5.05 | LDLRA_1 | prosite domains | PS01209 | 42 | 2 | 12186 | 35 |
SORL1,LDLRAD4 |
6.426e-03 | -5.05 | cytoplasmic vesicle | cellular component | GO:0031410 | 2521 | 13 | 19108 | 47 |
ARHGAP26,LDLRAD4,PTPRJ,FCHSD2,ATP8B4,SSH2,ITPR2,SORL1,DISC1,ABCC4,PICALM,SLC9A9,SYNDIG1 |
6.429e-03 | -5.05 | extremity | COSMIC cancer mutations | extremity | 1876 | 12 | 16828 | 49 |
SYNDIG1,DOCK4,EPB41L2,MAP4K4,ATP8B4,SSH2,FCHSD2,APBB1IP,SORL1,HDAC9,NAV3,MED13L |
6.492e-03 | -5.04 | muscle cell differentiation | biological process | GO:0042692 | 289 | 4 | 18204 | 47 |
MEF2C,QKI,MEF2A,SLC8A1 |
6.499e-03 | -5.04 | positive regulation of catalytic activity | biological process | GO:0043085 | 868 | 7 | 18204 | 47 |
MAP4K4,ARHGAP22,GNAQ,DOCK8,TBC1D22A,MEF2C,ARHGAP24 |
6.500e-03 | -5.04 | ZNRF2 (zinc and ring finger 2) | protein interactions | 223082 | 47 | 2 | 19454 | 50 |
UBE2E2,ANKRD44 |
6.556e-03 | -5.03 | intracellular vesicle | cellular component | GO:0097708 | 2527 | 13 | 19108 | 47 |
SLC9A9,SYNDIG1,PICALM,ABCC4,SORL1,DISC1,ITPR2,SSH2,ATP8B4,FCHSD2,LDLRAD4,PTPRJ,ARHGAP26 |
6.624e-03 | -5.02 | MCAM (melanoma cell adhesion molecule) | protein interactions | 4162 | 464 | 5 | 19454 | 50 |
MAP4K4,DIP2B,PICALM,PTPRJ,EPB41L2 |
6.646e-03 | -5.01 | skin-trunk-malignant_melanoma | COSMIC cancer mutations | skin-trunk-malignant_melanoma | 2647 | 15 | 16828 | 49 |
MAML2,TCF12,FCHSD2,APBB1IP,SORL1,ADAM28,DIP2B,ATP8B4,DSCAM,PTPRJ,ANKRD44,SSH2,ABCC4,SYNDIG1,SFMBT2 |
6.722e-03 | -5.00 | LDLRA_2 | prosite domains | PS50068 | 43 | 2 | 12186 | 35 |
LDLRAD4,SORL1 |
6.806e-03 | -4.99 | MYH9 (myosin heavy chain 9) | protein interactions | 4627 | 663 | 6 | 19454 | 50 |
ITPR2,SSH2,PICALM,ZBTB20,ARHGAP24,EPB41L2 |
6.812e-03 | -4.99 | neuronal cell body | cellular component | GO:0043025 | 489 | 5 | 19108 | 47 |
DSCAM,DIP2B,SLC8A1,PICALM,SORL1 |
6.824e-03 | -4.99 | regulation of amyloid-beta formation | biological process | GO:1902003 | 48 | 2 | 18204 | 47 |
SORL1,PICALM |
6.836e-03 | -4.99 | cellular response to stimulus | biological process | GO:0051716 | 6307 | 25 | 18204 | 47 |
ARHGAP26,HDAC9,MAML2,MAML3,SLC8A1,ARHGAP22,MEF2C,GNAQ,CHST11,ELMO1,MAP4K4,ITPR2,PTPRJ,MEF2A,DISC1,ZBTB20,SORL1,ABCC4,APBB1IP,UBE2E2,DOCK8,KCNQ3,ARHGAP24,DOCK4,DSCAM |
6.853e-03 | -4.98 | LDL_receptor-like_sf | interpro domains | IPR036055 | 46 | 2 | 18521 | 50 |
SORL1,LDLRAD4 |
6.853e-03 | -4.98 | LDrepeatLR_classA_rpt | interpro domains | IPR002172 | 46 | 2 | 18521 | 50 |
SORL1,LDLRAD4 |
6.939e-03 | -4.97 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-follicular_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-follicular_lymphoma | 981 | 8 | 16828 | 49 |
DSCAM,ITPR2,PLXDC2,ST6GALNAC3,SLC9A9,UBE2E2,SLC8A1,GNAQ |
7.049e-03 | -4.95 | CYTH1 (cytohesin 1) | protein interactions | 9267 | 49 | 2 | 19454 | 50 |
FRMD4A,GNAQ |
7.049e-03 | -4.95 | HBZ (hemoglobin subunit zeta) | protein interactions | 3050 | 49 | 2 | 19454 | 50 |
DOCK8,ARHGAP24 |
7.055e-03 | -4.95 | positive regulation of nervous system development | biological process | GO:0051962 | 296 | 4 | 18204 | 47 |
SYNDIG1,QKI,DSCAM,DISC1 |
7.064e-03 | -4.95 | pelvis | COSMIC cancer mutations | pelvis | 984 | 8 | 16828 | 49 |
NAV3,ZFHX3,SSH2,DOCK8,MAML3,SYNDIG1,MAP4K4,SLC8A1 |
7.099e-03 | -4.95 | response to stimulus | biological process | GO:0050896 | 7803 | 29 | 18204 | 47 |
DOCK8,KCNQ3,ARHGAP24,ST6GAL1,DSCAM,DOCK4,PTPRJ,MEF2A,DISC1,ZBTB20,SORL1,ABCC4,APBB1IP,UBE2E2,MEF2C,GNAQ,CHST11,ELMO1,ZFHX3,MAP4K4,ITPR2,SLC9A9,ARHGAP26,HDAC9,MAML3,MAML2,TCF12,SLC8A1,ARHGAP22 |
7.266e-03 | -4.92 | soft_tissue-striated_muscle-rhabdomyosarcoma | COSMIC cancer mutations | soft_tissue-striated_muscle-rhabdomyosarcoma | 594 | 6 | 16828 | 49 |
ATP8B4,MEF2A,ARHGAP26,DIP2B,EPB41L2,DOCK4 |
7.330e-03 | -4.92 | MAGI3 (membrane associated guanylate kinase, WW and PDZ domain containing 3) | protein interactions | 260425 | 50 | 2 | 19454 | 50 |
LDLRAD4,DSCAM |
7.400e-03 | -4.91 | skin-face-malignant_melanoma | COSMIC cancer mutations | skin-face-malignant_melanoma | 137 | 3 | 16828 | 49 |
ADAM28,PTPRJ,GNAQ |
7.420e-03 | -4.90 | FERM_M | pfam domains | PF00373 | 47 | 2 | 17795 | 49 |
EPB41L2,FRMD4A |
7.439e-03 | -4.90 | lymphocyte activation | biological process | GO:0046649 | 476 | 5 | 18204 | 47 |
MEF2C,DOCK8,APBB1IP,PTPRJ,HDAC9 |
7.443e-03 | -4.90 | FERM_domain | interpro domains | IPR000299 | 48 | 2 | 18521 | 50 |
FRMD4A,EPB41L2 |
7.462e-03 | -4.90 | regulation of cell differentiation | biological process | GO:0045595 | 1622 | 10 | 18204 | 47 |
MEF2C,QKI,HDAC9,DIP2B,SORL1,LDLRAD4,TCF12,ZFHX3,DISC1,DSCAM |
7.568e-03 | -4.88 | secretory granule membrane | cellular component | GO:0030667 | 317 | 4 | 19108 | 47 |
ATP8B4,PTPRJ,ABCC4,ITPR2 |
7.592e-03 | -4.88 | third_ventricle | COSMIC cancer mutations | third_ventricle | 45 | 2 | 16828 | 49 |
GNAQ,QKI |
7.691e-03 | -4.87 | TULP1 (TUB like protein 1) | protein interactions | 7287 | 3 | 1 | 19454 | 50 |
ARHGAP26 |
7.691e-03 | -4.87 | ZNF506 (zinc finger protein 506) | protein interactions | 440515 | 3 | 1 | 19454 | 50 |
ARHGAP24 |
7.691e-03 | -4.87 | ZNF682 (zinc finger protein 682) | protein interactions | 91120 | 3 | 1 | 19454 | 50 |
ARHGAP24 |
7.691e-03 | -4.87 | KLHL4 (kelch like family member 4) | protein interactions | 56062 | 3 | 1 | 19454 | 50 |
DSCAM |
7.691e-03 | -4.87 | ZNF257 (zinc finger protein 257) | protein interactions | 113835 | 3 | 1 | 19454 | 50 |
ARHGAP24 |
7.691e-03 | -4.87 | GALR2 (galanin receptor 2) | protein interactions | 8811 | 3 | 1 | 19454 | 50 |
GNAQ |
7.691e-03 | -4.87 | ADHFE1 (alcohol dehydrogenase iron containing 1) | protein interactions | 137872 | 3 | 1 | 19454 | 50 |
GNAQ |
7.691e-03 | -4.87 | ZNF549 (zinc finger protein 549) | protein interactions | 256051 | 3 | 1 | 19454 | 50 |
SORL1 |
7.691e-03 | -4.87 | ZNF716 (zinc finger protein 716) | protein interactions | 441234 | 3 | 1 | 19454 | 50 |
ARHGAP24 |
7.691e-03 | -4.87 | Srr (serine racemase) | protein interactions | 27364 | 3 | 1 | 19454 | 50 |
DISC1 |
7.691e-03 | -4.87 | ZNF540 (zinc finger protein 540) | protein interactions | 163255 | 3 | 1 | 19454 | 50 |
ARHGAP24 |
7.691e-03 | -4.87 | HERC2P2 (HERC2 pseudogene 2) | protein interactions | 400322 | 3 | 1 | 19454 | 50 |
DISC1 |
7.697e-03 | -4.87 | angioimmunoblastic_T_cell_lymphoma | COSMIC cancer mutations | angioimmunoblastic_T_cell_lymphoma | 269 | 4 | 16828 | 49 |
GNAQ,ZFHX3,ITPR2,MEF2C |
7.722e-03 | -4.86 | intracellular anatomical structure | cellular component | GO:0005622 | 15205 | 44 | 19108 | 47 |
EPB41L2,DOCK4,SFMBT2,DISC1,CHST11,ZBTB20,SSH2,TCF12,DOCK8,MED13L,PTPRJ,MEF2C,KCNQ3,HDAC9,SYNDIG1,MAML3,ABCC4,QKI,ITPR2,FRMD4A,ADAM28,ELMO1,GNAQ,LDLRAD4,HS3ST4,PICALM,SLC9A9,ATP8B4,ST6GAL1,ZFHX3,MEF2A,MAML2,SLC8A1,ARHGAP24,ARHGAP22,SORL1,MAP4K4,ST6GALNAC3,NAV3,FCHSD2,APBB1IP,ARHGAP26,DIP2B,UBE2E2 |
7.726e-03 | -4.86 | ventricular cardiac myofibril assembly | biological process | GO:0055005 | 3 | 1 | 18204 | 47 |
MEF2A |
7.726e-03 | -4.86 | regulation of locomotor rhythm | biological process | GO:1904059 | 3 | 1 | 18204 | 47 |
ZFHX3 |
7.726e-03 | -4.86 | pyramidal neuron migration to cerebral cortex | biological process | GO:0021852 | 3 | 1 | 18204 | 47 |
DISC1 |
7.726e-03 | -4.86 | negative regulation of vascular associated smooth muscle contraction | biological process | GO:1904694 | 3 | 1 | 18204 | 47 |
DOCK4 |
7.726e-03 | -4.86 | action potential initiation | biological process | GO:0099610 | 3 | 1 | 18204 | 47 |
KCNQ3 |
7.726e-03 | -4.86 | regulation of synaptic activity | biological process | GO:0060025 | 3 | 1 | 18204 | 47 |
MEF2C |
7.726e-03 | -4.86 | positive regulation of macrophage apoptotic process | biological process | GO:2000111 | 3 | 1 | 18204 | 47 |
MEF2C |
7.726e-03 | -4.86 | primary heart field specification | biological process | GO:0003138 | 3 | 1 | 18204 | 47 |
MEF2C |
7.726e-03 | -4.86 | inhibitory chemical synaptic transmission | biological process | GO:0098977 | 3 | 1 | 18204 | 47 |
KCNQ3 |
7.747e-03 | -4.86 | FERM_central | interpro domains | IPR019748 | 49 | 2 | 18521 | 50 |
FRMD4A,EPB41L2 |
7.800e-03 | -4.85 | abdomen | COSMIC cancer mutations | abdomen | 603 | 6 | 16828 | 49 |
PTPRJ,ABCC4,GNAQ,NAV3,ZFHX3,ITPR2 |
7.876e-03 | -4.84 | plasma membrane bounded cell projection | cellular component | GO:0120025 | 2285 | 12 | 19108 | 47 |
SLC8A1,FCHSD2,APBB1IP,KCNQ3,SYNDIG1,DOCK4,GNAQ,DOCK8,DISC1,DIP2B,DSCAM,PTPRJ |
7.886e-03 | -4.84 | intracellular organelle | cellular component | GO:0043229 | 13594 | 41 | 19108 | 47 |
TCF12,PTPRJ,MAML2,MEF2A,MED13L,ST6GAL1,SSH2,ATP8B4,ZFHX3,DISC1,CHST11,SFMBT2,DOCK4,ZBTB20,EPB41L2,PICALM,HS3ST4,SLC9A9,GNAQ,ARHGAP26,LDLRAD4,UBE2E2,DIP2B,APBB1IP,FCHSD2,QKI,FRMD4A,ADAM28,ITPR2,ST6GALNAC3,MAML3,SORL1,ABCC4,NAV3,SLC8A1,MEF2C,ARHGAP22,SYNDIG1,HDAC9,ARHGAP24,KCNQ3 |
7.909e-03 | -4.84 | SCMH1 (Scm polycomb group protein homolog 1) | protein interactions | 22955 | 52 | 2 | 19454 | 50 |
MAML3,SFMBT2 |
7.969e-03 | -4.83 | forebrain generation of neurons | biological process | GO:0021872 | 52 | 2 | 18204 | 47 |
ZSWIM6,DISC1 |
7.969e-03 | -4.83 | regulation of vascular associated smooth muscle cell migration | biological process | GO:1904752 | 52 | 2 | 18204 | 47 |
MEF2C,DOCK4 |
8.056e-03 | -4.82 | FERM_2 | interpro domains | IPR035963 | 50 | 2 | 18521 | 50 |
FRMD4A,EPB41L2 |
8.078e-03 | -4.82 | Dip2-like_dom | interpro domains | IPR037337 | 3 | 1 | 18521 | 50 |
DIP2B |
8.078e-03 | -4.82 | Na_Ca_Ex_C-exten | interpro domains | IPR032452 | 3 | 1 | 18521 | 50 |
SLC8A1 |
8.078e-03 | -4.82 | SSH-N | interpro domains | IPR043588 | 3 | 1 | 18521 | 50 |
SSH2 |
8.078e-03 | -4.82 | NHE-6/7/9 | interpro domains | IPR002090 | 3 | 1 | 18521 | 50 |
SLC9A9 |
8.078e-03 | -4.82 | ELMO_ARM | interpro domains | IPR024574 | 3 | 1 | 18521 | 50 |
ELMO1 |
8.078e-03 | -4.82 | Hist_deacetylase_Gln_rich_N | interpro domains | IPR024643 | 3 | 1 | 18521 | 50 |
HDAC9 |
8.078e-03 | -4.82 | Nav/unc-53 | interpro domains | IPR039041 | 3 | 1 | 18521 | 50 |
NAV3 |
8.078e-03 | -4.82 | Phosphatase_SSH-like | interpro domains | IPR043587 | 3 | 1 | 18521 | 50 |
SSH2 |
8.078e-03 | -4.82 | Na_Ca_Ex | interpro domains | IPR004836 | 3 | 1 | 18521 | 50 |
SLC8A1 |
8.078e-03 | -4.82 | InsP3_rcpt | interpro domains | IPR000493 | 3 | 1 | 18521 | 50 |
ITPR2 |
8.078e-03 | -4.82 | C2_Dock-C | interpro domains | IPR037808 | 3 | 1 | 18521 | 50 |
DOCK8 |
8.190e-03 | -4.80 | C11orf52 (chromosome 11 open reading frame 52) | protein interactions | 91894 | 310 | 4 | 19454 | 50 |
DIP2B,MAP4K4,PICALM,EPB41L2 |
8.206e-03 | -4.80 | ELMO2 (engulfment and cell motility 2) | protein interactions | 63916 | 53 | 2 | 19454 | 50 |
DOCK4,ELMO1 |
8.234e-03 | -4.80 | Low-density Lipoprotein Receptor | gene3d domains | 4.10.400.10 | 45 | 2 | 14470 | 44 |
LDLRAD4,SORL1 |
8.238e-03 | -4.80 | HDAC4_Gln | pfam domains | PF12203 | 3 | 1 | 17795 | 49 |
HDAC9 |
8.238e-03 | -4.80 | Na_Ca_ex_C | pfam domains | PF16494 | 3 | 1 | 17795 | 49 |
SLC8A1 |
8.238e-03 | -4.80 | ELMO_ARM | pfam domains | PF11841 | 3 | 1 | 17795 | 49 |
ELMO1 |
8.268e-03 | -4.80 | histone H4K16 deacetylase activity | molecular function | GO:0034739 | 3 | 1 | 18094 | 50 |
HDAC9 |
8.268e-03 | -4.80 | inositol 1,4,5-trisphosphate-gated calcium channel activity | molecular function | GO:0005220 | 3 | 1 | 18094 | 50 |
ITPR2 |
8.268e-03 | -4.80 | histone H4K deacetylase activity | molecular function | GO:0141051 | 3 | 1 | 18094 | 50 |
HDAC9 |
8.268e-03 | -4.80 | histone H3K9 deacetylase activity | molecular function | GO:0032129 | 3 | 1 | 18094 | 50 |
HDAC9 |
8.268e-03 | -4.80 | regulation of platelet activation | biological process | GO:0010543 | 53 | 2 | 18204 | 47 |
GNAQ,PTPRJ |
8.321e-03 | -4.79 | FERM_3 | prosite domains | PS50057 | 48 | 2 | 12186 | 35 |
FRMD4A,EPB41L2 |
8.343e-03 | -4.79 | TEAD1 (TEA domain transcription factor 1) | protein interactions | 7003 | 162 | 3 | 19454 | 50 |
ZFHX3,MEF2C,MEF2A |
8.370e-03 | -4.78 | Band_41_domain | interpro domains | IPR019749 | 51 | 2 | 18521 | 50 |
EPB41L2,FRMD4A |
8.370e-03 | -4.78 | FERM/acyl-CoA-bd_prot_sf | interpro domains | IPR014352 | 51 | 2 | 18521 | 50 |
EPB41L2,FRMD4A |
8.484e-03 | -4.77 | MORF4L2 (mortality factor 4 like 2) | protein interactions | 9643 | 163 | 3 | 19454 | 50 |
DISC1,DSCAM,HDAC9 |
8.505e-03 | -4.77 | regulation of catalytic activity | biological process | GO:0050790 | 1395 | 9 | 18204 | 47 |
ARHGAP22,SLC8A1,MAP4K4,ARHGAP24,PTPRJ,TBC1D22A,DOCK8,GNAQ,MEF2C |
8.507e-03 | -4.77 | TAFA4 (TAFA chemokine like family member 4) | protein interactions | 151647 | 54 | 2 | 19454 | 50 |
SORL1,ITPR2 |
8.542e-03 | -4.76 | chemical homeostasis | biological process | GO:0048878 | 914 | 7 | 18204 | 47 |
PICALM,SLC8A1,ZBTB20,DISC1,HDAC9,PTPRJ,SLC9A9 |
8.565e-03 | -4.76 | receptor-mediated endocytosis | biological process | GO:0006898 | 163 | 3 | 18204 | 47 |
SORL1,FCHSD2,PICALM |
8.572e-03 | -4.76 | viral gene expression | biological process | GO:0019080 | 54 | 2 | 18204 | 47 |
ST6GALNAC3,ST6GAL1 |
8.572e-03 | -4.76 | positive regulation of ossification | biological process | GO:0045778 | 54 | 2 | 18204 | 47 |
SLC8A1,MEF2C |
8.572e-03 | -4.76 | positive regulation of biomineral tissue development | biological process | GO:0070169 | 54 | 2 | 18204 | 47 |
SLC8A1,MEF2C |
8.649e-03 | -4.75 | regulation of developmental growth | biological process | GO:0048638 | 314 | 4 | 18204 | 47 |
DIP2B,DSCAM,MEF2C,DISC1 |
8.711e-03 | -4.74 | skin-hand-benign_melanocytic_nevus-blue | COSMIC cancer mutations | skin-hand-benign_melanocytic_nevus-blue | 3 | 1 | 16828 | 49 |
GNAQ |
8.711e-03 | -4.74 | skin-leg-benign_melanocytic_nevus-blue | COSMIC cancer mutations | skin-leg-benign_melanocytic_nevus-blue | 3 | 1 | 16828 | 49 |
GNAQ |
8.711e-03 | -4.74 | eye-uveal_tract-melanocytoma | COSMIC cancer mutations | eye-uveal_tract-melanocytoma | 3 | 1 | 16828 | 49 |
GNAQ |
8.711e-03 | -4.74 | skin-abdomen-benign_melanocytic_nevus-blue | COSMIC cancer mutations | skin-abdomen-benign_melanocytic_nevus-blue | 3 | 1 | 16828 | 49 |
GNAQ |
8.711e-03 | -4.74 | skin-ankle-benign_melanocytic_nevus | COSMIC cancer mutations | skin-ankle-benign_melanocytic_nevus | 3 | 1 | 16828 | 49 |
GNAQ |
8.711e-03 | -4.74 | eye-conjunctiva-other-primary_acquired_melanosis | COSMIC cancer mutations | eye-conjunctiva-other-primary_acquired_melanosis | 3 | 1 | 16828 | 49 |
GNAQ |
8.711e-03 | -4.74 | central_nervous_system-posterior_fossa-other-gangliocytoma | COSMIC cancer mutations | central_nervous_system-posterior_fossa-other-gangliocytoma | 3 | 1 | 16828 | 49 |
GNAQ |
8.711e-03 | -4.74 | central_nervous_system-temporal_lobe-glioma-astroblastoma | COSMIC cancer mutations | central_nervous_system-temporal_lobe-glioma-astroblastoma | 3 | 1 | 16828 | 49 |
GNAQ |
8.711e-03 | -4.74 | primary_acquired_melanosis | COSMIC cancer mutations | primary_acquired_melanosis | 3 | 1 | 16828 | 49 |
GNAQ |
8.711e-03 | -4.74 | malignant_blue_nevus | COSMIC cancer mutations | malignant_blue_nevus | 3 | 1 | 16828 | 49 |
GNAQ |
8.711e-03 | -4.74 | skin-shoulder-benign_melanocytic_nevus-blue | COSMIC cancer mutations | skin-shoulder-benign_melanocytic_nevus-blue | 3 | 1 | 16828 | 49 |
GNAQ |
8.711e-03 | -4.74 | eye-conjunctiva-benign_melanocytic_nevus | COSMIC cancer mutations | eye-conjunctiva-benign_melanocytic_nevus | 3 | 1 | 16828 | 49 |
GNAQ |
8.711e-03 | -4.74 | skin-back-benign_melanocytic_nevus-blue | COSMIC cancer mutations | skin-back-benign_melanocytic_nevus-blue | 3 | 1 | 16828 | 49 |
GNAQ |
8.711e-03 | -4.74 | skin-groin-benign_melanocytic_nevus | COSMIC cancer mutations | skin-groin-benign_melanocytic_nevus | 3 | 1 | 16828 | 49 |
GNAQ |
8.711e-03 | -4.74 | extraocular | COSMIC cancer mutations | extraocular | 3 | 1 | 16828 | 49 |
GNAQ |
8.711e-03 | -4.74 | skin-forearm-benign_melanocytic_nevus-blue | COSMIC cancer mutations | skin-forearm-benign_melanocytic_nevus-blue | 3 | 1 | 16828 | 49 |
GNAQ |
8.711e-03 | -4.74 | skin-foot-benign_melanocytic_nevus-blue | COSMIC cancer mutations | skin-foot-benign_melanocytic_nevus-blue | 3 | 1 | 16828 | 49 |
GNAQ |
8.711e-03 | -4.74 | skin-trunk-benign_melanocytic_nevus | COSMIC cancer mutations | skin-trunk-benign_melanocytic_nevus | 3 | 1 | 16828 | 49 |
GNAQ |
8.744e-03 | -4.74 | muscle organ development | biological process | GO:0007517 | 315 | 4 | 18204 | 47 |
TCF12,ZFHX3,MEF2C,MEF2A |
8.745e-03 | -4.74 | enzyme regulator activity | molecular function | GO:0030234 | 1305 | 9 | 18094 | 50 |
ARHGAP22,ELMO1,SORL1,DOCK8,ARHGAP26,ARHGAP24,GNAQ,DOCK4,TBC1D22A |
8.814e-03 | -4.73 | GJB7 (gap junction protein beta 7) | protein interactions | 375519 | 55 | 2 | 19454 | 50 |
GNAQ,EPB41L2 |
8.881e-03 | -4.72 | regulation of amyloid precursor protein catabolic process | biological process | GO:1902991 | 55 | 2 | 18204 | 47 |
SORL1,PICALM |
8.881e-03 | -4.72 | membrane depolarization | biological process | GO:0051899 | 55 | 2 | 18204 | 47 |
KCNQ3,SLC8A1 |
8.917e-03 | -4.72 | RBM11 (RNA binding motif protein 11) | protein interactions | 54033 | 166 | 3 | 19454 | 50 |
ZFHX3,MED13L,QKI |
8.959e-03 | -4.72 | Endocrine and other factor-regulated calcium reabsorption | KEGG pathways | ko04961 | 47 | 2 | 7161 | 22 |
GNAQ,SLC8A1 |
8.959e-03 | -4.72 | Endocrine and other factor-regulated calcium reabsorption | KEGG pathways | hsa04961 | 47 | 2 | 7161 | 22 |
GNAQ,SLC8A1 |
8.967e-03 | -4.71 | stereocilium | cellular component | GO:0032420 | 58 | 2 | 19108 | 47 |
FCHSD2,DOCK4 |
9.023e-03 | -4.71 | endocytosis | biological process | GO:0006897 | 499 | 5 | 18204 | 47 |
PICALM,ELMO1,KCNQ3,SORL1,FCHSD2 |
9.095e-03 | -4.70 | - | gene3d domains | 6.10.250.1550 | 3 | 1 | 14470 | 44 |
HDAC9 |
9.095e-03 | -4.70 | - | gene3d domains | 6.10.250.810 | 3 | 1 | 14470 | 44 |
ELMO1 |
9.139e-03 | -4.70 | foot | COSMIC cancer mutations | foot | 148 | 3 | 16828 | 49 |
GNAQ,PTPRJ,ADAM28 |
9.195e-03 | -4.69 | negative regulation of leukocyte apoptotic process | biological process | GO:2000107 | 56 | 2 | 18204 | 47 |
DOCK8,ST6GAL1 |
9.299e-03 | -4.68 | positive regulation of developmental growth | biological process | GO:0048639 | 168 | 3 | 18204 | 47 |
MEF2C,DISC1,DSCAM |
9.331e-03 | -4.67 | Notch signaling pathway | KEGG pathways | ko04330 | 48 | 2 | 7161 | 22 |
MAML2,MAML3 |
9.331e-03 | -4.67 | Notch signaling pathway | KEGG pathways | hsa04330 | 48 | 2 | 7161 | 22 |
MAML3,MAML2 |
9.361e-03 | -4.67 | LGALS8 (galectin 8) | protein interactions | 3964 | 169 | 3 | 19454 | 50 |
PTPRJ,SORL1,ABCC4 |
9.424e-03 | -4.66 | negative regulation of cellular component organization | biological process | GO:0051129 | 709 | 6 | 18204 | 47 |
SORL1,PICALM,SSH2,NAV3,ARHGAP24,DIP2B |
9.426e-03 | -4.66 | sulfotransferase activity | molecular function | GO:0008146 | 53 | 2 | 18094 | 50 |
HS3ST4,CHST11 |
9.440e-03 | -4.66 | Signaling events mediated by HDAC Class II | Pathway Interaction DB | hdac_classii_pathway | 34 | 2 | 2226 | 10 |
MEF2C,HDAC9 |
9.472e-03 | -4.66 | cellular response to organonitrogen compound | biological process | GO:0071417 | 505 | 5 | 18204 | 47 |
SLC8A1,ITPR2,HDAC9,MEF2C,GNAQ |
9.530e-03 | -4.65 | human chr12q24.21 | chromosome location | human chr12q24.21 | 5 | 1 | 26134 | 50 |
MED13L |
9.603e-03 | -4.65 | negative regulation of protein kinase activity | biological process | GO:0006469 | 170 | 3 | 18204 | 47 |
GNAQ,SLC8A1,PTPRJ |
9.697e-03 | -4.64 | cell development | biological process | GO:0048468 | 2236 | 12 | 18204 | 47 |
MAP4K4,DSCAM,MEF2C,QKI,KCNQ3,CHST11,DISC1,PICALM,SLC8A1,HDAC9,MEF2A,PTPRJ |
9.727e-03 | -4.63 | NACAEXCHNGR | prints domains | PR01259 | 3 | 1 | 5227 | 17 |
SLC8A1 |
9.727e-03 | -4.63 | NAHEXCHNGR6 | prints domains | PR01088 | 3 | 1 | 5227 | 17 |
SLC9A9 |
9.727e-03 | -4.63 | INSP3RECEPTR | prints domains | PR00779 | 3 | 1 | 5227 | 17 |
ITPR2 |
9.803e-03 | -4.63 | central region of growth cone | cellular component | GO:0090724 | 4 | 1 | 19108 | 47 |
DISC1 |
9.803e-03 | -4.63 | extrinsic component of presynaptic endocytic zone membrane | cellular component | GO:0098894 | 4 | 1 | 19108 | 47 |
PICALM |
9.862e-03 | -4.62 | Pre-NOTCH Expression and Processing | REACTOME pathways | R-HSA-1912422 | 47 | 2 | 10285 | 33 |
MAML3,MAML2 |
9.912e-03 | -4.61 | response to transforming growth factor beta | biological process | GO:0071559 | 172 | 3 | 18204 | 47 |
CHST11,MEF2C,ZFHX3 |
9.988e-03 | -4.61 | Signaling mediated by p38-alpha and p38-beta | Pathway Interaction DB | p38alphabetadownstreampathway | 35 | 2 | 2226 | 10 |
MEF2A,MEF2C |
1.007e-02 | -4.60 | regulation of cell size | biological process | GO:0008361 | 173 | 3 | 18204 | 47 |
DIP2B,DSCAM,DISC1 |
1.012e-02 | -4.59 | tibia | COSMIC cancer mutations | tibia | 836 | 7 | 16828 | 49 |
QKI,SLC9A9,FCHSD2,EPB41L2,ST6GALNAC3,ABCC4,PTPRJ |
1.017e-02 | -4.59 | regulation of dendritic spine development | biological process | GO:0060998 | 59 | 2 | 18204 | 47 |
MEF2C,DISC1 |
1.024e-02 | -4.58 | FBXO41 (F-box protein 41) | protein interactions | 150726 | 4 | 1 | 19454 | 50 |
DISC1 |
1.024e-02 | -4.58 | VGLL2 (vestigial like family member 2) | protein interactions | 245806 | 4 | 1 | 19454 | 50 |
MEF2C |
1.024e-02 | -4.58 | ZNF615 (zinc finger protein 615) | protein interactions | 284370 | 4 | 1 | 19454 | 50 |
ARHGAP24 |
1.024e-02 | -4.58 | MGAT3 (beta-1,4-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase) | protein interactions | 4248 | 4 | 1 | 19454 | 50 |
DISC1 |
1.024e-02 | -4.58 | ZNF879 (zinc finger protein 879) | protein interactions | 345462 | 4 | 1 | 19454 | 50 |
ARHGAP24 |
1.024e-02 | -4.58 | MRGPRX1 (MAS related GPR family member X1) | protein interactions | 259249 | 4 | 1 | 19454 | 50 |
GNAQ |
1.024e-02 | -4.58 | PSY3 (Psy3p) | protein interactions | 851091 | 4 | 1 | 19454 | 50 |
ZFHX3 |
1.024e-02 | -4.58 | ZNF749 (zinc finger protein 749) | protein interactions | 388567 | 4 | 1 | 19454 | 50 |
ARHGAP24 |
1.025e-02 | -4.58 | positive regulation of cellular component biogenesis | biological process | GO:0044089 | 515 | 5 | 18204 | 47 |
SYNDIG1,PTPRJ,FCHSD2,MAP4K4,NAV3 |
1.026e-02 | -4.58 | papillary_renal_cell_carcinoma | COSMIC cancer mutations | papillary_renal_cell_carcinoma | 6364 | 27 | 16828 | 49 |
MED13L,MAML2,DOCK8,MAML3,HDAC9,DIP2B,ARHGAP26,ELMO1,ITPR2,ZSWIM6,SSH2,ZBTB20,DOCK4,SLC8A1,NAV3,ADAM28,SORL1,DSCAM,ZFHX3,PLXDC2,PTPRJ,ANKRD44,ABCC4,MAP4K4,ARHGAP24,PICALM,ARHGAP22 |
1.026e-02 | -4.58 | kidney-carcinoma-papillary_renal_cell_carcinoma | COSMIC cancer mutations | kidney-carcinoma-papillary_renal_cell_carcinoma | 6364 | 27 | 16828 | 49 |
HDAC9,MAML3,DIP2B,DOCK8,MAML2,MED13L,DOCK4,SLC8A1,ZBTB20,ZSWIM6,SSH2,ARHGAP26,ELMO1,ITPR2,SORL1,ADAM28,NAV3,MAP4K4,ARHGAP22,PICALM,ARHGAP24,PTPRJ,ANKRD44,PLXDC2,ABCC4,DSCAM,ZFHX3 |
1.029e-02 | -4.58 | striatal medium spiny neuron differentiation | biological process | GO:0021773 | 4 | 1 | 18204 | 47 |
ZSWIM6 |
1.029e-02 | -4.58 | epithelial cell proliferation involved in renal tubule morphogenesis | biological process | GO:2001013 | 4 | 1 | 18204 | 47 |
MEF2C |
1.029e-02 | -4.58 | positive regulation of establishment of T cell polarity | biological process | GO:1903905 | 4 | 1 | 18204 | 47 |
DOCK8 |
1.029e-02 | -4.58 | positive regulation of ER to Golgi vesicle-mediated transport | biological process | GO:1902953 | 4 | 1 | 18204 | 47 |
SORL1 |
1.029e-02 | -4.58 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell | biological process | GO:0002291 | 4 | 1 | 18204 | 47 |
APBB1IP |
1.029e-02 | -4.58 | insulin receptor recycling | biological process | GO:0038020 | 4 | 1 | 18204 | 47 |
SORL1 |
1.029e-02 | -4.58 | regulation of early endosome to recycling endosome transport | biological process | GO:1902954 | 4 | 1 | 18204 | 47 |
SORL1 |
1.039e-02 | -4.57 | Rho GTPase cycle | REACTOME pathways | R-HSA-194840 | 142 | 3 | 10285 | 33 |
ARHGAP26,ARHGAP22,ARHGAP24 |
1.041e-02 | -4.57 | thyroid | COSMIC cancer mutations | thyroid | 9867 | 37 | 16828 | 49 |
DIP2B,HDAC9,MAML3,DOCK8,MAML2,MED13L,MEF2C,SFMBT2,SLC8A1,DOCK4,EPB41L2,SLC9A9,ZFAND3,SSH2,ZSWIM6,ITPR2,FRMD4A,ARHGAP26,ELMO1,GNAQ,SORL1,UBE2E2,APBB1IP,FCHSD2,HS3ST4,CHST11,NAV3,ARHGAP22,PICALM,MAP4K4,ABCC4,PTPRJ,ANKRD44,PLXDC2,ZFHX3,DSCAM,ATP8B4 |
1.045e-02 | -4.56 | AP3B1 (adaptor related protein complex 3 subunit beta 1) | protein interactions | 8546 | 176 | 3 | 19454 | 50 |
EPB41L2,ARHGAP24,MAP4K4 |
1.048e-02 | -4.56 | - | gene3d domains | 1.20.80.10 | 51 | 2 | 14470 | 44 |
EPB41L2,FRMD4A |
1.050e-02 | -4.56 | proteoglycan biosynthetic process | biological process | GO:0030166 | 60 | 2 | 18204 | 47 |
CHST11,HS3ST4 |
1.054e-02 | -4.55 | haematopoietic_and_lymphoid_tissue-lymph_node-lymphoid_neoplasm-acute_lymphoblastic_leukaemia | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymph_node-lymphoid_neoplasm-acute_lymphoblastic_leukaemia | 156 | 3 | 16828 | 49 |
MEF2C,TCF12,ARHGAP24 |
1.074e-02 | -4.53 | Oxytocin signaling pathway | KEGG pathways | ko04921 | 152 | 3 | 7161 | 22 |
MEF2C,ITPR2,GNAQ |
1.074e-02 | -4.53 | Oxytocin signaling pathway | KEGG pathways | hsa04921 | 152 | 3 | 7161 | 22 |
MEF2C,ITPR2,GNAQ |
1.076e-02 | -4.53 | GRAF_fam | interpro domains | IPR047234 | 4 | 1 | 18521 | 50 |
ARHGAP26 |
1.076e-02 | -4.53 | HDAC4/5/7/9 | interpro domains | IPR046949 | 4 | 1 | 18521 | 50 |
HDAC9 |
1.076e-02 | -4.53 | Gprotein_alpha_Q | interpro domains | IPR000654 | 4 | 1 | 18521 | 50 |
GNAQ |
1.076e-02 | -4.53 | Band_4 | interpro domains | IPR008379 | 4 | 1 | 18521 | 50 |
EPB41L2 |
1.076e-02 | -4.53 | PH_GRAF | interpro domains | IPR047225 | 4 | 1 | 18521 | 50 |
ARHGAP26 |
1.076e-02 | -4.53 | ANTH_dom | interpro domains | IPR011417 | 4 | 1 | 18521 | 50 |
PICALM |
1.076e-02 | -4.53 | SAB_dom | interpro domains | IPR007477 | 4 | 1 | 18521 | 50 |
EPB41L2 |
1.076e-02 | -4.53 | ZSWIM4-8_C | interpro domains | IPR048370 | 4 | 1 | 18521 | 50 |
ZSWIM6 |
1.076e-02 | -4.53 | CUPID | interpro domains | IPR021774 | 4 | 1 | 18521 | 50 |
FRMD4A |
1.076e-02 | -4.53 | DEK_C | interpro domains | IPR014876 | 4 | 1 | 18521 | 50 |
SSH2 |
1.076e-02 | -4.53 | PTBP2 (polypyrimidine tract binding protein 2) | protein interactions | 58155 | 61 | 2 | 19454 | 50 |
QKI,UBE2E2 |
1.078e-02 | -4.53 | nodular | COSMIC cancer mutations | nodular | 1515 | 10 | 16828 | 49 |
ARHGAP26,ZFHX3,ANKRD44,DOCK8,DISC1,SORL1,DIP2B,SFMBT2,GNAQ,SLC8A1 |
1.079e-02 | -4.53 | glycoprotein metabolic process | biological process | GO:0009100 | 335 | 4 | 18204 | 47 |
ST6GAL1,ST6GALNAC3,CHST11,HS3ST4 |
1.097e-02 | -4.51 | ZSWIM4-8_C | pfam domains | PF21055 | 4 | 1 | 17795 | 49 |
ZSWIM6 |
1.097e-02 | -4.51 | CUPID | pfam domains | PF11819 | 4 | 1 | 17795 | 49 |
FRMD4A |
1.097e-02 | -4.51 | SAB | pfam domains | PF04382 | 4 | 1 | 17795 | 49 |
EPB41L2 |
1.097e-02 | -4.51 | 4_1_CTD | pfam domains | PF05902 | 4 | 1 | 17795 | 49 |
EPB41L2 |
1.097e-02 | -4.51 | ANTH | pfam domains | PF07651 | 4 | 1 | 17795 | 49 |
PICALM |
1.097e-02 | -4.51 | DEK_C | pfam domains | PF08766 | 4 | 1 | 17795 | 49 |
SSH2 |
1.101e-02 | -4.51 | histone H3K deacetylase activity | molecular function | GO:0141050 | 4 | 1 | 18094 | 50 |
HDAC9 |
1.101e-02 | -4.51 | ATPase-coupled organic acid transmembrane transporter activity | molecular function | GO:0033283 | 4 | 1 | 18094 | 50 |
ABCC4 |
1.101e-02 | -4.51 | ATPase-coupled carboxylic acid transmembrane transporter activity | molecular function | GO:0033284 | 4 | 1 | 18094 | 50 |
ABCC4 |
1.101e-02 | -4.51 | ABC-type bile acid transporter activity | molecular function | GO:0015432 | 4 | 1 | 18094 | 50 |
ABCC4 |
1.101e-02 | -4.51 | ISG15 transferase activity | molecular function | GO:0042296 | 4 | 1 | 18094 | 50 |
UBE2E2 |
1.101e-02 | -4.51 | ATPase-coupled monocarboxylic acid transmembrane transporter activity | molecular function | GO:0033285 | 4 | 1 | 18094 | 50 |
ABCC4 |
1.101e-02 | -4.51 | chondroitin 4-sulfotransferase activity | molecular function | GO:0047756 | 4 | 1 | 18094 | 50 |
CHST11 |
1.110e-02 | -4.50 | DTX3L (deltex E3 ubiquitin ligase 3L) | protein interactions | 151636 | 62 | 2 | 19454 | 50 |
UBE2E2,EPB41L2 |
1.110e-02 | -4.50 | EPHA4 (EPH receptor A4) | protein interactions | 2043 | 180 | 3 | 19454 | 50 |
TBC1D22A,DIP2B,MAP4K4 |
1.110e-02 | -4.50 | MYOD1 (myogenic differentiation 1) | protein interactions | 4654 | 180 | 3 | 19454 | 50 |
TCF12,MEF2C,MEF2A |
1.111e-02 | -4.50 | homeostatic process | biological process | GO:0042592 | 1456 | 9 | 18204 | 47 |
MEF2C,SLC9A9,PTPRJ,HDAC9,DISC1,SORL1,ZBTB20,SLC8A1,PICALM |
1.116e-02 | -4.50 | stereocilium bundle | cellular component | GO:0032421 | 65 | 2 | 19108 | 47 |
FCHSD2,DOCK4 |
1.118e-02 | -4.49 | parietal_lobe | COSMIC cancer mutations | parietal_lobe | 55 | 2 | 16828 | 49 |
QKI,GNAQ |
1.125e-02 | -4.49 | skin-trunk-malignant_melanoma-nodular | COSMIC cancer mutations | skin-trunk-malignant_melanoma-nodular | 1291 | 9 | 16828 | 49 |
DOCK8,DISC1,SORL1,SFMBT2,DIP2B,SLC8A1,ARHGAP26,ZFHX3,ANKRD44 |
1.138e-02 | -4.48 | negative regulation of kinase activity | biological process | GO:0033673 | 181 | 3 | 18204 | 47 |
GNAQ,SLC8A1,PTPRJ |
1.138e-02 | -4.48 | head_neck | COSMIC cancer mutations | head_neck | 15361 | 49 | 16828 | 49 |
SYNDIG1,PICALM,ST6GALNAC3,ZFHX3,ADAM28,APBB1IP,HS3ST4,NAV3,SLC9A9,TBC1D22A,ITPR2,FRMD4A,MAML3,DIP2B,DOCK8,MAML2,MEF2C,ST6GAL1,MAP4K4,ARHGAP22,ARHGAP24,PTPRJ,ANKRD44,PLXDC2,ABCC4,DSCAM,ATP8B4,GNAQ,FCHSD2,DISC1,SORL1,UBE2E2,CHST11,DOCK4,EPB41L2,SFMBT2,SLC8A1,ZBTB20,ZFAND3,ZSWIM6,SSH2,MEF2A,ELMO1,ARHGAP26,HDAC9,KCNQ3,QKI,MED13L,TCF12 |
1.144e-02 | -4.47 | Calcium Regulation in the Cardiac Cell | WikiPathways | WP536 | 151 | 3 | 5310 | 17 |
SLC8A1,GNAQ,ITPR2 |
1.144e-02 | -4.47 | DEK_C | prosite domains | PS51998 | 4 | 1 | 12186 | 35 |
SSH2 |
1.151e-02 | -4.46 | blood vessel development | biological process | GO:0001568 | 530 | 5 | 18204 | 47 |
MEF2C,ARHGAP22,QKI,ARHGAP24,PTPRJ |
1.153e-02 | -4.46 | regulation of focal adhesion assembly | biological process | GO:0051893 | 63 | 2 | 18204 | 47 |
MAP4K4,PTPRJ |
1.153e-02 | -4.46 | regulation of cell-substrate junction assembly | biological process | GO:0090109 | 63 | 2 | 18204 | 47 |
PTPRJ,MAP4K4 |
1.160e-02 | -4.46 | central_nervous_system-occipital_lobe-other-ganglioglioma | COSMIC cancer mutations | central_nervous_system-occipital_lobe-other-ganglioglioma | 4 | 1 | 16828 | 49 |
GNAQ |
1.160e-02 | -4.46 | skin-benign_melanocytic_nevus-blue | COSMIC cancer mutations | skin-benign_melanocytic_nevus-blue | 4 | 1 | 16828 | 49 |
GNAQ |
1.160e-02 | -4.46 | skin-elbow-benign_melanocytic_nevus-Spitz | COSMIC cancer mutations | skin-elbow-benign_melanocytic_nevus-Spitz | 4 | 1 | 16828 | 49 |
GNAQ |
1.160e-02 | -4.46 | soft_tissue-nerve_sheath-schwannoma-melanotic | COSMIC cancer mutations | soft_tissue-nerve_sheath-schwannoma-melanotic | 4 | 1 | 16828 | 49 |
GNAQ |
1.160e-02 | -4.46 | skin-scalp-benign_melanocytic_nevus-blue | COSMIC cancer mutations | skin-scalp-benign_melanocytic_nevus-blue | 4 | 1 | 16828 | 49 |
GNAQ |
1.160e-02 | -4.46 | skin-flank-benign_melanocytic_nevus | COSMIC cancer mutations | skin-flank-benign_melanocytic_nevus | 4 | 1 | 16828 | 49 |
GNAQ |
1.160e-02 | -4.46 | skin-malignant_melanoma-spitzoid | COSMIC cancer mutations | skin-malignant_melanoma-spitzoid | 4 | 1 | 16828 | 49 |
GNAQ |
1.167e-02 | -4.45 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-peripheral_T_cell_lymphoma_unspecified | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-peripheral_T_cell_lymphoma_unspecified | 162 | 3 | 16828 | 49 |
DIP2B,ITPR2,ATP8B4 |
1.195e-02 | -4.43 | PDE4DIP (phosphodiesterase 4D interacting protein) | protein interactions | 9659 | 185 | 3 | 19454 | 50 |
DSCAM,DISC1,FCHSD2 |
1.196e-02 | -4.43 | LDLa | smart domains | SM00192 | 45 | 2 | 9717 | 36 |
SORL1,LDLRAD4 |
1.207e-02 | -4.42 | cellular response to metal ion | biological process | GO:0071248 | 185 | 3 | 18204 | 47 |
KCNQ3,MEF2A,MEF2C |
1.211e-02 | -4.41 | Platelet activation, signaling and aggregation | REACTOME pathways | R-HSA-76002 | 282 | 4 | 10285 | 33 |
ITPR2,APBB1IP,GNAQ,ABCC4 |
1.213e-02 | -4.41 | molecular adaptor activity | molecular function | GO:0060090 | 1138 | 8 | 18094 | 50 |
QKI,DISC1,SFMBT2,HDAC9,MAML2,MAML3,MED13L,FRMD4A |
1.214e-02 | -4.41 | transcription coregulator activity | molecular function | GO:0003712 | 501 | 5 | 18094 | 50 |
MAML2,MAML3,SFMBT2,MED13L,HDAC9 |
1.216e-02 | -4.41 | haematopoietic_and_lymphoid_tissue-lymph_node-lymphoid_neoplasm-mantle_cell_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymph_node-lymphoid_neoplasm-mantle_cell_lymphoma | 476 | 5 | 16828 | 49 |
ZSWIM6,MAML2,DSCAM,ZFHX3,ZFAND3 |
1.224e-02 | -4.40 | perinucleolar compartment | cellular component | GO:0097356 | 5 | 1 | 19108 | 47 |
SORL1 |
1.224e-02 | -4.40 | neurofibrillary tangle | cellular component | GO:0097418 | 5 | 1 | 19108 | 47 |
PICALM |
1.250e-02 | -4.38 | KATNA1 (katanin catalytic subunit A1) | protein interactions | 11104 | 66 | 2 | 19454 | 50 |
LDLRAD4,ARHGAP24 |
1.250e-02 | -4.38 | CFAP206 (cilia and flagella associated protein 206) | protein interactions | 154313 | 66 | 2 | 19454 | 50 |
TCF12,DISC1 |
1.260e-02 | -4.37 | endosome membrane | cellular component | GO:0010008 | 569 | 5 | 19108 | 47 |
SLC9A9,LDLRAD4,SYNDIG1,SORL1,ARHGAP26 |
1.260e-02 | -4.37 | cardiac muscle cell development | biological process | GO:0055013 | 66 | 2 | 18204 | 47 |
MEF2A,SLC8A1 |
1.262e-02 | -4.37 | bone-pelvis-chondrosarcoma | COSMIC cancer mutations | bone-pelvis-chondrosarcoma | 311 | 4 | 16828 | 49 |
MAML3,SYNDIG1,ZFHX3,NAV3 |
1.266e-02 | -4.37 | peripheral_T_cell_lymphoma_unspecified | COSMIC cancer mutations | peripheral_T_cell_lymphoma_unspecified | 167 | 3 | 16828 | 49 |
ITPR2,ATP8B4,DIP2B |
1.275e-02 | -4.36 | Oxytocin signaling | WikiPathways | WP2889 | 4 | 1 | 5310 | 17 |
GNAQ |
1.275e-02 | -4.36 | Serotonin Receptor 2 and STAT3 Signaling | WikiPathways | WP733 | 4 | 1 | 5310 | 17 |
GNAQ |
1.278e-02 | -4.36 | B cell activation | biological process | GO:0042113 | 189 | 3 | 18204 | 47 |
MEF2C,HDAC9,PTPRJ |
1.279e-02 | -4.36 | ZNF571 (zinc finger protein 571) | protein interactions | 51276 | 5 | 1 | 19454 | 50 |
ARHGAP24 |
1.279e-02 | -4.36 | ORF48 (ORF48) | protein interactions | 4961458 | 5 | 1 | 19454 | 50 |
ANKRD44 |
1.279e-02 | -4.36 | ASTN1 (astrotactin 1) | protein interactions | 460 | 5 | 1 | 19454 | 50 |
DSCAM |
1.279e-02 | -4.36 | ZNF836 (zinc finger protein 836) | protein interactions | 162962 | 5 | 1 | 19454 | 50 |
ARHGAP24 |
1.279e-02 | -4.36 | SLC16A14 (solute carrier family 16 member 14) | protein interactions | 151473 | 5 | 1 | 19454 | 50 |
GNAQ |
1.279e-02 | -4.36 | POU2F3 (POU class 2 homeobox 3) | protein interactions | 25833 | 5 | 1 | 19454 | 50 |
ARHGAP24 |
1.279e-02 | -4.36 | TRPM6 (transient receptor potential cation channel subfamily M member 6) | protein interactions | 140803 | 5 | 1 | 19454 | 50 |
ARHGAP24 |
1.279e-02 | -4.36 | ZNF93 (zinc finger protein 93) | protein interactions | 81931 | 5 | 1 | 19454 | 50 |
ARHGAP24 |
1.279e-02 | -4.36 | HOXC12 (homeobox C12) | protein interactions | 3228 | 5 | 1 | 19454 | 50 |
SORL1 |
1.284e-02 | -4.35 | positive regulation of the force of heart contraction | biological process | GO:0098735 | 5 | 1 | 18204 | 47 |
SLC8A1 |
1.284e-02 | -4.35 | psychomotor behavior | biological process | GO:0036343 | 5 | 1 | 18204 | 47 |
KCNQ3 |
1.284e-02 | -4.35 | positive regulation of Fc receptor mediated stimulatory signaling pathway | biological process | GO:0060369 | 5 | 1 | 18204 | 47 |
PTPRJ |
1.284e-02 | -4.35 | negative regulation of triglyceride catabolic process | biological process | GO:0010897 | 5 | 1 | 18204 | 47 |
SORL1 |
1.284e-02 | -4.35 | negative regulation of Rac protein signal transduction | biological process | GO:0035021 | 5 | 1 | 18204 | 47 |
ARHGAP24 |
1.284e-02 | -4.35 | protein retention in Golgi apparatus | biological process | GO:0045053 | 5 | 1 | 18204 | 47 |
SORL1 |
1.284e-02 | -4.35 | prostaglandin secretion | biological process | GO:0032310 | 5 | 1 | 18204 | 47 |
ABCC4 |
1.293e-02 | -4.35 | Myometrial Relaxation and Contraction Pathways | WikiPathways | WP289 | 158 | 3 | 5310 | 17 |
SLC8A1,GNAQ,ITPR2 |
1.295e-02 | -4.35 | GPROTEINAQ | prints domains | PR00442 | 4 | 1 | 5227 | 17 |
GNAQ |
1.302e-02 | -4.34 | ovary | COSMIC cancer mutations | ovary | 14770 | 48 | 16828 | 49 |
ZBTB20,SLC9A9,ZFAND3,SFMBT2,SLC8A1,DOCK4,EPB41L2,ITPR2,FRMD4A,MEF2A,ARHGAP26,ELMO1,SSH2,TBC1D22A,ZSWIM6,KCNQ3,QKI,DOCK8,DIP2B,HDAC9,MAML3,MEF2C,TCF12,MAML2,MED13L,ARHGAP22,ARHGAP24,PICALM,MAP4K4,ST6GAL1,SYNDIG1,DSCAM,ZFHX3,ATP8B4,ABCC4,ST6GALNAC3,PTPRJ,ANKRD44,PLXDC2,SORL1,ADAM28,APBB1IP,UBE2E2,FCHSD2,GNAQ,CHST11,NAV3,HS3ST4 |
1.303e-02 | -4.34 | negative regulation of multicellular organismal process | biological process | GO:0051241 | 1237 | 8 | 18204 | 47 |
SORL1,LDLRAD4,DOCK4,MEF2C,NAV3,QKI,HDAC9,DIP2B |
1.304e-02 | -4.34 | SH3_9 | pfam domains | PF14604 | 63 | 2 | 17795 | 49 |
ARHGAP26,FCHSD2 |
1.305e-02 | -4.34 | actin cytoskeleton organization | biological process | GO:0030036 | 547 | 5 | 18204 | 47 |
EPB41L2,SSH2,ARHGAP26,ELMO1,MEF2A |
1.320e-02 | -4.33 | MED17 (mediator complex subunit 17) | protein interactions | 9440 | 192 | 3 | 19454 | 50 |
MED13L,PICALM,QKI |
1.333e-02 | -4.32 | regulation of neuron differentiation | biological process | GO:0045664 | 192 | 3 | 18204 | 47 |
MEF2C,ZFHX3,TCF12 |
1.334e-02 | -4.32 | regulation of cell-substrate junction organization | biological process | GO:0150116 | 68 | 2 | 18204 | 47 |
MAP4K4,PTPRJ |
1.334e-02 | -4.32 | vasculature development | biological process | GO:0001944 | 550 | 5 | 18204 | 47 |
MEF2C,ARHGAP24,QKI,ARHGAP22,PTPRJ |
1.343e-02 | -4.31 | Sortilin_C | interpro domains | IPR031777 | 5 | 1 | 18521 | 50 |
SORL1 |
1.343e-02 | -4.31 | DOCK_N_sub1 | interpro domains | IPR042455 | 5 | 1 | 18521 | 50 |
DOCK4 |
1.343e-02 | -4.31 | VPS10 | interpro domains | IPR006581 | 5 | 1 | 18521 | 50 |
SORL1 |
1.343e-02 | -4.31 | PH_APBB1IP | interpro domains | IPR039665 | 5 | 1 | 18521 | 50 |
APBB1IP |
1.343e-02 | -4.31 | DOCK_N | interpro domains | IPR032376 | 5 | 1 | 18521 | 50 |
DOCK4 |
1.343e-02 | -4.31 | SLED_sf | interpro domains | IPR038348 | 5 | 1 | 18521 | 50 |
SFMBT2 |
1.343e-02 | -4.31 | K_chnl_volt-dep_KCNQ_C | interpro domains | IPR013821 | 5 | 1 | 18521 | 50 |
KCNQ3 |
1.343e-02 | -4.31 | BBP-like | interpro domains | IPR045071 | 5 | 1 | 18521 | 50 |
QKI |
1.343e-02 | -4.31 | K_chnl_volt-dep_KCNQ | interpro domains | IPR003937 | 5 | 1 | 18521 | 50 |
KCNQ3 |
1.343e-02 | -4.31 | GRB/APBB1IP | interpro domains | IPR039664 | 5 | 1 | 18521 | 50 |
APBB1IP |
1.343e-02 | -4.31 | SLED | interpro domains | IPR021987 | 5 | 1 | 18521 | 50 |
SFMBT2 |
1.343e-02 | -4.31 | Sortilin_N | interpro domains | IPR031778 | 5 | 1 | 18521 | 50 |
SORL1 |
1.343e-02 | -4.31 | Ubiquitin-like_domsf | interpro domains | IPR029071 | 184 | 3 | 18521 | 50 |
FRMD4A,APBB1IP,EPB41L2 |
1.351e-02 | -4.30 | cellular response to xenobiotic stimulus | biological process | GO:0071466 | 193 | 3 | 18204 | 47 |
MEF2C,ABCC4,KCNQ3 |
1.357e-02 | -4.30 | inclusion body | cellular component | GO:0016234 | 72 | 2 | 19108 | 47 |
PICALM,SFMBT2 |
1.362e-02 | -4.30 | intracellular signal transduction | biological process | GO:0035556 | 1505 | 9 | 18204 | 47 |
DOCK8,MEF2C,MEF2A,ELMO1,DISC1,MAP4K4,DOCK4,SLC8A1,ITPR2 |
1.367e-02 | -4.29 | neoplasm | COSMIC cancer mutations | neoplasm | 14787 | 48 | 16828 | 49 |
MEF2C,MAML2,DOCK8,MAML3,DIP2B,ITPR2,FRMD4A,TBC1D22A,SLC9A9,NAV3,HS3ST4,ADAM28,APBB1IP,ZFHX3,ST6GALNAC3,SYNDIG1,PICALM,MED13L,TCF12,KCNQ3,QKI,HDAC9,MEF2A,ELMO1,ARHGAP26,ZSWIM6,SSH2,ZBTB20,ZFAND3,EPB41L2,DOCK4,SFMBT2,SLC8A1,CHST11,FCHSD2,SORL1,UBE2E2,GNAQ,DSCAM,ATP8B4,ANKRD44,PTPRJ,PLXDC2,ABCC4,ST6GAL1,MAP4K4,ARHGAP22,ARHGAP24 |
1.369e-02 | -4.29 | SLED | pfam domains | PF12140 | 5 | 1 | 17795 | 49 |
SFMBT2 |
1.369e-02 | -4.29 | DOCK_N | pfam domains | PF16172 | 5 | 1 | 17795 | 49 |
DOCK4 |
1.369e-02 | -4.29 | Sortilin_C | pfam domains | PF15901 | 5 | 1 | 17795 | 49 |
SORL1 |
1.369e-02 | -4.29 | KCNQ_channel | pfam domains | PF03520 | 5 | 1 | 17795 | 49 |
KCNQ3 |
1.369e-02 | -4.29 | DMAP_binding | pfam domains | PF06464 | 5 | 1 | 17795 | 49 |
DIP2B |
1.369e-02 | -4.29 | Sortilin-Vps10 | pfam domains | PF15902 | 5 | 1 | 17795 | 49 |
SORL1 |
1.374e-02 | -4.29 | glutathione transmembrane transporter activity | molecular function | GO:0034634 | 5 | 1 | 18094 | 50 |
ABCC4 |
1.374e-02 | -4.29 | N-acetylgalactosamine 4-O-sulfotransferase activity | molecular function | GO:0001537 | 5 | 1 | 18094 | 50 |
CHST11 |
1.374e-02 | -4.29 | guanine nucleotide transmembrane transporter activity | molecular function | GO:0001409 | 5 | 1 | 18094 | 50 |
ABCC4 |
1.375e-02 | -4.29 | skin-upper_back-malignant_melanoma | COSMIC cancer mutations | skin-upper_back-malignant_melanoma | 319 | 4 | 16828 | 49 |
PTPRJ,KCNQ3,ATP8B4,ELMO1 |
1.380e-02 | -4.28 | Ion homeostasis | REACTOME pathways | R-HSA-5578775 | 56 | 2 | 10285 | 33 |
ITPR2,SLC8A1 |
1.389e-02 | -4.28 | Cardiac Hypertrophic Response | WikiPathways | WP2795 | 57 | 2 | 5310 | 17 |
MEF2A,HDAC9 |
1.399e-02 | -4.27 | CTDNEP1 (CTD nuclear envelope phosphatase 1) | protein interactions | 23399 | 70 | 2 | 19454 | 50 |
ITPR2,PLXDC2 |
1.409e-02 | -4.26 | cardiac conduction | biological process | GO:0061337 | 70 | 2 | 18204 | 47 |
MEF2A,SLC8A1 |
1.413e-02 | -4.26 | lower_leg | COSMIC cancer mutations | lower_leg | 174 | 3 | 16828 | 49 |
ADAM28,GNAQ,PTPRJ |
1.414e-02 | -4.26 | recycling endosome | cellular component | GO:0055037 | 206 | 3 | 19108 | 47 |
SLC9A9,FCHSD2,SORL1 |
1.414e-02 | -4.26 | GAR1 (GAR1 ribonucleoprotein) | protein interactions | 54433 | 197 | 3 | 19454 | 50 |
ARHGAP22,DOCK4,MAP4K4 |
1.418e-02 | -4.26 | liver-carcinoma-hepatocellular_carcinoma | COSMIC cancer mutations | liver-carcinoma-hepatocellular_carcinoma | 14800 | 48 | 16828 | 49 |
DSCAM,ATP8B4,PTPRJ,ANKRD44,PLXDC2,ABCC4,ST6GAL1,MAP4K4,ARHGAP22,ARHGAP24,CHST11,DISC1,SORL1,UBE2E2,GNAQ,MEF2A,ARHGAP26,ELMO1,ZSWIM6,SSH2,ZBTB20,ZFAND3,DOCK4,EPB41L2,SFMBT2,SLC8A1,MED13L,TCF12,KCNQ3,QKI,HDAC9,ZFHX3,ST6GALNAC3,SYNDIG1,PICALM,NAV3,HS3ST4,ADAM28,APBB1IP,ITPR2,FRMD4A,TBC1D22A,SLC9A9,MEF2C,MAML2,DOCK8,MAML3,DIP2B |
1.418e-02 | -4.26 | hepatocellular_carcinoma | COSMIC cancer mutations | hepatocellular_carcinoma | 14800 | 48 | 16828 | 49 |
SLC9A9,FRMD4A,ITPR2,TBC1D22A,DOCK8,MAML3,DIP2B,MEF2C,MAML2,SYNDIG1,PICALM,ZFHX3,ST6GALNAC3,APBB1IP,ADAM28,NAV3,HS3ST4,ZFAND3,ZBTB20,EPB41L2,DOCK4,SLC8A1,SFMBT2,ARHGAP26,ELMO1,MEF2A,ZSWIM6,SSH2,QKI,KCNQ3,HDAC9,MED13L,TCF12,ST6GAL1,MAP4K4,ARHGAP24,ARHGAP22,ATP8B4,DSCAM,PLXDC2,ANKRD44,PTPRJ,ABCC4,UBE2E2,SORL1,DISC1,GNAQ,CHST11 |
1.432e-02 | -4.25 | Long-term depression | KEGG pathways | hsa04730 | 60 | 2 | 7161 | 22 |
GNAQ,ITPR2 |
1.432e-02 | -4.25 | Long-term depression | KEGG pathways | ko04730 | 60 | 2 | 7161 | 22 |
ITPR2,GNAQ |
1.448e-02 | -4.24 | skin-forearm-benign_melanocytic_nevus-Spitz | COSMIC cancer mutations | skin-forearm-benign_melanocytic_nevus-Spitz | 5 | 1 | 16828 | 49 |
GNAQ |
1.448e-02 | -4.24 | skin-foot-benign_melanocytic_nevus-melanocytic_tumour | COSMIC cancer mutations | skin-foot-benign_melanocytic_nevus-melanocytic_tumour | 5 | 1 | 16828 | 49 |
GNAQ |
1.448e-02 | -4.24 | skin-forearm-benign_melanocytic_nevus | COSMIC cancer mutations | skin-forearm-benign_melanocytic_nevus | 5 | 1 | 16828 | 49 |
GNAQ |
1.448e-02 | -4.24 | skin-ankle-benign_melanocytic_nevus-Spitz | COSMIC cancer mutations | skin-ankle-benign_melanocytic_nevus-Spitz | 5 | 1 | 16828 | 49 |
GNAQ |
1.448e-02 | -4.24 | skin-lower_back-benign_melanocytic_nevus-blue | COSMIC cancer mutations | skin-lower_back-benign_melanocytic_nevus-blue | 5 | 1 | 16828 | 49 |
GNAQ |
1.448e-02 | -4.24 | skin-arm-benign_melanocytic_nevus-blue | COSMIC cancer mutations | skin-arm-benign_melanocytic_nevus-blue | 5 | 1 | 16828 | 49 |
GNAQ |
1.448e-02 | -4.24 | skin-scalp-benign_melanocytic_nevus | COSMIC cancer mutations | skin-scalp-benign_melanocytic_nevus | 5 | 1 | 16828 | 49 |
GNAQ |
1.448e-02 | -4.24 | skin-face-benign_melanocytic_nevus-melanocytic_tumour | COSMIC cancer mutations | skin-face-benign_melanocytic_nevus-melanocytic_tumour | 5 | 1 | 16828 | 49 |
GNAQ |
1.448e-02 | -4.24 | skin-face-benign_melanocytic_nevus | COSMIC cancer mutations | skin-face-benign_melanocytic_nevus | 5 | 1 | 16828 | 49 |
GNAQ |
1.448e-02 | -4.24 | skin-buttock-benign_melanocytic_nevus-melanocytic_tumour | COSMIC cancer mutations | skin-buttock-benign_melanocytic_nevus-melanocytic_tumour | 5 | 1 | 16828 | 49 |
GNAQ |
1.448e-02 | -4.24 | central_nervous_system-brainstem-other-ganglioglioma | COSMIC cancer mutations | central_nervous_system-brainstem-other-ganglioglioma | 5 | 1 | 16828 | 49 |
GNAQ |
1.455e-02 | -4.23 | Activation of PKC Through G Protein-Coupled Receptor | SMPDB pathways | SMP0000749 | 4 | 1 | 1369 | 5 |
GNAQ |
1.466e-02 | -4.22 | cardiac muscle tissue development | biological process | GO:0048738 | 199 | 3 | 18204 | 47 |
SLC8A1,MEF2A,MEF2C |
1.467e-02 | -4.22 | external side of apical plasma membrane | cellular component | GO:0098591 | 6 | 1 | 19108 | 47 |
ABCC4 |
1.467e-02 | -4.22 | extrinsic component of presynaptic membrane | cellular component | GO:0098888 | 6 | 1 | 19108 | 47 |
PICALM |
1.467e-02 | -4.22 | platelet dense granule membrane | cellular component | GO:0031088 | 6 | 1 | 19108 | 47 |
ABCC4 |
1.476e-02 | -4.22 | DGCR6 (DiGeorge syndrome critical region gene 6) | protein interactions | 8214 | 72 | 2 | 19454 | 50 |
DOCK8,TCF12 |
1.477e-02 | -4.22 | endosome | cellular component | GO:0005768 | 1067 | 7 | 19108 | 47 |
SYNDIG1,SLC9A9,FCHSD2,PICALM,LDLRAD4,SORL1,ARHGAP26 |
1.486e-02 | -4.21 | negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | biological process | GO:0090101 | 200 | 3 | 18204 | 47 |
SORL1,LDLRAD4,CHST11 |
1.487e-02 | -4.21 | PH | smart domains | SM00233 | 259 | 4 | 9717 | 36 |
ARHGAP22,ARHGAP26,APBB1IP,ARHGAP24 |
1.491e-02 | -4.21 | DBN1 (drebrin 1) | protein interactions | 1627 | 370 | 4 | 19454 | 50 |
SSH2,PICALM,DISC1,ARHGAP24 |
1.511e-02 | -4.19 | SLED domain | gene3d domains | 3.90.1150.190 | 5 | 1 | 14470 | 44 |
SFMBT2 |
1.511e-02 | -4.19 | - | gene3d domains | 6.10.140.1910 | 5 | 1 | 14470 | 44 |
KCNQ3 |
1.511e-02 | -4.19 | - | gene3d domains | 3.30.60.270 | 5 | 1 | 14470 | 44 |
SORL1 |
1.511e-02 | -4.19 | Dedicator of cytokinesis N-terminal subdomain | gene3d domains | 1.20.1270.350 | 5 | 1 | 14470 | 44 |
DOCK4 |
1.511e-02 | -4.19 | - | gene3d domains | 2.10.70.80 | 5 | 1 | 14470 | 44 |
SORL1 |
1.515e-02 | -4.19 | AGAP3 (ArfGAP with GTPase domain, ankyrin repeat and PH domain 3) | protein interactions | 116988 | 73 | 2 | 19454 | 50 |
ARHGAP24,ARHGAP22 |
1.518e-02 | -4.19 | B41 | smart domains | SM00295 | 51 | 2 | 9717 | 36 |
EPB41L2,FRMD4A |
1.520e-02 | -4.19 | skin-scalp-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | skin-scalp-carcinoma-squamous_cell_carcinoma | 1596 | 10 | 16828 | 49 |
SLC8A1,SFMBT2,SYNDIG1,SORL1,KCNQ3,CHST11,ZFHX3,DSCAM,ELMO1,NAV3 |
1.524e-02 | -4.18 | adrenal_gland | COSMIC cancer mutations | adrenal_gland | 2628 | 14 | 16828 | 49 |
ST6GAL1,DOCK4,ZBTB20,PTPRJ,ABCC4,MEF2A,ELMO1,FRMD4A,ATP8B4,HDAC9,GNAQ,DIP2B,DOCK8,MAML2 |
1.526e-02 | -4.18 | regulation of protein polymerization | biological process | GO:0032271 | 202 | 3 | 18204 | 47 |
NAV3,FCHSD2,SSH2 |
1.526e-02 | -4.18 | cardiac cell development | biological process | GO:0055006 | 73 | 2 | 18204 | 47 |
SLC8A1,MEF2A |
1.526e-02 | -4.18 | vasculogenesis | biological process | GO:0001570 | 73 | 2 | 18204 | 47 |
QKI,PTPRJ |
1.526e-02 | -4.18 | regulation of insulin receptor signaling pathway | biological process | GO:0046626 | 73 | 2 | 18204 | 47 |
PTPRJ,SORL1 |
1.530e-02 | -4.18 | intracellular membrane-bounded organelle | cellular component | GO:0043231 | 12479 | 38 | 19108 | 47 |
SLC9A9,HS3ST4,PICALM,EPB41L2,ZBTB20,DOCK4,SFMBT2,CHST11,DISC1,ZFHX3,ATP8B4,SSH2,ST6GAL1,MED13L,MEF2A,PTPRJ,MAML2,TCF12,KCNQ3,HDAC9,ARHGAP22,SYNDIG1,MEF2C,SLC8A1,NAV3,ABCC4,SORL1,MAML3,ST6GALNAC3,ITPR2,ADAM28,QKI,FCHSD2,DIP2B,LDLRAD4,UBE2E2,ARHGAP26,GNAQ |
1.532e-02 | -4.18 | Dock11 (dedicator of cytokinesis 11) | protein interactions | 75974 | 6 | 1 | 19454 | 50 |
EPB41L2 |
1.532e-02 | -4.18 | IL1RAPL1 (interleukin 1 receptor accessory protein like 1) | protein interactions | 11141 | 6 | 1 | 19454 | 50 |
ARHGAP22 |
1.532e-02 | -4.18 | ZNF713 (zinc finger protein 713) | protein interactions | 349075 | 6 | 1 | 19454 | 50 |
SORL1 |
1.532e-02 | -4.18 | S1PR3 (sphingosine-1-phosphate receptor 3) | protein interactions | 1903 | 6 | 1 | 19454 | 50 |
GNAQ |
1.532e-02 | -4.18 | ZNF311 (zinc finger protein 311) | protein interactions | 282890 | 6 | 1 | 19454 | 50 |
ARHGAP24 |
1.532e-02 | -4.18 | KCNN1 (potassium calcium-activated channel subfamily N member 1) | protein interactions | 3780 | 6 | 1 | 19454 | 50 |
DSCAM |
1.532e-02 | -4.18 | DAZ4 (deleted in azoospermia 4) | protein interactions | 57135 | 6 | 1 | 19454 | 50 |
QKI |
1.532e-02 | -4.18 | HRD1 (E3 ubiquitin-protein ligase HRD1) | protein interactions | 854149 | 6 | 1 | 19454 | 50 |
UBE2E2 |
1.532e-02 | -4.18 | PBP2 (Pbp2p) | protein interactions | 852533 | 6 | 1 | 19454 | 50 |
QKI |
1.532e-02 | -4.18 | AKR1C4 (aldo-keto reductase family 1 member C4) | protein interactions | 1109 | 6 | 1 | 19454 | 50 |
PLXDC2 |
1.539e-02 | -4.17 | positive regulation of peptidyl-lysine acetylation | biological process | GO:2000758 | 6 | 1 | 18204 | 47 |
DIP2B |
1.539e-02 | -4.17 | mitochondrial depolarization | biological process | GO:0051882 | 6 | 1 | 18204 | 47 |
KCNQ3 |
1.539e-02 | -4.17 | radial glia-guided pyramidal neuron migration | biological process | GO:0140650 | 6 | 1 | 18204 | 47 |
DISC1 |
1.539e-02 | -4.17 | positive regulation of protein localization to cell cortex | biological process | GO:1904778 | 6 | 1 | 18204 | 47 |
EPB41L2 |
1.539e-02 | -4.17 | regulation of focal adhesion disassembly | biological process | GO:0120182 | 6 | 1 | 18204 | 47 |
MAP4K4 |
1.539e-02 | -4.17 | positive regulation of focal adhesion disassembly | biological process | GO:0120183 | 6 | 1 | 18204 | 47 |
MAP4K4 |
1.539e-02 | -4.17 | regulation of establishment of T cell polarity | biological process | GO:1903903 | 6 | 1 | 18204 | 47 |
DOCK8 |
1.539e-02 | -4.17 | peptidyl-lysine deacetylation | biological process | GO:0034983 | 6 | 1 | 18204 | 47 |
HDAC9 |
1.539e-02 | -4.17 | ISG15-protein conjugation | biological process | GO:0032020 | 6 | 1 | 18204 | 47 |
UBE2E2 |
1.539e-02 | -4.17 | post-embryonic animal morphogenesis | biological process | GO:0009886 | 6 | 1 | 18204 | 47 |
DSCAM |
1.541e-02 | -4.17 | clathrin-coated pit | cellular component | GO:0005905 | 77 | 2 | 19108 | 47 |
PICALM,FCHSD2 |
1.547e-02 | -4.17 | heart development | biological process | GO:0007507 | 571 | 5 | 18204 | 47 |
PTPRJ,SLC8A1,MEF2A,HDAC9,MEF2C |
1.570e-02 | -4.15 | central_nervous_system-brainstem-primitive_neuroectodermal_tumour-medulloblastoma-WNT_subtype | COSMIC cancer mutations | central_nervous_system-brainstem-primitive_neuroectodermal_tumour-medulloblastoma-WNT_subtype | 181 | 3 | 16828 | 49 |
ARHGAP26,ELMO1,ZFHX3 |
1.573e-02 | -4.15 | Signaling by BRAF and RAF fusions | REACTOME pathways | R-HSA-6802952 | 60 | 2 | 10285 | 33 |
APBB1IP,QKI |
1.582e-02 | -4.15 | TRIM25 (tripartite motif containing 25) | protein interactions | 7706 | 2387 | 12 | 19454 | 50 |
CHST11,GNAQ,SSH2,TCF12,ZFAND3,PTPRJ,DIP2B,MAP4K4,MED13L,ABCC4,ZFHX3,PICALM |
1.587e-02 | -4.14 | striated muscle tissue development | biological process | GO:0014706 | 205 | 3 | 18204 | 47 |
MEF2C,MEF2A,SLC8A1 |
1.593e-02 | -4.14 | WNT_subtype | COSMIC cancer mutations | WNT_subtype | 182 | 3 | 16828 | 49 |
ZFHX3,ELMO1,ARHGAP26 |
1.594e-02 | -4.14 | JUND (JunD proto-oncogene, AP-1 transcription factor subunit) | protein interactions | 3727 | 75 | 2 | 19454 | 50 |
MEF2A,ARHGAP22 |
1.594e-02 | -4.14 | SSH3 (slingshot protein phosphatase 3) | protein interactions | 54961 | 75 | 2 | 19454 | 50 |
SSH2,ARHGAP24 |
1.600e-02 | -4.13 | other | COSMIC cancer mutations | other | 14843 | 48 | 16828 | 49 |
ZFAND3,ZBTB20,DOCK4,EPB41L2,SLC8A1,SFMBT2,ARHGAP26,ELMO1,MEF2A,ZSWIM6,SSH2,QKI,KCNQ3,HDAC9,MED13L,TCF12,ST6GAL1,MAP4K4,ARHGAP24,ARHGAP22,ATP8B4,DSCAM,PLXDC2,ANKRD44,PTPRJ,ABCC4,FCHSD2,UBE2E2,SORL1,GNAQ,CHST11,SLC9A9,FRMD4A,ITPR2,TBC1D22A,DOCK8,MAML3,DIP2B,MEF2C,MAML2,SYNDIG1,PICALM,ZFHX3,ST6GALNAC3,APBB1IP,ADAM28,NAV3,HS3ST4 |
1.606e-02 | -4.13 | regulation of cellular response to insulin stimulus | biological process | GO:1900076 | 75 | 2 | 18204 | 47 |
PTPRJ,SORL1 |
1.606e-02 | -4.13 | regulation of behavior | biological process | GO:0050795 | 75 | 2 | 18204 | 47 |
ZFHX3,MEF2C |
1.609e-02 | -4.13 | DOCK_C/D_N | interpro domains | IPR021816 | 6 | 1 | 18521 | 50 |
DOCK8 |
1.609e-02 | -4.13 | RIH_dom | interpro domains | IPR000699 | 6 | 1 | 18521 | 50 |
ITPR2 |
1.609e-02 | -4.13 | Ryanodine_IP3_receptor | interpro domains | IPR015925 | 6 | 1 | 18521 | 50 |
ITPR2 |
1.609e-02 | -4.13 | Ins145_P3_rcpt | interpro domains | IPR014821 | 6 | 1 | 18521 | 50 |
ITPR2 |
1.609e-02 | -4.13 | RyR/IP3R_RIH_dom_sf | interpro domains | IPR035910 | 6 | 1 | 18521 | 50 |
ITPR2 |
1.609e-02 | -4.13 | DMAP1-bd | interpro domains | IPR010506 | 6 | 1 | 18521 | 50 |
DIP2B |
1.609e-02 | -4.13 | RIH_assoc-dom | interpro domains | IPR013662 | 6 | 1 | 18521 | 50 |
ITPR2 |
1.609e-02 | -4.13 | ELMO_dom | interpro domains | IPR006816 | 6 | 1 | 18521 | 50 |
ELMO1 |
1.616e-02 | -4.13 | KCNQCHANNEL | prints domains | PR01459 | 5 | 1 | 5227 | 17 |
KCNQ3 |
1.630e-02 | -4.12 | Notch Signaling Pathway | WikiPathways | WP61 | 62 | 2 | 5310 | 17 |
MAML2,MAML3 |
1.635e-02 | -4.11 | KIF5A (kinesin family member 5A) | protein interactions | 3798 | 76 | 2 | 19454 | 50 |
MAP4K4,DSCAM |
1.635e-02 | -4.11 | PGM3 (phosphoglucomutase 3) | protein interactions | 5238 | 76 | 2 | 19454 | 50 |
ARHGAP24,DISC1 |
1.635e-02 | -4.11 | CYP1A1 (cytochrome P450 family 1 subfamily A member 1) | protein interactions | 1543 | 76 | 2 | 19454 | 50 |
PICALM,QKI |
1.641e-02 | -4.11 | ELMO_CED12 | pfam domains | PF04727 | 6 | 1 | 17795 | 49 |
ELMO1 |
1.641e-02 | -4.11 | RYDR_ITPR | pfam domains | PF01365 | 6 | 1 | 17795 | 49 |
ITPR2 |
1.641e-02 | -4.11 | RIH_assoc | pfam domains | PF08454 | 6 | 1 | 17795 | 49 |
ITPR2 |
1.641e-02 | -4.11 | DOCK_C-D_N | pfam domains | PF11878 | 6 | 1 | 17795 | 49 |
DOCK8 |
1.641e-02 | -4.11 | Ins145_P3_rec | pfam domains | PF08709 | 6 | 1 | 17795 | 49 |
ITPR2 |
1.645e-02 | -4.11 | cellular response to nitrogen compound | biological process | GO:1901699 | 580 | 5 | 18204 | 47 |
GNAQ,MEF2C,HDAC9,SLC8A1,ITPR2 |
1.647e-02 | -4.11 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity | molecular function | GO:0001665 | 6 | 1 | 18094 | 50 |
ST6GALNAC3 |
1.647e-02 | -4.11 | creatine kinase activity | molecular function | GO:0004111 | 6 | 1 | 18094 | 50 |
MAP4K4 |
1.647e-02 | -4.11 | chondroitin sulfotransferase activity | molecular function | GO:0034481 | 6 | 1 | 18094 | 50 |
CHST11 |
1.647e-02 | -4.11 | transferase activity, transferring sulphur-containing groups | molecular function | GO:0016782 | 71 | 2 | 18094 | 50 |
CHST11,HS3ST4 |
1.656e-02 | -4.10 | intracellular chemical homeostasis | biological process | GO:0055082 | 581 | 5 | 18204 | 47 |
SLC8A1,PICALM,DISC1,SLC9A9,ZBTB20 |
1.656e-02 | -4.10 | somatodendritic compartment | cellular component | GO:0036477 | 842 | 6 | 19108 | 47 |
SORL1,DSCAM,DIP2B,SLC8A1,PICALM,SYNDIG1 |
1.660e-02 | -4.10 | negative regulation of cell migration | biological process | GO:0030336 | 381 | 4 | 18204 | 47 |
PTPRJ,MEF2C,NAV3,LDLRAD4 |
1.667e-02 | -4.09 | Renin secretion | KEGG pathways | ko04924 | 65 | 2 | 7161 | 22 |
ITPR2,GNAQ |
1.667e-02 | -4.09 | Renin secretion | KEGG pathways | hsa04924 | 65 | 2 | 7161 | 22 |
GNAQ,ITPR2 |
1.670e-02 | -4.09 | regulation of chemotaxis | biological process | GO:0050920 | 209 | 3 | 18204 | 47 |
PTPRJ,ST6GAL1,DSCAM |
1.674e-02 | -4.09 | buttock | COSMIC cancer mutations | buttock | 68 | 2 | 16828 | 49 |
PTPRJ,GNAQ |
1.675e-02 | -4.09 | skin-head_neck-malignant_melanoma-superficial_spreading | COSMIC cancer mutations | skin-head_neck-malignant_melanoma-superficial_spreading | 923 | 7 | 16828 | 49 |
KCNQ3,APBB1IP,DIP2B,TCF12,ABCC4,SLC8A1,PLXDC2 |
1.676e-02 | -4.09 | FKBP2 (FKBP prolyl isomerase 2) | protein interactions | 2286 | 77 | 2 | 19454 | 50 |
QKI,EPB41L2 |
1.688e-02 | -4.08 | regulation of synaptic transmission, glutamatergic | biological process | GO:0051966 | 77 | 2 | 18204 | 47 |
MEF2C,DISC1 |
1.688e-02 | -4.08 | positive regulation of axonogenesis | biological process | GO:0050772 | 77 | 2 | 18204 | 47 |
DISC1,DSCAM |
1.688e-02 | -4.08 | positive regulation of small GTPase mediated signal transduction | biological process | GO:0051057 | 77 | 2 | 18204 | 47 |
MAP4K4,PICALM |
1.705e-02 | -4.07 | Tyr_Pase_AS | interpro domains | IPR016130 | 74 | 2 | 18521 | 50 |
PTPRJ,SSH2 |
1.711e-02 | -4.07 | ELMO | prosite domains | PS51335 | 6 | 1 | 12186 | 35 |
ELMO1 |
1.711e-02 | -4.07 | DMAP1_BIND | prosite domains | PS51912 | 6 | 1 | 12186 | 35 |
DIP2B |
1.712e-02 | -4.07 | cellular response to chemical stimulus | biological process | GO:0070887 | 2411 | 12 | 18204 | 47 |
MEF2C,DOCK8,GNAQ,MEF2A,KCNQ3,PTPRJ,HDAC9,ZBTB20,ITPR2,ABCC4,SLC8A1,DOCK4 |
1.717e-02 | -4.06 | CSTPP1 (centriolar satellite-associated tubulin polyglutamylase complex regulator 1) | protein interactions | 79096 | 78 | 2 | 19454 | 50 |
PICALM,ZFHX3 |
1.718e-02 | -4.06 | Calcium signaling pathway | KEGG pathways | ko04020 | 181 | 3 | 7161 | 22 |
ITPR2,SLC8A1,GNAQ |
1.718e-02 | -4.06 | Calcium signaling pathway | KEGG pathways | hsa04020 | 181 | 3 | 7161 | 22 |
GNAQ,SLC8A1,ITPR2 |
1.721e-02 | -4.06 | skin-ankle-malignant_melanoma | COSMIC cancer mutations | skin-ankle-malignant_melanoma | 69 | 2 | 16828 | 49 |
PTPRJ,ADAM28 |
1.724e-02 | -4.06 | synaptic vesicle | cellular component | GO:0008021 | 222 | 3 | 19108 | 47 |
PICALM,DISC1,SYNDIG1 |
1.726e-02 | -4.06 | Synthesis of substrates in N-glycan biosythesis | REACTOME pathways | R-HSA-446219 | 63 | 2 | 10285 | 33 |
ST6GALNAC3,ST6GAL1 |
1.730e-02 | -4.06 | mouth | COSMIC cancer mutations | mouth | 9004 | 34 | 16828 | 49 |
ZBTB20,SFMBT2,SLC8A1,DOCK4,EPB41L2,ITPR2,ELMO1,ARHGAP26,SSH2,ZSWIM6,KCNQ3,QKI,DOCK8,DIP2B,HDAC9,MAML3,MEF2C,MAML2,MED13L,ARHGAP22,ST6GAL1,MAP4K4,SYNDIG1,DSCAM,ZFHX3,ANKRD44,DISC1,ADAM28,SORL1,UBE2E2,FCHSD2,GNAQ,CHST11,NAV3 |
1.735e-02 | -4.05 | astroblastoma | COSMIC cancer mutations | astroblastoma | 6 | 1 | 16828 | 49 |
GNAQ |
1.735e-02 | -4.05 | skin-shoulder-malignant_melanoma-lentigo_maligna | COSMIC cancer mutations | skin-shoulder-malignant_melanoma-lentigo_maligna | 6 | 1 | 16828 | 49 |
GNAQ |
1.735e-02 | -4.05 | skin-sun_exposed_site-malignant_melanoma | COSMIC cancer mutations | skin-sun_exposed_site-malignant_melanoma | 6 | 1 | 16828 | 49 |
GNAQ |
1.735e-02 | -4.05 | skin-shoulder-benign_melanocytic_nevus | COSMIC cancer mutations | skin-shoulder-benign_melanocytic_nevus | 6 | 1 | 16828 | 49 |
GNAQ |
1.735e-02 | -4.05 | spitzoid | COSMIC cancer mutations | spitzoid | 6 | 1 | 16828 | 49 |
GNAQ |
1.735e-02 | -4.05 | central_nervous_system-pineal_gland-glioma-astrocytoma_Grade_I | COSMIC cancer mutations | central_nervous_system-pineal_gland-glioma-astrocytoma_Grade_I | 6 | 1 | 16828 | 49 |
GNAQ |
1.735e-02 | -4.05 | skin-knee-benign_melanocytic_nevus-melanocytic_tumour | COSMIC cancer mutations | skin-knee-benign_melanocytic_nevus-melanocytic_tumour | 6 | 1 | 16828 | 49 |
GNAQ |
1.735e-02 | -4.05 | skin-ear-benign_melanocytic_nevus-blue | COSMIC cancer mutations | skin-ear-benign_melanocytic_nevus-blue | 6 | 1 | 16828 | 49 |
GNAQ |
1.735e-02 | -4.05 | skin-chest-benign_melanocytic_nevus | COSMIC cancer mutations | skin-chest-benign_melanocytic_nevus | 6 | 1 | 16828 | 49 |
GNAQ |
1.735e-02 | -4.05 | skin-upper_leg-benign_melanocytic_nevus | COSMIC cancer mutations | skin-upper_leg-benign_melanocytic_nevus | 6 | 1 | 16828 | 49 |
GNAQ |
1.735e-02 | -4.05 | skin-upper_arm-benign_melanocytic_nevus-blue | COSMIC cancer mutations | skin-upper_arm-benign_melanocytic_nevus-blue | 6 | 1 | 16828 | 49 |
GNAQ |
1.735e-02 | -4.05 | skin-back-benign_melanocytic_nevus-melanocytic_tumour | COSMIC cancer mutations | skin-back-benign_melanocytic_nevus-melanocytic_tumour | 6 | 1 | 16828 | 49 |
GNAQ |
1.735e-02 | -4.05 | large_intestine-anus-malignant_melanoma | COSMIC cancer mutations | large_intestine-anus-malignant_melanoma | 6 | 1 | 16828 | 49 |
GNAQ |
1.735e-02 | -4.05 | gangliocytoma | COSMIC cancer mutations | gangliocytoma | 6 | 1 | 16828 | 49 |
GNAQ |
1.735e-02 | -4.05 | meninges-melanocytoma | COSMIC cancer mutations | meninges-melanocytoma | 6 | 1 | 16828 | 49 |
GNAQ |
1.735e-02 | -4.05 | skin-arm-benign_melanocytic_nevus-melanocytic_tumour | COSMIC cancer mutations | skin-arm-benign_melanocytic_nevus-melanocytic_tumour | 6 | 1 | 16828 | 49 |
GNAQ |
1.735e-02 | -4.05 | skin-upper_back-benign_melanocytic_nevus-melanocytic_tumour | COSMIC cancer mutations | skin-upper_back-benign_melanocytic_nevus-melanocytic_tumour | 6 | 1 | 16828 | 49 |
GNAQ |
1.735e-02 | -4.05 | melanocytoma | COSMIC cancer mutations | melanocytoma | 6 | 1 | 16828 | 49 |
GNAQ |
1.735e-02 | -4.05 | skin-upper_arm-benign_melanocytic_nevus-Spitz | COSMIC cancer mutations | skin-upper_arm-benign_melanocytic_nevus-Spitz | 6 | 1 | 16828 | 49 |
GNAQ |
1.735e-02 | -4.05 | skin-eye-malignant_melanoma | COSMIC cancer mutations | skin-eye-malignant_melanoma | 6 | 1 | 16828 | 49 |
GNAQ |
1.735e-02 | -4.05 | skin-lower_leg-benign_melanocytic_nevus | COSMIC cancer mutations | skin-lower_leg-benign_melanocytic_nevus | 6 | 1 | 16828 | 49 |
GNAQ |
1.735e-02 | -4.05 | skin-upper_leg-benign_melanocytic_nevus-blue | COSMIC cancer mutations | skin-upper_leg-benign_melanocytic_nevus-blue | 6 | 1 | 16828 | 49 |
GNAQ |
1.735e-02 | -4.05 | skin-scalp-benign_melanocytic_nevus-melanocytic_tumour | COSMIC cancer mutations | skin-scalp-benign_melanocytic_nevus-melanocytic_tumour | 6 | 1 | 16828 | 49 |
GNAQ |
1.735e-02 | -4.05 | skin-ankle-malignant_melanoma-nodular | COSMIC cancer mutations | skin-ankle-malignant_melanoma-nodular | 6 | 1 | 16828 | 49 |
GNAQ |
1.735e-02 | -4.05 | skin-sun_unexposed_site-malignant_melanoma | COSMIC cancer mutations | skin-sun_unexposed_site-malignant_melanoma | 6 | 1 | 16828 | 49 |
GNAQ |
1.735e-02 | -4.05 | skin-buttock-benign_melanocytic_nevus-blue | COSMIC cancer mutations | skin-buttock-benign_melanocytic_nevus-blue | 6 | 1 | 16828 | 49 |
GNAQ |
1.735e-02 | -4.05 | skin-subungual-malignant_melanoma | COSMIC cancer mutations | skin-subungual-malignant_melanoma | 6 | 1 | 16828 | 49 |
GNAQ |
1.735e-02 | -4.05 | skin-upper_arm-benign_melanocytic_nevus | COSMIC cancer mutations | skin-upper_arm-benign_melanocytic_nevus | 6 | 1 | 16828 | 49 |
GNAQ |
1.741e-02 | -4.05 | FN3 | prosite domains | PS50853 | 192 | 3 | 12186 | 35 |
SORL1,DSCAM,PTPRJ |
1.743e-02 | -4.05 | FN3_sf | interpro domains | IPR036116 | 203 | 3 | 18521 | 50 |
SORL1,PTPRJ,DSCAM |
1.743e-02 | -4.05 | FN3_dom | interpro domains | IPR003961 | 203 | 3 | 18521 | 50 |
PTPRJ,SORL1,DSCAM |
1.743e-02 | -4.05 | FN3 | smart domains | SM00060 | 149 | 3 | 9717 | 36 |
PTPRJ,SORL1,DSCAM |
1.756e-02 | -4.04 | negative regulation of transferase activity | biological process | GO:0051348 | 213 | 3 | 18204 | 47 |
GNAQ,SLC8A1,PTPRJ |
1.766e-02 | -4.04 | Long-term potentiation | KEGG pathways | hsa04720 | 67 | 2 | 7161 | 22 |
ITPR2,GNAQ |
1.766e-02 | -4.04 | Long-term potentiation | KEGG pathways | ko04720 | 67 | 2 | 7161 | 22 |
ITPR2,GNAQ |
1.777e-02 | -4.03 | cellular response to inorganic substance | biological process | GO:0071241 | 214 | 3 | 18204 | 47 |
MEF2C,MEF2A,KCNQ3 |
1.778e-02 | -4.03 | MAP kinase activation in TLR cascade | REACTOME pathways | R-HSA-450294 | 64 | 2 | 10285 | 33 |
MEF2C,MEF2A |
1.782e-02 | -4.03 | positive regulation of cell migration | biological process | GO:0030335 | 592 | 5 | 18204 | 47 |
DOCK8,MAP4K4,HDAC9,DOCK4,PTPRJ |
1.783e-02 | -4.03 | Endochondral Ossification | WikiPathways | WP474 | 65 | 2 | 5310 | 17 |
MEF2C,CHST11 |
1.786e-02 | -4.03 | MYT1L (myelin transcription factor 1 like) | protein interactions | 23040 | 7 | 1 | 19454 | 50 |
DISC1 |
1.786e-02 | -4.03 | FGD3 (FYVE, RhoGEF and PH domain containing 3) | protein interactions | 89846 | 7 | 1 | 19454 | 50 |
ARHGAP22 |
1.786e-02 | -4.03 | SOX18 (SRY-box transcription factor 18) | protein interactions | 54345 | 7 | 1 | 19454 | 50 |
MEF2C |
1.786e-02 | -4.03 | MESP2 (mesoderm posterior bHLH transcription factor 2) | protein interactions | 145873 | 7 | 1 | 19454 | 50 |
TCF12 |
1.786e-02 | -4.03 | OR10S1 (olfactory receptor family 10 subfamily S member 1) | protein interactions | 219873 | 7 | 1 | 19454 | 50 |
ABCC4 |
1.786e-02 | -4.03 | RGS18 (regulator of G protein signaling 18) | protein interactions | 64407 | 7 | 1 | 19454 | 50 |
GNAQ |
1.786e-02 | -4.03 | ZBTB45 (zinc finger and BTB domain containing 45) | protein interactions | 84878 | 7 | 1 | 19454 | 50 |
ZBTB20 |
1.786e-02 | -4.03 | Pum2 (pumilio RNA-binding family member 2) | protein interactions | 80913 | 7 | 1 | 19454 | 50 |
QKI |
1.786e-02 | -4.03 | Cfl1 (cofilin 1, non-muscle) | protein interactions | 12631 | 7 | 1 | 19454 | 50 |
SSH2 |
1.786e-02 | -4.03 | ZNF701 (zinc finger protein 701) | protein interactions | 55762 | 7 | 1 | 19454 | 50 |
ARHGAP24 |
1.786e-02 | -4.03 | ZNF501 (zinc finger protein 501) | protein interactions | 115560 | 7 | 1 | 19454 | 50 |
ARHGAP24 |
1.793e-02 | -4.02 | AH/BAR_dom_sf | interpro domains | IPR027267 | 76 | 2 | 18521 | 50 |
ARHGAP26,FCHSD2 |
1.794e-02 | -4.02 | negative regulation of ruffle assembly | biological process | GO:1900028 | 7 | 1 | 18204 | 47 |
ARHGAP24 |
1.794e-02 | -4.02 | platelet degranulation | biological process | GO:0002576 | 7 | 1 | 18204 | 47 |
ABCC4 |
1.794e-02 | -4.02 | relaxation of smooth muscle | biological process | GO:0044557 | 7 | 1 | 18204 | 47 |
SLC8A1 |
1.794e-02 | -4.02 | leukotriene transport | biological process | GO:0071716 | 7 | 1 | 18204 | 47 |
ABCC4 |
1.794e-02 | -4.02 | positive regulation of skeletal muscle cell differentiation | biological process | GO:2001016 | 7 | 1 | 18204 | 47 |
MEF2C |
1.794e-02 | -4.02 | regulation of 3'-UTR-mediated mRNA stabilization | biological process | GO:1905868 | 7 | 1 | 18204 | 47 |
QKI |
1.794e-02 | -4.02 | positive regulation of behavioral fear response | biological process | GO:2000987 | 7 | 1 | 18204 | 47 |
MEF2C |
1.794e-02 | -4.02 | glutathione transmembrane transport | biological process | GO:0034775 | 7 | 1 | 18204 | 47 |
ABCC4 |
1.794e-02 | -4.02 | positive regulation of axon extension involved in axon guidance | biological process | GO:0048842 | 7 | 1 | 18204 | 47 |
DSCAM |
1.794e-02 | -4.02 | response to gonadotropin-releasing hormone | biological process | GO:0097210 | 7 | 1 | 18204 | 47 |
TCF12 |
1.794e-02 | -4.02 | amyloid-beta clearance by transcytosis | biological process | GO:0150093 | 7 | 1 | 18204 | 47 |
PICALM |
1.801e-02 | -4.02 | MED13 (mediator complex subunit 13) | protein interactions | 9969 | 80 | 2 | 19454 | 50 |
MED13L,QKI |
1.806e-02 | -4.01 | TYR_PHOSPHATASE_1 | prosite domains | PS00383 | 72 | 2 | 12186 | 35 |
PTPRJ,SSH2 |
1.811e-02 | -4.01 | IP3 receptor type 1 binding core, RIH domain | gene3d domains | 1.25.10.30 | 6 | 1 | 14470 | 44 |
ITPR2 |
1.815e-02 | -4.01 | Bile Acid Direct Signalling Pathway (1) | SMPDB pathways | SMP0086608 | 5 | 1 | 1369 | 5 |
ABCC4 |
1.816e-02 | -4.01 | frontal_lobe | COSMIC cancer mutations | frontal_lobe | 71 | 2 | 16828 | 49 |
GNAQ,ZFHX3 |
1.824e-02 | -4.00 | upper_aerodigestive_tract-mouth-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | upper_aerodigestive_tract-mouth-carcinoma-squamous_cell_carcinoma | 6953 | 28 | 16828 | 49 |
SFMBT2,SLC8A1,EPB41L2,DOCK4,ZBTB20,SSH2,ITPR2,ELMO1,DIP2B,HDAC9,MAML3,KCNQ3,QKI,MAML2,MED13L,MEF2C,ST6GAL1,MAP4K4,ANKRD44,DSCAM,ZFHX3,GNAQ,ADAM28,DISC1,SORL1,UBE2E2,FCHSD2,NAV3 |
1.828e-02 | -4.00 | protein-macromolecule adaptor activity | molecular function | GO:0030674 | 989 | 7 | 18094 | 50 |
MAML3,MAML2,FRMD4A,MED13L,SFMBT2,QKI,HDAC9 |
1.831e-02 | -4.00 | O-linked glycosylation of mucins | REACTOME pathways | R-HSA-913709 | 65 | 2 | 10285 | 33 |
ST6GALNAC3,ST6GAL1 |
1.839e-02 | -4.00 | VPS10 | smart domains | SM00602 | 5 | 1 | 9717 | 36 |
SORL1 |
1.843e-02 | -3.99 | CUEDC1 (CUE domain containing 1) | protein interactions | 404093 | 81 | 2 | 19454 | 50 |
UBE2E2,LDLRAD4 |
1.857e-02 | -3.99 | regulation of amide metabolic process | biological process | GO:0034248 | 81 | 2 | 18204 | 47 |
SORL1,PICALM |
1.865e-02 | -3.98 | leukocyte activation | biological process | GO:0045321 | 599 | 5 | 18204 | 47 |
DOCK8,MEF2C,HDAC9,APBB1IP,PTPRJ |
1.875e-02 | -3.98 | Carb_sulfotrans_8-10 | interpro domains | IPR018011 | 7 | 1 | 18521 | 50 |
CHST11 |
1.875e-02 | -3.98 | Znf_A20 | interpro domains | IPR002653 | 7 | 1 | 18521 | 50 |
ZFAND3 |
1.881e-02 | -3.97 | pharynx | COSMIC cancer mutations | pharynx | 2696 | 14 | 16828 | 49 |
SLC8A1,SFMBT2,DOCK4,ZFHX3,DSCAM,ARHGAP26,ZSWIM6,QKI,DOCK8,GNAQ,DIP2B,HDAC9,MEF2C,MED13L |
1.881e-02 | -3.97 | HDAC4 (histone deacetylase 4) | protein interactions | 9759 | 397 | 4 | 19454 | 50 |
FCHSD2,HDAC9,MEF2A,MEF2C |
1.885e-02 | -3.97 | negative regulation of cell motility | biological process | GO:2000146 | 396 | 4 | 18204 | 47 |
LDLRAD4,MEF2C,NAV3,PTPRJ |
1.886e-02 | -3.97 | MED30 (mediator complex subunit 30) | protein interactions | 90390 | 82 | 2 | 19454 | 50 |
MED13L,DOCK8 |
1.886e-02 | -3.97 | MEF2D (myocyte enhancer factor 2D) | protein interactions | 4209 | 82 | 2 | 19454 | 50 |
MEF2A,MEF2C |
1.897e-02 | -3.97 | NOP2 (NOP2 nucleolar protein) | protein interactions | 4839 | 398 | 4 | 19454 | 50 |
HDAC9,PTPRJ,MAP4K4,ARHGAP24 |
1.897e-02 | -3.96 | human chr9q21.2 | chromosome location | human chr9q21.2 | 10 | 1 | 26134 | 50 |
GNAQ |
1.897e-02 | -3.96 | human chr12p11.23 | chromosome location | human chr12p11.23 | 10 | 1 | 26134 | 50 |
ITPR2 |
1.901e-02 | -3.96 | regulation of bone mineralization | biological process | GO:0030500 | 82 | 2 | 18204 | 47 |
MEF2C,SLC8A1 |
1.911e-02 | -3.96 | chondroblastoma | COSMIC cancer mutations | chondroblastoma | 534 | 5 | 16828 | 49 |
ST6GALNAC3,ARHGAP26,ZFAND3,SLC9A9,DSCAM |
1.912e-02 | -3.96 | zf-A20 | pfam domains | PF01754 | 7 | 1 | 17795 | 49 |
ZFAND3 |
1.913e-02 | -3.96 | regulation of growth | biological process | GO:0040008 | 603 | 5 | 18204 | 47 |
DSCAM,PTPRJ,DIP2B,MEF2C,DISC1 |
1.914e-02 | -3.96 | lung-left_lower_lobe-carcinoma-adenocarcinoma | COSMIC cancer mutations | lung-left_lower_lobe-carcinoma-adenocarcinoma | 73 | 2 | 16828 | 49 |
HDAC9,NAV3 |
1.916e-02 | -3.95 | developmental process | biological process | GO:0032502 | 5716 | 22 | 18204 | 47 |
ZFHX3,MAP4K4,CHST11,MEF2C,ADAM28,SLC8A1,PICALM,ARHGAP22,TCF12,ARHGAP26,DIP2B,HDAC9,NAV3,DSCAM,KCNQ3,ARHGAP24,QKI,DISC1,ZSWIM6,PTPRJ,MEF2A,SSH2 |
1.919e-02 | -3.95 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity | molecular function | GO:0008467 | 7 | 1 | 18094 | 50 |
HS3ST4 |
1.919e-02 | -3.95 | phosphotransferase activity, nitrogenous group as acceptor | molecular function | GO:0016775 | 7 | 1 | 18094 | 50 |
MAP4K4 |
1.919e-02 | -3.95 | tripeptide transmembrane transporter activity | molecular function | GO:0042937 | 7 | 1 | 18094 | 50 |
ABCC4 |
1.930e-02 | -3.95 | GGA2 (golgi associated, gamma adaptin ear containing, ARF binding protein 2) | protein interactions | 23062 | 83 | 2 | 19454 | 50 |
PICALM,SORL1 |
1.930e-02 | -3.95 | NEXN (nexilin F-actin binding protein) | protein interactions | 91624 | 83 | 2 | 19454 | 50 |
ARHGAP24,DISC1 |
1.951e-02 | -3.94 | presynaptic endocytic zone membrane | cellular component | GO:0098835 | 8 | 1 | 19108 | 47 |
PICALM |
1.954e-02 | -3.94 | SH3-like_dom_sf | interpro domains | IPR036028 | 212 | 3 | 18521 | 50 |
DOCK4,ARHGAP26,FCHSD2 |
1.957e-02 | -3.93 | MAPK cascade | biological process | GO:0000165 | 222 | 3 | 18204 | 47 |
MEF2C,MAP4K4,MEF2A |
1.958e-02 | -3.93 | skin-shoulder-malignant_melanoma | COSMIC cancer mutations | skin-shoulder-malignant_melanoma | 355 | 4 | 16828 | 49 |
GNAQ,PTPRJ,FRMD4A,ADAM28 |
1.962e-02 | -3.93 | skin-nipple-malignant_melanoma | COSMIC cancer mutations | skin-nipple-malignant_melanoma | 197 | 3 | 16828 | 49 |
DSCAM,DISC1,SORL1 |
1.962e-02 | -3.93 | nipple | COSMIC cancer mutations | nipple | 197 | 3 | 16828 | 49 |
DISC1,SORL1,DSCAM |
1.964e-02 | -3.93 | regulation of cell growth | biological process | GO:0001558 | 401 | 4 | 18204 | 47 |
DSCAM,DIP2B,PTPRJ,DISC1 |
1.972e-02 | -3.93 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-acute_lymphoblastic_T_cell_leukaemia | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-acute_lymphoblastic_T_cell_leukaemia | 739 | 6 | 16828 | 49 |
ZSWIM6,TBC1D22A,SLC8A1,SFMBT2,DSCAM,ZFHX3 |
1.972e-02 | -3.93 | acute_lymphoblastic_T_cell_leukaemia | COSMIC cancer mutations | acute_lymphoblastic_T_cell_leukaemia | 739 | 6 | 16828 | 49 |
ZSWIM6,TBC1D22A,SLC8A1,SFMBT2,ZFHX3,DSCAM |
1.974e-02 | -3.93 | SERF2 (small EDRK-rich factor 2) | protein interactions | 10169 | 84 | 2 | 19454 | 50 |
QKI,NAV3 |
1.977e-02 | -3.92 | chondrosarcoma | COSMIC cancer mutations | chondrosarcoma | 1181 | 8 | 16828 | 49 |
NAV3,CHST11,ZFHX3,HS3ST4,TCF12,DOCK4,SYNDIG1,MAML3 |
1.985e-02 | -3.92 | MAPRE3 (microtubule associated protein RP/EB family member 3) | protein interactions | 22924 | 224 | 3 | 19454 | 50 |
DOCK4,MAP4K4,DIP2B |
1.989e-02 | -3.92 | proteoglycan metabolic process | biological process | GO:0006029 | 84 | 2 | 18204 | 47 |
CHST11,HS3ST4 |
1.994e-02 | -3.92 | ZF_A20 | prosite domains | PS51036 | 7 | 1 | 12186 | 35 |
ZFAND3 |
2.021e-02 | -3.90 | skin-arm-benign_melanocytic_nevus | COSMIC cancer mutations | skin-arm-benign_melanocytic_nevus | 7 | 1 | 16828 | 49 |
GNAQ |
2.021e-02 | -3.90 | skin-lower_back-benign_melanocytic_nevus-congenital | COSMIC cancer mutations | skin-lower_back-benign_melanocytic_nevus-congenital | 7 | 1 | 16828 | 49 |
GNAQ |
2.021e-02 | -3.90 | blue | COSMIC cancer mutations | blue | 7 | 1 | 16828 | 49 |
GNAQ |
2.021e-02 | -3.90 | central_nervous_system-temporal_lobe-other-ganglioglioma | COSMIC cancer mutations | central_nervous_system-temporal_lobe-other-ganglioglioma | 7 | 1 | 16828 | 49 |
GNAQ |
2.021e-02 | -3.90 | skin-benign_melanocytic_nevus-intradermal | COSMIC cancer mutations | skin-benign_melanocytic_nevus-intradermal | 7 | 1 | 16828 | 49 |
GNAQ |
2.021e-02 | -3.90 | sun_unexposed_site | COSMIC cancer mutations | sun_unexposed_site | 7 | 1 | 16828 | 49 |
GNAQ |
2.027e-02 | -3.90 | striated muscle cell differentiation | biological process | GO:0051146 | 225 | 3 | 18204 | 47 |
MEF2C,MEF2A,SLC8A1 |
2.033e-02 | -3.90 | chondrocyte differentiation | biological process | GO:0002062 | 85 | 2 | 18204 | 47 |
CHST11,MEF2C |
2.038e-02 | -3.89 | KMO (kynurenine 3-monooxygenase) | protein interactions | 8564 | 8 | 1 | 19454 | 50 |
DISC1 |
2.038e-02 | -3.89 | GRM4 (glutamate metabotropic receptor 4) | protein interactions | 2914 | 8 | 1 | 19454 | 50 |
GNAQ |
2.038e-02 | -3.89 | Id2 (inhibitor of DNA binding 2) | protein interactions | 15902 | 8 | 1 | 19454 | 50 |
TCF12 |
2.038e-02 | -3.89 | ZNF568 (zinc finger protein 568) | protein interactions | 374900 | 8 | 1 | 19454 | 50 |
ARHGAP24 |
2.038e-02 | -3.89 | SH3BGR (SH3 domain binding glutamate rich protein) | protein interactions | 6450 | 8 | 1 | 19454 | 50 |
FCHSD2 |
2.038e-02 | -3.89 | ZNF236 (zinc finger protein 236) | protein interactions | 7776 | 8 | 1 | 19454 | 50 |
ARHGAP24 |
2.038e-02 | -3.89 | Tamalin (trafficking regulator and scaffold protein tamalin) | protein interactions | 192254 | 8 | 1 | 19454 | 50 |
FCHSD2 |
2.038e-02 | -3.89 | ZNF28 (zinc finger protein 28) | protein interactions | 7576 | 8 | 1 | 19454 | 50 |
ARHGAP24 |
2.038e-02 | -3.89 | DEPP1 (DEPP autophagy regulator 1) | protein interactions | 11067 | 8 | 1 | 19454 | 50 |
QKI |
2.047e-02 | -3.89 | regulation of germinal center formation | biological process | GO:0002634 | 8 | 1 | 18204 | 47 |
MEF2C |
2.047e-02 | -3.89 | membrane hyperpolarization | biological process | GO:0060081 | 8 | 1 | 18204 | 47 |
KCNQ3 |
2.047e-02 | -3.89 | negative regulation of macrophage apoptotic process | biological process | GO:2000110 | 8 | 1 | 18204 | 47 |
ST6GAL1 |
2.047e-02 | -3.89 | cardiac ventricle formation | biological process | GO:0003211 | 8 | 1 | 18204 | 47 |
MEF2C |
2.047e-02 | -3.89 | contact inhibition | biological process | GO:0060242 | 8 | 1 | 18204 | 47 |
PTPRJ |
2.047e-02 | -3.89 | positive regulation of Arp2/3 complex-mediated actin nucleation | biological process | GO:2000601 | 8 | 1 | 18204 | 47 |
FCHSD2 |
2.047e-02 | -3.89 | positive regulation of fear response | biological process | GO:1903367 | 8 | 1 | 18204 | 47 |
MEF2C |
2.047e-02 | -3.89 | positive regulation of endocytic recycling | biological process | GO:2001137 | 8 | 1 | 18204 | 47 |
SORL1 |
2.055e-02 | -3.88 | MAP4K4 (mitogen-activated protein kinase kinase kinase kinase 4) | protein interactions | 9448 | 227 | 3 | 19454 | 50 |
DISC1,MAP4K4,DSCAM |
2.063e-02 | -3.88 | H2AC18 (H2A clustered histone 18) | protein interactions | 8337 | 86 | 2 | 19454 | 50 |
PICALM,MAP4K4 |
2.071e-02 | -3.88 | postsynapse | cellular component | GO:0098794 | 646 | 5 | 19108 | 47 |
DISC1,SLC8A1,PICALM,MEF2C,SYNDIG1 |
2.073e-02 | -3.88 | stomach | COSMIC cancer mutations | stomach | 15550 | 49 | 16828 | 49 |
MAML2,MEF2C,DIP2B,MAML3,DOCK8,TBC1D22A,ITPR2,FRMD4A,SLC9A9,HS3ST4,NAV3,ADAM28,APBB1IP,ST6GALNAC3,ZFHX3,PICALM,SYNDIG1,TCF12,MED13L,HDAC9,KCNQ3,QKI,SSH2,ZSWIM6,MEF2A,ELMO1,ARHGAP26,SFMBT2,SLC8A1,EPB41L2,DOCK4,ZBTB20,ZFAND3,CHST11,GNAQ,SORL1,DISC1,UBE2E2,FCHSD2,ABCC4,PTPRJ,ANKRD44,PLXDC2,DSCAM,ATP8B4,ARHGAP22,ARHGAP24,ST6GAL1,MAP4K4 |
2.082e-02 | -3.87 | humerus | COSMIC cancer mutations | humerus | 546 | 5 | 16828 | 49 |
DOCK4,ST6GALNAC3,ARHGAP26,DSCAM,ZFHX3 |
2.108e-02 | -3.86 | CDK19 (cyclin dependent kinase 19) | protein interactions | 23097 | 87 | 2 | 19454 | 50 |
GNAQ,MED13L |
2.108e-02 | -3.86 | PAPOLA (poly(A) polymerase alpha) | protein interactions | 10914 | 87 | 2 | 19454 | 50 |
ARHGAP24,PICALM |
2.110e-02 | -3.86 | - | gene3d domains | 1.20.5.4770 | 7 | 1 | 14470 | 44 |
ZFAND3 |
2.111e-02 | -3.86 | specific granule membrane | cellular component | GO:0035579 | 91 | 2 | 19108 | 47 |
ATP8B4,PTPRJ |
2.117e-02 | -3.86 | positive regulation of cell motility | biological process | GO:2000147 | 619 | 5 | 18204 | 47 |
DOCK8,MAP4K4,HDAC9,DOCK4,PTPRJ |
2.121e-02 | -3.85 | axon | cellular component | GO:0030424 | 650 | 5 | 19108 | 47 |
KCNQ3,DIP2B,DSCAM,SLC8A1,DISC1 |
2.127e-02 | -3.85 | BICD1 (BICD cargo adaptor 1) | protein interactions | 636 | 230 | 3 | 19454 | 50 |
DSCAM,DISC1,DOCK4 |
2.129e-02 | -3.85 | Thyroid hormone synthesis | KEGG pathways | ko04918 | 74 | 2 | 7161 | 22 |
ITPR2,GNAQ |
2.129e-02 | -3.85 | Thyroid hormone synthesis | KEGG pathways | hsa04918 | 74 | 2 | 7161 | 22 |
GNAQ,ITPR2 |
2.138e-02 | -3.85 | exocytic vesicle | cellular component | GO:0070382 | 241 | 3 | 19108 | 47 |
SYNDIG1,DISC1,PICALM |
2.140e-02 | -3.84 | AN1-like_Znf | interpro domains | IPR035896 | 8 | 1 | 18521 | 50 |
ZFAND3 |
2.140e-02 | -3.84 | Znf_AN1 | interpro domains | IPR000058 | 8 | 1 | 18521 | 50 |
ZFAND3 |
2.159e-02 | -3.84 | TRIM37 (tripartite motif containing 37) | protein interactions | 4591 | 624 | 5 | 19454 | 50 |
DSCAM,ARHGAP22,UBE2E2,DISC1,TCF12 |
2.159e-02 | -3.84 | CSK (C-terminal Src kinase) | protein interactions | 1445 | 854 | 6 | 19454 | 50 |
DISC1,FCHSD2,SLC8A1,ADAM28,ARHGAP26,ELMO1 |
2.167e-02 | -3.83 | left_lower_lobe | COSMIC cancer mutations | left_lower_lobe | 78 | 2 | 16828 | 49 |
NAV3,HDAC9 |
2.182e-02 | -3.82 | zf-AN1 | pfam domains | PF01428 | 8 | 1 | 17795 | 49 |
ZFAND3 |
2.184e-02 | -3.82 | Gastric acid secretion | KEGG pathways | ko04971 | 75 | 2 | 7161 | 22 |
ITPR2,GNAQ |
2.184e-02 | -3.82 | Gastric acid secretion | KEGG pathways | hsa04971 | 75 | 2 | 7161 | 22 |
ITPR2,GNAQ |
2.190e-02 | -3.82 | aspartic-type endopeptidase inhibitor activity | molecular function | GO:0019828 | 8 | 1 | 18094 | 50 |
SORL1 |
2.190e-02 | -3.82 | ABC-type glutathione S-conjugate transporter activity | molecular function | GO:0015431 | 8 | 1 | 18094 | 50 |
ABCC4 |
2.190e-02 | -3.82 | PH domain binding | molecular function | GO:0042731 | 8 | 1 | 18094 | 50 |
EPB41L2 |
2.193e-02 | -3.82 | spectrin | cellular component | GO:0008091 | 9 | 1 | 19108 | 47 |
EPB41L2 |
2.193e-02 | -3.82 | platelet dense tubular network membrane | cellular component | GO:0031095 | 9 | 1 | 19108 | 47 |
ITPR2 |
2.193e-02 | -3.82 | presynaptic endocytic zone | cellular component | GO:0098833 | 9 | 1 | 19108 | 47 |
PICALM |
2.194e-02 | -3.82 | cell motility | biological process | GO:0048870 | 1101 | 7 | 18204 | 47 |
DOCK8,SORL1,DISC1,MEF2C,ARHGAP24,DOCK4,ELMO1 |
2.203e-02 | -3.82 | DMAP_binding | smart domains | SM01137 | 6 | 1 | 9717 | 36 |
DIP2B |
2.203e-02 | -3.82 | SH3_domain | interpro domains | IPR001452 | 222 | 3 | 18521 | 50 |
ARHGAP26,FCHSD2,DOCK4 |
2.212e-02 | -3.81 | RHOJ (ras homolog family member J) | protein interactions | 57381 | 628 | 5 | 19454 | 50 |
DIP2B,MAP4K4,PICALM,DOCK8,PTPRJ |
2.216e-02 | -3.81 | post-embryonic development | biological process | GO:0009791 | 89 | 2 | 18204 | 47 |
DSCAM,CHST11 |
2.220e-02 | -3.81 | transport vesicle | cellular component | GO:0030133 | 437 | 4 | 19108 | 47 |
SYNDIG1,DISC1,SORL1,PICALM |
2.234e-02 | -3.80 | Arfaptin homology (AH) domain/BAR domain | gene3d domains | 1.20.1270.60 | 76 | 2 | 14470 | 44 |
FCHSD2,ARHGAP26 |
2.243e-02 | -3.80 | follicular_lymphoma | COSMIC cancer mutations | follicular_lymphoma | 1209 | 8 | 16828 | 49 |
PLXDC2,ST6GALNAC3,DSCAM,ITPR2,SLC8A1,GNAQ,SLC9A9,UBE2E2 |
2.246e-02 | -3.80 | CDKN2C (cyclin dependent kinase inhibitor 2C) | protein interactions | 1031 | 90 | 2 | 19454 | 50 |
ANKRD44,TCF12 |
2.260e-02 | -3.79 | Tyr_Pase_dom | interpro domains | IPR000387 | 86 | 2 | 18521 | 50 |
SSH2,PTPRJ |
2.266e-02 | -3.79 | regulation of protein-containing complex assembly | biological process | GO:0043254 | 419 | 4 | 18204 | 47 |
NAV3,FCHSD2,SSH2,SORL1 |
2.272e-02 | -3.78 | human chr6q26 | chromosome location | human chr6q26 | 12 | 1 | 26134 | 50 |
QKI |
2.275e-02 | -3.78 | ZF_AN1 | prosite domains | PS51039 | 8 | 1 | 12186 | 35 |
ZFAND3 |
2.290e-02 | -3.78 | SEMA3A (semaphorin 3A) | protein interactions | 10371 | 9 | 1 | 19454 | 50 |
DISC1 |
2.290e-02 | -3.78 | SCRT1 (scratch family transcriptional repressor 1) | protein interactions | 83482 | 9 | 1 | 19454 | 50 |
SORL1 |
2.290e-02 | -3.78 | ZNF766 (zinc finger protein 766) | protein interactions | 90321 | 9 | 1 | 19454 | 50 |
ARHGAP24 |
2.290e-02 | -3.78 | CHKA (choline kinase alpha) | protein interactions | 1119 | 9 | 1 | 19454 | 50 |
FCHSD2 |
2.290e-02 | -3.78 | PPFIA4 (PTPRF interacting protein alpha 4) | protein interactions | 8497 | 9 | 1 | 19454 | 50 |
DISC1 |
2.290e-02 | -3.78 | Ywhag (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma polypeptide) | protein interactions | 22628 | 9 | 1 | 19454 | 50 |
QKI |
2.290e-02 | -3.78 | AKR1D1 (aldo-keto reductase family 1 member D1) | protein interactions | 6718 | 9 | 1 | 19454 | 50 |
PLXDC2 |
2.290e-02 | -3.78 | PSD (pleckstrin and Sec7 domain containing) | protein interactions | 5662 | 9 | 1 | 19454 | 50 |
GNAQ |
2.290e-02 | -3.78 | LRTM2 (leucine rich repeats and transmembrane domains 2) | protein interactions | 654429 | 9 | 1 | 19454 | 50 |
ABCC4 |
2.290e-02 | -3.78 | KLB (klotho beta) | protein interactions | 152831 | 9 | 1 | 19454 | 50 |
ARHGAP24 |
2.290e-02 | -3.78 | CUX2 (cut like homeobox 2) | protein interactions | 23316 | 9 | 1 | 19454 | 50 |
NAV3 |
2.290e-02 | -3.78 | GBP3 (guanylate binding protein 3) | protein interactions | 2635 | 9 | 1 | 19454 | 50 |
MAP4K4 |
2.290e-02 | -3.78 | OPHN1 (oligophrenin 1) | protein interactions | 4983 | 9 | 1 | 19454 | 50 |
ARHGAP26 |
2.290e-02 | -3.78 | PCNX4 (pecanex 4) | protein interactions | 64430 | 9 | 1 | 19454 | 50 |
DISC1 |
2.290e-02 | -3.78 | CFAP91 (cilia and flagella associated protein 91) | protein interactions | 89876 | 9 | 1 | 19454 | 50 |
DSCAM |
2.292e-02 | -3.78 | DAD1 (defender against cell death 1) | protein interactions | 1603 | 91 | 2 | 19454 | 50 |
LDLRAD4,PICALM |
2.292e-02 | -3.78 | TRIO (trio Rho guanine nucleotide exchange factor) | protein interactions | 7204 | 91 | 2 | 19454 | 50 |
NAV3,DISC1 |
2.295e-02 | -3.77 | Signaling events mediated by focal adhesion kinase | Pathway Interaction DB | fak_pathway | 54 | 2 | 2226 | 10 |
ELMO1,ARHGAP26 |
2.300e-02 | -3.77 | phospholipase C-activating dopamine receptor signaling pathway | biological process | GO:0060158 | 9 | 1 | 18204 | 47 |
GNAQ |
2.300e-02 | -3.77 | detection of cell density | biological process | GO:0060245 | 9 | 1 | 18204 | 47 |
PTPRJ |
2.300e-02 | -3.77 | positive regulation of myeloid cell apoptotic process | biological process | GO:0033034 | 9 | 1 | 18204 | 47 |
MEF2C |
2.300e-02 | -3.77 | positive regulation of protein localization to early endosome | biological process | GO:1902966 | 9 | 1 | 18204 | 47 |
SORL1 |
2.300e-02 | -3.77 | tripeptide transmembrane transport | biological process | GO:0035443 | 9 | 1 | 18204 | 47 |
ABCC4 |
2.300e-02 | -3.77 | regulation of protein localization to cell cortex | biological process | GO:1904776 | 9 | 1 | 18204 | 47 |
EPB41L2 |
2.300e-02 | -3.77 | regulation of protein localization to early endosome | biological process | GO:1902965 | 9 | 1 | 18204 | 47 |
SORL1 |
2.300e-02 | -3.77 | glomerulus morphogenesis | biological process | GO:0072102 | 9 | 1 | 18204 | 47 |
MEF2C |
2.300e-02 | -3.77 | glutathione transport | biological process | GO:0034635 | 9 | 1 | 18204 | 47 |
ABCC4 |
2.300e-02 | -3.77 | netrin-activated signaling pathway | biological process | GO:0038007 | 9 | 1 | 18204 | 47 |
DSCAM |
2.300e-02 | -3.77 | regulation of vascular associated smooth muscle contraction | biological process | GO:0003056 | 9 | 1 | 18204 | 47 |
DOCK4 |
2.306e-02 | -3.77 | skin-vulva-malignant_melanoma-superficial_spreading | COSMIC cancer mutations | skin-vulva-malignant_melanoma-superficial_spreading | 8 | 1 | 16828 | 49 |
GNAQ |
2.306e-02 | -3.77 | skin-mucosal-malignant_melanoma-desmoplastic | COSMIC cancer mutations | skin-mucosal-malignant_melanoma-desmoplastic | 8 | 1 | 16828 | 49 |
GNAQ |
2.306e-02 | -3.77 | melanocytic_neoplasm | COSMIC cancer mutations | melanocytic_neoplasm | 8 | 1 | 16828 | 49 |
GNAQ |
2.306e-02 | -3.77 | eye-malignant_melanoma | COSMIC cancer mutations | eye-malignant_melanoma | 8 | 1 | 16828 | 49 |
GNAQ |
2.306e-02 | -3.77 | meninges-malignant_melanoma | COSMIC cancer mutations | meninges-malignant_melanoma | 8 | 1 | 16828 | 49 |
GNAQ |
2.306e-02 | -3.77 | skin-vulva-malignant_melanoma-nodular | COSMIC cancer mutations | skin-vulva-malignant_melanoma-nodular | 8 | 1 | 16828 | 49 |
GNAQ |
2.306e-02 | -3.77 | skin-vulva-malignant_melanoma-mucosal_lentiginous | COSMIC cancer mutations | skin-vulva-malignant_melanoma-mucosal_lentiginous | 8 | 1 | 16828 | 49 |
GNAQ |
2.306e-02 | -3.77 | central_nervous_system-chiasm-glioma-astrocytoma_Grade_I | COSMIC cancer mutations | central_nervous_system-chiasm-glioma-astrocytoma_Grade_I | 8 | 1 | 16828 | 49 |
QKI |
2.306e-02 | -3.77 | skin-chronically_sun_exposed_site-malignant_melanoma | COSMIC cancer mutations | skin-chronically_sun_exposed_site-malignant_melanoma | 8 | 1 | 16828 | 49 |
GNAQ |
2.306e-02 | -3.77 | meninges-melanocytic_neoplasm | COSMIC cancer mutations | meninges-melanocytic_neoplasm | 8 | 1 | 16828 | 49 |
GNAQ |
2.306e-02 | -3.77 | skin-acral-malignant_melanoma-acral_lentiginous | COSMIC cancer mutations | skin-acral-malignant_melanoma-acral_lentiginous | 8 | 1 | 16828 | 49 |
GNAQ |
2.306e-02 | -3.77 | skin-mucosal-malignant_melanoma-superficial_spreading | COSMIC cancer mutations | skin-mucosal-malignant_melanoma-superficial_spreading | 8 | 1 | 16828 | 49 |
GNAQ |
2.306e-02 | -3.77 | chronically_sun_exposed_site | COSMIC cancer mutations | chronically_sun_exposed_site | 8 | 1 | 16828 | 49 |
GNAQ |
2.309e-02 | -3.77 | positive regulation of protein polymerization | biological process | GO:0032273 | 91 | 2 | 18204 | 47 |
FCHSD2,NAV3 |
2.313e-02 | -3.77 | chondroitin sulfate biosynthesis (late stages) | BIOCYC pathways | META_PWY-6567 | 7 | 1 | 902 | 3 |
CHST11 |
2.325e-02 | -3.76 | forearm | COSMIC cancer mutations | forearm | 81 | 2 | 16828 | 49 |
GNAQ,PTPRJ |
2.332e-02 | -3.76 | sarcoplasm | cellular component | GO:0016528 | 96 | 2 | 19108 | 47 |
MEF2C,ITPR2 |
2.335e-02 | -3.76 | Oncogenic MAPK signaling | REACTOME pathways | R-HSA-6802957 | 74 | 2 | 10285 | 33 |
APBB1IP,QKI |
2.338e-02 | -3.76 | PRNP (prion protein (Kanno blood group)) | protein interactions | 5621 | 1118 | 7 | 19454 | 50 |
PICALM,SSH2,MAML2,QKI,MEF2C,EPB41L2,DOCK4 |
2.339e-02 | -3.76 | CAMK1 (calcium/calmodulin dependent protein kinase I) | protein interactions | 8536 | 92 | 2 | 19454 | 50 |
HDAC9,ST6GALNAC3 |
2.357e-02 | -3.75 | positive regulation of mononuclear cell migration | biological process | GO:0071677 | 92 | 2 | 18204 | 47 |
DOCK8,PTPRJ |
2.375e-02 | -3.74 | bone-osteosarcoma | COSMIC cancer mutations | bone-osteosarcoma | 212 | 3 | 16828 | 49 |
ELMO1,ARHGAP26,SFMBT2 |
2.387e-02 | -3.74 | FAM76B (family with sequence similarity 76 member B) | protein interactions | 143684 | 93 | 2 | 19454 | 50 |
EPB41L2,SORL1 |
2.404e-02 | -3.73 | NaCa_Exmemb | interpro domains | IPR004837 | 9 | 1 | 18521 | 50 |
SLC8A1 |
2.404e-02 | -3.73 | NCX_ion-bd_dom_sf | interpro domains | IPR044880 | 9 | 1 | 18521 | 50 |
SLC8A1 |
2.404e-02 | -3.73 | Mbt | interpro domains | IPR004092 | 9 | 1 | 18521 | 50 |
SFMBT2 |
2.404e-02 | -3.73 | CalX-like_sf | interpro domains | IPR038081 | 9 | 1 | 18521 | 50 |
SLC8A1 |
2.404e-02 | -3.73 | Znf_SWIM | interpro domains | IPR007527 | 9 | 1 | 18521 | 50 |
ZSWIM6 |
2.404e-02 | -3.73 | Calx_beta | interpro domains | IPR003644 | 9 | 1 | 18521 | 50 |
SLC8A1 |
2.404e-02 | -3.73 | NaH_exchanger | interpro domains | IPR004709 | 9 | 1 | 18521 | 50 |
SLC9A9 |
2.405e-02 | -3.73 | osteosarcoma | COSMIC cancer mutations | osteosarcoma | 213 | 3 | 16828 | 49 |
SFMBT2,ARHGAP26,ELMO1 |
2.405e-02 | -3.73 | positive regulation of cellular component organization | biological process | GO:0051130 | 1122 | 7 | 18204 | 47 |
NAV3,SYNDIG1,PTPRJ,MAP4K4,FCHSD2,DISC1,DSCAM |
2.407e-02 | -3.73 | AN1-like Zinc finger | gene3d domains | 4.10.1110.10 | 8 | 1 | 14470 | 44 |
ZFAND3 |
2.411e-02 | -3.72 | TYR_PHOSPHATASE_2 | prosite domains | PS50056 | 84 | 2 | 12186 | 35 |
SSH2,PTPRJ |
2.417e-02 | -3.72 | positive regulation of developmental process | biological process | GO:0051094 | 1385 | 8 | 18204 | 47 |
MEF2C,SYNDIG1,QKI,DISC1,TCF12,SORL1,SLC8A1,DSCAM |
2.427e-02 | -3.72 | intracellular monoatomic cation homeostasis | biological process | GO:0030003 | 428 | 4 | 18204 | 47 |
DISC1,SLC9A9,SLC8A1,PICALM |
2.433e-02 | -3.72 | Golgi trans cisterna | cellular component | GO:0000138 | 10 | 1 | 19108 | 47 |
ST6GAL1 |
2.435e-02 | -3.72 | TRAF3IP1 (TRAF3 interacting protein 1) | protein interactions | 26146 | 94 | 2 | 19454 | 50 |
DISC1,FRMD4A |
2.452e-02 | -3.71 | Calx-beta | pfam domains | PF03160 | 9 | 1 | 17795 | 49 |
SLC8A1 |
2.452e-02 | -3.71 | Na_Ca_ex | pfam domains | PF01699 | 9 | 1 | 17795 | 49 |
SLC8A1 |
2.452e-02 | -3.71 | MBT | pfam domains | PF02820 | 9 | 1 | 17795 | 49 |
SFMBT2 |
2.452e-02 | -3.71 | PH_12 | pfam domains | PF16457 | 9 | 1 | 17795 | 49 |
ELMO1 |
2.453e-02 | -3.71 | positive regulation of neuron differentiation | biological process | GO:0045666 | 94 | 2 | 18204 | 47 |
MEF2C,TCF12 |
2.453e-02 | -3.71 | negative regulation of protein serine/threonine kinase activity | biological process | GO:0071901 | 94 | 2 | 18204 | 47 |
SLC8A1,PTPRJ |
2.460e-02 | -3.70 | ATPase-coupled lipid transmembrane transporter activity | molecular function | GO:0034040 | 9 | 1 | 18094 | 50 |
ABCC4 |
2.460e-02 | -3.70 | urate transmembrane transporter activity | molecular function | GO:0015143 | 9 | 1 | 18094 | 50 |
ABCC4 |
2.460e-02 | -3.70 | delta-catenin binding | molecular function | GO:0070097 | 9 | 1 | 18094 | 50 |
PTPRJ |
2.479e-02 | -3.70 | RBPJ (recombination signal binding protein for immunoglobulin kappa J region) | protein interactions | 3516 | 244 | 3 | 19454 | 50 |
SFMBT2,MAML3,MAML2 |
2.483e-02 | -3.70 | DDX3Y (DEAD-box helicase 3 Y-linked) | protein interactions | 8653 | 95 | 2 | 19454 | 50 |
ARHGAP24,PICALM |
2.483e-02 | -3.70 | RNF111 (ring finger protein 111) | protein interactions | 54778 | 95 | 2 | 19454 | 50 |
UBE2E2,GNAQ |
2.483e-02 | -3.70 | CKS1B (CDC28 protein kinase regulatory subunit 1B) | protein interactions | 1163 | 95 | 2 | 19454 | 50 |
TCF12,GNAQ |
2.483e-02 | -3.70 | LIMK1 (LIM domain kinase 1) | protein interactions | 3984 | 95 | 2 | 19454 | 50 |
SSH2,DSCAM |
2.494e-02 | -3.69 | regulation of developmental process | biological process | GO:0050793 | 2540 | 12 | 18204 | 47 |
HDAC9,QKI,DIP2B,SYNDIG1,MEF2C,DSCAM,SLC8A1,LDLRAD4,TCF12,SORL1,DISC1,ZFHX3 |
2.502e-02 | -3.69 | calcium ion transmembrane import into cytosol | biological process | GO:0097553 | 95 | 2 | 18204 | 47 |
ITPR2,SLC8A1 |
2.507e-02 | -3.69 | guanyl-nucleotide exchange factor activity | molecular function | GO:0005085 | 228 | 3 | 18094 | 50 |
DOCK4,ELMO1,DOCK8 |
2.515e-02 | -3.68 | amyloid-beta binding | molecular function | GO:0001540 | 89 | 2 | 18094 | 50 |
PICALM,SORL1 |
2.516e-02 | -3.68 | extrinsic component of plasma membrane | cellular component | GO:0019897 | 100 | 2 | 19108 | 47 |
GNAQ,PICALM |
2.531e-02 | -3.68 | BCAS2 (BCAS2 pre-mRNA processing factor) | protein interactions | 10286 | 246 | 3 | 19454 | 50 |
QKI,DISC1,EPB41L2 |
2.532e-02 | -3.68 | RPS6KA4 (ribosomal protein S6 kinase A4) | protein interactions | 8986 | 96 | 2 | 19454 | 50 |
PTPRJ,PICALM |
2.532e-02 | -3.68 | GNG12 (G protein subunit gamma 12) | protein interactions | 55970 | 96 | 2 | 19454 | 50 |
MEF2A,GNAQ |
2.532e-02 | -3.68 | MED16 (mediator complex subunit 16) | protein interactions | 10025 | 96 | 2 | 19454 | 50 |
QKI,MED13L |
2.534e-02 | -3.68 | Sulfite Oxidase Deficiency | SMPDB pathways | SMP0000532 | 7 | 1 | 1369 | 5 |
CHST11 |
2.534e-02 | -3.68 | G-Protein Signaling Through Tubby Proteins | SMPDB pathways | SMP0089843 | 7 | 1 | 1369 | 5 |
GNAQ |
2.534e-02 | -3.68 | Sulfate/Sulfite Metabolism | SMPDB pathways | SMP0000041 | 7 | 1 | 1369 | 5 |
CHST11 |
2.539e-02 | -3.67 | Rap1 signaling pathway | KEGG pathways | ko04015 | 210 | 3 | 7161 | 22 |
APBB1IP,GNAQ,DOCK4 |
2.539e-02 | -3.67 | Rap1 signaling pathway | KEGG pathways | hsa04015 | 210 | 3 | 7161 | 22 |
APBB1IP,GNAQ,DOCK4 |
2.539e-02 | -3.67 | Free fatty acids regulate insulin secretion | REACTOME pathways | R-HSA-400451 | 8 | 1 | 10285 | 33 |
GNAQ |
2.539e-02 | -3.67 | Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | REACTOME pathways | R-HSA-434316 | 8 | 1 | 10285 | 33 |
GNAQ |
2.539e-02 | -3.67 | Nef and signal transduction | REACTOME pathways | R-HSA-164944 | 8 | 1 | 10285 | 33 |
ELMO1 |
2.541e-02 | -3.67 | CCDC15 (coiled-coil domain containing 15) | protein interactions | 80071 | 10 | 1 | 19454 | 50 |
MEF2A |
2.541e-02 | -3.67 | ZNF852 (zinc finger protein 852) | protein interactions | 285346 | 10 | 1 | 19454 | 50 |
ARHGAP24 |
2.541e-02 | -3.67 | TUL1 (ubiquitin-protein ligase TUL1) | protein interactions | 853832 | 10 | 1 | 19454 | 50 |
UBE2E2 |
2.541e-02 | -3.67 | ZNF563 (zinc finger protein 563) | protein interactions | 147837 | 10 | 1 | 19454 | 50 |
SORL1 |
2.541e-02 | -3.67 | Mrpl13 (mitochondrial ribosomal protein L13) | protein interactions | 68537 | 10 | 1 | 19454 | 50 |
QKI |
2.541e-02 | -3.67 | BANK1 (B cell scaffold protein with ankyrin repeats 1) | protein interactions | 55024 | 10 | 1 | 19454 | 50 |
ITPR2 |
2.541e-02 | -3.67 | METTL26 (methyltransferase like 26) | protein interactions | 84326 | 10 | 1 | 19454 | 50 |
DISC1 |
2.541e-02 | -3.67 | TBPL2 (TATA-box binding protein like 2) | protein interactions | 387332 | 10 | 1 | 19454 | 50 |
MAP4K4 |
2.541e-02 | -3.67 | PRTG (protogenin) | protein interactions | 283659 | 10 | 1 | 19454 | 50 |
DISC1 |
2.541e-02 | -3.67 | Arhgef2 (Rho/Rac guanine nucleotide exchange factor 2) | protein interactions | 16800 | 10 | 1 | 19454 | 50 |
SORL1 |
2.541e-02 | -3.67 | Hsp90aa1 (heat shock protein 90, alpha (cytosolic), class A member 1) | protein interactions | 15519 | 10 | 1 | 19454 | 50 |
QKI |
2.541e-02 | -3.67 | ZNF606 (zinc finger protein 606) | protein interactions | 80095 | 10 | 1 | 19454 | 50 |
ARHGAP24 |
2.544e-02 | -3.67 | SH3 | prosite domains | PS50002 | 222 | 3 | 12186 | 35 |
ARHGAP26,DOCK4,FCHSD2 |
2.553e-02 | -3.67 | regulation of behavioral fear response | biological process | GO:2000822 | 10 | 1 | 18204 | 47 |
MEF2C |
2.553e-02 | -3.67 | regulation of peptidyl-lysine acetylation | biological process | GO:2000756 | 10 | 1 | 18204 | 47 |
DIP2B |
2.553e-02 | -3.67 | guanine nucleotide transmembrane transport | biological process | GO:1903790 | 10 | 1 | 18204 | 47 |
ABCC4 |
2.553e-02 | -3.67 | positive regulation of adipose tissue development | biological process | GO:1904179 | 10 | 1 | 18204 | 47 |
SORL1 |
2.553e-02 | -3.67 | synaptic vesicle budding from presynaptic endocytic zone membrane | biological process | GO:0016185 | 10 | 1 | 18204 | 47 |
PICALM |
2.553e-02 | -3.67 | regulation of Fc receptor mediated stimulatory signaling pathway | biological process | GO:0060368 | 10 | 1 | 18204 | 47 |
PTPRJ |
2.553e-02 | -3.67 | ventricular cardiac muscle cell development | biological process | GO:0055015 | 10 | 1 | 18204 | 47 |
MEF2A |
2.553e-02 | -3.67 | cellular response to parathyroid hormone stimulus | biological process | GO:0071374 | 10 | 1 | 18204 | 47 |
MEF2C |
2.553e-02 | -3.67 | germinal center formation | biological process | GO:0002467 | 10 | 1 | 18204 | 47 |
MEF2C |
2.553e-02 | -3.67 | sialylation | biological process | GO:0097503 | 10 | 1 | 18204 | 47 |
ST6GAL1 |
2.553e-02 | -3.67 | embryonic viscerocranium morphogenesis | biological process | GO:0048703 | 10 | 1 | 18204 | 47 |
CHST11 |
2.553e-02 | -3.67 | regulation of ER to Golgi vesicle-mediated transport | biological process | GO:0060628 | 10 | 1 | 18204 | 47 |
SORL1 |
2.555e-02 | -3.67 | positive regulation of neurogenesis | biological process | GO:0050769 | 246 | 3 | 18204 | 47 |
DISC1,QKI,DSCAM |
2.556e-02 | -3.67 | ZF_SWIM | prosite domains | PS50966 | 9 | 1 | 12186 | 35 |
ZSWIM6 |
2.556e-02 | -3.67 | ENTH | prosite domains | PS50942 | 9 | 1 | 12186 | 35 |
PICALM |
2.556e-02 | -3.67 | MBT | prosite domains | PS51079 | 9 | 1 | 12186 | 35 |
SFMBT2 |
2.557e-02 | -3.67 | blood vessel morphogenesis | biological process | GO:0048514 | 435 | 4 | 18204 | 47 |
PTPRJ,ARHGAP22,ARHGAP24,QKI |
2.566e-02 | -3.66 | ZnF_A20 | smart domains | SM00259 | 7 | 1 | 9717 | 36 |
ZFAND3 |
2.566e-02 | -3.66 | adrenal_cortical_carcinoma | COSMIC cancer mutations | adrenal_cortical_carcinoma | 2256 | 12 | 16828 | 49 |
PTPRJ,ABCC4,ELMO1,MEF2A,ATP8B4,FRMD4A,DOCK4,ST6GAL1,ZBTB20,MAML2,HDAC9,DOCK8 |
2.576e-02 | -3.66 | Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | REACTOME pathways | R-HSA-446193 | 78 | 2 | 10285 | 33 |
ST6GALNAC3,ST6GAL1 |
2.579e-02 | -3.66 | response to endogenous stimulus | biological process | GO:0009719 | 1402 | 8 | 18204 | 47 |
TCF12,ZFHX3,ITPR2,SLC8A1,GNAQ,MEF2C,HDAC9,CHST11 |
2.580e-02 | -3.66 | Aldosterone synthesis and secretion | KEGG pathways | ko04925 | 82 | 2 | 7161 | 22 |
GNAQ,ITPR2 |
2.580e-02 | -3.66 | Aldosterone synthesis and secretion | KEGG pathways | hsa04925 | 82 | 2 | 7161 | 22 |
GNAQ,ITPR2 |
2.581e-02 | -3.66 | SYNE1 (spectrin repeat containing nuclear envelope protein 1) | protein interactions | 23345 | 97 | 2 | 19454 | 50 |
DSCAM,DISC1 |
2.585e-02 | -3.66 | KIFC3 (kinesin family member C3) | protein interactions | 3801 | 248 | 3 | 19454 | 50 |
FCHSD2,DISC1,DSCAM |
2.586e-02 | -3.65 | ZFPL1 (zinc finger protein like 1) | protein interactions | 7542 | 438 | 4 | 19454 | 50 |
EPB41L2,PICALM,MAP4K4,DISC1 |
2.589e-02 | -3.65 | shoulder | COSMIC cancer mutations | shoulder | 387 | 4 | 16828 | 49 |
ADAM28,FRMD4A,PTPRJ,GNAQ |
2.591e-02 | -3.65 | skin-mucosal-malignant_melanoma-mucosal_lentiginous | COSMIC cancer mutations | skin-mucosal-malignant_melanoma-mucosal_lentiginous | 9 | 1 | 16828 | 49 |
GNAQ |
2.591e-02 | -3.65 | skin-chest-malignant_melanoma-superficial_spreading | COSMIC cancer mutations | skin-chest-malignant_melanoma-superficial_spreading | 9 | 1 | 16828 | 49 |
GNAQ |
2.591e-02 | -3.65 | sun_exposed_site | COSMIC cancer mutations | sun_exposed_site | 9 | 1 | 16828 | 49 |
GNAQ |
2.591e-02 | -3.65 | skin-ear-benign_melanocytic_nevus-melanocytic_tumour | COSMIC cancer mutations | skin-ear-benign_melanocytic_nevus-melanocytic_tumour | 9 | 1 | 16828 | 49 |
GNAQ |
2.591e-02 | -3.65 | mucosal_lentiginous | COSMIC cancer mutations | mucosal_lentiginous | 9 | 1 | 16828 | 49 |
GNAQ |
2.591e-02 | -3.65 | skin-benign_melanocytic_nevus-congenital | COSMIC cancer mutations | skin-benign_melanocytic_nevus-congenital | 9 | 1 | 16828 | 49 |
GNAQ |
2.591e-02 | -3.65 | melanotic | COSMIC cancer mutations | melanotic | 9 | 1 | 16828 | 49 |
GNAQ |
2.591e-02 | -3.65 | skin-mucosal-malignant_melanoma-nodular | COSMIC cancer mutations | skin-mucosal-malignant_melanoma-nodular | 9 | 1 | 16828 | 49 |
GNAQ |
2.594e-02 | -3.65 | intracellular monoatomic ion homeostasis | biological process | GO:0006873 | 437 | 4 | 18204 | 47 |
PICALM,SLC8A1,SLC9A9,DISC1 |
2.612e-02 | -3.65 | MYO19 (myosin XIX) | protein interactions | 80179 | 249 | 3 | 19454 | 50 |
PICALM,SSH2,ZBTB20 |
2.612e-02 | -3.65 | TPR (translocated promoter region, nuclear basket protein) | protein interactions | 7175 | 249 | 3 | 19454 | 50 |
DOCK8,EPB41L2,HDAC9 |
2.631e-02 | -3.64 | MED27 (mediator complex subunit 27) | protein interactions | 9442 | 98 | 2 | 19454 | 50 |
MED13L,QKI |
2.636e-02 | -3.64 | regulation of muscle system process | biological process | GO:0090257 | 249 | 3 | 18204 | 47 |
MEF2A,SLC8A1,DOCK4 |
2.640e-02 | -3.63 | chondroitin sulfate biosynthesis (late stages) | BIOCYC pathways | HUMAN_PWY-6567 | 8 | 1 | 902 | 3 |
CHST11 |
2.650e-02 | -3.63 | regulation of striated muscle cell differentiation | biological process | GO:0051153 | 98 | 2 | 18204 | 47 |
HDAC9,MEF2C |
2.668e-02 | -3.62 | ENTH | interpro domains | IPR013809 | 10 | 1 | 18521 | 50 |
PICALM |
2.668e-02 | -3.62 | MIR_motif | interpro domains | IPR016093 | 10 | 1 | 18521 | 50 |
ITPR2 |
2.668e-02 | -3.62 | MIR_dom_sf | interpro domains | IPR036300 | 10 | 1 | 18521 | 50 |
ITPR2 |
2.673e-02 | -3.62 | nuclear envelope lumen | cellular component | GO:0005641 | 11 | 1 | 19108 | 47 |
SORL1 |
2.673e-02 | -3.62 | platelet dense tubular network | cellular component | GO:0031094 | 11 | 1 | 19108 | 47 |
ITPR2 |
2.680e-02 | -3.62 | WASHC4 (WASH complex subunit 4) | protein interactions | 23325 | 99 | 2 | 19454 | 50 |
DSCAM,LDLRAD4 |
2.700e-02 | -3.61 | Regulation of insulin secretion | REACTOME pathways | R-HSA-422356 | 80 | 2 | 10285 | 33 |
ITPR2,GNAQ |
2.704e-02 | -3.61 | - | gene3d domains | 2.60.40.2030 | 9 | 1 | 14470 | 44 |
SLC8A1 |
2.704e-02 | -3.61 | NCX, central ion-binding region | gene3d domains | 1.20.1420.30 | 9 | 1 | 14470 | 44 |
SLC8A1 |
2.710e-02 | -3.61 | cell morphogenesis involved in neuron differentiation | biological process | GO:0048667 | 443 | 4 | 18204 | 47 |
MEF2C,DSCAM,PICALM,MEF2A |
2.720e-02 | -3.60 | mucosal | COSMIC cancer mutations | mucosal | 2009 | 11 | 16828 | 49 |
EPB41L2,ARHGAP22,SLC8A1,PLXDC2,ELMO1,ZFHX3,GNAQ,DIP2B,ADAM28,SORL1,APBB1IP |
2.720e-02 | -3.60 | skin-mucosal-malignant_melanoma | COSMIC cancer mutations | skin-mucosal-malignant_melanoma | 2009 | 11 | 16828 | 49 |
APBB1IP,SORL1,ADAM28,GNAQ,DIP2B,ZFHX3,ELMO1,PLXDC2,SLC8A1,ARHGAP22,EPB41L2 |
2.720e-02 | -3.60 | MIR | pfam domains | PF02815 | 10 | 1 | 17795 | 49 |
ITPR2 |
2.730e-02 | -3.60 | salt transmembrane transporter activity | molecular function | GO:1901702 | 10 | 1 | 18094 | 50 |
ABCC4 |
2.730e-02 | -3.60 | calcium:sodium antiporter activity | molecular function | GO:0005432 | 10 | 1 | 18094 | 50 |
SLC8A1 |
2.730e-02 | -3.60 | minor groove of adenine-thymine-rich DNA binding | molecular function | GO:0003680 | 10 | 1 | 18094 | 50 |
MEF2C |
2.730e-02 | -3.60 | ATPase-coupled inorganic anion transmembrane transporter activity | molecular function | GO:0043225 | 10 | 1 | 18094 | 50 |
ABCC4 |
2.731e-02 | -3.60 | SUFU (SUFU negative regulator of hedgehog signaling) | protein interactions | 51684 | 100 | 2 | 19454 | 50 |
LDLRAD4,DISC1 |
2.731e-02 | -3.60 | MED29 (mediator complex subunit 29) | protein interactions | 55588 | 100 | 2 | 19454 | 50 |
MED13L,QKI |
2.731e-02 | -3.60 | MUL1 (mitochondrial E3 ubiquitin protein ligase 1) | protein interactions | 79594 | 100 | 2 | 19454 | 50 |
UBE2E2,DOCK4 |
2.731e-02 | -3.60 | MED10 (mediator complex subunit 10) | protein interactions | 84246 | 100 | 2 | 19454 | 50 |
QKI,MED13L |
2.737e-02 | -3.60 | pancreas-other-adenoma | COSMIC cancer mutations | pancreas-other-adenoma | 224 | 3 | 16828 | 49 |
NAV3,KCNQ3,ATP8B4 |
2.769e-02 | -3.59 | pancreas-other-cystic_tumour | COSMIC cancer mutations | pancreas-other-cystic_tumour | 89 | 2 | 16828 | 49 |
ZBTB20,SFMBT2 |
2.769e-02 | -3.59 | cystic_tumour | COSMIC cancer mutations | cystic_tumour | 89 | 2 | 16828 | 49 |
SFMBT2,ZBTB20 |
2.781e-02 | -3.58 | LDB1 (LIM domain binding 1) | protein interactions | 8861 | 101 | 2 | 19454 | 50 |
ZFHX3,DSCAM |
2.792e-02 | -3.58 | RGS5 (regulator of G protein signaling 5) | protein interactions | 8490 | 11 | 1 | 19454 | 50 |
GNAQ |
2.792e-02 | -3.58 | TAL2 (TAL bHLH transcription factor 2) | protein interactions | 6887 | 11 | 1 | 19454 | 50 |
TCF12 |
2.792e-02 | -3.58 | ZNF726 (zinc finger protein 726) | protein interactions | 730087 | 11 | 1 | 19454 | 50 |
ARHGAP24 |
2.792e-02 | -3.58 | SPBC36B7.05c (putative ubiquitin-protein ligase E/phosphatidylinositol(3)-phosphate binding protein) | protein interactions | 2540987 | 11 | 1 | 19454 | 50 |
UBE2E2 |
2.792e-02 | -3.58 | NYAP1 (neuronal tyrosine phosphorylated phosphoinositide-3-kinase adaptor 1) | protein interactions | 222950 | 11 | 1 | 19454 | 50 |
ARHGAP26 |
2.792e-02 | -3.58 | DAZ1 (deleted in azoospermia 1) | protein interactions | 1617 | 11 | 1 | 19454 | 50 |
QKI |
2.792e-02 | -3.58 | IL7 (interleukin 7) | protein interactions | 3574 | 11 | 1 | 19454 | 50 |
QKI |
2.792e-02 | -3.58 | CIMAP3 (ciliary microtubule associated protein 3) | protein interactions | 128344 | 11 | 1 | 19454 | 50 |
GNAQ |
2.792e-02 | -3.58 | TCF23 (transcription factor 23) | protein interactions | 150921 | 11 | 1 | 19454 | 50 |
TCF12 |
2.792e-02 | -3.58 | NEUROD4 (neuronal differentiation 4) | protein interactions | 58158 | 11 | 1 | 19454 | 50 |
TCF12 |
2.792e-02 | -3.58 | PYY (peptide YY) | protein interactions | 5697 | 11 | 1 | 19454 | 50 |
PLXDC2 |
2.792e-02 | -3.58 | IRAG1 (inositol 1,4,5-triphosphate receptor associated 1) | protein interactions | 10335 | 11 | 1 | 19454 | 50 |
ITPR2 |
2.792e-02 | -3.58 | CCDC141 (coiled-coil domain containing 141) | protein interactions | 285025 | 11 | 1 | 19454 | 50 |
DISC1 |
2.794e-02 | -3.58 | regulation of plasma membrane bounded cell projection organization | biological process | GO:0120035 | 666 | 5 | 18204 | 47 |
DISC1,TBC1D22A,DIP2B,DSCAM,ARHGAP24 |
2.804e-02 | -3.57 | cyclic nucleotide transport | biological process | GO:0070729 | 11 | 1 | 18204 | 47 |
ABCC4 |
2.804e-02 | -3.57 | intracellular mRNA localization | biological process | GO:0008298 | 11 | 1 | 18204 | 47 |
QKI |
2.804e-02 | -3.57 | cardiac chamber formation | biological process | GO:0003207 | 11 | 1 | 18204 | 47 |
MEF2C |
2.804e-02 | -3.57 | pyramidal neuron development | biological process | GO:0021860 | 11 | 1 | 18204 | 47 |
DISC1 |
2.804e-02 | -3.57 | guanine nucleotide transport | biological process | GO:0001408 | 11 | 1 | 18204 | 47 |
ABCC4 |
2.804e-02 | -3.57 | synaptic vesicle budding | biological process | GO:0070142 | 11 | 1 | 18204 | 47 |
PICALM |
2.804e-02 | -3.57 | phototransduction, visible light | biological process | GO:0007603 | 11 | 1 | 18204 | 47 |
GNAQ |
2.804e-02 | -3.57 | secondary heart field specification | biological process | GO:0003139 | 11 | 1 | 18204 | 47 |
MEF2C |
2.804e-02 | -3.57 | regulation of fear response | biological process | GO:1903365 | 11 | 1 | 18204 | 47 |
MEF2C |
2.804e-02 | -3.57 | cellular response to caffeine | biological process | GO:0071313 | 11 | 1 | 18204 | 47 |
SLC8A1 |
2.804e-02 | -3.57 | positive regulation of cardiac muscle cell differentiation | biological process | GO:2000727 | 11 | 1 | 18204 | 47 |
MEF2C |
2.804e-02 | -3.57 | regulation of skeletal muscle fiber development | biological process | GO:0048742 | 11 | 1 | 18204 | 47 |
HDAC9 |
2.804e-02 | -3.57 | tripeptide transport | biological process | GO:0042939 | 11 | 1 | 18204 | 47 |
ABCC4 |
2.804e-02 | -3.57 | synaptic vesicle clustering | biological process | GO:0097091 | 11 | 1 | 18204 | 47 |
SYNDIG1 |
2.804e-02 | -3.57 | urate transport | biological process | GO:0015747 | 11 | 1 | 18204 | 47 |
ABCC4 |
2.810e-02 | -3.57 | SYNCRIP (synaptotagmin binding cytoplasmic RNA interacting protein) | protein interactions | 10492 | 669 | 5 | 19454 | 50 |
EPB41L2,MED13L,ARHGAP24,QKI,DISC1 |
2.822e-02 | -3.57 | anatomical structure development | biological process | GO:0048856 | 5207 | 20 | 18204 | 47 |
ZFHX3,MAP4K4,DSCAM,MEF2C,QKI,ARHGAP24,KCNQ3,CHST11,ZSWIM6,TCF12,DISC1,ARHGAP22,PICALM,SLC8A1,NAV3,HDAC9,ARHGAP26,PTPRJ,MEF2A,DIP2B |
2.830e-02 | -3.56 | positive regulation of growth | biological process | GO:0045927 | 256 | 3 | 18204 | 47 |
DSCAM,DISC1,MEF2C |
2.831e-02 | -3.56 | ankle | COSMIC cancer mutations | ankle | 398 | 4 | 16828 | 49 |
GNAQ,ARHGAP22,PTPRJ,ADAM28 |
2.832e-02 | -3.56 | human chr10p12.31 | chromosome location | human chr10p12.31 | 15 | 1 | 26134 | 50 |
PLXDC2 |
2.832e-02 | -3.56 | human chr4q31.1 | chromosome location | human chr4q31.1 | 15 | 1 | 26134 | 50 |
MAML3 |
2.832e-02 | -3.56 | human chr9p24.3 | chromosome location | human chr9p24.3 | 15 | 1 | 26134 | 50 |
DOCK8 |
2.832e-02 | -3.56 | human chr11q14.2 | chromosome location | human chr11q14.2 | 15 | 1 | 26134 | 50 |
PICALM |
2.832e-02 | -3.56 | human chr12q21.2 | chromosome location | human chr12q21.2 | 15 | 1 | 26134 | 50 |
NAV3 |
2.832e-02 | -3.56 | ZSCAN21 (zinc finger and SCAN domain containing 21) | protein interactions | 7589 | 102 | 2 | 19454 | 50 |
SORL1,ARHGAP24 |
2.832e-02 | -3.56 | CHRNB2 (cholinergic receptor nicotinic beta 2 subunit) | protein interactions | 1141 | 102 | 2 | 19454 | 50 |
ST6GALNAC3,CHST11 |
2.832e-02 | -3.56 | TTC23 (tetratricopeptide repeat domain 23) | protein interactions | 64927 | 102 | 2 | 19454 | 50 |
ZFHX3,DISC1 |
2.832e-02 | -3.56 | H3C15 (H3 clustered histone 15) | protein interactions | 333932 | 102 | 2 | 19454 | 50 |
MAP4K4,HDAC9 |
2.836e-02 | -3.56 | MIR | prosite domains | PS50919 | 10 | 1 | 12186 | 35 |
ITPR2 |
2.851e-02 | -3.56 | recycling endosome membrane | cellular component | GO:0055038 | 107 | 2 | 19108 | 47 |
SLC9A9,SORL1 |
2.852e-02 | -3.56 | Sodium/Proton exchangers | REACTOME pathways | R-HSA-425986 | 9 | 1 | 10285 | 33 |
SLC9A9 |
2.865e-02 | -3.55 | urinary_tract-bladder-carcinoma | COSMIC cancer mutations | urinary_tract-bladder-carcinoma | 14050 | 46 | 16828 | 49 |
MEF2C,MAML2,DOCK8,MAML3,DIP2B,FRMD4A,ITPR2,TBC1D22A,SLC9A9,NAV3,HS3ST4,APBB1IP,ADAM28,ZFHX3,ST6GALNAC3,SYNDIG1,PICALM,MED13L,TCF12,QKI,KCNQ3,HDAC9,ARHGAP26,ELMO1,MEF2A,SSH2,ZBTB20,DOCK4,EPB41L2,SLC8A1,SFMBT2,CHST11,FCHSD2,UBE2E2,SORL1,GNAQ,ATP8B4,DSCAM,PLXDC2,ANKRD44,PTPRJ,ABCC4,MAP4K4,ST6GAL1,ARHGAP24,ARHGAP22 |
2.875e-02 | -3.55 | skin-shoulder-malignant_melanoma-superficial_spreading | COSMIC cancer mutations | skin-shoulder-malignant_melanoma-superficial_spreading | 10 | 1 | 16828 | 49 |
GNAQ |
2.875e-02 | -3.55 | chiasm | COSMIC cancer mutations | chiasm | 10 | 1 | 16828 | 49 |
QKI |
2.875e-02 | -3.55 | intradermal | COSMIC cancer mutations | intradermal | 10 | 1 | 16828 | 49 |
GNAQ |
2.875e-02 | -3.55 | melanocytic_tumour | COSMIC cancer mutations | melanocytic_tumour | 10 | 1 | 16828 | 49 |
GNAQ |
2.875e-02 | -3.55 | elbow | COSMIC cancer mutations | elbow | 10 | 1 | 16828 | 49 |
GNAQ |
2.875e-02 | -3.55 | eye-conjunctiva-malignant_melanoma | COSMIC cancer mutations | eye-conjunctiva-malignant_melanoma | 10 | 1 | 16828 | 49 |
GNAQ |
2.875e-02 | -3.55 | skin-back-malignant_melanoma-nodular | COSMIC cancer mutations | skin-back-malignant_melanoma-nodular | 10 | 1 | 16828 | 49 |
GNAQ |
2.875e-02 | -3.55 | skin-abdomen-malignant_melanoma-superficial_spreading | COSMIC cancer mutations | skin-abdomen-malignant_melanoma-superficial_spreading | 10 | 1 | 16828 | 49 |
GNAQ |
2.884e-02 | -3.55 | NEUROG3 (neurogenin 3) | protein interactions | 50674 | 103 | 2 | 19454 | 50 |
TCF12,MAP4K4 |
2.887e-02 | -3.54 | small GTPase-mediated signal transduction | biological process | GO:0007264 | 258 | 3 | 18204 | 47 |
DOCK8,ELMO1,DOCK4 |
2.892e-02 | -3.54 | NAHEXCHNGR | prints domains | PR01084 | 9 | 1 | 5227 | 17 |
SLC9A9 |
2.892e-02 | -3.54 | Isothipendyl H1-Antihistamine Action | SMPDB pathways | SMP0059716 | 8 | 1 | 1369 | 5 |
GNAQ |
2.892e-02 | -3.54 | Quifenadine H1-Antihistamine Action | SMPDB pathways | SMP0060743 | 8 | 1 | 1369 | 5 |
GNAQ |
2.892e-02 | -3.54 | Alimemazine H1-Antihistamine Action | SMPDB pathways | SMP0059689 | 8 | 1 | 1369 | 5 |
GNAQ |
2.892e-02 | -3.54 | Tolpropamine H1-Antihistamine Action | SMPDB pathways | SMP0062621 | 8 | 1 | 1369 | 5 |
GNAQ |
2.892e-02 | -3.54 | Epinastine H1-Antihistamine Action | SMPDB pathways | SMP0061191 | 8 | 1 | 1369 | 5 |
GNAQ |
2.892e-02 | -3.54 | Doxylamine H1-Antihistamine Action | SMPDB pathways | SMP0058803 | 8 | 1 | 1369 | 5 |
GNAQ |
2.892e-02 | -3.54 | Oxatomide H1-Antihistamine Action | SMPDB pathways | SMP0059044 | 8 | 1 | 1369 | 5 |
GNAQ |
2.892e-02 | -3.54 | Antazoline H1-Antihistamine Action | SMPDB pathways | SMP0057584 | 8 | 1 | 1369 | 5 |
GNAQ |
2.892e-02 | -3.54 | Ebastine H1-Antihistamine Action | SMPDB pathways | SMP0060204 | 8 | 1 | 1369 | 5 |
GNAQ |
2.892e-02 | -3.54 | Tripelennamine H1-Antihistamine Action | SMPDB pathways | SMP0057587 | 8 | 1 | 1369 | 5 |
GNAQ |
2.892e-02 | -3.54 | Doxepin H1-Antihistamine Action | SMPDB pathways | SMP0059872 | 8 | 1 | 1369 | 5 |
GNAQ |
2.892e-02 | -3.54 | Levocetirizine H1-Antihistamine Action | SMPDB pathways | SMP0059114 | 8 | 1 | 1369 | 5 |
GNAQ |
2.892e-02 | -3.54 | Hydroxyethylpromethazine H1-Antihistamine Action | SMPDB pathways | SMP0059710 | 8 | 1 | 1369 | 5 |
GNAQ |
2.892e-02 | -3.54 | Bromodiphenhydramine H1-Antihistamine Action | SMPDB pathways | SMP0058813 | 8 | 1 | 1369 | 5 |
GNAQ |
2.892e-02 | -3.54 | Promethazine H1-Antihistamine Action | SMPDB pathways | SMP0059211 | 8 | 1 | 1369 | 5 |
GNAQ |
2.892e-02 | -3.54 | Azelastine H1-Antihistamine Action | SMPDB pathways | SMP0060741 | 8 | 1 | 1369 | 5 |
GNAQ |
2.892e-02 | -3.54 | Latrepirdine H1-Antihistamine Action | SMPDB pathways | SMP0062623 | 8 | 1 | 1369 | 5 |
GNAQ |
2.892e-02 | -3.54 | Meclizine H1-Antihistamine Action | SMPDB pathways | SMP0058956 | 8 | 1 | 1369 | 5 |
GNAQ |
2.892e-02 | -3.54 | Pheniramine H1-Antihistamine Action | SMPDB pathways | SMP0056662 | 8 | 1 | 1369 | 5 |
GNAQ |
2.892e-02 | -3.54 | Clemastine H1-Antihistamine Action | SMPDB pathways | SMP0058891 | 8 | 1 | 1369 | 5 |
GNAQ |
2.892e-02 | -3.54 | Pyrrobutamine H1-Antihistamine Action | SMPDB pathways | SMP0062887 | 8 | 1 | 1369 | 5 |
GNAQ |
2.892e-02 | -3.54 | Homochlorcyclizine H1-Antihistamine Action | SMPDB pathways | SMP0062795 | 8 | 1 | 1369 | 5 |
GNAQ |
2.892e-02 | -3.54 | Chlorphenoxamine H1-Antihistamine Action | SMPDB pathways | SMP0058903 | 8 | 1 | 1369 | 5 |
GNAQ |
2.892e-02 | -3.54 | Quetiapine H1-Antihistamine Action | SMPDB pathways | SMP0062884 | 8 | 1 | 1369 | 5 |
GNAQ |
2.892e-02 | -3.54 | Tritoqualine H1-Antihistamine Action | SMPDB pathways | SMP0062895 | 8 | 1 | 1369 | 5 |
GNAQ |
2.892e-02 | -3.54 | Acrivastine H1-Antihistamine Action | SMPDB pathways | SMP0059881 | 8 | 1 | 1369 | 5 |
GNAQ |
2.892e-02 | -3.54 | Deptropine H1-Antihistamine Action | SMPDB pathways | SMP0062883 | 8 | 1 | 1369 | 5 |
GNAQ |
2.892e-02 | -3.54 | Oxomemazine H1-Antihistamine Action | SMPDB pathways | SMP0059738 | 8 | 1 | 1369 | 5 |
GNAQ |
2.892e-02 | -3.54 | Phenbenzamine H1-Antihistamine Action | SMPDB pathways | SMP0059702 | 8 | 1 | 1369 | 5 |
GNAQ |
2.892e-02 | -3.54 | Desloratadine H1-Antihistamine Action | SMPDB pathways | SMP0060201 | 8 | 1 | 1369 | 5 |
GNAQ |
2.892e-02 | -3.54 | Triprolidine H1-Antihistamine Action | SMPDB pathways | SMP0057581 | 8 | 1 | 1369 | 5 |
GNAQ |
2.892e-02 | -3.54 | Thenyldiamine H1-Antihistamine Action | SMPDB pathways | SMP0062624 | 8 | 1 | 1369 | 5 |
GNAQ |
2.892e-02 | -3.54 | Methdilazine H1-Antihistamine Action | SMPDB pathways | SMP0059730 | 8 | 1 | 1369 | 5 |
GNAQ |
2.892e-02 | -3.54 | Alcaftadine H1-Antihistamine Action | SMPDB pathways | SMP0062881 | 8 | 1 | 1369 | 5 |
GNAQ |
2.892e-02 | -3.54 | Dexchlorpheniramine H1-Antihistamine Action | SMPDB pathways | SMP0056811 | 8 | 1 | 1369 | 5 |
GNAQ |
2.892e-02 | -3.54 | Carbinoxamine H1-Antihistamine Action | SMPDB pathways | SMP0058797 | 8 | 1 | 1369 | 5 |
GNAQ |
2.892e-02 | -3.54 | Diphenhydramine H1-Antihistamine Action | SMPDB pathways | SMP0058785 | 8 | 1 | 1369 | 5 |
GNAQ |
2.892e-02 | -3.54 | Betahistine H1-Antihistamine Action | SMPDB pathways | SMP0060744 | 8 | 1 | 1369 | 5 |
GNAQ |
2.892e-02 | -3.54 | Chlorcyclizine H1-Antihistamine Action | SMPDB pathways | SMP0058931 | 8 | 1 | 1369 | 5 |
GNAQ |
2.892e-02 | -3.54 | Flunarizine H1-Antihistamine Action | SMPDB pathways | SMP0061047 | 8 | 1 | 1369 | 5 |
GNAQ |
2.892e-02 | -3.54 | Mepyramine H1-Antihistamine Action | SMPDB pathways | SMP0057583 | 8 | 1 | 1369 | 5 |
GNAQ |
2.892e-02 | -3.54 | Diphenylpyraline H1-Antihistamine Action | SMPDB pathways | SMP0058908 | 8 | 1 | 1369 | 5 |
GNAQ |
2.892e-02 | -3.54 | Buclizine H1-Antihistamine Action | SMPDB pathways | SMP0058964 | 8 | 1 | 1369 | 5 |
GNAQ |
2.892e-02 | -3.54 | Rupatadine H1-Antihistamine Action | SMPDB pathways | SMP0060235 | 8 | 1 | 1369 | 5 |
GNAQ |
2.892e-02 | -3.54 | Phenindamine H1-Antihistamine Action | SMPDB pathways | SMP0061190 | 8 | 1 | 1369 | 5 |
GNAQ |
2.892e-02 | -3.54 | Loratadine H1-Antihistamine Action | SMPDB pathways | SMP0060195 | 8 | 1 | 1369 | 5 |
GNAQ |
2.892e-02 | -3.54 | Bamipine H1-Antihistamine Action | SMPDB pathways | SMP0062882 | 8 | 1 | 1369 | 5 |
GNAQ |
2.892e-02 | -3.54 | Emedastine H1-Antihistamine Action | SMPDB pathways | SMP0061040 | 8 | 1 | 1369 | 5 |
GNAQ |
2.892e-02 | -3.54 | Mebhydrolin H1-Antihistamine Action | SMPDB pathways | SMP0061052 | 8 | 1 | 1369 | 5 |
GNAQ |
2.892e-02 | -3.54 | Phenyltoloxamine H1-Antihistamine Action | SMPDB pathways | SMP0058916 | 8 | 1 | 1369 | 5 |
GNAQ |
2.892e-02 | -3.54 | Olopatadine H1-Antihistamine Action | SMPDB pathways | SMP0060740 | 8 | 1 | 1369 | 5 |
GNAQ |
2.892e-02 | -3.54 | Dimetindene H1-Antihistamine Action | SMPDB pathways | SMP0057582 | 8 | 1 | 1369 | 5 |
GNAQ |
2.892e-02 | -3.54 | Histapyrrodine H1-Antihistamine Action | SMPDB pathways | SMP0058732 | 8 | 1 | 1369 | 5 |
GNAQ |
2.892e-02 | -3.54 | Orphenadrine H1-Antihistamine Action | SMPDB pathways | SMP0058808 | 8 | 1 | 1369 | 5 |
GNAQ |
2.892e-02 | -3.54 | Cyproheptadine H1-Antihistamine Action | SMPDB pathways | SMP0059694 | 8 | 1 | 1369 | 5 |
GNAQ |
2.892e-02 | -3.54 | Propiomazine H1-Antihistamine Action | SMPDB pathways | SMP0062625 | 8 | 1 | 1369 | 5 |
GNAQ |
2.892e-02 | -3.54 | Cetirizine H1-Antihistamine Action | SMPDB pathways | SMP0059058 | 8 | 1 | 1369 | 5 |
GNAQ |
2.892e-02 | -3.54 | Mizolastine H1-Antihistamine Action | SMPDB pathways | SMP0060230 | 8 | 1 | 1369 | 5 |
GNAQ |
2.892e-02 | -3.54 | Azatadine H1-Antihistamine Action | SMPDB pathways | SMP0059865 | 8 | 1 | 1369 | 5 |
GNAQ |
2.892e-02 | -3.54 | Terfenadine H1-Antihistamine Action | SMPDB pathways | SMP0060208 | 8 | 1 | 1369 | 5 |
GNAQ |
2.892e-02 | -3.54 | Cinnarizine H1-Antihistamine Action | SMPDB pathways | SMP0059110 | 8 | 1 | 1369 | 5 |
GNAQ |
2.892e-02 | -3.54 | Chlorphenamine H1-Antihistamine Action | SMPDB pathways | SMP0056661 | 8 | 1 | 1369 | 5 |
GNAQ |
2.892e-02 | -3.54 | Talastine H1-Antihistamine Action | SMPDB pathways | SMP0057586 | 8 | 1 | 1369 | 5 |
GNAQ |
2.892e-02 | -3.54 | Histamine H1 Receptor Activation | SMPDB pathways | SMP0063452 | 8 | 1 | 1369 | 5 |
GNAQ |
2.892e-02 | -3.54 | Thiazinamium H1-Antihistamine Action | SMPDB pathways | SMP0060742 | 8 | 1 | 1369 | 5 |
GNAQ |
2.892e-02 | -3.54 | Dexbrompheniramine H1-Antihistamine Action | SMPDB pathways | SMP0057580 | 8 | 1 | 1369 | 5 |
GNAQ |
2.892e-02 | -3.54 | Levocabastine H1-Antihistamine Action | SMPDB pathways | SMP0060224 | 8 | 1 | 1369 | 5 |
GNAQ |
2.892e-02 | -3.54 | Thenalidine H1-Antihistamine Action | SMPDB pathways | SMP0062894 | 8 | 1 | 1369 | 5 |
GNAQ |
2.892e-02 | -3.54 | Mirtazapine H1-Antihistamine Action | SMPDB pathways | SMP0062885 | 8 | 1 | 1369 | 5 |
GNAQ |
2.892e-02 | -3.54 | Thonzylamine H1-Antihistamine Action | SMPDB pathways | SMP0058769 | 8 | 1 | 1369 | 5 |
GNAQ |
2.892e-02 | -3.54 | Cyclizine H1-Antihistamine Action | SMPDB pathways | SMP0058923 | 8 | 1 | 1369 | 5 |
GNAQ |
2.892e-02 | -3.54 | Temelastine H1-Antihistamine Action | SMPDB pathways | SMP0062880 | 8 | 1 | 1369 | 5 |
GNAQ |
2.892e-02 | -3.54 | Hydroxyzine H1-Antihistamine Action | SMPDB pathways | SMP0058936 | 8 | 1 | 1369 | 5 |
GNAQ |
2.892e-02 | -3.54 | Methapyrilene H1-Antihistamine Action | SMPDB pathways | SMP0058741 | 8 | 1 | 1369 | 5 |
GNAQ |
2.892e-02 | -3.54 | Bepotastine H1-Antihistamine Action | SMPDB pathways | SMP0060058 | 8 | 1 | 1369 | 5 |
GNAQ |
2.892e-02 | -3.54 | Fexofenadine H1-Antihistamine Action | SMPDB pathways | SMP0060218 | 8 | 1 | 1369 | 5 |
GNAQ |
2.892e-02 | -3.54 | Ketotifen H1-Antihistamine Action | SMPDB pathways | SMP0059868 | 8 | 1 | 1369 | 5 |
GNAQ |
2.892e-02 | -3.54 | Bilastine H1-Antihistamine Action | SMPDB pathways | SMP0060170 | 8 | 1 | 1369 | 5 |
GNAQ |
2.892e-02 | -3.54 | Fenethazine H1-Antihistamine Action | SMPDB pathways | SMP0059707 | 8 | 1 | 1369 | 5 |
GNAQ |
2.892e-02 | -3.54 | Chloropyramine H1-Antihistamine Action | SMPDB pathways | SMP0057585 | 8 | 1 | 1369 | 5 |
GNAQ |
2.892e-02 | -3.54 | Mequitazine H1-Antihistamine Action | SMPDB pathways | SMP0059720 | 8 | 1 | 1369 | 5 |
GNAQ |
2.892e-02 | -3.54 | Brompheniramine H1-Antihistamine Action | SMPDB pathways | SMP0057579 | 8 | 1 | 1369 | 5 |
GNAQ |
2.892e-02 | -3.54 | Clocinizine H1-Antihistamine Action | SMPDB pathways | SMP0062788 | 8 | 1 | 1369 | 5 |
GNAQ |
2.892e-02 | -3.54 | Astemizole H1-Antihistamine Action | SMPDB pathways | SMP0059897 | 8 | 1 | 1369 | 5 |
GNAQ |
2.892e-02 | -3.54 | Pimethixene H1-Antihistamine Action | SMPDB pathways | SMP0062886 | 8 | 1 | 1369 | 5 |
GNAQ |
2.892e-02 | -3.54 | Embramine H1-Antihistamine Action | SMPDB pathways | SMP0062622 | 8 | 1 | 1369 | 5 |
GNAQ |
2.905e-02 | -3.54 | regulation of biomineral tissue development | biological process | GO:0070167 | 103 | 2 | 18204 | 47 |
SLC8A1,MEF2C |
2.908e-02 | -3.54 | regulation of cell communication | biological process | GO:0010646 | 3541 | 15 | 18204 | 47 |
MAP4K4,KCNQ3,CHST11,ARHGAP24,MEF2C,DOCK8,GNAQ,SLC8A1,ARHGAP22,PICALM,DISC1,SORL1,LDLRAD4,ARHGAP26,PTPRJ |
2.913e-02 | -3.54 | Golgi medial cisterna | cellular component | GO:0005797 | 12 | 1 | 19108 | 47 |
ST6GAL1 |
2.927e-02 | -3.53 | Calx_beta | smart domains | SM00237 | 8 | 1 | 9717 | 36 |
SLC8A1 |
2.927e-02 | -3.53 | ZnF_AN1 | smart domains | SM00154 | 8 | 1 | 9717 | 36 |
ZFAND3 |
2.931e-02 | -3.53 | His_deacetylse_dom_sf | interpro domains | IPR037138 | 11 | 1 | 18521 | 50 |
HDAC9 |
2.931e-02 | -3.53 | His_deacetylse_dom | interpro domains | IPR023801 | 11 | 1 | 18521 | 50 |
HDAC9 |
2.931e-02 | -3.53 | NST/OST | interpro domains | IPR037359 | 11 | 1 | 18521 | 50 |
HS3ST4 |
2.931e-02 | -3.53 | His_deacetylse | interpro domains | IPR000286 | 11 | 1 | 18521 | 50 |
HDAC9 |
2.931e-02 | -3.53 | Cation/H_exchanger_CPA1 | interpro domains | IPR018422 | 11 | 1 | 18521 | 50 |
SLC9A9 |
2.932e-02 | -3.53 | Protein tyrosine phosphatase superfamily | gene3d domains | 3.90.190.10 | 88 | 2 | 14470 | 44 |
PTPRJ,SSH2 |
2.940e-02 | -3.53 | response to organonitrogen compound | biological process | GO:0010243 | 915 | 6 | 18204 | 47 |
HDAC9,SLC8A1,ITPR2,GNAQ,TCF12,MEF2C |
2.941e-02 | -3.53 | Gap junction | KEGG pathways | ko04540 | 88 | 2 | 7161 | 22 |
ITPR2,GNAQ |
2.941e-02 | -3.53 | Gap junction | KEGG pathways | hsa04540 | 88 | 2 | 7161 | 22 |
GNAQ,ITPR2 |
2.946e-02 | -3.52 | DIRAS3 (DIRAS family GTPase 3) | protein interactions | 9077 | 261 | 3 | 19454 | 50 |
EPB41L2,MAP4K4,PICALM |
2.948e-02 | -3.52 | distal axon | cellular component | GO:0150034 | 273 | 3 | 19108 | 47 |
DISC1,SLC8A1,DSCAM |
2.955e-02 | -3.52 | Toll Like Receptor 5 (TLR5) Cascade | REACTOME pathways | R-HSA-168176 | 84 | 2 | 10285 | 33 |
MEF2A,MEF2C |
2.955e-02 | -3.52 | MyD88 cascade initiated on plasma membrane | REACTOME pathways | R-HSA-975871 | 84 | 2 | 10285 | 33 |
MEF2C,MEF2A |
2.955e-02 | -3.52 | Toll Like Receptor 10 (TLR10) Cascade | REACTOME pathways | R-HSA-168142 | 84 | 2 | 10285 | 33 |
MEF2C,MEF2A |
2.958e-02 | -3.52 | inorganic cation import across plasma membrane | biological process | GO:0098659 | 104 | 2 | 18204 | 47 |
SLC9A9,SLC8A1 |
2.958e-02 | -3.52 | inorganic ion import across plasma membrane | biological process | GO:0099587 | 104 | 2 | 18204 | 47 |
SLC8A1,SLC9A9 |
2.963e-02 | -3.52 | regulation of molecular function | biological process | GO:0065009 | 2005 | 10 | 18204 | 47 |
PTPRJ,ARHGAP24,MEF2C,GNAQ,TBC1D22A,DOCK8,SLC8A1,ARHGAP22,DISC1,MAP4K4 |
2.973e-02 | -3.52 | regulation of blood circulation | biological process | GO:1903522 | 261 | 3 | 18204 | 47 |
DOCK4,SLC8A1,MEF2A |
2.988e-02 | -3.51 | MED26 (mediator complex subunit 26) | protein interactions | 9441 | 105 | 2 | 19454 | 50 |
QKI,MED13L |
2.988e-02 | -3.51 | WDR59 (WD repeat domain 59) | protein interactions | 79726 | 105 | 2 | 19454 | 50 |
DSCAM,EPB41L2 |
2.988e-02 | -3.51 | Hist_deacetyl | pfam domains | PF00850 | 11 | 1 | 17795 | 49 |
HDAC9 |
2.999e-02 | -3.51 | oligopeptide transmembrane transporter activity | molecular function | GO:0035673 | 11 | 1 | 18094 | 50 |
ABCC4 |
2.999e-02 | -3.51 | clathrin heavy chain binding | molecular function | GO:0032050 | 11 | 1 | 18094 | 50 |
PICALM |
3.000e-02 | -3.51 | - | gene3d domains | 6.10.140.1330 | 10 | 1 | 14470 | 44 |
SLC9A9 |
3.010e-02 | -3.50 | regulation of postsynapse organization | biological process | GO:0099175 | 105 | 2 | 18204 | 47 |
ARHGAP22,DISC1 |
3.018e-02 | -3.50 | human chr5q12.1 | chromosome location | human chr5q12.1 | 16 | 1 | 26134 | 50 |
ZSWIM6 |
3.018e-02 | -3.50 | human chr2p22.1 | chromosome location | human chr2p22.1 | 16 | 1 | 26134 | 50 |
SLC8A1 |
3.023e-02 | -3.50 | cell migration | biological process | GO:0016477 | 921 | 6 | 18204 | 47 |
ARHGAP24,DOCK4,DISC1,MEF2C,DOCK8,SORL1 |
3.033e-02 | -3.50 | synaptic signaling | biological process | GO:0099536 | 459 | 4 | 18204 | 47 |
KCNQ3,FCHSD2,MEF2C,GNAQ |
3.039e-02 | -3.49 | skin-hand-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | skin-hand-carcinoma-squamous_cell_carcinoma | 407 | 4 | 16828 | 49 |
ATP8B4,DSCAM,SFMBT2,DIP2B |
3.040e-02 | -3.49 | THRA (thyroid hormone receptor alpha) | protein interactions | 7067 | 106 | 2 | 19454 | 50 |
MEF2A,ARHGAP24 |
3.042e-02 | -3.49 | LOC102724560 (cystathionine beta-synthase like) | protein interactions | 102724560 | 12 | 1 | 19454 | 50 |
ARHGAP24 |
3.042e-02 | -3.49 | NUDT4 (nudix hydrolase 4) | protein interactions | 11163 | 12 | 1 | 19454 | 50 |
DISC1 |
3.042e-02 | -3.49 | GCSAML (germinal center associated signaling and motility like) | protein interactions | 148823 | 12 | 1 | 19454 | 50 |
PLXDC2 |
3.042e-02 | -3.49 | TCF21 (transcription factor 21) | protein interactions | 6943 | 12 | 1 | 19454 | 50 |
TCF12 |
3.042e-02 | -3.49 | TM7SF2 (transmembrane 7 superfamily member 2) | protein interactions | 7108 | 12 | 1 | 19454 | 50 |
DISC1 |
3.042e-02 | -3.49 | ADGRB3 (adhesion G protein-coupled receptor B3) | protein interactions | 577 | 12 | 1 | 19454 | 50 |
ELMO1 |
3.042e-02 | -3.49 | ISG20 (interferon stimulated exonuclease gene 20) | protein interactions | 3669 | 12 | 1 | 19454 | 50 |
GNAQ |
3.042e-02 | -3.49 | ZNF26 (zinc finger protein 26) | protein interactions | 7574 | 12 | 1 | 19454 | 50 |
SORL1 |
3.042e-02 | -3.49 | C8orf76 (chromosome 8 open reading frame 76) | protein interactions | 84933 | 12 | 1 | 19454 | 50 |
DISC1 |
3.042e-02 | -3.49 | TCF15 (transcription factor 15) | protein interactions | 6939 | 12 | 1 | 19454 | 50 |
TCF12 |
3.042e-02 | -3.49 | ZNF91 (zinc finger protein 91) | protein interactions | 7644 | 12 | 1 | 19454 | 50 |
ARHGAP24 |
3.042e-02 | -3.49 | ZNF843 (zinc finger protein 843) | protein interactions | 283933 | 12 | 1 | 19454 | 50 |
GNAQ |
3.042e-02 | -3.49 | ZNF235 (zinc finger protein 235) | protein interactions | 9310 | 12 | 1 | 19454 | 50 |
ARHGAP24 |
3.042e-02 | -3.49 | ZNF584 (zinc finger protein 584) | protein interactions | 201514 | 12 | 1 | 19454 | 50 |
SORL1 |
3.042e-02 | -3.49 | HNRNPCL3 (heterogeneous nuclear ribonucleoprotein C like 3) | protein interactions | 649330 | 12 | 1 | 19454 | 50 |
MAP4K4 |
3.042e-02 | -3.49 | upper_aerodigestive_tract | COSMIC cancer mutations | upper_aerodigestive_tract | 13181 | 44 | 16828 | 49 |
PICALM,ARHGAP24,ARHGAP22,SYNDIG1,MAP4K4,ST6GAL1,ST6GALNAC3,PTPRJ,ANKRD44,ATP8B4,DSCAM,ZFHX3,GNAQ,APBB1IP,UBE2E2,SORL1,ADAM28,DISC1,FCHSD2,CHST11,NAV3,SLC8A1,SFMBT2,DOCK4,EPB41L2,SLC9A9,ZBTB20,SSH2,ZSWIM6,TBC1D22A,FRMD4A,ITPR2,ARHGAP26,ELMO1,DIP2B,MAML3,HDAC9,QKI,KCNQ3,DOCK8,TCF12,MED13L,MAML2,MEF2C |
3.044e-02 | -3.49 | Prot-tyrosine_phosphatase-like | interpro domains | IPR029021 | 101 | 2 | 18521 | 50 |
SSH2,PTPRJ |
3.056e-02 | -3.49 | negative regulation of smooth muscle contraction | biological process | GO:0045986 | 12 | 1 | 18204 | 47 |
DOCK4 |
3.056e-02 | -3.49 | negative regulation of protein localization to cell surface | biological process | GO:2000009 | 12 | 1 | 18204 | 47 |
PICALM |
3.056e-02 | -3.49 | excitatory chemical synaptic transmission | biological process | GO:0098976 | 12 | 1 | 18204 | 47 |
KCNQ3 |
3.056e-02 | -3.49 | heart field specification | biological process | GO:0003128 | 12 | 1 | 18204 | 47 |
MEF2C |
3.056e-02 | -3.49 | positive regulation of keratinocyte migration | biological process | GO:0051549 | 12 | 1 | 18204 | 47 |
MAP4K4 |
3.056e-02 | -3.49 | negative regulation of inclusion body assembly | biological process | GO:0090084 | 12 | 1 | 18204 | 47 |
SORL1 |
3.056e-02 | -3.49 | microglia differentiation | biological process | GO:0014004 | 12 | 1 | 18204 | 47 |
QKI |
3.056e-02 | -3.49 | N-acetylneuraminate metabolic process | biological process | GO:0006054 | 12 | 1 | 18204 | 47 |
ST6GAL1 |
3.056e-02 | -3.49 | cellular response to antibiotic | biological process | GO:0071236 | 12 | 1 | 18204 | 47 |
MEF2C |
3.056e-02 | -3.49 | oligopeptide transmembrane transport | biological process | GO:0035672 | 12 | 1 | 18204 | 47 |
ABCC4 |
3.056e-02 | -3.49 | positive regulation of protein localization to endosome | biological process | GO:1905668 | 12 | 1 | 18204 | 47 |
SORL1 |
3.056e-02 | -3.49 | negative regulation of vasoconstriction | biological process | GO:0045906 | 12 | 1 | 18204 | 47 |
DOCK4 |
3.066e-02 | -3.48 | Salivary secretion | KEGG pathways | ko04970 | 90 | 2 | 7161 | 22 |
GNAQ,ITPR2 |
3.066e-02 | -3.48 | Salivary secretion | KEGG pathways | hsa04970 | 90 | 2 | 7161 | 22 |
GNAQ,ITPR2 |
3.070e-02 | -3.48 | regulation of cell projection organization | biological process | GO:0031344 | 683 | 5 | 18204 | 47 |
DISC1,TBC1D22A,DIP2B,DSCAM,ARHGAP24 |
3.074e-02 | -3.48 | organelle membrane | cellular component | GO:0031090 | 3742 | 15 | 19108 | 47 |
ARHGAP26,GNAQ,PTPRJ,LDLRAD4,ST6GAL1,ATP8B4,ITPR2,SORL1,CHST11,ST6GALNAC3,NAV3,ABCC4,HS3ST4,SLC9A9,SYNDIG1 |
3.086e-02 | -3.48 | Fcgamma receptor (FCGR) dependent phagocytosis | REACTOME pathways | R-HSA-2029480 | 86 | 2 | 10285 | 33 |
ELMO1,ITPR2 |
3.093e-02 | -3.48 | KIFAP3 (kinesin associated protein 3) | protein interactions | 22920 | 107 | 2 | 19454 | 50 |
DISC1,GNAQ |
3.103e-02 | -3.47 | tube morphogenesis | biological process | GO:0035239 | 685 | 5 | 18204 | 47 |
ARHGAP24,QKI,ARHGAP22,PTPRJ,MEF2C |
3.118e-02 | -3.47 | regulation of membrane potential | biological process | GO:0042391 | 463 | 4 | 18204 | 47 |
KCNQ3,SLC8A1,MEF2C,GNAQ |
3.119e-02 | -3.47 | protein tyrosine phosphatase activity | molecular function | GO:0004725 | 100 | 2 | 18094 | 50 |
PTPRJ,SSH2 |
3.120e-02 | -3.47 | endometrium-carcinoma-endometrioid_carcinoma | COSMIC cancer mutations | endometrium-carcinoma-endometrioid_carcinoma | 15680 | 49 | 16828 | 49 |
APBB1IP,ADAM28,HS3ST4,NAV3,PICALM,SYNDIG1,ST6GALNAC3,ZFHX3,DIP2B,MAML3,DOCK8,MAML2,MEF2C,SLC9A9,TBC1D22A,FRMD4A,ITPR2,GNAQ,UBE2E2,DISC1,SORL1,FCHSD2,CHST11,ARHGAP24,ARHGAP22,ST6GAL1,MAP4K4,ABCC4,PLXDC2,PTPRJ,ANKRD44,ATP8B4,DSCAM,HDAC9,QKI,KCNQ3,TCF12,MED13L,SLC8A1,SFMBT2,DOCK4,EPB41L2,ZFAND3,ZBTB20,SSH2,ZSWIM6,ELMO1,ARHGAP26,MEF2A |
3.137e-02 | -3.46 | cell morphogenesis | biological process | GO:0000902 | 687 | 5 | 18204 | 47 |
MEF2C,MAP4K4,DSCAM,PICALM,MEF2A |
3.139e-02 | -3.46 | cellular response to organic cyclic compound | biological process | GO:0071407 | 464 | 4 | 18204 | 47 |
MEF2C,GNAQ,SLC8A1,ITPR2 |
3.147e-02 | -3.46 | GGT7 (gamma-glutamyltransferase 7) | protein interactions | 2686 | 108 | 2 | 19454 | 50 |
ARHGAP24,ST6GALNAC3 |
3.149e-02 | -3.46 | PFN1 (profilin 1) | protein interactions | 5216 | 466 | 4 | 19454 | 50 |
DOCK4,ARHGAP24,DOCK8,APBB1IP |
3.152e-02 | -3.46 | early phagosome | cellular component | GO:0032009 | 13 | 1 | 19108 | 47 |
SLC9A9 |
3.154e-02 | -3.46 | hemopoiesis | biological process | GO:0030097 | 688 | 5 | 18204 | 47 |
HDAC9,PICALM,QKI,PTPRJ,MEF2C |
3.158e-02 | -3.46 | congenital | COSMIC cancer mutations | congenital | 11 | 1 | 16828 | 49 |
GNAQ |
3.158e-02 | -3.46 | skin-back-malignant_melanoma-superficial_spreading | COSMIC cancer mutations | skin-back-malignant_melanoma-superficial_spreading | 11 | 1 | 16828 | 49 |
GNAQ |
3.158e-02 | -3.46 | skin-scalp-malignant_melanoma-lentigo_maligna | COSMIC cancer mutations | skin-scalp-malignant_melanoma-lentigo_maligna | 11 | 1 | 16828 | 49 |
GNAQ |
3.158e-02 | -3.46 | central_nervous_system-posterior_fossa-glioma-astrocytoma_Grade_I | COSMIC cancer mutations | central_nervous_system-posterior_fossa-glioma-astrocytoma_Grade_I | 11 | 1 | 16828 | 49 |
GNAQ |
3.158e-02 | -3.46 | bone-extraskeletal-chondrosarcoma-myxoid | COSMIC cancer mutations | bone-extraskeletal-chondrosarcoma-myxoid | 11 | 1 | 16828 | 49 |
TCF12 |
3.158e-02 | -3.46 | skin-back-benign_melanocytic_nevus | COSMIC cancer mutations | skin-back-benign_melanocytic_nevus | 11 | 1 | 16828 | 49 |
GNAQ |
3.164e-02 | -3.45 | Acetylcholine regulates insulin secretion | REACTOME pathways | R-HSA-399997 | 10 | 1 | 10285 | 33 |
GNAQ |
3.171e-02 | -3.45 | cellular homeostasis | biological process | GO:0019725 | 689 | 5 | 18204 | 47 |
DISC1,ZBTB20,SLC9A9,SLC8A1,PICALM |
3.183e-02 | -3.45 | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-myelofibrosis | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-myelofibrosis | 413 | 4 | 16828 | 49 |
MED13L,ST6GAL1,MAP4K4,TCF12 |
3.183e-02 | -3.45 | myelofibrosis | COSMIC cancer mutations | myelofibrosis | 413 | 4 | 16828 | 49 |
ST6GAL1,MAP4K4,MED13L,TCF12 |
3.192e-02 | -3.44 | Th1 and Th2 cell differentiation | KEGG pathways | ko04658 | 92 | 2 | 7161 | 22 |
MAML2,MAML3 |
3.192e-02 | -3.44 | GnRH signaling pathway | KEGG pathways | ko04912 | 92 | 2 | 7161 | 22 |
ITPR2,GNAQ |
3.192e-02 | -3.44 | GnRH signaling pathway | KEGG pathways | hsa04912 | 92 | 2 | 7161 | 22 |
ITPR2,GNAQ |
3.192e-02 | -3.44 | Th1 and Th2 cell differentiation | KEGG pathways | hsa04658 | 92 | 2 | 7161 | 22 |
MAML2,MAML3 |
3.193e-02 | -3.44 | Sulfotransferase | interpro domains | IPR005331 | 12 | 1 | 18521 | 50 |
CHST11 |
3.210e-02 | -3.44 | positive regulation of molecular function | biological process | GO:0044093 | 1192 | 7 | 18204 | 47 |
ARHGAP22,MAP4K4,ARHGAP24,DOCK8,GNAQ,TBC1D22A,MEF2C |
3.219e-02 | -3.44 | endometrioid_carcinoma | COSMIC cancer mutations | endometrioid_carcinoma | 15690 | 49 | 16828 | 49 |
ST6GAL1,MAP4K4,ARHGAP22,ARHGAP24,DSCAM,ATP8B4,ANKRD44,PTPRJ,PLXDC2,ABCC4,FCHSD2,SORL1,DISC1,UBE2E2,GNAQ,CHST11,ZBTB20,ZFAND3,EPB41L2,DOCK4,SFMBT2,SLC8A1,MEF2A,ELMO1,ARHGAP26,ZSWIM6,SSH2,KCNQ3,QKI,HDAC9,MED13L,TCF12,SYNDIG1,PICALM,ZFHX3,ST6GALNAC3,ADAM28,APBB1IP,NAV3,HS3ST4,SLC9A9,ITPR2,FRMD4A,TBC1D22A,DOCK8,MAML3,DIP2B,MEF2C,MAML2 |
3.224e-02 | -3.43 | positive regulation of tumor necrosis factor production | biological process | GO:0032760 | 109 | 2 | 18204 | 47 |
ZBTB20,PTPRJ |
3.239e-02 | -3.43 | endometrium | COSMIC cancer mutations | endometrium | 15692 | 49 | 16828 | 49 |
CHST11,DISC1,SORL1,UBE2E2,FCHSD2,GNAQ,DSCAM,ATP8B4,ABCC4,PTPRJ,ANKRD44,PLXDC2,ARHGAP22,ARHGAP24,ST6GAL1,MAP4K4,TCF12,MED13L,KCNQ3,QKI,HDAC9,MEF2A,ARHGAP26,ELMO1,SSH2,ZSWIM6,ZBTB20,ZFAND3,SFMBT2,SLC8A1,EPB41L2,DOCK4,NAV3,HS3ST4,ADAM28,APBB1IP,ZFHX3,ST6GALNAC3,PICALM,SYNDIG1,MEF2C,MAML2,DOCK8,DIP2B,MAML3,ITPR2,FRMD4A,TBC1D22A,SLC9A9 |
3.241e-02 | -3.43 | GNB1 (G protein subunit beta 1) | protein interactions | 2782 | 271 | 3 | 19454 | 50 |
SLC9A9,GNAQ,DISC1 |
3.245e-02 | -3.43 | skin-knee-malignant_melanoma | COSMIC cancer mutations | skin-knee-malignant_melanoma | 97 | 2 | 16828 | 49 |
PTPRJ,ADAM28 |
3.256e-02 | -3.42 | Sulfotransfer_2 | pfam domains | PF03567 | 12 | 1 | 17795 | 49 |
CHST11 |
3.256e-02 | -3.42 | BAR_3 | pfam domains | PF16746 | 12 | 1 | 17795 | 49 |
ARHGAP26 |
3.267e-02 | -3.42 | prostaglandin transmembrane transporter activity | molecular function | GO:0015132 | 12 | 1 | 18094 | 50 |
ABCC4 |
3.267e-02 | -3.42 | gamma-catenin binding | molecular function | GO:0045295 | 12 | 1 | 18094 | 50 |
PTPRJ |
3.267e-02 | -3.42 | inositol 1,4,5 trisphosphate binding | molecular function | GO:0070679 | 12 | 1 | 18094 | 50 |
ITPR2 |
3.267e-02 | -3.42 | cAMP response element binding | molecular function | GO:0035497 | 12 | 1 | 18094 | 50 |
TCF12 |
3.279e-02 | -3.42 | large_intestine-colon-carcinoma | COSMIC cancer mutations | large_intestine-colon-carcinoma | 2612 | 13 | 16828 | 49 |
FRMD4A,DSCAM,ZFHX3,ITPR2,TBC1D22A,PTPRJ,SLC8A1,PICALM,ARHGAP22,NAV3,UBE2E2,SORL1,GNAQ |
3.287e-02 | -3.42 | MBT | smart domains | SM00561 | 9 | 1 | 9717 | 36 |
SFMBT2 |
3.287e-02 | -3.42 | ENTH | smart domains | SM00273 | 9 | 1 | 9717 | 36 |
PICALM |
3.291e-02 | -3.41 | ST3GAL5 (ST3 beta-galactoside alpha-2,3-sialyltransferase 5) | protein interactions | 8869 | 13 | 1 | 19454 | 50 |
PICALM |
3.291e-02 | -3.41 | KCNQ4 (potassium voltage-gated channel subfamily Q member 4) | protein interactions | 9132 | 13 | 1 | 19454 | 50 |
KCNQ3 |
3.291e-02 | -3.41 | PCAT1 (prostate cancer associated transcript 1) | protein interactions | 100750225 | 13 | 1 | 19454 | 50 |
NAV3 |
3.291e-02 | -3.41 | MYO16 (myosin XVI) | protein interactions | 23026 | 13 | 1 | 19454 | 50 |
ARHGAP26 |
3.291e-02 | -3.41 | MRNIP (MRN complex interacting protein) | protein interactions | 51149 | 13 | 1 | 19454 | 50 |
ANKRD44 |
3.291e-02 | -3.41 | MSC (musculin) | protein interactions | 9242 | 13 | 1 | 19454 | 50 |
TCF12 |
3.291e-02 | -3.41 | Rbm47 (RNA binding motif protein 47) | protein interactions | 245945 | 13 | 1 | 19454 | 50 |
QKI |
3.291e-02 | -3.41 | IBSP (integrin binding sialoprotein) | protein interactions | 3381 | 13 | 1 | 19454 | 50 |
PLXDC2 |
3.291e-02 | -3.41 | ZNF284 (zinc finger protein 284) | protein interactions | 342909 | 13 | 1 | 19454 | 50 |
SORL1 |
3.291e-02 | -3.41 | ZNF718 (zinc finger protein 718) | protein interactions | 255403 | 13 | 1 | 19454 | 50 |
ARHGAP24 |
3.291e-02 | -3.41 | LYSMD1 (LysM domain containing 1) | protein interactions | 388695 | 13 | 1 | 19454 | 50 |
TCF12 |
3.291e-02 | -3.41 | CRYGC (crystallin gamma C) | protein interactions | 1420 | 13 | 1 | 19454 | 50 |
DISC1 |
3.291e-02 | -3.41 | RTL10 (retrotransposon Gag like 10) | protein interactions | 79680 | 13 | 1 | 19454 | 50 |
DSCAM |
3.291e-02 | -3.41 | PLEKHH1 (pleckstrin homology, MyTH4 and FERM domain containing H1) | protein interactions | 57475 | 13 | 1 | 19454 | 50 |
APBB1IP |
3.291e-02 | -3.41 | KCNQ2 (potassium voltage-gated channel subfamily Q member 2) | protein interactions | 3785 | 13 | 1 | 19454 | 50 |
KCNQ3 |
3.291e-02 | -3.41 | OGN (osteoglycin) | protein interactions | 4969 | 13 | 1 | 19454 | 50 |
SORL1 |
3.296e-02 | -3.41 | Histone deacetylase domain | gene3d domains | 3.40.800.20 | 11 | 1 | 14470 | 44 |
HDAC9 |
3.306e-02 | -3.41 | positive regulation of protein exit from endoplasmic reticulum | biological process | GO:0070863 | 13 | 1 | 18204 | 47 |
SORL1 |
3.306e-02 | -3.41 | lipid export from cell | biological process | GO:0140353 | 13 | 1 | 18204 | 47 |
ABCC4 |
3.306e-02 | -3.41 | negative regulation of cytosolic calcium ion concentration | biological process | GO:0051481 | 13 | 1 | 18204 | 47 |
SLC8A1 |
3.306e-02 | -3.41 | response to parathyroid hormone | biological process | GO:0071107 | 13 | 1 | 18204 | 47 |
MEF2C |
3.306e-02 | -3.41 | regulation of triglyceride catabolic process | biological process | GO:0010896 | 13 | 1 | 18204 | 47 |
SORL1 |
3.306e-02 | -3.41 | negative regulation of platelet-derived growth factor receptor signaling pathway | biological process | GO:0010642 | 13 | 1 | 18204 | 47 |
PTPRJ |
3.306e-02 | -3.41 | calcium ion transport into cytosol | biological process | GO:0060402 | 13 | 1 | 18204 | 47 |
SLC8A1 |
3.306e-02 | -3.41 | positive regulation of platelet activation | biological process | GO:0010572 | 13 | 1 | 18204 | 47 |
PTPRJ |
3.306e-02 | -3.41 | diet induced thermogenesis | biological process | GO:0002024 | 13 | 1 | 18204 | 47 |
SORL1 |
3.306e-02 | -3.41 | regulation of protein localization to endosome | biological process | GO:1905666 | 13 | 1 | 18204 | 47 |
SORL1 |
3.306e-02 | -3.41 | bone-tibia-other-chondroblastoma | COSMIC cancer mutations | bone-tibia-other-chondroblastoma | 98 | 2 | 16828 | 49 |
SLC9A9,ST6GALNAC3 |
3.307e-02 | -3.41 | Golgi cisterna | cellular component | GO:0031985 | 116 | 2 | 19108 | 47 |
ST6GAL1,SORL1 |
3.309e-02 | -3.41 | TTC17 (tetratricopeptide repeat domain 17) | protein interactions | 55761 | 111 | 2 | 19454 | 50 |
PLXDC2,DSCAM |
3.310e-02 | -3.41 | bladder | COSMIC cancer mutations | bladder | 14112 | 46 | 16828 | 49 |
TCF12,MED13L,HDAC9,KCNQ3,QKI,SSH2,MEF2A,ARHGAP26,ELMO1,SFMBT2,SLC8A1,EPB41L2,DOCK4,ZBTB20,CHST11,GNAQ,SORL1,UBE2E2,FCHSD2,ABCC4,PTPRJ,ANKRD44,PLXDC2,DSCAM,ATP8B4,ARHGAP22,ARHGAP24,MAP4K4,ST6GAL1,MAML2,MEF2C,DIP2B,MAML3,DOCK8,TBC1D22A,ITPR2,FRMD4A,SLC9A9,HS3ST4,NAV3,ADAM28,APBB1IP,ST6GALNAC3,ZFHX3,PICALM,SYNDIG1 |
3.310e-02 | -3.41 | urinary_tract | COSMIC cancer mutations | urinary_tract | 14112 | 46 | 16828 | 49 |
ADAM28,APBB1IP,NAV3,HS3ST4,SYNDIG1,PICALM,ZFHX3,ST6GALNAC3,DOCK8,MAML3,DIP2B,MEF2C,MAML2,SLC9A9,ITPR2,FRMD4A,TBC1D22A,FCHSD2,SORL1,UBE2E2,GNAQ,CHST11,MAP4K4,ST6GAL1,ARHGAP22,ARHGAP24,DSCAM,ATP8B4,ANKRD44,PTPRJ,PLXDC2,ABCC4,KCNQ3,QKI,HDAC9,MED13L,TCF12,ZBTB20,EPB41L2,DOCK4,SFMBT2,SLC8A1,MEF2A,ARHGAP26,ELMO1,SSH2 |
3.322e-02 | -3.40 | protein domain specific binding | molecular function | GO:0019904 | 651 | 5 | 18094 | 50 |
EPB41L2,ELMO1,TCF12,QKI,DOCK4 |
3.347e-02 | -3.40 | metal ion transmembrane transporter activity | molecular function | GO:0046873 | 442 | 4 | 18094 | 50 |
ITPR2,SLC9A9,KCNQ3,SLC8A1 |
3.386e-02 | -3.39 | Pancreatic secretion | KEGG pathways | ko04972 | 95 | 2 | 7161 | 22 |
GNAQ,ITPR2 |
3.386e-02 | -3.39 | Pancreatic secretion | KEGG pathways | hsa04972 | 95 | 2 | 7161 | 22 |
GNAQ,ITPR2 |
3.390e-02 | -3.38 | extrinsic component of synaptic membrane | cellular component | GO:0099243 | 14 | 1 | 19108 | 47 |
PICALM |
3.390e-02 | -3.38 | phospholipid-translocating ATPase complex | cellular component | GO:1990531 | 14 | 1 | 19108 | 47 |
ATP8B4 |
3.395e-02 | -3.38 | gliogenesis | biological process | GO:0042063 | 275 | 3 | 18204 | 47 |
QKI,PTPRJ,DISC1 |
3.415e-02 | -3.38 | NGF signalling via TRKA from the plasma membrane | REACTOME pathways | R-HSA-187037 | 387 | 4 | 10285 | 33 |
MEF2C,MEF2A,APBB1IP,ITPR2 |
3.418e-02 | -3.38 | GYS1 (glycogen synthase 1) | protein interactions | 2997 | 113 | 2 | 19454 | 50 |
MAP4K4,ARHGAP24 |
3.418e-02 | -3.38 | RBM6 (RNA binding motif protein 6) | protein interactions | 10180 | 113 | 2 | 19454 | 50 |
DISC1,ARHGAP22 |
3.418e-02 | -3.38 | CARS1 (cysteinyl-tRNA synthetase 1) | protein interactions | 833 | 113 | 2 | 19454 | 50 |
PICALM,ARHGAP24 |
3.423e-02 | -3.37 | Platelet homeostasis | REACTOME pathways | R-HSA-418346 | 91 | 2 | 10285 | 33 |
ITPR2,SLC8A1 |
3.423e-02 | -3.37 | TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | REACTOME pathways | R-HSA-975138 | 91 | 2 | 10285 | 33 |
MEF2A,MEF2C |
3.440e-02 | -3.37 | haematopoietic_and_lymphoid_tissue-lymph_node-lymphoid_neoplasm-angioimmunoblastic_T_cell_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymph_node-lymphoid_neoplasm-angioimmunoblastic_T_cell_lymphoma | 12 | 1 | 16828 | 49 |
GNAQ |
3.440e-02 | -3.37 | perivascular_epithelioid_cell_tumour_(PEComa) | COSMIC cancer mutations | perivascular_epithelioid_cell_tumour_(PEComa) | 12 | 1 | 16828 | 49 |
GNAQ |
3.440e-02 | -3.37 | skin-abdomen-malignant_melanoma-nodular | COSMIC cancer mutations | skin-abdomen-malignant_melanoma-nodular | 12 | 1 | 16828 | 49 |
GNAQ |
3.440e-02 | -3.37 | central_nervous_system-cerebellum-other-rosette-forming_glioneuronal_tumour | COSMIC cancer mutations | central_nervous_system-cerebellum-other-rosette-forming_glioneuronal_tumour | 12 | 1 | 16828 | 49 |
GNAQ |
3.440e-02 | -3.37 | central_nervous_system-fourth_ventricle-glioma-astrocytoma_Grade_I | COSMIC cancer mutations | central_nervous_system-fourth_ventricle-glioma-astrocytoma_Grade_I | 12 | 1 | 16828 | 49 |
QKI |
3.440e-02 | -3.37 | soft_tissue-blood_vessel-perivascular_epithelioid_cell_tumour_(PEComa) | COSMIC cancer mutations | soft_tissue-blood_vessel-perivascular_epithelioid_cell_tumour_(PEComa) | 12 | 1 | 16828 | 49 |
GNAQ |
3.440e-02 | -3.37 | skin-benign_melanocytic_nevus | COSMIC cancer mutations | skin-benign_melanocytic_nevus | 12 | 1 | 16828 | 49 |
GNAQ |
3.440e-02 | -3.37 | central_nervous_system-third_ventricle-other-rosette-forming_glioneuronal_tumour | COSMIC cancer mutations | central_nervous_system-third_ventricle-other-rosette-forming_glioneuronal_tumour | 12 | 1 | 16828 | 49 |
GNAQ |
3.444e-02 | -3.37 | positive regulation of tumor necrosis factor superfamily cytokine production | biological process | GO:1903557 | 113 | 2 | 18204 | 47 |
PTPRJ,ZBTB20 |
3.449e-02 | -3.37 | vesicle | cellular component | GO:0031982 | 4141 | 16 | 19108 | 47 |
EPB41L2,PICALM,SYNDIG1,SLC9A9,DISC1,SORL1,ABCC4,SSH2,ATP8B4,FCHSD2,ITPR2,GNAQ,ARHGAP26,PTPRJ,LDLRAD4,DIP2B |
3.454e-02 | -3.37 | CD225/Dispanin_fam | interpro domains | IPR007593 | 13 | 1 | 18521 | 50 |
SYNDIG1 |
3.454e-02 | -3.37 | FA | interpro domains | IPR014847 | 13 | 1 | 18521 | 50 |
EPB41L2 |
3.467e-02 | -3.36 | regulation of multicellular organismal development | biological process | GO:2000026 | 1484 | 8 | 18204 | 47 |
SORL1,DISC1,DSCAM,SLC8A1,MEF2C,QKI,SYNDIG1,DIP2B |
3.470e-02 | -3.36 | positive regulation of gene expression | biological process | GO:0010628 | 1212 | 7 | 18204 | 47 |
ZBTB20,SORL1,TCF12,MEF2C,QKI,PTPRJ,MEF2A |
3.474e-02 | -3.36 | ORF3b (ORF3b protein) | protein interactions | 1489670 | 114 | 2 | 19454 | 50 |
ZBTB20,PTPRJ |
3.475e-02 | -3.36 | DSCAM interactions | REACTOME pathways | R-HSA-376172 | 11 | 1 | 10285 | 33 |
DSCAM |
3.500e-02 | -3.35 | Notch signaling pathway | biological process | GO:0007219 | 114 | 2 | 18204 | 47 |
MAML2,MAML3 |
3.500e-02 | -3.35 | regulation of circadian rhythm | biological process | GO:0042752 | 114 | 2 | 18204 | 47 |
GNAQ,ZFHX3 |
3.500e-02 | -3.35 | Ion_trans_dom | interpro domains | IPR005821 | 109 | 2 | 18521 | 50 |
ITPR2,KCNQ3 |
3.518e-02 | -3.35 | Inflammatory mediator regulation of TRP channels | KEGG pathways | ko04750 | 97 | 2 | 7161 | 22 |
ITPR2,GNAQ |
3.518e-02 | -3.35 | Inflammatory mediator regulation of TRP channels | KEGG pathways | hsa04750 | 97 | 2 | 7161 | 22 |
GNAQ,ITPR2 |
3.522e-02 | -3.35 | CD225 | pfam domains | PF04505 | 13 | 1 | 17795 | 49 |
SYNDIG1 |
3.522e-02 | -3.35 | Ldl_recept_b | pfam domains | PF00058 | 13 | 1 | 17795 | 49 |
SORL1 |
3.522e-02 | -3.35 | FA | pfam domains | PF08736 | 13 | 1 | 17795 | 49 |
EPB41L2 |
3.523e-02 | -3.35 | HDASUPER | prints domains | PR01270 | 11 | 1 | 5227 | 17 |
HDAC9 |
3.535e-02 | -3.34 | icosanoid transmembrane transporter activity | molecular function | GO:0071714 | 13 | 1 | 18094 | 50 |
ABCC4 |
3.535e-02 | -3.34 | calcium:monoatomic cation antiporter activity | molecular function | GO:0015368 | 13 | 1 | 18094 | 50 |
SLC8A1 |
3.535e-02 | -3.34 | HMG box domain binding | molecular function | GO:0071837 | 13 | 1 | 18094 | 50 |
TCF12 |
3.539e-02 | -3.34 | transcription regulator complex | cellular component | GO:0005667 | 506 | 4 | 19108 | 47 |
TCF12,ZFHX3,MEF2A,HDAC9 |
3.540e-02 | -3.34 | DACT2 (dishevelled binding antagonist of beta catenin 2) | protein interactions | 168002 | 14 | 1 | 19454 | 50 |
ZBTB20 |
3.540e-02 | -3.34 | RSPO1 (R-spondin 1) | protein interactions | 284654 | 14 | 1 | 19454 | 50 |
SORL1 |
3.540e-02 | -3.34 | MB (myoglobin) | protein interactions | 4151 | 14 | 1 | 19454 | 50 |
MAML2 |
3.540e-02 | -3.34 | PLA2G12A (phospholipase A2 group XIIA) | protein interactions | 81579 | 14 | 1 | 19454 | 50 |
MEF2C |
3.540e-02 | -3.34 | TTLL7 (tubulin tyrosine ligase like 7) | protein interactions | 79739 | 14 | 1 | 19454 | 50 |
MEF2A |
3.540e-02 | -3.34 | CSF3 (colony stimulating factor 3) | protein interactions | 1440 | 14 | 1 | 19454 | 50 |
PTPRJ |
3.540e-02 | -3.34 | TAS2R7 (taste 2 receptor member 7) | protein interactions | 50837 | 14 | 1 | 19454 | 50 |
GNAQ |
3.540e-02 | -3.34 | ASCL3 (achaete-scute family bHLH transcription factor 3) | protein interactions | 56676 | 14 | 1 | 19454 | 50 |
TCF12 |
3.540e-02 | -3.34 | PGPEP1 (pyroglutamyl-peptidase I) | protein interactions | 54858 | 14 | 1 | 19454 | 50 |
UBE2E2 |
3.540e-02 | -3.34 | KCNQ3 (potassium voltage-gated channel subfamily Q member 3) | protein interactions | 3786 | 14 | 1 | 19454 | 50 |
KCNQ3 |
3.540e-02 | -3.34 | PTF1A (pancreas associated transcription factor 1a) | protein interactions | 256297 | 14 | 1 | 19454 | 50 |
TCF12 |
3.540e-02 | -3.34 | XYLT1 (xylosyltransferase 1) | protein interactions | 64131 | 14 | 1 | 19454 | 50 |
MEF2A |
3.540e-02 | -3.34 | HOXC6 (homeobox C6) | protein interactions | 3223 | 14 | 1 | 19454 | 50 |
PTPRJ |
3.540e-02 | -3.34 | RGS13 (regulator of G protein signaling 13) | protein interactions | 6003 | 14 | 1 | 19454 | 50 |
GNAQ |
3.540e-02 | -3.34 | Iqgap3 (IQ motif containing GTPase activating protein 3) | protein interactions | 404710 | 14 | 1 | 19454 | 50 |
MEF2A |
3.545e-02 | -3.34 | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-mast_cell_neoplasm | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-mast_cell_neoplasm | 248 | 3 | 16828 | 49 |
FRMD4A,DSCAM,SLC9A9 |
3.545e-02 | -3.34 | mast_cell_neoplasm | COSMIC cancer mutations | mast_cell_neoplasm | 248 | 3 | 16828 | 49 |
DSCAM,FRMD4A,SLC9A9 |
3.556e-02 | -3.34 | neuron remodeling | biological process | GO:0016322 | 14 | 1 | 18204 | 47 |
KCNQ3 |
3.556e-02 | -3.34 | protein deacetylation | biological process | GO:0006476 | 14 | 1 | 18204 | 47 |
HDAC9 |
3.556e-02 | -3.34 | regulation of keratinocyte migration | biological process | GO:0051547 | 14 | 1 | 18204 | 47 |
MAP4K4 |
3.556e-02 | -3.34 | immunological synapse formation | biological process | GO:0001771 | 14 | 1 | 18204 | 47 |
DOCK8 |
3.556e-02 | -3.34 | positive regulation of actin nucleation | biological process | GO:0051127 | 14 | 1 | 18204 | 47 |
FCHSD2 |
3.556e-02 | -3.34 | relaxation of cardiac muscle | biological process | GO:0055119 | 14 | 1 | 18204 | 47 |
SLC8A1 |
3.556e-02 | -3.34 | dendrite self-avoidance | biological process | GO:0070593 | 14 | 1 | 18204 | 47 |
DSCAM |
3.556e-02 | -3.34 | cellular response to ethanol | biological process | GO:0071361 | 14 | 1 | 18204 | 47 |
ITPR2 |
3.556e-02 | -3.34 | oligopeptide transport | biological process | GO:0006857 | 14 | 1 | 18204 | 47 |
ABCC4 |
3.556e-02 | -3.34 | cellular response to purine-containing compound | biological process | GO:0071415 | 14 | 1 | 18204 | 47 |
SLC8A1 |
3.562e-02 | -3.33 | Toll Like Receptor 7/8 (TLR7/8) Cascade | REACTOME pathways | R-HSA-168181 | 93 | 2 | 10285 | 33 |
MEF2C,MEF2A |
3.562e-02 | -3.33 | MyD88 dependent cascade initiated on endosome | REACTOME pathways | R-HSA-975155 | 93 | 2 | 10285 | 33 |
MEF2C,MEF2A |
3.574e-02 | -3.33 | human chr3q24 | chromosome location | human chr3q24 | 19 | 1 | 26134 | 50 |
SLC9A9 |
3.585e-02 | -3.33 | Estrogen signaling pathway | KEGG pathways | ko04915 | 98 | 2 | 7161 | 22 |
ITPR2,GNAQ |
3.585e-02 | -3.33 | Estrogen signaling pathway | KEGG pathways | hsa04915 | 98 | 2 | 7161 | 22 |
GNAQ,ITPR2 |
3.586e-02 | -3.33 | ATP6V1F (ATPase H+ transporting V1 subunit F) | protein interactions | 9296 | 116 | 2 | 19454 | 50 |
PICALM,PLXDC2 |
3.627e-02 | -3.32 | Ion_trans | pfam domains | PF00520 | 109 | 2 | 17795 | 49 |
ITPR2,KCNQ3 |
3.629e-02 | -3.32 | neuron projection morphogenesis | biological process | GO:0048812 | 486 | 4 | 18204 | 47 |
DSCAM,PICALM,MEF2A,MAP4K4 |
3.642e-02 | -3.31 | SHTN1 (shootin 1) | protein interactions | 57698 | 117 | 2 | 19454 | 50 |
DSCAM,ARHGAP24 |
3.645e-02 | -3.31 | chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma | COSMIC cancer mutations | chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma | 3511 | 16 | 16828 | 49 |
CHST11,HDAC9,GNAQ,DOCK8,SORL1,PLXDC2,ABCC4,ARHGAP26,DSCAM,ZFHX3,ATP8B4,FRMD4A,MAP4K4,DOCK4,SFMBT2,SLC8A1 |
3.645e-02 | -3.31 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma | 3511 | 16 | 16828 | 49 |
DOCK4,MAP4K4,SLC8A1,SFMBT2,ARHGAP26,ATP8B4,FRMD4A,ZFHX3,DSCAM,PLXDC2,ABCC4,DOCK8,SORL1,HDAC9,GNAQ,CHST11 |
3.645e-02 | -3.31 | MIR | smart domains | SM00472 | 10 | 1 | 9717 | 36 |
ITPR2 |
3.660e-02 | -3.31 | negative regulation of cellular metabolic process | biological process | GO:0031324 | 2998 | 13 | 18204 | 47 |
PTPRJ,MEF2A,QKI,HDAC9,MEF2C,NAV3,GNAQ,SLC8A1,PICALM,ZFHX3,ZBTB20,SORL1,SFMBT2 |
3.661e-02 | -3.31 | anatomical structure formation involved in morphogenesis | biological process | GO:0048646 | 964 | 6 | 18204 | 47 |
MEF2A,PTPRJ,ARHGAP22,ARHGAP24,DSCAM,MEF2C |
3.661e-02 | -3.31 | PSPC1 (paraspeckle component 1) | protein interactions | 55269 | 489 | 4 | 19454 | 50 |
ARHGAP24,DISC1,ARHGAP26,ARHGAP22 |
3.669e-02 | -3.31 | regulation of synapse assembly | biological process | GO:0051963 | 117 | 2 | 18204 | 47 |
MEF2C,SYNDIG1 |
3.672e-02 | -3.30 | LDLRB | prosite domains | PS51120 | 13 | 1 | 12186 | 35 |
SORL1 |
3.685e-02 | -3.30 | transcription regulator activity | molecular function | GO:0140110 | 1937 | 10 | 18094 | 50 |
SFMBT2,MEF2A,HDAC9,ZFHX3,MEF2C,MAML3,TCF12,MAML2,ZBTB20,MED13L |
3.694e-02 | -3.30 | cell-cell junction | cellular component | GO:0005911 | 513 | 4 | 19108 | 47 |
SLC8A1,ARHGAP24,FRMD4A,PTPRJ |
3.699e-02 | -3.30 | PLCD3 (phospholipase C delta 3) | protein interactions | 113026 | 118 | 2 | 19454 | 50 |
DISC1,ARHGAP22 |
3.699e-02 | -3.30 | KLC4 (kinesin light chain 4) | protein interactions | 89953 | 118 | 2 | 19454 | 50 |
MEF2A,EPB41L2 |
3.703e-02 | -3.30 | Toll Like Receptor TLR1:TLR2 Cascade | REACTOME pathways | R-HSA-168179 | 95 | 2 | 10285 | 33 |
MEF2A,MEF2C |
3.703e-02 | -3.30 | Toll Like Receptor TLR6:TLR2 Cascade | REACTOME pathways | R-HSA-168188 | 95 | 2 | 10285 | 33 |
MEF2A,MEF2C |
3.703e-02 | -3.30 | Toll Like Receptor 2 (TLR2) Cascade | REACTOME pathways | R-HSA-181438 | 95 | 2 | 10285 | 33 |
MEF2A,MEF2C |
3.703e-02 | -3.30 | MyD88:Mal cascade initiated on plasma membrane | REACTOME pathways | R-HSA-166058 | 95 | 2 | 10285 | 33 |
MEF2A,MEF2C |
3.715e-02 | -3.29 | Cation/H_exchanger | interpro domains | IPR006153 | 14 | 1 | 18521 | 50 |
SLC9A9 |
3.715e-02 | -3.29 | P_typ_ATPase_c | interpro domains | IPR032630 | 14 | 1 | 18521 | 50 |
ATP8B4 |
3.715e-02 | -3.29 | P-type_ATPase_N | interpro domains | IPR032631 | 14 | 1 | 18521 | 50 |
ATP8B4 |
3.715e-02 | -3.29 | LDLR_classB_rpt | interpro domains | IPR000033 | 14 | 1 | 18521 | 50 |
SORL1 |
3.715e-02 | -3.29 | P-type_ATPase_IV | interpro domains | IPR006539 | 14 | 1 | 18521 | 50 |
ATP8B4 |
3.715e-02 | -3.29 | Ureohydrolase_dom_sf | interpro domains | IPR023696 | 14 | 1 | 18521 | 50 |
HDAC9 |
3.719e-02 | -3.29 | stomach-carcinoma-adenocarcinoma | COSMIC cancer mutations | stomach-carcinoma-adenocarcinoma | 15150 | 48 | 16828 | 49 |
MAML2,MEF2C,DIP2B,MAML3,DOCK8,TBC1D22A,ITPR2,FRMD4A,SLC9A9,HS3ST4,NAV3,ADAM28,APBB1IP,ST6GALNAC3,ZFHX3,PICALM,SYNDIG1,TCF12,MED13L,HDAC9,KCNQ3,QKI,SSH2,MEF2A,ELMO1,ARHGAP26,SFMBT2,SLC8A1,EPB41L2,DOCK4,ZBTB20,ZFAND3,CHST11,GNAQ,SORL1,DISC1,UBE2E2,FCHSD2,ABCC4,ANKRD44,PTPRJ,PLXDC2,DSCAM,ATP8B4,ARHGAP22,ARHGAP24,MAP4K4,ST6GAL1 |
3.721e-02 | -3.29 | skin-shoulder-malignant_melanoma-nodular | COSMIC cancer mutations | skin-shoulder-malignant_melanoma-nodular | 13 | 1 | 16828 | 49 |
GNAQ |
3.721e-02 | -3.29 | skin-scalp-malignant_melanoma-nodular | COSMIC cancer mutations | skin-scalp-malignant_melanoma-nodular | 13 | 1 | 16828 | 49 |
GNAQ |
3.721e-02 | -3.29 | skin-malignant_melanoma-lentigo_maligna | COSMIC cancer mutations | skin-malignant_melanoma-lentigo_maligna | 13 | 1 | 16828 | 49 |
GNAQ |
3.721e-02 | -3.29 | autonomic_ganglia-adrenal_gland-paraganglioma-benign | COSMIC cancer mutations | autonomic_ganglia-adrenal_gland-paraganglioma-benign | 13 | 1 | 16828 | 49 |
DIP2B |
3.721e-02 | -3.29 | stomach-adenoma | COSMIC cancer mutations | stomach-adenoma | 13 | 1 | 16828 | 49 |
GNAQ |
3.721e-02 | -3.29 | central_nervous_system-hypothalamus-glioma-astrocytoma_Grade_I | COSMIC cancer mutations | central_nervous_system-hypothalamus-glioma-astrocytoma_Grade_I | 13 | 1 | 16828 | 49 |
QKI |
3.721e-02 | -3.29 | anus | COSMIC cancer mutations | anus | 13 | 1 | 16828 | 49 |
GNAQ |
3.747e-02 | -3.28 | plasma membrane bounded cell projection morphogenesis | biological process | GO:0120039 | 491 | 4 | 18204 | 47 |
PICALM,DSCAM,MEF2A,MAP4K4 |
3.756e-02 | -3.28 | HLA-DPA1 (major histocompatibility complex, class II, DP alpha 1) | protein interactions | 3113 | 119 | 2 | 19454 | 50 |
CHST11,SORL1 |
3.756e-02 | -3.28 | H2BC18 (H2B clustered histone 18) | protein interactions | 440689 | 119 | 2 | 19454 | 50 |
ARHGAP24,FRMD4A |
3.788e-02 | -3.27 | HOXA11 (homeobox A11) | protein interactions | 3207 | 15 | 1 | 19454 | 50 |
PICALM |
3.788e-02 | -3.27 | TESPA1 (thymocyte expressed, positive selection associated 1) | protein interactions | 9840 | 15 | 1 | 19454 | 50 |
ITPR2 |
3.788e-02 | -3.27 | ZNF616 (zinc finger protein 616) | protein interactions | 90317 | 15 | 1 | 19454 | 50 |
ARHGAP24 |
3.788e-02 | -3.27 | ASIP (agouti signaling protein) | protein interactions | 434 | 15 | 1 | 19454 | 50 |
SORL1 |
3.788e-02 | -3.27 | ZNF816 (zinc finger protein 816) | protein interactions | 125893 | 15 | 1 | 19454 | 50 |
SORL1 |
3.788e-02 | -3.27 | DEFB123 (defensin beta 123) | protein interactions | 245936 | 15 | 1 | 19454 | 50 |
SORL1 |
3.788e-02 | -3.27 | NYAP2 (neuronal tyrosine-phosphorylated phosphoinositide-3-kinase adaptor 2) | protein interactions | 57624 | 15 | 1 | 19454 | 50 |
ARHGAP26 |
3.788e-02 | -3.27 | TIAM2 (TIAM Rac1 associated GEF 2) | protein interactions | 26230 | 15 | 1 | 19454 | 50 |
DISC1 |
3.788e-02 | -3.27 | ZNF714 (zinc finger protein 714) | protein interactions | 148206 | 15 | 1 | 19454 | 50 |
ARHGAP24 |
3.788e-02 | -3.27 | ENTPD1 (ectonucleoside triphosphate diphosphohydrolase 1) | protein interactions | 953 | 15 | 1 | 19454 | 50 |
ANKRD44 |
3.788e-02 | -3.27 | ZNF813 (zinc finger protein 813) | protein interactions | 126017 | 15 | 1 | 19454 | 50 |
ARHGAP24 |
3.788e-02 | -3.27 | HOPX (HOP homeobox) | protein interactions | 84525 | 15 | 1 | 19454 | 50 |
TCF12 |
3.788e-02 | -3.27 | ADRA1B (adrenoceptor alpha 1B) | protein interactions | 147 | 15 | 1 | 19454 | 50 |
GNAQ |
3.788e-02 | -3.27 | ASCL4 (achaete-scute family bHLH transcription factor 4) | protein interactions | 121549 | 15 | 1 | 19454 | 50 |
TCF12 |
3.788e-02 | -3.27 | GRM7 (glutamate metabotropic receptor 7) | protein interactions | 2917 | 15 | 1 | 19454 | 50 |
GNAQ |
3.788e-02 | -3.27 | TMEM255B (transmembrane protein 255B) | protein interactions | 348013 | 15 | 1 | 19454 | 50 |
PLXDC2 |
3.788e-02 | -3.27 | CDHR5 (cadherin related family member 5) | protein interactions | 53841 | 15 | 1 | 19454 | 50 |
SORL1 |
3.788e-02 | -3.27 | FERD3L (Fer3 like bHLH transcription factor) | protein interactions | 222894 | 15 | 1 | 19454 | 50 |
TCF12 |
3.788e-02 | -3.27 | PRSS22 (serine protease 22) | protein interactions | 64063 | 15 | 1 | 19454 | 50 |
SORL1 |
3.788e-02 | -3.27 | Retrograde endocannabinoid signaling | KEGG pathways | hsa04723 | 101 | 2 | 7161 | 22 |
GNAQ,ITPR2 |
3.788e-02 | -3.27 | Retrograde endocannabinoid signaling | KEGG pathways | ko04723 | 101 | 2 | 7161 | 22 |
GNAQ,ITPR2 |
3.788e-02 | -3.27 | PhoLip_ATPase_C | pfam domains | PF16212 | 14 | 1 | 17795 | 49 |
ATP8B4 |
3.788e-02 | -3.27 | PhoLip_ATPase_N | pfam domains | PF16209 | 14 | 1 | 17795 | 49 |
ATP8B4 |
3.788e-02 | -3.27 | Na_H_Exchanger | pfam domains | PF00999 | 14 | 1 | 17795 | 49 |
SLC9A9 |
3.801e-02 | -3.27 | ABC-type xenobiotic transporter activity | molecular function | GO:0008559 | 14 | 1 | 18094 | 50 |
ABCC4 |
3.801e-02 | -3.27 | potassium:proton antiporter activity | molecular function | GO:0015386 | 14 | 1 | 18094 | 50 |
SLC9A9 |
3.801e-02 | -3.27 | platelet-derived growth factor receptor binding | molecular function | GO:0005161 | 14 | 1 | 18094 | 50 |
PTPRJ |
3.805e-02 | -3.27 | positive regulation of protein acetylation | biological process | GO:1901985 | 15 | 1 | 18204 | 47 |
DIP2B |
3.805e-02 | -3.27 | glycosylceramide metabolic process | biological process | GO:0006677 | 15 | 1 | 18204 | 47 |
ST6GALNAC3 |
3.805e-02 | -3.27 | response to caffeine | biological process | GO:0031000 | 15 | 1 | 18204 | 47 |
SLC8A1 |
3.805e-02 | -3.27 | pyramidal neuron differentiation | biological process | GO:0021859 | 15 | 1 | 18204 | 47 |
DISC1 |
3.805e-02 | -3.27 | endosome to plasma membrane protein transport | biological process | GO:0099638 | 15 | 1 | 18204 | 47 |
SORL1 |
3.814e-02 | -3.27 | ZDHHC15 (zinc finger DHHC-type palmitoyltransferase 15) | protein interactions | 158866 | 120 | 2 | 19454 | 50 |
DOCK4,MED13L |
3.814e-02 | -3.27 | RUNX1T1 (RUNX1 partner transcriptional co-repressor 1) | protein interactions | 862 | 120 | 2 | 19454 | 50 |
UBE2E2,TCF12 |
3.814e-02 | -3.27 | MED24 (mediator complex subunit 24) | protein interactions | 9862 | 120 | 2 | 19454 | 50 |
QKI,MED13L |
3.814e-02 | -3.27 | FFAR2 (free fatty acid receptor 2) | protein interactions | 2867 | 120 | 2 | 19454 | 50 |
SYNDIG1,GNAQ |
3.823e-02 | -3.26 | cell activation | biological process | GO:0001775 | 725 | 5 | 18204 | 47 |
DOCK8,MEF2C,HDAC9,PTPRJ,APBB1IP |
3.824e-02 | -3.26 | SH3 | smart domains | SM00326 | 202 | 3 | 9717 | 36 |
DOCK4,FCHSD2,ARHGAP26 |
3.846e-02 | -3.26 | Toll Like Receptor 9 (TLR9) Cascade | REACTOME pathways | R-HSA-168138 | 97 | 2 | 10285 | 33 |
MEF2A,MEF2C |
3.857e-02 | -3.26 | Glucagon signaling pathway | KEGG pathways | hsa04922 | 102 | 2 | 7161 | 22 |
ITPR2,GNAQ |
3.857e-02 | -3.26 | Glucagon signaling pathway | KEGG pathways | ko04922 | 102 | 2 | 7161 | 22 |
ITPR2,GNAQ |
3.865e-02 | -3.25 | T cell receptor complex | cellular component | GO:0042101 | 16 | 1 | 19108 | 47 |
APBB1IP |
3.865e-02 | -3.25 | node of Ranvier | cellular component | GO:0033268 | 16 | 1 | 19108 | 47 |
KCNQ3 |
3.866e-02 | -3.25 | cell projection morphogenesis | biological process | GO:0048858 | 496 | 4 | 18204 | 47 |
MEF2A,DSCAM,PICALM,MAP4K4 |
3.872e-02 | -3.25 | MED15 (mediator complex subunit 15) | protein interactions | 51586 | 121 | 2 | 19454 | 50 |
MED13L,QKI |
3.874e-02 | -3.25 | TRIM27 (tripartite motif containing 27) | protein interactions | 5987 | 498 | 4 | 19454 | 50 |
ARHGAP22,ZFHX3,DISC1,UBE2E2 |
3.900e-02 | -3.24 | regulation of epithelial to mesenchymal transition | biological process | GO:0010717 | 121 | 2 | 18204 | 47 |
QKI,LDLRAD4 |
3.930e-02 | -3.24 | H2BC1 (H2B clustered histone 1) | protein interactions | 255626 | 122 | 2 | 19454 | 50 |
MEF2A,ARHGAP24 |
3.943e-02 | -3.23 | human chr13q32.1 | chromosome location | human chr13q32.1 | 21 | 1 | 26134 | 50 |
ABCC4 |
3.946e-02 | -3.23 | negative regulation of protein phosphorylation | biological process | GO:0001933 | 292 | 3 | 18204 | 47 |
SLC8A1,PTPRJ,GNAQ |
3.970e-02 | -3.23 | bone-tibia-Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour | COSMIC cancer mutations | bone-tibia-Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour | 649 | 5 | 16828 | 49 |
EPB41L2,PTPRJ,ABCC4,FCHSD2,QKI |
3.975e-02 | -3.23 | Sialyl_trans | interpro domains | IPR012163 | 15 | 1 | 18521 | 50 |
ST6GAL1 |
3.975e-02 | -3.23 | CNH_dom | interpro domains | IPR001180 | 15 | 1 | 18521 | 50 |
MAP4K4 |
3.991e-02 | -3.22 | Toll Like Receptor 3 (TLR3) Cascade | REACTOME pathways | R-HSA-168164 | 99 | 2 | 10285 | 33 |
MEF2A,MEF2C |
3.991e-02 | -3.22 | TRIF-mediated TLR3/TLR4 signaling | REACTOME pathways | R-HSA-937061 | 99 | 2 | 10285 | 33 |
MEF2A,MEF2C |
3.991e-02 | -3.22 | MyD88-independent TLR3/TLR4 cascade | REACTOME pathways | R-HSA-166166 | 99 | 2 | 10285 | 33 |
MEF2C,MEF2A |
4.002e-02 | -3.22 | conjunctiva | COSMIC cancer mutations | conjunctiva | 14 | 1 | 16828 | 49 |
GNAQ |
4.035e-02 | -3.21 | APC2 (APC regulator of WNT signaling pathway 2) | protein interactions | 10297 | 16 | 1 | 19454 | 50 |
DSCAM |
4.035e-02 | -3.21 | AKAP6 (A-kinase anchoring protein 6) | protein interactions | 9472 | 16 | 1 | 19454 | 50 |
DISC1 |
4.035e-02 | -3.21 | CDC42EP2 (CDC42 effector protein 2) | protein interactions | 10435 | 16 | 1 | 19454 | 50 |
ARHGAP26 |
4.035e-02 | -3.21 | HS3ST2 (heparan sulfate-glucosamine 3-sulfotransferase 2) | protein interactions | 9956 | 16 | 1 | 19454 | 50 |
HS3ST4 |
4.035e-02 | -3.21 | GMPR2 (guanosine monophosphate reductase 2) | protein interactions | 51292 | 16 | 1 | 19454 | 50 |
ARHGAP24 |
4.035e-02 | -3.21 | CDH12 (cadherin 12) | protein interactions | 1010 | 16 | 1 | 19454 | 50 |
FRMD4A |
4.035e-02 | -3.21 | FIGLA (folliculogenesis specific bHLH transcription factor) | protein interactions | 344018 | 16 | 1 | 19454 | 50 |
TCF12 |
4.035e-02 | -3.21 | RGS16 (regulator of G protein signaling 16) | protein interactions | 6004 | 16 | 1 | 19454 | 50 |
GNAQ |
4.035e-02 | -3.21 | Sumo3 (small ubiquitin-like modifier 3) | protein interactions | 20610 | 16 | 1 | 19454 | 50 |
ITPR2 |
4.035e-02 | -3.21 | NEUROG1 (neurogenin 1) | protein interactions | 4762 | 16 | 1 | 19454 | 50 |
TCF12 |
4.045e-02 | -3.21 | PTK2 (protein tyrosine kinase 2) | protein interactions | 5747 | 296 | 3 | 19454 | 50 |
APBB1IP,ARHGAP26,MAP4K4 |
4.045e-02 | -3.21 | CSNK1E (casein kinase 1 epsilon) | protein interactions | 1454 | 296 | 3 | 19454 | 50 |
ARHGAP26,LDLRAD4,ARHGAP22 |
4.053e-02 | -3.21 | CNH | pfam domains | PF00780 | 15 | 1 | 17795 | 49 |
MAP4K4 |
4.054e-02 | -3.21 | heparan sulfate proteoglycan metabolic process | biological process | GO:0030201 | 16 | 1 | 18204 | 47 |
HS3ST4 |
4.054e-02 | -3.21 | regulation of axon extension involved in axon guidance | biological process | GO:0048841 | 16 | 1 | 18204 | 47 |
DSCAM |
4.054e-02 | -3.21 | xenobiotic transmembrane transport | biological process | GO:0006855 | 16 | 1 | 18204 | 47 |
ABCC4 |
4.054e-02 | -3.21 | regulation of cell communication by electrical coupling | biological process | GO:0010649 | 16 | 1 | 18204 | 47 |
SLC8A1 |
4.054e-02 | -3.21 | regulation of adipose tissue development | biological process | GO:1904177 | 16 | 1 | 18204 | 47 |
SORL1 |
4.054e-02 | -3.21 | wound healing, spreading of epidermal cells | biological process | GO:0035313 | 16 | 1 | 18204 | 47 |
ARHGAP24 |
4.054e-02 | -3.21 | vascular associated smooth muscle contraction | biological process | GO:0014829 | 16 | 1 | 18204 | 47 |
SLC8A1 |
4.054e-02 | -3.21 | prostaglandin transport | biological process | GO:0015732 | 16 | 1 | 18204 | 47 |
ABCC4 |
4.067e-02 | -3.20 | heparan sulfate sulfotransferase activity | molecular function | GO:0034483 | 15 | 1 | 18094 | 50 |
HS3ST4 |
4.067e-02 | -3.20 | low-density lipoprotein particle receptor activity | molecular function | GO:0005041 | 15 | 1 | 18094 | 50 |
SORL1 |
4.067e-02 | -3.20 | 1-phosphatidylinositol binding | molecular function | GO:0005545 | 15 | 1 | 18094 | 50 |
PICALM |
4.067e-02 | -3.20 | efflux transmembrane transporter activity | molecular function | GO:0015562 | 15 | 1 | 18094 | 50 |
ABCC4 |
4.068e-02 | -3.20 | phosphatidylinositol binding | molecular function | GO:0035091 | 276 | 3 | 18094 | 50 |
ITPR2,PICALM,FCHSD2 |
4.077e-02 | -3.20 | regulation of ossification | biological process | GO:0030278 | 124 | 2 | 18204 | 47 |
SLC8A1,MEF2C |
4.079e-02 | -3.20 | SP7 (Sp7 transcription factor) | protein interactions | 121340 | 297 | 3 | 19454 | 50 |
QKI,SORL1,MEF2A |
4.079e-02 | -3.20 | urinary_tract-bladder-carcinoma-transitional_cell_carcinoma | COSMIC cancer mutations | urinary_tract-bladder-carcinoma-transitional_cell_carcinoma | 6040 | 24 | 16828 | 49 |
CHST11,NAV3,GNAQ,SORL1,ABCC4,PLXDC2,ANKRD44,PTPRJ,ATP8B4,DSCAM,ZFHX3,ST6GAL1,TCF12,MED13L,DIP2B,DOCK8,TBC1D22A,FRMD4A,ITPR2,ELMO1,ARHGAP26,SLC8A1,EPB41L2,ZBTB20 |
4.087e-02 | -3.20 | monoatomic cation homeostasis | biological process | GO:0055080 | 505 | 4 | 18204 | 47 |
SLC9A9,DISC1,PICALM,SLC8A1 |
4.087e-02 | -3.20 | Cell-type Dependent Selectivity of CCK2R Signaling | WikiPathways | WP3679 | 13 | 1 | 5310 | 17 |
GNAQ |
4.094e-02 | -3.20 | Sodium/Calcium exchangers | REACTOME pathways | R-HSA-425561 | 13 | 1 | 10285 | 33 |
SLC8A1 |
4.094e-02 | -3.20 | CLEC7A (Dectin-1) induces NFAT activation | REACTOME pathways | R-HSA-5607763 | 13 | 1 | 10285 | 33 |
ITPR2 |
4.095e-02 | -3.20 | transitional_cell_carcinoma | COSMIC cancer mutations | transitional_cell_carcinoma | 6042 | 24 | 16828 | 49 |
MED13L,TCF12,DOCK8,DIP2B,ELMO1,ARHGAP26,ITPR2,FRMD4A,TBC1D22A,ZBTB20,EPB41L2,SLC8A1,NAV3,CHST11,SORL1,GNAQ,DSCAM,ZFHX3,ATP8B4,PTPRJ,ANKRD44,PLXDC2,ABCC4,ST6GAL1 |
4.106e-02 | -3.19 | GPRASP2 (G protein-coupled receptor associated sorting protein 2) | protein interactions | 114928 | 125 | 2 | 19454 | 50 |
DISC1,FCHSD2 |
4.127e-02 | -3.19 | human chr3q13.31 | chromosome location | human chr3q13.31 | 22 | 1 | 26134 | 50 |
ZBTB20 |
4.137e-02 | -3.19 | actomyosin structure organization | biological process | GO:0031032 | 125 | 2 | 18204 | 47 |
EPB41L2,MEF2A |
4.145e-02 | -3.18 | skin-acral-malignant_melanoma | COSMIC cancer mutations | skin-acral-malignant_melanoma | 264 | 3 | 16828 | 49 |
ABCC4,ARHGAP22,GNAQ |
4.145e-02 | -3.18 | rib | COSMIC cancer mutations | rib | 264 | 3 | 16828 | 49 |
MAML3,CHST11,SORL1 |
4.147e-02 | -3.18 | AMOT (angiomotin) | protein interactions | 154796 | 299 | 3 | 19454 | 50 |
MAP4K4,ARHGAP24,DISC1 |
4.151e-02 | -3.18 | DISINTEGRIN | prints domains | PR00289 | 13 | 1 | 5227 | 17 |
ADAM28 |
4.162e-02 | -3.18 | circulatory system process | biological process | GO:0003013 | 508 | 4 | 18204 | 47 |
DOCK4,SLC8A1,ABCC4,PTPRJ |
4.166e-02 | -3.18 | RNF115 (ring finger protein 115) | protein interactions | 27246 | 126 | 2 | 19454 | 50 |
DOCK4,UBE2E2 |
4.166e-02 | -3.18 | VPS18 (VPS18 core subunit of CORVET and HOPS complexes) | protein interactions | 57617 | 126 | 2 | 19454 | 50 |
LDLRAD4,DISC1 |
4.184e-02 | -3.17 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-angioimmunoblastic_T_cell_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-angioimmunoblastic_T_cell_lymphoma | 265 | 3 | 16828 | 49 |
ZFHX3,ITPR2,MEF2C |
4.196e-02 | -3.17 | ductolobular_carcinoma | COSMIC cancer mutations | ductolobular_carcinoma | 1619 | 9 | 16828 | 49 |
HS3ST4,ATP8B4,MEF2C,NAV3,GNAQ,SFMBT2,QKI,SORL1,KCNQ3 |
4.196e-02 | -3.17 | breast-carcinoma-ductolobular_carcinoma | COSMIC cancer mutations | breast-carcinoma-ductolobular_carcinoma | 1619 | 9 | 16828 | 49 |
HS3ST4,ATP8B4,MEF2C,NAV3,GNAQ,SFMBT2,QKI,SORL1,KCNQ3 |
4.196e-02 | -3.17 | breast-carcinoma-ER-PR-positive_carcinoma | COSMIC cancer mutations | breast-carcinoma-ER-PR-positive_carcinoma | 1881 | 10 | 16828 | 49 |
MEF2A,ARHGAP26,ELMO1,MEF2C,MAML2,TCF12,MAP4K4,MAML3,GNAQ,PICALM |
4.196e-02 | -3.17 | ER-PR-positive_carcinoma | COSMIC cancer mutations | ER-PR-positive_carcinoma | 1881 | 10 | 16828 | 49 |
MAML3,MAP4K4,PICALM,GNAQ,MAML2,TCF12,ELMO1,ARHGAP26,MEF2A,MEF2C |
4.197e-02 | -3.17 | response to ethanol | biological process | GO:0045471 | 126 | 2 | 18204 | 47 |
ITPR2,ST6GAL1 |
4.212e-02 | -3.17 | DNA-binding transcription factor binding | molecular function | GO:0140297 | 476 | 4 | 18094 | 50 |
TCF12,MEF2A,HDAC9,MEF2C |
4.220e-02 | -3.17 | regulation of epithelial cell migration | biological process | GO:0010632 | 300 | 3 | 18204 | 47 |
HDAC9,MEF2C,MAP4K4 |
4.223e-02 | -3.16 | large_intestine-adenoma | COSMIC cancer mutations | large_intestine-adenoma | 266 | 3 | 16828 | 49 |
TCF12,KCNQ3,NAV3 |
4.225e-02 | -3.16 | CNH | prosite domains | PS50219 | 15 | 1 | 12186 | 35 |
MAP4K4 |
4.235e-02 | -3.16 | Gprotein_alpha_su | interpro domains | IPR001019 | 16 | 1 | 18521 | 50 |
GNAQ |
4.235e-02 | -3.16 | GproteinA_insert | interpro domains | IPR011025 | 16 | 1 | 18521 | 50 |
GNAQ |
4.235e-02 | -3.16 | Disintegrin_CS | interpro domains | IPR018358 | 16 | 1 | 18521 | 50 |
ADAM28 |
4.235e-02 | -3.16 | Ez/rad/moesin-like | interpro domains | IPR000798 | 16 | 1 | 18521 | 50 |
EPB41L2 |
4.236e-02 | -3.16 | regulation of intracellular signal transduction | biological process | GO:1902531 | 1832 | 9 | 18204 | 47 |
MAP4K4,LDLRAD4,PICALM,ARHGAP22,MEF2C,DOCK8,PTPRJ,ARHGAP26,ARHGAP24 |
4.282e-02 | -3.15 | hypothalamus | COSMIC cancer mutations | hypothalamus | 15 | 1 | 16828 | 49 |
QKI |
4.282e-02 | -3.15 | rosette-forming_glioneuronal_tumour | COSMIC cancer mutations | rosette-forming_glioneuronal_tumour | 15 | 1 | 16828 | 49 |
GNAQ |
4.282e-02 | -3.15 | central_nervous_system-fourth_ventricle-other-rosette-forming_glioneuronal_tumour | COSMIC cancer mutations | central_nervous_system-fourth_ventricle-other-rosette-forming_glioneuronal_tumour | 15 | 1 | 16828 | 49 |
GNAQ |
4.282e-02 | -3.15 | Pef1 (penta-EF hand domain containing 1) | protein interactions | 67898 | 17 | 1 | 19454 | 50 |
QKI |
4.282e-02 | -3.15 | OLFM1 (olfactomedin 1) | protein interactions | 10439 | 17 | 1 | 19454 | 50 |
DISC1 |
4.282e-02 | -3.15 | ZDHHC22 (zinc finger DHHC-type palmitoyltransferase 22) | protein interactions | 283576 | 17 | 1 | 19454 | 50 |
LDLRAD4 |
4.282e-02 | -3.15 | Abr (active BCR-related gene) | protein interactions | 109934 | 17 | 1 | 19454 | 50 |
DOCK4 |
4.282e-02 | -3.15 | CPPED1 (calcineurin like phosphoesterase domain containing 1) | protein interactions | 55313 | 17 | 1 | 19454 | 50 |
PICALM |
4.282e-02 | -3.15 | ARL4A (ADP ribosylation factor like GTPase 4A) | protein interactions | 10124 | 17 | 1 | 19454 | 50 |
ELMO1 |
4.282e-02 | -3.15 | DPRX (divergent-paired related homeobox) | protein interactions | 503834 | 17 | 1 | 19454 | 50 |
ZFHX3 |
4.282e-02 | -3.15 | ZNF557 (zinc finger protein 557) | protein interactions | 79230 | 17 | 1 | 19454 | 50 |
ARHGAP24 |
4.290e-02 | -3.15 | organelle | cellular component | GO:0043226 | 14500 | 41 | 19108 | 47 |
TCF12,PTPRJ,MAML2,MEF2A,MED13L,SSH2,ST6GAL1,ATP8B4,ZFHX3,CHST11,DISC1,SFMBT2,DOCK4,ZBTB20,EPB41L2,PICALM,HS3ST4,SLC9A9,GNAQ,ARHGAP26,UBE2E2,LDLRAD4,DIP2B,APBB1IP,FCHSD2,QKI,ADAM28,FRMD4A,ITPR2,ST6GALNAC3,MAML3,SORL1,ABCC4,NAV3,SLC8A1,MEF2C,SYNDIG1,ARHGAP22,HDAC9,ARHGAP24,KCNQ3 |
4.292e-02 | -3.15 | postsynaptic density | cellular component | GO:0014069 | 317 | 3 | 19108 | 47 |
SYNDIG1,SLC8A1,DISC1 |
4.297e-02 | -3.15 | RAC1 (Rac family small GTPase 1) | protein interactions | 5879 | 1005 | 6 | 19454 | 50 |
PTPRJ,DOCK8,MAP4K4,DOCK4,ARHGAP22,PICALM |
4.301e-02 | -3.15 | regulation of inclusion body assembly | biological process | GO:0090083 | 17 | 1 | 18204 | 47 |
SORL1 |
4.301e-02 | -3.15 | cell communication by electrical coupling involved in cardiac conduction | biological process | GO:0086064 | 17 | 1 | 18204 | 47 |
SLC8A1 |
4.301e-02 | -3.15 | specification of animal organ identity | biological process | GO:0010092 | 17 | 1 | 18204 | 47 |
MEF2C |
4.301e-02 | -3.15 | negative regulation of triglyceride metabolic process | biological process | GO:0090209 | 17 | 1 | 18204 | 47 |
SORL1 |
4.301e-02 | -3.15 | membrane depolarization during cardiac muscle cell action potential | biological process | GO:0086012 | 17 | 1 | 18204 | 47 |
SLC8A1 |
4.301e-02 | -3.15 | ganglioside biosynthetic process | biological process | GO:0001574 | 17 | 1 | 18204 | 47 |
ST6GALNAC3 |
4.301e-02 | -3.15 | muscle cell fate commitment | biological process | GO:0042693 | 17 | 1 | 18204 | 47 |
MEF2C |
4.301e-02 | -3.15 | microvillus assembly | biological process | GO:0030033 | 17 | 1 | 18204 | 47 |
MAP4K4 |
4.302e-02 | -3.15 | acral | COSMIC cancer mutations | acral | 268 | 3 | 16828 | 49 |
ARHGAP22,GNAQ,ABCC4 |
4.317e-02 | -3.14 | negative regulation of transforming growth factor beta receptor signaling pathway | biological process | GO:0030512 | 128 | 2 | 18204 | 47 |
LDLRAD4,CHST11 |
4.318e-02 | -3.14 | G-alpha | pfam domains | PF00503 | 16 | 1 | 17795 | 49 |
GNAQ |
4.321e-02 | -3.14 | C3orf52 (chromosome 3 open reading frame 52) | protein interactions | 79669 | 304 | 3 | 19454 | 50 |
ITPR2,ST6GALNAC3,ABCC4 |
4.329e-02 | -3.14 | small GTPase binding | molecular function | GO:0031267 | 283 | 3 | 18094 | 50 |
SORL1,DOCK4,PICALM |
4.333e-02 | -3.14 | sodium:proton antiporter activity | molecular function | GO:0015385 | 16 | 1 | 18094 | 50 |
SLC9A9 |
4.338e-02 | -3.14 | clathrin coat of coated pit | cellular component | GO:0030132 | 18 | 1 | 19108 | 47 |
PICALM |
4.340e-02 | -3.14 | monoatomic ion homeostasis | biological process | GO:0050801 | 515 | 4 | 18204 | 47 |
DISC1,SLC9A9,SLC8A1,PICALM |
4.346e-02 | -3.14 | protein binding | molecular function | GO:0005515 | 13983 | 44 | 18094 | 50 |
KCNQ3,ZFAND3,ADAM28,ARHGAP22,MEF2C,GNAQ,TBC1D22A,ITPR2,ABCC4,ELMO1,MEF2A,LDLRAD4,ANKRD44,QKI,MAML2,SFMBT2,DISC1,ST6GAL1,SLC9A9,PLXDC2,PICALM,TCF12,ARHGAP24,DOCK4,PTPRJ,FCHSD2,DOCK8,ATP8B4,MAP4K4,ST6GALNAC3,ZFHX3,SSH2,SLC8A1,DIP2B,ARHGAP26,SORL1,EPB41L2,HDAC9,MAML3,NAV3,SYNDIG1,DSCAM,UBE2E2,APBB1IP |
4.348e-02 | -3.14 | protein kinase binding | molecular function | GO:0019901 | 701 | 5 | 18094 | 50 |
HDAC9,DSCAM,DOCK4,MEF2A,PTPRJ |
4.352e-02 | -3.13 | skin-chest-malignant_melanoma | COSMIC cancer mutations | skin-chest-malignant_melanoma | 114 | 2 | 16828 | 49 |
PTPRJ,GNAQ |
4.402e-02 | -3.12 | Reduction of cytosolic Ca++ levels | REACTOME pathways | R-HSA-418359 | 14 | 1 | 10285 | 33 |
SLC8A1 |
4.407e-02 | -3.12 | ARHGEF1 (Rho guanine nucleotide exchange factor 1) | protein interactions | 9138 | 130 | 2 | 19454 | 50 |
DOCK4,GNAQ |
4.407e-02 | -3.12 | SORL1 (sortilin related receptor 1) | protein interactions | 6653 | 130 | 2 | 19454 | 50 |
SORL1,DISC1 |
4.440e-02 | -3.11 | lymphocyte proliferation | biological process | GO:0046651 | 130 | 2 | 18204 | 47 |
MEF2C,DOCK8 |
4.440e-02 | -3.11 | B cell differentiation | biological process | GO:0030183 | 130 | 2 | 18204 | 47 |
HDAC9,PTPRJ |
4.440e-02 | -3.11 | detection of external stimulus | biological process | GO:0009581 | 130 | 2 | 18204 | 47 |
GNAQ,DISC1 |
4.468e-02 | -3.11 | LGALS7 (galectin 7) | protein interactions | 3963 | 131 | 2 | 19454 | 50 |
PTPRJ,DOCK8 |
4.492e-02 | -3.10 | Signal Transduction | REACTOME pathways | R-HSA-162582 | 2547 | 13 | 10285 | 33 |
GNAQ,ARHGAP26,PTPRJ,MEF2C,ARHGAP24,HDAC9,APBB1IP,ELMO1,MAML3,MEF2A,ARHGAP22,ITPR2,MAML2 |
4.494e-02 | -3.10 | human chr3p24.3 | chromosome location | human chr3p24.3 | 24 | 1 | 26134 | 50 |
UBE2E2 |
4.494e-02 | -3.10 | human chr8q24.22 | chromosome location | human chr8q24.22 | 24 | 1 | 26134 | 50 |
KCNQ3 |
4.494e-02 | -3.10 | human chr11q24.1 | chromosome location | human chr11q24.1 | 24 | 1 | 26134 | 50 |
SORL1 |
4.499e-02 | -3.10 | ITCH (itchy E3 ubiquitin protein ligase) | protein interactions | 83737 | 309 | 3 | 19454 | 50 |
UBE2E2,DISC1,LDLRAD4 |
4.500e-02 | -3.10 | DISINTEGRIN_1 | prosite domains | PS00427 | 16 | 1 | 12186 | 35 |
ADAM28 |
4.500e-02 | -3.10 | G_ALPHA | prosite domains | PS51882 | 16 | 1 | 12186 | 35 |
GNAQ |
4.508e-02 | -3.10 | vesicle-mediated transport | biological process | GO:0016192 | 1283 | 7 | 18204 | 47 |
ELMO1,ABCC4,SYNDIG1,KCNQ3,PICALM,FCHSD2,SORL1 |
4.515e-02 | -3.10 | Glycosphingolipid biosynthesis - ganglio series | KEGG pathways | hsa00604 | 15 | 1 | 7161 | 22 |
ST6GALNAC3 |
4.515e-02 | -3.10 | Glycosphingolipid biosynthesis - ganglio series | KEGG pathways | ko00604 | 15 | 1 | 7161 | 22 |
ST6GALNAC3 |
4.524e-02 | -3.10 | pancreatic_intraepithelial_neoplasia_(PanIN) | COSMIC cancer mutations | pancreatic_intraepithelial_neoplasia_(PanIN) | 673 | 5 | 16828 | 49 |
NAV3,MAML3,DOCK4,MAP4K4,ABCC4 |
4.524e-02 | -3.10 | pancreas-pancreatic_intraepithelial_neoplasia_(PanIN) | COSMIC cancer mutations | pancreas-pancreatic_intraepithelial_neoplasia_(PanIN) | 673 | 5 | 16828 | 49 |
ABCC4,MAML3,MAP4K4,DOCK4,NAV3 |
4.529e-02 | -3.09 | ZNF224 (zinc finger protein 224) | protein interactions | 7767 | 18 | 1 | 19454 | 50 |
SORL1 |
4.529e-02 | -3.09 | ACAP1 (ArfGAP with coiled-coil, ankyrin repeat and PH domains 1) | protein interactions | 9744 | 18 | 1 | 19454 | 50 |
FCHSD2 |
4.529e-02 | -3.09 | AK9 (adenylate kinase 9) | protein interactions | 221264 | 18 | 1 | 19454 | 50 |
ARHGAP24 |
4.529e-02 | -3.09 | CCN6 (cellular communication network factor 6) | protein interactions | 8838 | 18 | 1 | 19454 | 50 |
SORL1 |
4.529e-02 | -3.09 | CYP17A1 (cytochrome P450 family 17 subfamily A member 1) | protein interactions | 1586 | 18 | 1 | 19454 | 50 |
PTPRJ |
4.529e-02 | -3.09 | ZNF100 (zinc finger protein 100) | protein interactions | 163227 | 18 | 1 | 19454 | 50 |
ARHGAP24 |
4.529e-02 | -3.09 | CXXC5 (CXXC finger protein 5) | protein interactions | 51523 | 18 | 1 | 19454 | 50 |
DSCAM |
4.529e-02 | -3.09 | SRR (serine racemase) | protein interactions | 63826 | 18 | 1 | 19454 | 50 |
DISC1 |
4.529e-02 | -3.09 | RILPL1 (Rab interacting lysosomal protein like 1) | protein interactions | 353116 | 18 | 1 | 19454 | 50 |
DSCAM |
4.529e-02 | -3.09 | ADO (2-aminoethanethiol dioxygenase) | protein interactions | 84890 | 18 | 1 | 19454 | 50 |
DISC1 |
4.529e-02 | -3.09 | FAM25A (family with sequence similarity 25 member A) | protein interactions | 643161 | 18 | 1 | 19454 | 50 |
ZFAND3 |
4.529e-02 | -3.09 | SPARCL1 (SPARC like 1) | protein interactions | 8404 | 18 | 1 | 19454 | 50 |
DISC1 |
4.549e-02 | -3.09 | clathrin coat assembly | biological process | GO:0048268 | 18 | 1 | 18204 | 47 |
PICALM |
4.549e-02 | -3.09 | negative regulation of vascular permeability | biological process | GO:0043116 | 18 | 1 | 18204 | 47 |
PTPRJ |
4.549e-02 | -3.09 | positive regulation of cardiocyte differentiation | biological process | GO:1905209 | 18 | 1 | 18204 | 47 |
MEF2C |
4.549e-02 | -3.09 | cardiac myofibril assembly | biological process | GO:0055003 | 18 | 1 | 18204 | 47 |
MEF2A |
4.549e-02 | -3.09 | heart formation | biological process | GO:0060914 | 18 | 1 | 18204 | 47 |
MEF2C |
4.561e-02 | -3.09 | eye-uveal_tract-malignant_melanoma-epithelioid | COSMIC cancer mutations | eye-uveal_tract-malignant_melanoma-epithelioid | 16 | 1 | 16828 | 49 |
GNAQ |
4.561e-02 | -3.09 | neurocristic_hamartoma | COSMIC cancer mutations | neurocristic_hamartoma | 16 | 1 | 16828 | 49 |
GNAQ |
4.561e-02 | -3.09 | pineal_gland | COSMIC cancer mutations | pineal_gland | 16 | 1 | 16828 | 49 |
GNAQ |
4.561e-02 | -3.09 | myxoid | COSMIC cancer mutations | myxoid | 16 | 1 | 16828 | 49 |
TCF12 |
4.561e-02 | -3.09 | central_nervous_system-temporal_lobe-glioma-astrocytoma_Grade_II | COSMIC cancer mutations | central_nervous_system-temporal_lobe-glioma-astrocytoma_Grade_II | 16 | 1 | 16828 | 49 |
GNAQ |
4.561e-02 | -3.09 | skin-other-neurocristic_hamartoma | COSMIC cancer mutations | skin-other-neurocristic_hamartoma | 16 | 1 | 16828 | 49 |
GNAQ |
4.561e-02 | -3.09 | flank | COSMIC cancer mutations | flank | 16 | 1 | 16828 | 49 |
GNAQ |
4.563e-02 | -3.09 | negative regulation of neurogenesis | biological process | GO:0050768 | 132 | 2 | 18204 | 47 |
SORL1,DIP2B |
4.569e-02 | -3.09 | Serotonergic synapse | KEGG pathways | hsa04726 | 112 | 2 | 7161 | 22 |
GNAQ,ITPR2 |
4.574e-02 | -3.08 | phospholipid binding | molecular function | GO:0005543 | 489 | 4 | 18094 | 50 |
FCHSD2,ARHGAP26,PICALM,ITPR2 |
4.591e-02 | -3.08 | H2BC26 (H2B clustered histone 26) | protein interactions | 128312 | 133 | 2 | 19454 | 50 |
ARHGAP24,MAP4K4 |
4.591e-02 | -3.08 | CBS (cystathionine beta-synthase) | protein interactions | 875 | 133 | 2 | 19454 | 50 |
ARHGAP24,ARHGAP26 |
4.593e-02 | -3.08 | Transport of inorganic cations/anions and amino acids/oligopeptides | REACTOME pathways | R-HSA-425393 | 107 | 2 | 10285 | 33 |
SLC9A9,SLC8A1 |
4.597e-02 | -3.08 | low-density lipoprotein particle binding | molecular function | GO:0030169 | 17 | 1 | 18094 | 50 |
SORL1 |
4.606e-02 | -3.08 | extraskeletal | COSMIC cancer mutations | extraskeletal | 903 | 6 | 16828 | 49 |
TCF12,GNAQ,ANKRD44,ZFHX3,ITPR2,ADAM28 |
4.607e-02 | -3.08 | ACTN1 (actinin alpha 1) | protein interactions | 87 | 312 | 3 | 19454 | 50 |
ARHGAP24,DISC1,DSCAM |
4.625e-02 | -3.07 | detection of abiotic stimulus | biological process | GO:0009582 | 133 | 2 | 18204 | 47 |
DISC1,GNAQ |
4.625e-02 | -3.07 | regulation of sequestering of calcium ion | biological process | GO:0051282 | 133 | 2 | 18204 | 47 |
ITPR2,SLC8A1 |
4.635e-02 | -3.07 | response to nitrogen compound | biological process | GO:1901698 | 1021 | 6 | 18204 | 47 |
HDAC9,ITPR2,SLC8A1,GNAQ,TCF12,MEF2C |
4.643e-02 | -3.07 | inorganic molecular entity transmembrane transporter activity | molecular function | GO:0015318 | 714 | 5 | 18094 | 50 |
ABCC4,ITPR2,SLC9A9,KCNQ3,SLC8A1 |
4.644e-02 | -3.07 | HIF1AN (hypoxia inducible factor 1 subunit alpha inhibitor) | protein interactions | 55662 | 313 | 3 | 19454 | 50 |
MAP4K4,ANKRD44,TCF12 |
4.677e-02 | -3.06 | protein tyrosine kinase binding | molecular function | GO:1990782 | 125 | 2 | 18094 | 50 |
DSCAM,DOCK4 |
4.677e-02 | -3.06 | human chr7q31.1 | chromosome location | human chr7q31.1 | 25 | 1 | 26134 | 50 |
DOCK4 |
4.680e-02 | -3.06 | ARIH2 (ariadne RBR E3 ubiquitin protein ligase 2) | protein interactions | 10425 | 314 | 3 | 19454 | 50 |
DISC1,UBE2E2,DSCAM |
4.686e-02 | -3.06 | negative regulation of phosphorylation | biological process | GO:0042326 | 313 | 3 | 18204 | 47 |
PTPRJ,SLC8A1,GNAQ |
4.688e-02 | -3.06 | mononuclear cell proliferation | biological process | GO:0032943 | 134 | 2 | 18204 | 47 |
MEF2C,DOCK8 |
4.688e-02 | -3.06 | regulation of actin filament polymerization | biological process | GO:0030833 | 134 | 2 | 18204 | 47 |
FCHSD2,SSH2 |
4.709e-02 | -3.06 | N-Glycan antennae elongation | REACTOME pathways | R-HSA-975577 | 15 | 1 | 10285 | 33 |
ST6GAL1 |
4.714e-02 | -3.05 | FA | smart domains | SM01195 | 13 | 1 | 9717 | 36 |
EPB41L2 |
4.716e-02 | -3.05 | HDAC7 (histone deacetylase 7) | protein interactions | 51564 | 135 | 2 | 19454 | 50 |
MEF2A,MEF2C |
4.718e-02 | -3.05 | Glutamatergic synapse | KEGG pathways | hsa04724 | 114 | 2 | 7161 | 22 |
GNAQ,ITPR2 |
4.718e-02 | -3.05 | Glutamatergic synapse | KEGG pathways | ko04724 | 114 | 2 | 7161 | 22 |
ITPR2,GNAQ |
4.722e-02 | -3.05 | central_nervous_system-brain-glioma-astrocytoma_Grade_IV | COSMIC cancer mutations | central_nervous_system-brain-glioma-astrocytoma_Grade_IV | 15813 | 49 | 16828 | 49 |
CHST11,UBE2E2,DISC1,SORL1,FCHSD2,GNAQ,ATP8B4,DSCAM,ABCC4,PLXDC2,ANKRD44,PTPRJ,ARHGAP24,ARHGAP22,ST6GAL1,MAP4K4,TCF12,MED13L,QKI,KCNQ3,HDAC9,ELMO1,ARHGAP26,MEF2A,SSH2,ZSWIM6,ZFAND3,ZBTB20,SLC8A1,SFMBT2,EPB41L2,DOCK4,NAV3,HS3ST4,APBB1IP,ADAM28,ZFHX3,ST6GALNAC3,PICALM,SYNDIG1,MEF2C,MAML2,DOCK8,DIP2B,MAML3,FRMD4A,ITPR2,TBC1D22A,SLC9A9 |
4.758e-02 | -3.05 | GI Alpha 1, domain 2-like | gene3d domains | 1.10.400.10 | 16 | 1 | 14470 | 44 |
GNAQ |
4.774e-02 | -3.04 | FAM25C (family with sequence similarity 25 member C) | protein interactions | 644054 | 19 | 1 | 19454 | 50 |
ZFAND3 |
4.774e-02 | -3.04 | PLCB2 (phospholipase C beta 2) | protein interactions | 5330 | 19 | 1 | 19454 | 50 |
GNAQ |
4.774e-02 | -3.04 | ZNF138 (zinc finger protein 138) | protein interactions | 7697 | 19 | 1 | 19454 | 50 |
ARHGAP24 |
4.774e-02 | -3.04 | DRD1 (dopamine receptor D1) | protein interactions | 1812 | 19 | 1 | 19454 | 50 |
EPB41L2 |
4.774e-02 | -3.04 | INKA1 (inka box actin regulator 1) | protein interactions | 389119 | 19 | 1 | 19454 | 50 |
ZBTB20 |
4.774e-02 | -3.04 | SP6 (Sp6 transcription factor) | protein interactions | 80320 | 19 | 1 | 19454 | 50 |
SORL1 |
4.774e-02 | -3.04 | LRRC42 (leucine rich repeat containing 42) | protein interactions | 115353 | 19 | 1 | 19454 | 50 |
PLXDC2 |
4.774e-02 | -3.04 | ACADS (acyl-CoA dehydrogenase short chain) | protein interactions | 35 | 19 | 1 | 19454 | 50 |
ARHGAP26 |
4.774e-02 | -3.04 | CRYBB1 (crystallin beta B1) | protein interactions | 1414 | 19 | 1 | 19454 | 50 |
DISC1 |
4.774e-02 | -3.04 | ZNF197 (zinc finger protein 197) | protein interactions | 10168 | 19 | 1 | 19454 | 50 |
DISC1 |
4.774e-02 | -3.04 | RIT2 (Ras like without CAAX 2) | protein interactions | 6014 | 19 | 1 | 19454 | 50 |
ARHGAP24 |
4.774e-02 | -3.04 | EGFL6 (EGF like domain multiple 6) | protein interactions | 25975 | 19 | 1 | 19454 | 50 |
SORL1 |
4.779e-02 | -3.04 | NEFL (neurofilament light chain) | protein interactions | 4747 | 136 | 2 | 19454 | 50 |
ARHGAP24,DSCAM |
4.786e-02 | -3.04 | regulation of response to stimulus | biological process | GO:0048583 | 4104 | 16 | 18204 | 47 |
PTPRJ,ARHGAP26,MEF2A,SORL1,LDLRAD4,DISC1,PICALM,ARHGAP22,DOCK8,GNAQ,MEF2C,ARHGAP24,ST6GAL1,CHST11,MAP4K4,DSCAM |
4.787e-02 | -3.04 | regulation of signal transduction | biological process | GO:0009966 | 3114 | 13 | 18204 | 47 |
MEF2C,DOCK8,GNAQ,CHST11,ARHGAP24,MAP4K4,ARHGAP26,PTPRJ,DISC1,LDLRAD4,SORL1,ARHGAP22,PICALM |
4.793e-02 | -3.04 | skin-back-malignant_melanoma | COSMIC cancer mutations | skin-back-malignant_melanoma | 280 | 3 | 16828 | 49 |
GNAQ,PTPRJ,ADAM28 |
4.795e-02 | -3.04 | microvillus organization | biological process | GO:0032528 | 19 | 1 | 18204 | 47 |
MAP4K4 |
4.795e-02 | -3.04 | positive regulation of macrophage chemotaxis | biological process | GO:0010759 | 19 | 1 | 18204 | 47 |
PTPRJ |
4.795e-02 | -3.04 | regulation of skeletal muscle cell differentiation | biological process | GO:2001014 | 19 | 1 | 18204 | 47 |
MEF2C |
4.795e-02 | -3.04 | vascular associated smooth muscle cell differentiation | biological process | GO:0035886 | 19 | 1 | 18204 | 47 |
QKI |
4.795e-02 | -3.04 | positive regulation of Ras protein signal transduction | biological process | GO:0046579 | 19 | 1 | 18204 | 47 |
PICALM |
4.795e-02 | -3.04 | mitochondrion distribution | biological process | GO:0048311 | 19 | 1 | 18204 | 47 |
MEF2A |
4.795e-02 | -3.04 | post-anal tail morphogenesis | biological process | GO:0036342 | 19 | 1 | 18204 | 47 |
CHST11 |
4.795e-02 | -3.04 | detection of temperature stimulus involved in sensory perception of pain | biological process | GO:0050965 | 19 | 1 | 18204 | 47 |
DISC1 |
4.795e-02 | -3.04 | chondroitin sulfate biosynthetic process | biological process | GO:0030206 | 19 | 1 | 18204 | 47 |
CHST11 |
4.795e-02 | -3.04 | GABAergic neuron differentiation | biological process | GO:0097154 | 19 | 1 | 18204 | 47 |
ZSWIM6 |
4.809e-02 | -3.03 | N-glycan biosynthesis, complex type | KEGG pathways | hsa_M00075 | 16 | 1 | 7161 | 22 |
ST6GAL1 |
4.809e-02 | -3.03 | N-glycan biosynthesis, complex type | KEGG pathways | M00075 | 16 | 1 | 7161 | 22 |
ST6GAL1 |
4.814e-02 | -3.03 | protein dephosphorylation | biological process | GO:0006470 | 136 | 2 | 18204 | 47 |
PTPRJ,SSH2 |
4.839e-02 | -3.03 | thymus-thymoma | COSMIC cancer mutations | thymus-thymoma | 17 | 1 | 16828 | 49 |
GNAQ |
4.839e-02 | -3.03 | central_nervous_system-optic_nerve-glioma-astrocytoma_Grade_I | COSMIC cancer mutations | central_nervous_system-optic_nerve-glioma-astrocytoma_Grade_I | 17 | 1 | 16828 | 49 |
QKI |
4.839e-02 | -3.03 | thymoma | COSMIC cancer mutations | thymoma | 17 | 1 | 16828 | 49 |
GNAQ |
4.839e-02 | -3.03 | optic_nerve | COSMIC cancer mutations | optic_nerve | 17 | 1 | 16828 | 49 |
QKI |
4.842e-02 | -3.03 | TOX4 (TOX high mobility group box family member 4) | protein interactions | 9878 | 137 | 2 | 19454 | 50 |
EPB41L2,ARHGAP26 |
4.844e-02 | -3.03 | ADAM_CR | pfam domains | PF08516 | 18 | 1 | 17795 | 49 |
ADAM28 |
4.845e-02 | -3.03 | asymmetric synapse | cellular component | GO:0032279 | 333 | 3 | 19108 | 47 |
SYNDIG1,SLC8A1,DISC1 |
4.861e-02 | -3.02 | intracellularly gated calcium channel activity | molecular function | GO:0015278 | 18 | 1 | 18094 | 50 |
ITPR2 |
4.861e-02 | -3.02 | lipoprotein particle receptor activity | molecular function | GO:0030228 | 18 | 1 | 18094 | 50 |
SORL1 |
4.877e-02 | -3.02 | cell recognition | biological process | GO:0008037 | 137 | 2 | 18204 | 47 |
DSCAM,DOCK8 |
4.902e-02 | -3.02 | lung-carcinoma-undifferentiated_carcinoma | COSMIC cancer mutations | lung-carcinoma-undifferentiated_carcinoma | 1408 | 8 | 16828 | 49 |
MAML3,PICALM,GNAQ,ARHGAP26,MEF2A,MEF2C,MAML2,TCF12 |
4.906e-02 | -3.01 | Integration of energy metabolism | REACTOME pathways | R-HSA-163685 | 111 | 2 | 10285 | 33 |
ITPR2,GNAQ |
4.941e-02 | -3.01 | sodium ion transmembrane transport | biological process | GO:0035725 | 138 | 2 | 18204 | 47 |
SLC9A9,SLC8A1 |
4.941e-02 | -3.01 | negative regulation of nervous system development | biological process | GO:0051961 | 138 | 2 | 18204 | 47 |
SORL1,DIP2B |
4.941e-02 | -3.01 | regulation of protein localization to cell periphery | biological process | GO:1904375 | 138 | 2 | 18204 | 47 |
EPB41L2,PICALM |
4.947e-02 | -3.01 | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | biological process | GO:0090092 | 320 | 3 | 18204 | 47 |
LDLRAD4,SORL1,CHST11 |
4.962e-02 | -3.00 | thalamus | COSMIC cancer mutations | thalamus | 284 | 3 | 16828 | 49 |
QKI,ZFHX3,GNAQ |
4.968e-02 | -3.00 | DUSP22 (dual specificity phosphatase 22) | protein interactions | 56940 | 139 | 2 | 19454 | 50 |
GNAQ,QKI |
4.968e-02 | -3.00 | MAGI1 (membrane associated guanylate kinase, WW and PDZ domain containing 1) | protein interactions | 9223 | 139 | 2 | 19454 | 50 |
FCHSD2,LDLRAD4 |
4.968e-02 | -3.00 | NEFM (neurofilament medium chain) | protein interactions | 4741 | 139 | 2 | 19454 | 50 |
DISC1,DSCAM |
4.977e-02 | -3.00 | ITGB1 (integrin subunit beta 1) | protein interactions | 3688 | 322 | 3 | 19454 | 50 |
MAP4K4,PICALM,MEF2A |
4.985e-02 | -3.00 | wound healing | biological process | GO:0042060 | 321 | 3 | 18204 | 47 |
PTPRJ,ARHGAP24,GNAQ |
4.993e-02 | -3.00 | response to organic substance | biological process | GO:0010033 | 2498 | 11 | 18204 | 47 |
HDAC9,PTPRJ,TCF12,ZBTB20,SLC8A1,GNAQ,DOCK8,MEF2C,ST6GAL1,KCNQ3,ITPR2 |